<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html
PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
"DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head>
    <link rel="stylesheet" type="text/css" href="css/style-vis.css"/>
    <script type="text/javascript" src="js/head.js"></script>
    <title> View prodigy relations</title>
</head>

<body>
    <!-- Start BRAT (always static) -->
    <script type="text/javascript">
        var bratLocation = 'brat-v1.3_Crunchy_Frog';
        head.js(
        // External libraries
        bratLocation + '/client/lib/jquery.min.js',
        bratLocation + '/client/lib/jquery.svg.min.js',
        bratLocation + '/client/lib/jquery.svgdom.min.js',
        // brat helper modules
        bratLocation + '/client/src/configuration.js',
        bratLocation + '/client/src/util.js',
        bratLocation + '/client/src/annotation_log.js',
        bratLocation + '/client/lib/webfont.js',
        // brat modules
        bratLocation + '/client/src/dispatcher.js',
        bratLocation + '/client/src/url_monitor.js',
        bratLocation + '/client/src/visualizer.js'
        );
        var webFontURLs = [
            bratLocation + '/static/fonts/Astloch-Bold.ttf',
            bratLocation + '/static/fonts/PT_Sans-Caption-Web-Regular.ttf',
            bratLocation + '/static/fonts/Liberation_Sans-Regular.ttf'
        ];
    
    </script>

<div id="embedding-0" style="margin:50px"><p> Sentence#: 0
Task hash: 875108610</p></div><div id="embedding-1" style="margin:50px"><p> Sentence#: 1
Task hash: -1249531855</p></div><div id="embedding-2" style="margin:50px"><p> Sentence#: 2
Task hash: 1710761595</p></div><div id="embedding-3" style="margin:50px"><p> Sentence#: 3
Task hash: -1775396403</p></div><div id="embedding-4" style="margin:50px"><p> Sentence#: 4
Task hash: 921206871</p></div><div id="embedding-5" style="margin:50px"><p> Sentence#: 5
Task hash: 1544577110</p></div><div id="embedding-6" style="margin:50px"><p> Sentence#: 6
Task hash: 1562933335</p></div><div id="embedding-7" style="margin:50px"><p> Sentence#: 7
Task hash: 1630826211</p></div><div id="embedding-8" style="margin:50px"><p> Sentence#: 8
Task hash: 2093916708</p></div><div id="embedding-9" style="margin:50px"><p> Sentence#: 9
Task hash: 477272400</p></div><div id="embedding-10" style="margin:50px"><p> Sentence#: 10
Task hash: -2019189183</p></div><div id="embedding-11" style="margin:50px"><p> Sentence#: 11
Task hash: -922250077</p></div><div id="embedding-12" style="margin:50px"><p> Sentence#: 12
Task hash: -1854943769</p></div><div id="embedding-13" style="margin:50px"><p> Sentence#: 13
Task hash: -1315610824</p></div><div id="embedding-14" style="margin:50px"><p> Sentence#: 14
Task hash: 745685300</p></div><div id="embedding-15" style="margin:50px"><p> Sentence#: 15
Task hash: 362412290</p></div><div id="embedding-16" style="margin:50px"><p> Sentence#: 16
Task hash: -417646178</p></div><div id="embedding-17" style="margin:50px"><p> Sentence#: 17
Task hash: -1000068282</p></div><div id="embedding-18" style="margin:50px"><p> Sentence#: 18
Task hash: -158253243</p></div><div id="embedding-19" style="margin:50px"><p> Sentence#: 19
Task hash: 475770857</p></div><div id="embedding-20" style="margin:50px"><p> Sentence#: 20
Task hash: -1972181870</p></div><div id="embedding-21" style="margin:50px"><p> Sentence#: 21
Task hash: -328820906</p></div><div id="embedding-22" style="margin:50px"><p> Sentence#: 22
Task hash: 1442960431</p></div><div id="embedding-23" style="margin:50px"><p> Sentence#: 23
Task hash: 1891005801</p></div><div id="embedding-24" style="margin:50px"><p> Sentence#: 24
Task hash: 84937664</p></div><div id="embedding-25" style="margin:50px"><p> Sentence#: 25
Task hash: -1274670321</p></div><div id="embedding-26" style="margin:50px"><p> Sentence#: 26
Task hash: -291233172</p></div><div id="embedding-27" style="margin:50px"><p> Sentence#: 27
Task hash: 1160689348</p></div><div id="embedding-28" style="margin:50px"><p> Sentence#: 28
Task hash: 1017556017</p></div><div id="embedding-29" style="margin:50px"><p> Sentence#: 29
Task hash: 401670452</p></div><div id="embedding-30" style="margin:50px"><p> Sentence#: 30
Task hash: 1653023969</p></div><div id="embedding-31" style="margin:50px"><p> Sentence#: 31
Task hash: -1920258623</p></div><div id="embedding-32" style="margin:50px"><p> Sentence#: 32
Task hash: -872473329</p></div><div id="embedding-33" style="margin:50px"><p> Sentence#: 33
Task hash: 707299597</p></div><div id="embedding-34" style="margin:50px"><p> Sentence#: 34
Task hash: -960290416</p></div><div id="embedding-35" style="margin:50px"><p> Sentence#: 35
Task hash: 2010990087</p></div><div id="embedding-36" style="margin:50px"><p> Sentence#: 36
Task hash: 1483268172</p></div><div id="embedding-37" style="margin:50px"><p> Sentence#: 37
Task hash: 22627245</p></div><div id="embedding-38" style="margin:50px"><p> Sentence#: 38
Task hash: 1849628417</p></div><div id="embedding-39" style="margin:50px"><p> Sentence#: 39
Task hash: -424252256</p></div><div id="embedding-40" style="margin:50px"><p> Sentence#: 40
Task hash: -1108901211</p></div><div id="embedding-41" style="margin:50px"><p> Sentence#: 41
Task hash: -1676326288</p></div><div id="embedding-42" style="margin:50px"><p> Sentence#: 42
Task hash: -989092402</p></div><div id="embedding-43" style="margin:50px"><p> Sentence#: 43
Task hash: -870167172</p></div><div id="embedding-44" style="margin:50px"><p> Sentence#: 44
Task hash: -1433688334</p></div><div id="embedding-45" style="margin:50px"><p> Sentence#: 45
Task hash: -210254152</p></div><div id="embedding-46" style="margin:50px"><p> Sentence#: 46
Task hash: 1896218377</p></div><div id="embedding-47" style="margin:50px"><p> Sentence#: 47
Task hash: -407713719</p></div><div id="embedding-48" style="margin:50px"><p> Sentence#: 48
Task hash: -1580766628</p></div><div id="embedding-49" style="margin:50px"><p> Sentence#: 49
Task hash: -1460484501</p></div><div id="embedding-50" style="margin:50px"><p> Sentence#: 50
Task hash: -372638354</p></div><div id="embedding-51" style="margin:50px"><p> Sentence#: 51
Task hash: -1454145563</p></div><div id="embedding-52" style="margin:50px"><p> Sentence#: 52
Task hash: -1151212635</p></div><div id="embedding-53" style="margin:50px"><p> Sentence#: 53
Task hash: -815667604</p></div><div id="embedding-54" style="margin:50px"><p> Sentence#: 54
Task hash: -875301262</p></div><div id="embedding-55" style="margin:50px"><p> Sentence#: 55
Task hash: 1094602730</p></div><div id="embedding-56" style="margin:50px"><p> Sentence#: 56
Task hash: -709376857</p></div><div id="embedding-57" style="margin:50px"><p> Sentence#: 57
Task hash: -2078252266</p></div><div id="embedding-58" style="margin:50px"><p> Sentence#: 58
Task hash: 1582770674</p></div><div id="embedding-59" style="margin:50px"><p> Sentence#: 59
Task hash: -1828348157</p></div><div id="embedding-60" style="margin:50px"><p> Sentence#: 60
Task hash: 1694664349</p></div><div id="embedding-61" style="margin:50px"><p> Sentence#: 61
Task hash: 1673290092</p></div><div id="embedding-62" style="margin:50px"><p> Sentence#: 62
Task hash: 1974863376</p></div><div id="embedding-63" style="margin:50px"><p> Sentence#: 63
Task hash: -1855531319</p></div><div id="embedding-64" style="margin:50px"><p> Sentence#: 64
Task hash: 1358115302</p></div><div id="embedding-65" style="margin:50px"><p> Sentence#: 65
Task hash: 792607250</p></div><div id="embedding-66" style="margin:50px"><p> Sentence#: 66
Task hash: 956657858</p></div><div id="embedding-67" style="margin:50px"><p> Sentence#: 67
Task hash: 764726020</p></div><div id="embedding-68" style="margin:50px"><p> Sentence#: 68
Task hash: 1008139182</p></div><div id="embedding-69" style="margin:50px"><p> Sentence#: 69
Task hash: -1773597027</p></div><div id="embedding-70" style="margin:50px"><p> Sentence#: 70
Task hash: -1312588409</p></div><div id="embedding-71" style="margin:50px"><p> Sentence#: 71
Task hash: 1165569139</p></div><div id="embedding-72" style="margin:50px"><p> Sentence#: 72
Task hash: -899249551</p></div><div id="embedding-73" style="margin:50px"><p> Sentence#: 73
Task hash: -1549004975</p></div><div id="embedding-74" style="margin:50px"><p> Sentence#: 74
Task hash: 805060370</p></div><div id="embedding-75" style="margin:50px"><p> Sentence#: 75
Task hash: 754349275</p></div><div id="embedding-76" style="margin:50px"><p> Sentence#: 76
Task hash: 371985144</p></div><div id="embedding-77" style="margin:50px"><p> Sentence#: 77
Task hash: -1732578404</p></div><div id="embedding-78" style="margin:50px"><p> Sentence#: 78
Task hash: -201559941</p></div><div id="embedding-79" style="margin:50px"><p> Sentence#: 79
Task hash: -594984825</p></div><div id="embedding-80" style="margin:50px"><p> Sentence#: 80
Task hash: -530774915</p></div><div id="embedding-81" style="margin:50px"><p> Sentence#: 81
Task hash: 756648256</p></div><div id="embedding-82" style="margin:50px"><p> Sentence#: 82
Task hash: 330596725</p></div><div id="embedding-83" style="margin:50px"><p> Sentence#: 83
Task hash: 1645605031</p></div><div id="embedding-84" style="margin:50px"><p> Sentence#: 84
Task hash: -2093919270</p></div><div id="embedding-85" style="margin:50px"><p> Sentence#: 85
Task hash: 86975279</p></div><div id="embedding-86" style="margin:50px"><p> Sentence#: 86
Task hash: -797969862</p></div><div id="embedding-87" style="margin:50px"><p> Sentence#: 87
Task hash: 146083387</p></div><div id="embedding-88" style="margin:50px"><p> Sentence#: 88
Task hash: 128655692</p></div><div id="embedding-89" style="margin:50px"><p> Sentence#: 89
Task hash: -413877881</p></div><div id="embedding-90" style="margin:50px"><p> Sentence#: 90
Task hash: -533382579</p></div><div id="embedding-91" style="margin:50px"><p> Sentence#: 91
Task hash: 2069563819</p></div><div id="embedding-92" style="margin:50px"><p> Sentence#: 92
Task hash: -622628709</p></div><div id="embedding-93" style="margin:50px"><p> Sentence#: 93
Task hash: 1029093301</p></div><div id="embedding-94" style="margin:50px"><p> Sentence#: 94
Task hash: 2078487146</p></div><div id="embedding-95" style="margin:50px"><p> Sentence#: 95
Task hash: -363191018</p></div><div id="embedding-96" style="margin:50px"><p> Sentence#: 96
Task hash: -386639493</p></div><div id="embedding-97" style="margin:50px"><p> Sentence#: 97
Task hash: -958271679</p></div><div id="embedding-98" style="margin:50px"><p> Sentence#: 98
Task hash: -626332749</p></div><div id="embedding-99" style="margin:50px"><p> Sentence#: 99
Task hash: 1218158612</p></div><div id="embedding-100" style="margin:50px"><p> Sentence#: 100
Task hash: 1279972568</p></div><div id="embedding-101" style="margin:50px"><p> Sentence#: 101
Task hash: -2121162512</p></div><div id="embedding-102" style="margin:50px"><p> Sentence#: 102
Task hash: 1241619253</p></div><div id="embedding-103" style="margin:50px"><p> Sentence#: 103
Task hash: 403283694</p></div><div id="embedding-104" style="margin:50px"><p> Sentence#: 104
Task hash: -1969160514</p></div><div id="embedding-105" style="margin:50px"><p> Sentence#: 105
Task hash: 1431268004</p></div><div id="embedding-106" style="margin:50px"><p> Sentence#: 106
Task hash: -1165088217</p></div><div id="embedding-107" style="margin:50px"><p> Sentence#: 107
Task hash: -830096518</p></div><div id="embedding-108" style="margin:50px"><p> Sentence#: 108
Task hash: 1278815656</p></div><div id="embedding-109" style="margin:50px"><p> Sentence#: 109
Task hash: -372677439</p></div><div id="embedding-110" style="margin:50px"><p> Sentence#: 110
Task hash: 1111212377</p></div><div id="embedding-111" style="margin:50px"><p> Sentence#: 111
Task hash: 2095038520</p></div><div id="embedding-112" style="margin:50px"><p> Sentence#: 112
Task hash: -629948100</p></div><div id="embedding-113" style="margin:50px"><p> Sentence#: 113
Task hash: -231190981</p></div><div id="embedding-114" style="margin:50px"><p> Sentence#: 114
Task hash: 1688228893</p></div><div id="embedding-115" style="margin:50px"><p> Sentence#: 115
Task hash: 1388158032</p></div><div id="embedding-116" style="margin:50px"><p> Sentence#: 116
Task hash: 60156623</p></div><div id="embedding-117" style="margin:50px"><p> Sentence#: 117
Task hash: -1409985280</p></div><div id="embedding-118" style="margin:50px"><p> Sentence#: 118
Task hash: 48463883</p></div><div id="embedding-119" style="margin:50px"><p> Sentence#: 119
Task hash: -1979100779</p></div><div id="embedding-120" style="margin:50px"><p> Sentence#: 120
Task hash: 1882666511</p></div><div id="embedding-121" style="margin:50px"><p> Sentence#: 121
Task hash: -511184619</p></div><div id="embedding-122" style="margin:50px"><p> Sentence#: 122
Task hash: -110738037</p></div><div id="embedding-123" style="margin:50px"><p> Sentence#: 123
Task hash: 269927898</p></div><div id="embedding-124" style="margin:50px"><p> Sentence#: 124
Task hash: -931176394</p></div><div id="embedding-125" style="margin:50px"><p> Sentence#: 125
Task hash: 815676520</p></div><div id="embedding-126" style="margin:50px"><p> Sentence#: 126
Task hash: -1671497917</p></div><div id="embedding-127" style="margin:50px"><p> Sentence#: 127
Task hash: -631406289</p></div><div id="embedding-128" style="margin:50px"><p> Sentence#: 128
Task hash: 2006726678</p></div><div id="embedding-129" style="margin:50px"><p> Sentence#: 129
Task hash: 1459596118</p></div><div id="embedding-130" style="margin:50px"><p> Sentence#: 130
Task hash: -1743274573</p></div><div id="embedding-131" style="margin:50px"><p> Sentence#: 131
Task hash: -1564611367</p></div><div id="embedding-132" style="margin:50px"><p> Sentence#: 132
Task hash: -771340763</p></div><div id="embedding-133" style="margin:50px"><p> Sentence#: 133
Task hash: -1041285719</p></div><div id="embedding-134" style="margin:50px"><p> Sentence#: 134
Task hash: -1773020756</p></div><div id="embedding-135" style="margin:50px"><p> Sentence#: 135
Task hash: -1431037088</p></div><div id="embedding-136" style="margin:50px"><p> Sentence#: 136
Task hash: 1749416341</p></div><div id="embedding-137" style="margin:50px"><p> Sentence#: 137
Task hash: -1052603924</p></div><div id="embedding-138" style="margin:50px"><p> Sentence#: 138
Task hash: -1063329600</p></div><div id="embedding-139" style="margin:50px"><p> Sentence#: 139
Task hash: 1351364331</p></div><div id="embedding-140" style="margin:50px"><p> Sentence#: 140
Task hash: 1411926840</p></div><div id="embedding-141" style="margin:50px"><p> Sentence#: 141
Task hash: -211291902</p></div><div id="embedding-142" style="margin:50px"><p> Sentence#: 142
Task hash: 877906997</p></div><div id="embedding-143" style="margin:50px"><p> Sentence#: 143
Task hash: -1390879088</p></div><div id="embedding-144" style="margin:50px"><p> Sentence#: 144
Task hash: 1697782161</p></div><div id="embedding-145" style="margin:50px"><p> Sentence#: 145
Task hash: -1891974032</p></div><div id="embedding-146" style="margin:50px"><p> Sentence#: 146
Task hash: 1688984999</p></div><div id="embedding-147" style="margin:50px"><p> Sentence#: 147
Task hash: -1456960278</p></div><div id="embedding-148" style="margin:50px"><p> Sentence#: 148
Task hash: 696641925</p></div><div id="embedding-149" style="margin:50px"><p> Sentence#: 149
Task hash: 99552921</p></div><div id="embedding-150" style="margin:50px"><p> Sentence#: 150
Task hash: -859451933</p></div><div id="embedding-151" style="margin:50px"><p> Sentence#: 151
Task hash: 333166949</p></div><div id="embedding-152" style="margin:50px"><p> Sentence#: 152
Task hash: 858462945</p></div><div id="embedding-153" style="margin:50px"><p> Sentence#: 153
Task hash: 747496004</p></div><div id="embedding-154" style="margin:50px"><p> Sentence#: 154
Task hash: 468140328</p></div><div id="embedding-155" style="margin:50px"><p> Sentence#: 155
Task hash: 1923607134</p></div><div id="embedding-156" style="margin:50px"><p> Sentence#: 156
Task hash: 2111014863</p></div><div id="embedding-157" style="margin:50px"><p> Sentence#: 157
Task hash: -878785733</p></div><div id="embedding-158" style="margin:50px"><p> Sentence#: 158
Task hash: 942888036</p></div><div id="embedding-159" style="margin:50px"><p> Sentence#: 159
Task hash: 1089036280</p></div><div id="embedding-160" style="margin:50px"><p> Sentence#: 160
Task hash: -756879509</p></div><div id="embedding-161" style="margin:50px"><p> Sentence#: 161
Task hash: -1285523797</p></div><div id="embedding-162" style="margin:50px"><p> Sentence#: 162
Task hash: -1798506006</p></div><div id="embedding-163" style="margin:50px"><p> Sentence#: 163
Task hash: 2084748208</p></div><div id="embedding-164" style="margin:50px"><p> Sentence#: 164
Task hash: -1140351683</p></div><div id="embedding-165" style="margin:50px"><p> Sentence#: 165
Task hash: -1319955548</p></div><div id="embedding-166" style="margin:50px"><p> Sentence#: 166
Task hash: -1004845054</p></div><div id="embedding-167" style="margin:50px"><p> Sentence#: 167
Task hash: -1296199049</p></div><div id="embedding-168" style="margin:50px"><p> Sentence#: 168
Task hash: 1689569907</p></div><div id="embedding-169" style="margin:50px"><p> Sentence#: 169
Task hash: 791183034</p></div><div id="embedding-170" style="margin:50px"><p> Sentence#: 170
Task hash: 1172388055</p></div><div id="embedding-171" style="margin:50px"><p> Sentence#: 171
Task hash: 1342873098</p></div><div id="embedding-172" style="margin:50px"><p> Sentence#: 172
Task hash: 1551884966</p></div><div id="embedding-173" style="margin:50px"><p> Sentence#: 173
Task hash: 1365662467</p></div><div id="embedding-174" style="margin:50px"><p> Sentence#: 174
Task hash: 270520352</p></div><div id="embedding-175" style="margin:50px"><p> Sentence#: 175
Task hash: -565094318</p></div><div id="embedding-176" style="margin:50px"><p> Sentence#: 176
Task hash: -462716852</p></div><div id="embedding-177" style="margin:50px"><p> Sentence#: 177
Task hash: -1611176274</p></div><div id="embedding-178" style="margin:50px"><p> Sentence#: 178
Task hash: -1719606347</p></div><div id="embedding-179" style="margin:50px"><p> Sentence#: 179
Task hash: 1049240191</p></div><div id="embedding-180" style="margin:50px"><p> Sentence#: 180
Task hash: -376584899</p></div><div id="embedding-181" style="margin:50px"><p> Sentence#: 181
Task hash: -1935294516</p></div><div id="embedding-182" style="margin:50px"><p> Sentence#: 182
Task hash: -519900489</p></div><div id="embedding-183" style="margin:50px"><p> Sentence#: 183
Task hash: 266686388</p></div><div id="embedding-184" style="margin:50px"><p> Sentence#: 184
Task hash: 981302944</p></div><div id="embedding-185" style="margin:50px"><p> Sentence#: 185
Task hash: -1566550768</p></div><div id="embedding-186" style="margin:50px"><p> Sentence#: 186
Task hash: 658997640</p></div><div id="embedding-187" style="margin:50px"><p> Sentence#: 187
Task hash: -434081901</p></div><div id="embedding-188" style="margin:50px"><p> Sentence#: 188
Task hash: -1473545919</p></div><div id="embedding-189" style="margin:50px"><p> Sentence#: 189
Task hash: 1238174683</p></div><div id="embedding-190" style="margin:50px"><p> Sentence#: 190
Task hash: -536372505</p></div><div id="embedding-191" style="margin:50px"><p> Sentence#: 191
Task hash: 583082025</p></div><div id="embedding-192" style="margin:50px"><p> Sentence#: 192
Task hash: 1351670487</p></div><div id="embedding-193" style="margin:50px"><p> Sentence#: 193
Task hash: -454026368</p></div><div id="embedding-194" style="margin:50px"><p> Sentence#: 194
Task hash: 450670857</p></div><div id="embedding-195" style="margin:50px"><p> Sentence#: 195
Task hash: -1088606884</p></div><div id="embedding-196" style="margin:50px"><p> Sentence#: 196
Task hash: 1465127426</p></div><div id="embedding-197" style="margin:50px"><p> Sentence#: 197
Task hash: -1280828869</p></div><div id="embedding-198" style="margin:50px"><p> Sentence#: 198
Task hash: 1249080264</p></div><div id="embedding-199" style="margin:50px"><p> Sentence#: 199
Task hash: 1464555716</p></div><div id="embedding-200" style="margin:50px"><p> Sentence#: 200
Task hash: 476502479</p></div><div id="embedding-201" style="margin:50px"><p> Sentence#: 201
Task hash: -1214740711</p></div><div id="embedding-202" style="margin:50px"><p> Sentence#: 202
Task hash: -908170865</p></div><div id="embedding-203" style="margin:50px"><p> Sentence#: 203
Task hash: 1734037697</p></div><div id="embedding-204" style="margin:50px"><p> Sentence#: 204
Task hash: 630363304</p></div><div id="embedding-205" style="margin:50px"><p> Sentence#: 205
Task hash: -1438425254</p></div><div id="embedding-206" style="margin:50px"><p> Sentence#: 206
Task hash: -1392746621</p></div><div id="embedding-207" style="margin:50px"><p> Sentence#: 207
Task hash: -631707436</p></div><div id="embedding-208" style="margin:50px"><p> Sentence#: 208
Task hash: 1926764692</p></div><div id="embedding-209" style="margin:50px"><p> Sentence#: 209
Task hash: 632316034</p></div><div id="embedding-210" style="margin:50px"><p> Sentence#: 210
Task hash: 1369968958</p></div><div id="embedding-211" style="margin:50px"><p> Sentence#: 211
Task hash: 1678414261</p></div><div id="embedding-212" style="margin:50px"><p> Sentence#: 212
Task hash: 540764094</p></div><div id="embedding-213" style="margin:50px"><p> Sentence#: 213
Task hash: -368617456</p></div><div id="embedding-214" style="margin:50px"><p> Sentence#: 214
Task hash: 87435754</p></div><div id="embedding-215" style="margin:50px"><p> Sentence#: 215
Task hash: 1417507391</p></div><div id="embedding-216" style="margin:50px"><p> Sentence#: 216
Task hash: 872395199</p></div><div id="embedding-217" style="margin:50px"><p> Sentence#: 217
Task hash: 146323497</p></div><div id="embedding-218" style="margin:50px"><p> Sentence#: 218
Task hash: 1694063125</p></div><div id="embedding-219" style="margin:50px"><p> Sentence#: 219
Task hash: -429167137</p></div><div id="embedding-220" style="margin:50px"><p> Sentence#: 220
Task hash: -29216093</p></div><div id="embedding-221" style="margin:50px"><p> Sentence#: 221
Task hash: -1157299160</p></div><div id="embedding-222" style="margin:50px"><p> Sentence#: 222
Task hash: -635964580</p></div><div id="embedding-223" style="margin:50px"><p> Sentence#: 223
Task hash: 809951628</p></div><div id="embedding-224" style="margin:50px"><p> Sentence#: 224
Task hash: -718797990</p></div><div id="embedding-225" style="margin:50px"><p> Sentence#: 225
Task hash: 843506110</p></div><div id="embedding-226" style="margin:50px"><p> Sentence#: 226
Task hash: -1314342359</p></div><div id="embedding-227" style="margin:50px"><p> Sentence#: 227
Task hash: 1272484622</p></div><div id="embedding-228" style="margin:50px"><p> Sentence#: 228
Task hash: -1372900752</p></div><div id="embedding-229" style="margin:50px"><p> Sentence#: 229
Task hash: -1641784382</p></div><div id="embedding-230" style="margin:50px"><p> Sentence#: 230
Task hash: -1027359998</p></div><div id="embedding-231" style="margin:50px"><p> Sentence#: 231
Task hash: -868230083</p></div><div id="embedding-232" style="margin:50px"><p> Sentence#: 232
Task hash: -8617914</p></div><div id="embedding-233" style="margin:50px"><p> Sentence#: 233
Task hash: 1848455164</p></div><div id="embedding-234" style="margin:50px"><p> Sentence#: 234
Task hash: -2016488946</p></div><div id="embedding-235" style="margin:50px"><p> Sentence#: 235
Task hash: -2000721164</p></div><div id="embedding-236" style="margin:50px"><p> Sentence#: 236
Task hash: -70203081</p></div><div id="embedding-237" style="margin:50px"><p> Sentence#: 237
Task hash: 1173636022</p></div><div id="embedding-238" style="margin:50px"><p> Sentence#: 238
Task hash: -10822605</p></div><div id="embedding-239" style="margin:50px"><p> Sentence#: 239
Task hash: -2063259418</p></div><div id="embedding-240" style="margin:50px"><p> Sentence#: 240
Task hash: -1727751599</p></div><div id="embedding-241" style="margin:50px"><p> Sentence#: 241
Task hash: 743107149</p></div><div id="embedding-242" style="margin:50px"><p> Sentence#: 242
Task hash: 236164000</p></div><div id="embedding-243" style="margin:50px"><p> Sentence#: 243
Task hash: 472932479</p></div><div id="embedding-244" style="margin:50px"><p> Sentence#: 244
Task hash: 581392172</p></div><div id="embedding-245" style="margin:50px"><p> Sentence#: 245
Task hash: 469657728</p></div><div id="embedding-246" style="margin:50px"><p> Sentence#: 246
Task hash: 932029833</p></div><div id="embedding-247" style="margin:50px"><p> Sentence#: 247
Task hash: -2016759811</p></div><div id="embedding-248" style="margin:50px"><p> Sentence#: 248
Task hash: -1762468490</p></div><div id="embedding-249" style="margin:50px"><p> Sentence#: 249
Task hash: 1769455336</p></div><div id="embedding-250" style="margin:50px"><p> Sentence#: 250
Task hash: -1194673641</p></div><div id="embedding-251" style="margin:50px"><p> Sentence#: 251
Task hash: 459010629</p></div><div id="embedding-252" style="margin:50px"><p> Sentence#: 252
Task hash: 1352909166</p></div><div id="embedding-253" style="margin:50px"><p> Sentence#: 253
Task hash: 328234758</p></div><div id="embedding-254" style="margin:50px"><p> Sentence#: 254
Task hash: 1134417834</p></div><div id="embedding-255" style="margin:50px"><p> Sentence#: 255
Task hash: 1698660451</p></div><div id="embedding-256" style="margin:50px"><p> Sentence#: 256
Task hash: -1585965247</p></div><div id="embedding-257" style="margin:50px"><p> Sentence#: 257
Task hash: 1638191980</p></div><div id="embedding-258" style="margin:50px"><p> Sentence#: 258
Task hash: 953769616</p></div><div id="embedding-259" style="margin:50px"><p> Sentence#: 259
Task hash: -1114950465</p></div><div id="embedding-260" style="margin:50px"><p> Sentence#: 260
Task hash: 1090639347</p></div><div id="embedding-261" style="margin:50px"><p> Sentence#: 261
Task hash: -1327774736</p></div><div id="embedding-262" style="margin:50px"><p> Sentence#: 262
Task hash: -1575309225</p></div><div id="embedding-263" style="margin:50px"><p> Sentence#: 263
Task hash: 1932381955</p></div><div id="embedding-264" style="margin:50px"><p> Sentence#: 264
Task hash: -1851211655</p></div><div id="embedding-265" style="margin:50px"><p> Sentence#: 265
Task hash: -1135338576</p></div><div id="embedding-266" style="margin:50px"><p> Sentence#: 266
Task hash: -1891824013</p></div><div id="embedding-267" style="margin:50px"><p> Sentence#: 267
Task hash: -1049340612</p></div><div id="embedding-268" style="margin:50px"><p> Sentence#: 268
Task hash: -273127398</p></div><div id="embedding-269" style="margin:50px"><p> Sentence#: 269
Task hash: -2036690160</p></div><div id="embedding-270" style="margin:50px"><p> Sentence#: 270
Task hash: 1951922773</p></div><div id="embedding-271" style="margin:50px"><p> Sentence#: 271
Task hash: -1076991341</p></div><div id="embedding-272" style="margin:50px"><p> Sentence#: 272
Task hash: -2128210397</p></div><div id="embedding-273" style="margin:50px"><p> Sentence#: 273
Task hash: 1884600963</p></div><div id="embedding-274" style="margin:50px"><p> Sentence#: 274
Task hash: 320091629</p></div><div id="embedding-275" style="margin:50px"><p> Sentence#: 275
Task hash: 237838474</p></div><div id="embedding-276" style="margin:50px"><p> Sentence#: 276
Task hash: -1652432319</p></div><div id="embedding-277" style="margin:50px"><p> Sentence#: 277
Task hash: -2043054095</p></div><div id="embedding-278" style="margin:50px"><p> Sentence#: 278
Task hash: -1912565169</p></div><div id="embedding-279" style="margin:50px"><p> Sentence#: 279
Task hash: 754102284</p></div><div id="embedding-280" style="margin:50px"><p> Sentence#: 280
Task hash: -260615363</p></div><div id="embedding-281" style="margin:50px"><p> Sentence#: 281
Task hash: -1194444267</p></div><div id="embedding-282" style="margin:50px"><p> Sentence#: 282
Task hash: -1673348732</p></div><div id="embedding-283" style="margin:50px"><p> Sentence#: 283
Task hash: 556275648</p></div><div id="embedding-284" style="margin:50px"><p> Sentence#: 284
Task hash: -1591359994</p></div><div id="embedding-285" style="margin:50px"><p> Sentence#: 285
Task hash: -1131402035</p></div><div id="embedding-286" style="margin:50px"><p> Sentence#: 286
Task hash: -1958691442</p></div><div id="embedding-287" style="margin:50px"><p> Sentence#: 287
Task hash: 437728721</p></div><div id="embedding-288" style="margin:50px"><p> Sentence#: 288
Task hash: -456338981</p></div><div id="embedding-289" style="margin:50px"><p> Sentence#: 289
Task hash: -511554778</p></div><div id="embedding-290" style="margin:50px"><p> Sentence#: 290
Task hash: -1558573909</p></div><div id="embedding-291" style="margin:50px"><p> Sentence#: 291
Task hash: 1830060726</p></div><div id="embedding-292" style="margin:50px"><p> Sentence#: 292
Task hash: -523988100</p></div><div id="embedding-293" style="margin:50px"><p> Sentence#: 293
Task hash: -742827328</p></div><div id="embedding-294" style="margin:50px"><p> Sentence#: 294
Task hash: 1105628523</p></div><div id="embedding-295" style="margin:50px"><p> Sentence#: 295
Task hash: 1935093812</p></div><div id="embedding-296" style="margin:50px"><p> Sentence#: 296
Task hash: 633015834</p></div><div id="embedding-297" style="margin:50px"><p> Sentence#: 297
Task hash: -1224448960</p></div><div id="embedding-298" style="margin:50px"><p> Sentence#: 298
Task hash: -2044799751</p></div><div id="embedding-299" style="margin:50px"><p> Sentence#: 299
Task hash: -486101049</p></div><div id="embedding-300" style="margin:50px"><p> Sentence#: 300
Task hash: -948675504</p></div><div id="embedding-301" style="margin:50px"><p> Sentence#: 301
Task hash: 1200538463</p></div><div id="embedding-302" style="margin:50px"><p> Sentence#: 302
Task hash: 1263944701</p></div><div id="embedding-303" style="margin:50px"><p> Sentence#: 303
Task hash: 1081232628</p></div><div id="embedding-304" style="margin:50px"><p> Sentence#: 304
Task hash: -1322937607</p></div><div id="embedding-305" style="margin:50px"><p> Sentence#: 305
Task hash: -355421915</p></div><div id="embedding-306" style="margin:50px"><p> Sentence#: 306
Task hash: 506227</p></div><div id="embedding-307" style="margin:50px"><p> Sentence#: 307
Task hash: -1826425683</p></div><div id="embedding-308" style="margin:50px"><p> Sentence#: 308
Task hash: -1072881144</p></div><div id="embedding-309" style="margin:50px"><p> Sentence#: 309
Task hash: -1873155470</p></div><div id="embedding-310" style="margin:50px"><p> Sentence#: 310
Task hash: -990954891</p></div><div id="embedding-311" style="margin:50px"><p> Sentence#: 311
Task hash: 791870636</p></div><div id="embedding-312" style="margin:50px"><p> Sentence#: 312
Task hash: 174297110</p></div><div id="embedding-313" style="margin:50px"><p> Sentence#: 313
Task hash: 1913413629</p></div><div id="embedding-314" style="margin:50px"><p> Sentence#: 314
Task hash: -83952216</p></div><div id="embedding-315" style="margin:50px"><p> Sentence#: 315
Task hash: 62087172</p></div><div id="embedding-316" style="margin:50px"><p> Sentence#: 316
Task hash: -1514224792</p></div><div id="embedding-317" style="margin:50px"><p> Sentence#: 317
Task hash: -890337971</p></div><div id="embedding-318" style="margin:50px"><p> Sentence#: 318
Task hash: -1244792390</p></div><div id="embedding-319" style="margin:50px"><p> Sentence#: 319
Task hash: 63668359</p></div><div id="embedding-320" style="margin:50px"><p> Sentence#: 320
Task hash: -2119509810</p></div><div id="embedding-321" style="margin:50px"><p> Sentence#: 321
Task hash: -1972183357</p></div><div id="embedding-322" style="margin:50px"><p> Sentence#: 322
Task hash: -1806506006</p></div><div id="embedding-323" style="margin:50px"><p> Sentence#: 323
Task hash: -538100805</p></div><div id="embedding-324" style="margin:50px"><p> Sentence#: 324
Task hash: -859834386</p></div><div id="embedding-325" style="margin:50px"><p> Sentence#: 325
Task hash: 1992490827</p></div><div id="embedding-326" style="margin:50px"><p> Sentence#: 326
Task hash: 652457282</p></div><div id="embedding-327" style="margin:50px"><p> Sentence#: 327
Task hash: 1590851932</p></div><div id="embedding-328" style="margin:50px"><p> Sentence#: 328
Task hash: 1573073184</p></div><div id="embedding-329" style="margin:50px"><p> Sentence#: 329
Task hash: 63599335</p></div><div id="embedding-330" style="margin:50px"><p> Sentence#: 330
Task hash: -2142947858</p></div><div id="embedding-331" style="margin:50px"><p> Sentence#: 331
Task hash: -1945222587</p></div><div id="embedding-332" style="margin:50px"><p> Sentence#: 332
Task hash: -983176734</p></div><div id="embedding-333" style="margin:50px"><p> Sentence#: 333
Task hash: 326729702</p></div><div id="embedding-334" style="margin:50px"><p> Sentence#: 334
Task hash: -2089354319</p></div><div id="embedding-335" style="margin:50px"><p> Sentence#: 335
Task hash: -106984999</p></div><div id="embedding-336" style="margin:50px"><p> Sentence#: 336
Task hash: 1740984062</p></div><div id="embedding-337" style="margin:50px"><p> Sentence#: 337
Task hash: -1621893865</p></div><div id="embedding-338" style="margin:50px"><p> Sentence#: 338
Task hash: -514172959</p></div><div id="embedding-339" style="margin:50px"><p> Sentence#: 339
Task hash: 68078821</p></div><div id="embedding-340" style="margin:50px"><p> Sentence#: 340
Task hash: -1367102477</p></div><div id="embedding-341" style="margin:50px"><p> Sentence#: 341
Task hash: -89005945</p></div><div id="embedding-342" style="margin:50px"><p> Sentence#: 342
Task hash: 702837939</p></div><div id="embedding-343" style="margin:50px"><p> Sentence#: 343
Task hash: 1553036738</p></div><div id="embedding-344" style="margin:50px"><p> Sentence#: 344
Task hash: -1606211003</p></div><div id="embedding-345" style="margin:50px"><p> Sentence#: 345
Task hash: 313061127</p></div><div id="embedding-346" style="margin:50px"><p> Sentence#: 346
Task hash: 1639223100</p></div><div id="embedding-347" style="margin:50px"><p> Sentence#: 347
Task hash: 302269646</p></div><div id="embedding-348" style="margin:50px"><p> Sentence#: 348
Task hash: 788380090</p></div><div id="embedding-349" style="margin:50px"><p> Sentence#: 349
Task hash: -2057588266</p></div><div id="embedding-350" style="margin:50px"><p> Sentence#: 350
Task hash: 533045490</p></div><div id="embedding-351" style="margin:50px"><p> Sentence#: 351
Task hash: -161855713</p></div><div id="embedding-352" style="margin:50px"><p> Sentence#: 352
Task hash: -11361744</p></div><div id="embedding-353" style="margin:50px"><p> Sentence#: 353
Task hash: -1550375387</p></div><div id="embedding-354" style="margin:50px"><p> Sentence#: 354
Task hash: 1574401455</p></div><div id="embedding-355" style="margin:50px"><p> Sentence#: 355
Task hash: 922451232</p></div><div id="embedding-356" style="margin:50px"><p> Sentence#: 356
Task hash: -676994322</p></div><div id="embedding-357" style="margin:50px"><p> Sentence#: 357
Task hash: -1314390971</p></div><div id="embedding-358" style="margin:50px"><p> Sentence#: 358
Task hash: -440462208</p></div><div id="embedding-359" style="margin:50px"><p> Sentence#: 359
Task hash: -1283977004</p></div><div id="embedding-360" style="margin:50px"><p> Sentence#: 360
Task hash: 527518937</p></div><div id="embedding-361" style="margin:50px"><p> Sentence#: 361
Task hash: -1496668469</p></div><div id="embedding-362" style="margin:50px"><p> Sentence#: 362
Task hash: -1033140212</p></div><div id="embedding-363" style="margin:50px"><p> Sentence#: 363
Task hash: -2091002692</p></div><div id="embedding-364" style="margin:50px"><p> Sentence#: 364
Task hash: 871243134</p></div><div id="embedding-365" style="margin:50px"><p> Sentence#: 365
Task hash: 1826349192</p></div><div id="embedding-366" style="margin:50px"><p> Sentence#: 366
Task hash: 1921652779</p></div><div id="embedding-367" style="margin:50px"><p> Sentence#: 367
Task hash: -417190901</p></div><div id="embedding-368" style="margin:50px"><p> Sentence#: 368
Task hash: 609636501</p></div><div id="embedding-369" style="margin:50px"><p> Sentence#: 369
Task hash: 1132315594</p></div><div id="embedding-370" style="margin:50px"><p> Sentence#: 370
Task hash: -2103073705</p></div><div id="embedding-371" style="margin:50px"><p> Sentence#: 371
Task hash: -1487322958</p></div><div id="embedding-372" style="margin:50px"><p> Sentence#: 372
Task hash: -2117906361</p></div><div id="embedding-373" style="margin:50px"><p> Sentence#: 373
Task hash: -1618517748</p></div><div id="embedding-374" style="margin:50px"><p> Sentence#: 374
Task hash: 1623655316</p></div><div id="embedding-375" style="margin:50px"><p> Sentence#: 375
Task hash: 1278316066</p></div><div id="embedding-376" style="margin:50px"><p> Sentence#: 376
Task hash: -1656155014</p></div><div id="embedding-377" style="margin:50px"><p> Sentence#: 377
Task hash: -1581234620</p></div><div id="embedding-378" style="margin:50px"><p> Sentence#: 378
Task hash: -596930617</p></div><div id="embedding-379" style="margin:50px"><p> Sentence#: 379
Task hash: 1741992389</p></div><div id="embedding-380" style="margin:50px"><p> Sentence#: 380
Task hash: -626823639</p></div><div id="embedding-381" style="margin:50px"><p> Sentence#: 381
Task hash: 1732159067</p></div><div id="embedding-382" style="margin:50px"><p> Sentence#: 382
Task hash: -802191783</p></div><div id="embedding-383" style="margin:50px"><p> Sentence#: 383
Task hash: -227562771</p></div><div id="embedding-384" style="margin:50px"><p> Sentence#: 384
Task hash: 1734174624</p></div><div id="embedding-385" style="margin:50px"><p> Sentence#: 385
Task hash: 1423604810</p></div><div id="embedding-386" style="margin:50px"><p> Sentence#: 386
Task hash: 1990730560</p></div><div id="embedding-387" style="margin:50px"><p> Sentence#: 387
Task hash: 375048755</p></div><div id="embedding-388" style="margin:50px"><p> Sentence#: 388
Task hash: 237455803</p></div><div id="embedding-389" style="margin:50px"><p> Sentence#: 389
Task hash: 1026176</p></div><div id="embedding-390" style="margin:50px"><p> Sentence#: 390
Task hash: -1228019264</p></div><div id="embedding-391" style="margin:50px"><p> Sentence#: 391
Task hash: -895143861</p></div><div id="embedding-392" style="margin:50px"><p> Sentence#: 392
Task hash: -166090267</p></div><div id="embedding-393" style="margin:50px"><p> Sentence#: 393
Task hash: -472440473</p></div><div id="embedding-394" style="margin:50px"><p> Sentence#: 394
Task hash: 1367124245</p></div><div id="embedding-395" style="margin:50px"><p> Sentence#: 395
Task hash: -1555578279</p></div><div id="embedding-396" style="margin:50px"><p> Sentence#: 396
Task hash: -1180101151</p></div><div id="embedding-397" style="margin:50px"><p> Sentence#: 397
Task hash: 1239049252</p></div><div id="embedding-398" style="margin:50px"><p> Sentence#: 398
Task hash: 556827005</p></div><div id="embedding-399" style="margin:50px"><p> Sentence#: 399
Task hash: 1570798230</p></div><div id="embedding-400" style="margin:50px"><p> Sentence#: 400
Task hash: -2120846349</p></div><div id="embedding-401" style="margin:50px"><p> Sentence#: 401
Task hash: 579254060</p></div><div id="embedding-402" style="margin:50px"><p> Sentence#: 402
Task hash: -285877249</p></div><div id="embedding-403" style="margin:50px"><p> Sentence#: 403
Task hash: 1841084650</p></div><div id="embedding-404" style="margin:50px"><p> Sentence#: 404
Task hash: -1859053763</p></div><div id="embedding-405" style="margin:50px"><p> Sentence#: 405
Task hash: -2056087793</p></div><div id="embedding-406" style="margin:50px"><p> Sentence#: 406
Task hash: 1383573631</p></div><div id="embedding-407" style="margin:50px"><p> Sentence#: 407
Task hash: 673167605</p></div><div id="embedding-408" style="margin:50px"><p> Sentence#: 408
Task hash: -861193908</p></div><div id="embedding-409" style="margin:50px"><p> Sentence#: 409
Task hash: 1908869018</p></div><div id="embedding-410" style="margin:50px"><p> Sentence#: 410
Task hash: -1949842393</p></div><div id="embedding-411" style="margin:50px"><p> Sentence#: 411
Task hash: 1833150552</p></div><div id="embedding-412" style="margin:50px"><p> Sentence#: 412
Task hash: -1657878567</p></div><div id="embedding-413" style="margin:50px"><p> Sentence#: 413
Task hash: -591444418</p></div><div id="embedding-414" style="margin:50px"><p> Sentence#: 414
Task hash: 886884280</p></div><div id="embedding-415" style="margin:50px"><p> Sentence#: 415
Task hash: 1845530520</p></div><div id="embedding-416" style="margin:50px"><p> Sentence#: 416
Task hash: -1052050374</p></div><div id="embedding-417" style="margin:50px"><p> Sentence#: 417
Task hash: -2059991561</p></div><div id="embedding-418" style="margin:50px"><p> Sentence#: 418
Task hash: -1823771790</p></div><div id="embedding-419" style="margin:50px"><p> Sentence#: 419
Task hash: -29296095</p></div><div id="embedding-420" style="margin:50px"><p> Sentence#: 420
Task hash: 617734523</p></div><div id="embedding-421" style="margin:50px"><p> Sentence#: 421
Task hash: 1977080737</p></div><div id="embedding-422" style="margin:50px"><p> Sentence#: 422
Task hash: -242383329</p></div><div id="embedding-423" style="margin:50px"><p> Sentence#: 423
Task hash: -72628336</p></div><div id="embedding-424" style="margin:50px"><p> Sentence#: 424
Task hash: -1940871942</p></div><div id="embedding-425" style="margin:50px"><p> Sentence#: 425
Task hash: -556705201</p></div><div id="embedding-426" style="margin:50px"><p> Sentence#: 426
Task hash: -714704679</p></div><div id="embedding-427" style="margin:50px"><p> Sentence#: 427
Task hash: -50886940</p></div><div id="embedding-428" style="margin:50px"><p> Sentence#: 428
Task hash: -810375700</p></div><div id="embedding-429" style="margin:50px"><p> Sentence#: 429
Task hash: -1256702428</p></div><div id="embedding-430" style="margin:50px"><p> Sentence#: 430
Task hash: 136931779</p></div><div id="embedding-431" style="margin:50px"><p> Sentence#: 431
Task hash: 350917710</p></div><div id="embedding-432" style="margin:50px"><p> Sentence#: 432
Task hash: -435024019</p></div><div id="embedding-433" style="margin:50px"><p> Sentence#: 433
Task hash: 520587351</p></div><div id="embedding-434" style="margin:50px"><p> Sentence#: 434
Task hash: 795950560</p></div><div id="embedding-435" style="margin:50px"><p> Sentence#: 435
Task hash: 1426784574</p></div><div id="embedding-436" style="margin:50px"><p> Sentence#: 436
Task hash: -835721494</p></div><div id="embedding-437" style="margin:50px"><p> Sentence#: 437
Task hash: 1978405028</p></div><div id="embedding-438" style="margin:50px"><p> Sentence#: 438
Task hash: 1368439946</p></div><div id="embedding-439" style="margin:50px"><p> Sentence#: 439
Task hash: 390126268</p></div><div id="embedding-440" style="margin:50px"><p> Sentence#: 440
Task hash: 355248590</p></div><div id="embedding-441" style="margin:50px"><p> Sentence#: 441
Task hash: 1009510538</p></div><div id="embedding-442" style="margin:50px"><p> Sentence#: 442
Task hash: 849759274</p></div><div id="embedding-443" style="margin:50px"><p> Sentence#: 443
Task hash: 2139163890</p></div><div id="embedding-444" style="margin:50px"><p> Sentence#: 444
Task hash: -473198837</p></div><div id="embedding-445" style="margin:50px"><p> Sentence#: 445
Task hash: 2066865854</p></div><div id="embedding-446" style="margin:50px"><p> Sentence#: 446
Task hash: -2113785729</p></div><div id="embedding-447" style="margin:50px"><p> Sentence#: 447
Task hash: 173538935</p></div><div id="embedding-448" style="margin:50px"><p> Sentence#: 448
Task hash: 274846199</p></div><div id="embedding-449" style="margin:50px"><p> Sentence#: 449
Task hash: 701999209</p></div><div id="embedding-450" style="margin:50px"><p> Sentence#: 450
Task hash: -240403890</p></div><div id="embedding-451" style="margin:50px"><p> Sentence#: 451
Task hash: -809600175</p></div><div id="embedding-452" style="margin:50px"><p> Sentence#: 452
Task hash: 1189683767</p></div><div id="embedding-453" style="margin:50px"><p> Sentence#: 453
Task hash: -665538077</p></div><div id="embedding-454" style="margin:50px"><p> Sentence#: 454
Task hash: 1023007688</p></div><div id="embedding-455" style="margin:50px"><p> Sentence#: 455
Task hash: -1757811392</p></div><div id="embedding-456" style="margin:50px"><p> Sentence#: 456
Task hash: -1008520400</p></div><div id="embedding-457" style="margin:50px"><p> Sentence#: 457
Task hash: 767074308</p></div><div id="embedding-458" style="margin:50px"><p> Sentence#: 458
Task hash: 1569770411</p></div><div id="embedding-459" style="margin:50px"><p> Sentence#: 459
Task hash: -928570008</p></div><div id="embedding-460" style="margin:50px"><p> Sentence#: 460
Task hash: -1936235236</p></div><div id="embedding-461" style="margin:50px"><p> Sentence#: 461
Task hash: -30572792</p></div><div id="embedding-462" style="margin:50px"><p> Sentence#: 462
Task hash: 1949377519</p></div><div id="embedding-463" style="margin:50px"><p> Sentence#: 463
Task hash: 1801413370</p></div><div id="embedding-464" style="margin:50px"><p> Sentence#: 464
Task hash: 1847081271</p></div><div id="embedding-465" style="margin:50px"><p> Sentence#: 465
Task hash: 1531824663</p></div><div id="embedding-466" style="margin:50px"><p> Sentence#: 466
Task hash: 631698751</p></div><div id="embedding-467" style="margin:50px"><p> Sentence#: 467
Task hash: -975363972</p></div><div id="embedding-468" style="margin:50px"><p> Sentence#: 468
Task hash: 2137711349</p></div><div id="embedding-469" style="margin:50px"><p> Sentence#: 469
Task hash: 269703005</p></div><div id="embedding-470" style="margin:50px"><p> Sentence#: 470
Task hash: 557275469</p></div><div id="embedding-471" style="margin:50px"><p> Sentence#: 471
Task hash: 1750020010</p></div><div id="embedding-472" style="margin:50px"><p> Sentence#: 472
Task hash: -282557458</p></div><div id="embedding-473" style="margin:50px"><p> Sentence#: 473
Task hash: -1095045616</p></div><div id="embedding-474" style="margin:50px"><p> Sentence#: 474
Task hash: -1488244645</p></div><div id="embedding-475" style="margin:50px"><p> Sentence#: 475
Task hash: 9433814</p></div><div id="embedding-476" style="margin:50px"><p> Sentence#: 476
Task hash: 170381472</p></div><div id="embedding-477" style="margin:50px"><p> Sentence#: 477
Task hash: -853280607</p></div><div id="embedding-478" style="margin:50px"><p> Sentence#: 478
Task hash: 1286430667</p></div><div id="embedding-479" style="margin:50px"><p> Sentence#: 479
Task hash: -698905866</p></div><div id="embedding-480" style="margin:50px"><p> Sentence#: 480
Task hash: 189567652</p></div><div id="embedding-481" style="margin:50px"><p> Sentence#: 481
Task hash: -815275949</p></div><div id="embedding-482" style="margin:50px"><p> Sentence#: 482
Task hash: 1165609641</p></div><div id="embedding-483" style="margin:50px"><p> Sentence#: 483
Task hash: -358947103</p></div><div id="embedding-484" style="margin:50px"><p> Sentence#: 484
Task hash: -598924990</p></div><div id="embedding-485" style="margin:50px"><p> Sentence#: 485
Task hash: -1752246375</p></div><div id="embedding-486" style="margin:50px"><p> Sentence#: 486
Task hash: -1636959423</p></div><div id="embedding-487" style="margin:50px"><p> Sentence#: 487
Task hash: 884631178</p></div><div id="embedding-488" style="margin:50px"><p> Sentence#: 488
Task hash: -1151814673</p></div><div id="embedding-489" style="margin:50px"><p> Sentence#: 489
Task hash: -1426940162</p></div><div id="embedding-490" style="margin:50px"><p> Sentence#: 490
Task hash: -1504837583</p></div><div id="embedding-491" style="margin:50px"><p> Sentence#: 491
Task hash: -1470699172</p></div><div id="embedding-492" style="margin:50px"><p> Sentence#: 492
Task hash: -355695759</p></div><div id="embedding-493" style="margin:50px"><p> Sentence#: 493
Task hash: 261562231</p></div><div id="embedding-494" style="margin:50px"><p> Sentence#: 494
Task hash: 182726627</p></div><div id="embedding-495" style="margin:50px"><p> Sentence#: 495
Task hash: -1798858119</p></div><div id="embedding-496" style="margin:50px"><p> Sentence#: 496
Task hash: -1328747292</p></div><div id="embedding-497" style="margin:50px"><p> Sentence#: 497
Task hash: 1444445273</p></div><div id="embedding-498" style="margin:50px"><p> Sentence#: 498
Task hash: -1822218155</p></div><div id="embedding-499" style="margin:50px"><p> Sentence#: 499
Task hash: -410233637</p></div><div id="embedding-500" style="margin:50px"><p> Sentence#: 500
Task hash: 1385589241</p></div><div id="embedding-501" style="margin:50px"><p> Sentence#: 501
Task hash: -809326969</p></div><div id="embedding-502" style="margin:50px"><p> Sentence#: 502
Task hash: -1201376081</p></div><div id="embedding-503" style="margin:50px"><p> Sentence#: 503
Task hash: 566806191</p></div><div id="embedding-504" style="margin:50px"><p> Sentence#: 504
Task hash: 1495912776</p></div><div id="embedding-505" style="margin:50px"><p> Sentence#: 505
Task hash: -2063456909</p></div><div id="embedding-506" style="margin:50px"><p> Sentence#: 506
Task hash: 669725505</p></div><div id="embedding-507" style="margin:50px"><p> Sentence#: 507
Task hash: 663353961</p></div><div id="embedding-508" style="margin:50px"><p> Sentence#: 508
Task hash: 1608221285</p></div><div id="embedding-509" style="margin:50px"><p> Sentence#: 509
Task hash: -1637254115</p></div><div id="embedding-510" style="margin:50px"><p> Sentence#: 510
Task hash: 988155928</p></div><div id="embedding-511" style="margin:50px"><p> Sentence#: 511
Task hash: 368936738</p></div><div id="embedding-512" style="margin:50px"><p> Sentence#: 512
Task hash: -890873887</p></div><div id="embedding-513" style="margin:50px"><p> Sentence#: 513
Task hash: -917483088</p></div><div id="embedding-514" style="margin:50px"><p> Sentence#: 514
Task hash: 33599711</p></div><div id="embedding-515" style="margin:50px"><p> Sentence#: 515
Task hash: 750890687</p></div><div id="embedding-516" style="margin:50px"><p> Sentence#: 516
Task hash: -2000618693</p></div><div id="embedding-517" style="margin:50px"><p> Sentence#: 517
Task hash: 1607756556</p></div><div id="embedding-518" style="margin:50px"><p> Sentence#: 518
Task hash: -1740747027</p></div><div id="embedding-519" style="margin:50px"><p> Sentence#: 519
Task hash: 1945399980</p></div><div id="embedding-520" style="margin:50px"><p> Sentence#: 520
Task hash: 538065398</p></div><div id="embedding-521" style="margin:50px"><p> Sentence#: 521
Task hash: 1609206992</p></div><div id="embedding-522" style="margin:50px"><p> Sentence#: 522
Task hash: 2107984567</p></div><div id="embedding-523" style="margin:50px"><p> Sentence#: 523
Task hash: -858423253</p></div><div id="embedding-524" style="margin:50px"><p> Sentence#: 524
Task hash: 47759810</p></div><div id="embedding-525" style="margin:50px"><p> Sentence#: 525
Task hash: 1268820344</p></div><div id="embedding-526" style="margin:50px"><p> Sentence#: 526
Task hash: -507435658</p></div><div id="embedding-527" style="margin:50px"><p> Sentence#: 527
Task hash: 1336176261</p></div><div id="embedding-528" style="margin:50px"><p> Sentence#: 528
Task hash: 195407761</p></div><div id="embedding-529" style="margin:50px"><p> Sentence#: 529
Task hash: 134967541</p></div><div id="embedding-530" style="margin:50px"><p> Sentence#: 530
Task hash: -282961950</p></div><div id="embedding-531" style="margin:50px"><p> Sentence#: 531
Task hash: 2099373263</p></div><div id="embedding-532" style="margin:50px"><p> Sentence#: 532
Task hash: 991750716</p></div><div id="embedding-533" style="margin:50px"><p> Sentence#: 533
Task hash: -1101801559</p></div><div id="embedding-534" style="margin:50px"><p> Sentence#: 534
Task hash: -904365522</p></div><div id="embedding-535" style="margin:50px"><p> Sentence#: 535
Task hash: 1489488746</p></div><div id="embedding-536" style="margin:50px"><p> Sentence#: 536
Task hash: 1189562082</p></div><div id="embedding-537" style="margin:50px"><p> Sentence#: 537
Task hash: -2030315895</p></div><div id="embedding-538" style="margin:50px"><p> Sentence#: 538
Task hash: 1382928417</p></div><div id="embedding-539" style="margin:50px"><p> Sentence#: 539
Task hash: 832925840</p></div><div id="embedding-540" style="margin:50px"><p> Sentence#: 540
Task hash: 941720508</p></div><div id="embedding-541" style="margin:50px"><p> Sentence#: 541
Task hash: 482203314</p></div><div id="embedding-542" style="margin:50px"><p> Sentence#: 542
Task hash: -1769063414</p></div><div id="embedding-543" style="margin:50px"><p> Sentence#: 543
Task hash: -2057463616</p></div><div id="embedding-544" style="margin:50px"><p> Sentence#: 544
Task hash: -822670852</p></div><div id="embedding-545" style="margin:50px"><p> Sentence#: 545
Task hash: -846658424</p></div><div id="embedding-546" style="margin:50px"><p> Sentence#: 546
Task hash: 1390668595</p></div><div id="embedding-547" style="margin:50px"><p> Sentence#: 547
Task hash: -1217546552</p></div><div id="embedding-548" style="margin:50px"><p> Sentence#: 548
Task hash: -297979785</p></div><div id="embedding-549" style="margin:50px"><p> Sentence#: 549
Task hash: 155243404</p></div><div id="embedding-550" style="margin:50px"><p> Sentence#: 550
Task hash: -315603626</p></div><div id="embedding-551" style="margin:50px"><p> Sentence#: 551
Task hash: -1689937147</p></div><div id="embedding-552" style="margin:50px"><p> Sentence#: 552
Task hash: 1346263576</p></div><div id="embedding-553" style="margin:50px"><p> Sentence#: 553
Task hash: -1230424452</p></div><div id="embedding-554" style="margin:50px"><p> Sentence#: 554
Task hash: 432367273</p></div><div id="embedding-555" style="margin:50px"><p> Sentence#: 555
Task hash: 1000079828</p></div><div id="embedding-556" style="margin:50px"><p> Sentence#: 556
Task hash: -1726477839</p></div><div id="embedding-557" style="margin:50px"><p> Sentence#: 557
Task hash: 1631913918</p></div><div id="embedding-558" style="margin:50px"><p> Sentence#: 558
Task hash: -1303773216</p></div><div id="embedding-559" style="margin:50px"><p> Sentence#: 559
Task hash: -1242027596</p></div><div id="embedding-560" style="margin:50px"><p> Sentence#: 560
Task hash: -1837809359</p></div><div id="embedding-561" style="margin:50px"><p> Sentence#: 561
Task hash: 613682213</p></div><div id="embedding-562" style="margin:50px"><p> Sentence#: 562
Task hash: -682936395</p></div><div id="embedding-563" style="margin:50px"><p> Sentence#: 563
Task hash: 646576441</p></div><div id="embedding-564" style="margin:50px"><p> Sentence#: 564
Task hash: -1888805973</p></div><div id="embedding-565" style="margin:50px"><p> Sentence#: 565
Task hash: -1025171349</p></div><div id="embedding-566" style="margin:50px"><p> Sentence#: 566
Task hash: -572899033</p></div><div id="embedding-567" style="margin:50px"><p> Sentence#: 567
Task hash: 776985581</p></div><div id="embedding-568" style="margin:50px"><p> Sentence#: 568
Task hash: 2082261660</p></div><div id="embedding-569" style="margin:50px"><p> Sentence#: 569
Task hash: -1188208936</p></div><div id="embedding-570" style="margin:50px"><p> Sentence#: 570
Task hash: -1168206105</p></div><div id="embedding-571" style="margin:50px"><p> Sentence#: 571
Task hash: -498032896</p></div><div id="embedding-572" style="margin:50px"><p> Sentence#: 572
Task hash: 241221166</p></div><div id="embedding-573" style="margin:50px"><p> Sentence#: 573
Task hash: -566097016</p></div><div id="embedding-574" style="margin:50px"><p> Sentence#: 574
Task hash: -109607125</p></div><div id="embedding-575" style="margin:50px"><p> Sentence#: 575
Task hash: 1708310250</p></div><div id="embedding-576" style="margin:50px"><p> Sentence#: 576
Task hash: 1427579163</p></div><div id="embedding-577" style="margin:50px"><p> Sentence#: 577
Task hash: 1998853020</p></div><div id="embedding-578" style="margin:50px"><p> Sentence#: 578
Task hash: -2088000237</p></div><div id="embedding-579" style="margin:50px"><p> Sentence#: 579
Task hash: -1928482435</p></div><div id="embedding-580" style="margin:50px"><p> Sentence#: 580
Task hash: -338591451</p></div><div id="embedding-581" style="margin:50px"><p> Sentence#: 581
Task hash: 217296874</p></div><div id="embedding-582" style="margin:50px"><p> Sentence#: 582
Task hash: 1188622474</p></div><div id="embedding-583" style="margin:50px"><p> Sentence#: 583
Task hash: 291372872</p></div><div id="embedding-584" style="margin:50px"><p> Sentence#: 584
Task hash: -284423515</p></div><div id="embedding-585" style="margin:50px"><p> Sentence#: 585
Task hash: 161625304</p></div><div id="embedding-586" style="margin:50px"><p> Sentence#: 586
Task hash: -1755879513</p></div><div id="embedding-587" style="margin:50px"><p> Sentence#: 587
Task hash: 668174001</p></div><div id="embedding-588" style="margin:50px"><p> Sentence#: 588
Task hash: 697038417</p></div><div id="embedding-589" style="margin:50px"><p> Sentence#: 589
Task hash: 1761368621</p></div><div id="embedding-590" style="margin:50px"><p> Sentence#: 590
Task hash: 902527829</p></div><div id="embedding-591" style="margin:50px"><p> Sentence#: 591
Task hash: -1978696013</p></div><div id="embedding-592" style="margin:50px"><p> Sentence#: 592
Task hash: -1486552710</p></div><div id="embedding-593" style="margin:50px"><p> Sentence#: 593
Task hash: -460581352</p></div><div id="embedding-594" style="margin:50px"><p> Sentence#: 594
Task hash: -2060127851</p></div><div id="embedding-595" style="margin:50px"><p> Sentence#: 595
Task hash: -1350009131</p></div><div id="embedding-596" style="margin:50px"><p> Sentence#: 596
Task hash: 752135122</p></div><div id="embedding-597" style="margin:50px"><p> Sentence#: 597
Task hash: -72094694</p></div><div id="embedding-598" style="margin:50px"><p> Sentence#: 598
Task hash: 1026671672</p></div><div id="embedding-599" style="margin:50px"><p> Sentence#: 599
Task hash: -1315736956</p></div><div id="embedding-600" style="margin:50px"><p> Sentence#: 600
Task hash: 679244521</p></div><div id="embedding-601" style="margin:50px"><p> Sentence#: 601
Task hash: -295825780</p></div><div id="embedding-602" style="margin:50px"><p> Sentence#: 602
Task hash: -1012256645</p></div><div id="embedding-603" style="margin:50px"><p> Sentence#: 603
Task hash: -1237143940</p></div><div id="embedding-604" style="margin:50px"><p> Sentence#: 604
Task hash: -1049824029</p></div><div id="embedding-605" style="margin:50px"><p> Sentence#: 605
Task hash: 837464857</p></div><div id="embedding-606" style="margin:50px"><p> Sentence#: 606
Task hash: 1789126577</p></div><div id="embedding-607" style="margin:50px"><p> Sentence#: 607
Task hash: -1339617195</p></div><div id="embedding-608" style="margin:50px"><p> Sentence#: 608
Task hash: -1984821940</p></div><div id="embedding-609" style="margin:50px"><p> Sentence#: 609
Task hash: -422876868</p></div><div id="embedding-610" style="margin:50px"><p> Sentence#: 610
Task hash: -1969493749</p></div><div id="embedding-611" style="margin:50px"><p> Sentence#: 611
Task hash: -1013040806</p></div><div id="embedding-612" style="margin:50px"><p> Sentence#: 612
Task hash: -1507454273</p></div><div id="embedding-613" style="margin:50px"><p> Sentence#: 613
Task hash: 2012229149</p></div><div id="embedding-614" style="margin:50px"><p> Sentence#: 614
Task hash: 1228417509</p></div><div id="embedding-615" style="margin:50px"><p> Sentence#: 615
Task hash: 593265984</p></div><div id="embedding-616" style="margin:50px"><p> Sentence#: 616
Task hash: -907830921</p></div><div id="embedding-617" style="margin:50px"><p> Sentence#: 617
Task hash: -1272918068</p></div><div id="embedding-618" style="margin:50px"><p> Sentence#: 618
Task hash: 1663211685</p></div><div id="embedding-619" style="margin:50px"><p> Sentence#: 619
Task hash: 139687929</p></div><div id="embedding-620" style="margin:50px"><p> Sentence#: 620
Task hash: -2118421577</p></div><div id="embedding-621" style="margin:50px"><p> Sentence#: 621
Task hash: 169119992</p></div><div id="embedding-622" style="margin:50px"><p> Sentence#: 622
Task hash: -478265029</p></div><div id="embedding-623" style="margin:50px"><p> Sentence#: 623
Task hash: -1930016385</p></div><div id="embedding-624" style="margin:50px"><p> Sentence#: 624
Task hash: 1259969382</p></div><div id="embedding-625" style="margin:50px"><p> Sentence#: 625
Task hash: -358750854</p></div><div id="embedding-626" style="margin:50px"><p> Sentence#: 626
Task hash: -1074453285</p></div><div id="embedding-627" style="margin:50px"><p> Sentence#: 627
Task hash: 1114897059</p></div><div id="embedding-628" style="margin:50px"><p> Sentence#: 628
Task hash: 2067686948</p></div><div id="embedding-629" style="margin:50px"><p> Sentence#: 629
Task hash: 1089951813</p></div><div id="embedding-630" style="margin:50px"><p> Sentence#: 630
Task hash: 836830435</p></div><div id="embedding-631" style="margin:50px"><p> Sentence#: 631
Task hash: -1717738212</p></div><div id="embedding-632" style="margin:50px"><p> Sentence#: 632
Task hash: -372160576</p></div><div id="embedding-633" style="margin:50px"><p> Sentence#: 633
Task hash: -899363047</p></div><div id="embedding-634" style="margin:50px"><p> Sentence#: 634
Task hash: 1591612122</p></div><div id="embedding-635" style="margin:50px"><p> Sentence#: 635
Task hash: -172731091</p></div><div id="embedding-636" style="margin:50px"><p> Sentence#: 636
Task hash: -562271563</p></div><div id="embedding-637" style="margin:50px"><p> Sentence#: 637
Task hash: 1956886332</p></div><div id="embedding-638" style="margin:50px"><p> Sentence#: 638
Task hash: -635764321</p></div><div id="embedding-639" style="margin:50px"><p> Sentence#: 639
Task hash: 251634514</p></div><div id="embedding-640" style="margin:50px"><p> Sentence#: 640
Task hash: -1580890572</p></div><div id="embedding-641" style="margin:50px"><p> Sentence#: 641
Task hash: 1318543778</p></div><div id="embedding-642" style="margin:50px"><p> Sentence#: 642
Task hash: -1794223121</p></div><div id="embedding-643" style="margin:50px"><p> Sentence#: 643
Task hash: 1934099043</p></div><div id="embedding-644" style="margin:50px"><p> Sentence#: 644
Task hash: 815091626</p></div><div id="embedding-645" style="margin:50px"><p> Sentence#: 645
Task hash: -1334292062</p></div><div id="embedding-646" style="margin:50px"><p> Sentence#: 646
Task hash: 721995188</p></div><div id="embedding-647" style="margin:50px"><p> Sentence#: 647
Task hash: 1701296666</p></div><div id="embedding-648" style="margin:50px"><p> Sentence#: 648
Task hash: -557769346</p></div><div id="embedding-649" style="margin:50px"><p> Sentence#: 649
Task hash: -1682485889</p></div><div id="embedding-650" style="margin:50px"><p> Sentence#: 650
Task hash: -901997023</p></div><div id="embedding-651" style="margin:50px"><p> Sentence#: 651
Task hash: -512206963</p></div><div id="embedding-652" style="margin:50px"><p> Sentence#: 652
Task hash: -246263564</p></div><div id="embedding-653" style="margin:50px"><p> Sentence#: 653
Task hash: -564503250</p></div><div id="embedding-654" style="margin:50px"><p> Sentence#: 654
Task hash: -1062915484</p></div><div id="embedding-655" style="margin:50px"><p> Sentence#: 655
Task hash: -740240099</p></div><div id="embedding-656" style="margin:50px"><p> Sentence#: 656
Task hash: 1833962140</p></div><div id="embedding-657" style="margin:50px"><p> Sentence#: 657
Task hash: 1848805066</p></div><div id="embedding-658" style="margin:50px"><p> Sentence#: 658
Task hash: -780820846</p></div><div id="embedding-659" style="margin:50px"><p> Sentence#: 659
Task hash: -1033339395</p></div><div id="embedding-660" style="margin:50px"><p> Sentence#: 660
Task hash: -25162873</p></div><div id="embedding-661" style="margin:50px"><p> Sentence#: 661
Task hash: 1230946466</p></div><div id="embedding-662" style="margin:50px"><p> Sentence#: 662
Task hash: 412375327</p></div><div id="embedding-663" style="margin:50px"><p> Sentence#: 663
Task hash: 631278044</p></div><div id="embedding-664" style="margin:50px"><p> Sentence#: 664
Task hash: 351210646</p></div><div id="embedding-665" style="margin:50px"><p> Sentence#: 665
Task hash: 1241215709</p></div><div id="embedding-666" style="margin:50px"><p> Sentence#: 666
Task hash: 1614427761</p></div><div id="embedding-667" style="margin:50px"><p> Sentence#: 667
Task hash: 1831373101</p></div><div id="embedding-668" style="margin:50px"><p> Sentence#: 668
Task hash: -772190868</p></div><div id="embedding-669" style="margin:50px"><p> Sentence#: 669
Task hash: -1683700961</p></div><div id="embedding-670" style="margin:50px"><p> Sentence#: 670
Task hash: -905051966</p></div><div id="embedding-671" style="margin:50px"><p> Sentence#: 671
Task hash: -1898433519</p></div><div id="embedding-672" style="margin:50px"><p> Sentence#: 672
Task hash: -942381254</p></div><div id="embedding-673" style="margin:50px"><p> Sentence#: 673
Task hash: 1137540428</p></div><div id="embedding-674" style="margin:50px"><p> Sentence#: 674
Task hash: -1369661463</p></div><div id="embedding-675" style="margin:50px"><p> Sentence#: 675
Task hash: -848910509</p></div><div id="embedding-676" style="margin:50px"><p> Sentence#: 676
Task hash: -690544990</p></div><div id="embedding-677" style="margin:50px"><p> Sentence#: 677
Task hash: -837740030</p></div><div id="embedding-678" style="margin:50px"><p> Sentence#: 678
Task hash: 668369014</p></div><div id="embedding-679" style="margin:50px"><p> Sentence#: 679
Task hash: -815983629</p></div><div id="embedding-680" style="margin:50px"><p> Sentence#: 680
Task hash: -964170293</p></div><div id="embedding-681" style="margin:50px"><p> Sentence#: 681
Task hash: -540960281</p></div><div id="embedding-682" style="margin:50px"><p> Sentence#: 682
Task hash: 957479809</p></div><div id="embedding-683" style="margin:50px"><p> Sentence#: 683
Task hash: -2041919707</p></div><div id="embedding-684" style="margin:50px"><p> Sentence#: 684
Task hash: -1554816470</p></div><div id="embedding-685" style="margin:50px"><p> Sentence#: 685
Task hash: -496481433</p></div><div id="embedding-686" style="margin:50px"><p> Sentence#: 686
Task hash: -551781775</p></div><div id="embedding-687" style="margin:50px"><p> Sentence#: 687
Task hash: -1529736806</p></div><div id="embedding-688" style="margin:50px"><p> Sentence#: 688
Task hash: -1771913575</p></div><div id="embedding-689" style="margin:50px"><p> Sentence#: 689
Task hash: 1902368469</p></div><div id="embedding-690" style="margin:50px"><p> Sentence#: 690
Task hash: 1151884980</p></div><div id="embedding-691" style="margin:50px"><p> Sentence#: 691
Task hash: -243783462</p></div><div id="embedding-692" style="margin:50px"><p> Sentence#: 692
Task hash: -779401899</p></div><div id="embedding-693" style="margin:50px"><p> Sentence#: 693
Task hash: 716764468</p></div><div id="embedding-694" style="margin:50px"><p> Sentence#: 694
Task hash: 1023218708</p></div><div id="embedding-695" style="margin:50px"><p> Sentence#: 695
Task hash: 144898097</p></div><div id="embedding-696" style="margin:50px"><p> Sentence#: 696
Task hash: 193382297</p></div><div id="embedding-697" style="margin:50px"><p> Sentence#: 697
Task hash: -1307815647</p></div><div id="embedding-698" style="margin:50px"><p> Sentence#: 698
Task hash: -926520781</p></div><div id="embedding-699" style="margin:50px"><p> Sentence#: 699
Task hash: -864521214</p></div><div id="embedding-700" style="margin:50px"><p> Sentence#: 700
Task hash: -1432171088</p></div><div id="embedding-701" style="margin:50px"><p> Sentence#: 701
Task hash: -1695429351</p></div><div id="embedding-702" style="margin:50px"><p> Sentence#: 702
Task hash: 1110416908</p></div><div id="embedding-703" style="margin:50px"><p> Sentence#: 703
Task hash: 275378759</p></div><div id="embedding-704" style="margin:50px"><p> Sentence#: 704
Task hash: 402056851</p></div><div id="embedding-705" style="margin:50px"><p> Sentence#: 705
Task hash: 254469478</p></div><div id="embedding-706" style="margin:50px"><p> Sentence#: 706
Task hash: 1494170524</p></div><div id="embedding-707" style="margin:50px"><p> Sentence#: 707
Task hash: 486812121</p></div><div id="embedding-708" style="margin:50px"><p> Sentence#: 708
Task hash: 185769729</p></div><div id="embedding-709" style="margin:50px"><p> Sentence#: 709
Task hash: -562011211</p></div><div id="embedding-710" style="margin:50px"><p> Sentence#: 710
Task hash: 376796739</p></div><div id="embedding-711" style="margin:50px"><p> Sentence#: 711
Task hash: 1785142187</p></div><div id="embedding-712" style="margin:50px"><p> Sentence#: 712
Task hash: -95641537</p></div><div id="embedding-713" style="margin:50px"><p> Sentence#: 713
Task hash: 673616211</p></div><div id="embedding-714" style="margin:50px"><p> Sentence#: 714
Task hash: 865344224</p></div><div id="embedding-715" style="margin:50px"><p> Sentence#: 715
Task hash: -234716291</p></div><div id="embedding-716" style="margin:50px"><p> Sentence#: 716
Task hash: -1495477029</p></div><div id="embedding-717" style="margin:50px"><p> Sentence#: 717
Task hash: -1268913479</p></div><div id="embedding-718" style="margin:50px"><p> Sentence#: 718
Task hash: 1351888204</p></div><div id="embedding-719" style="margin:50px"><p> Sentence#: 719
Task hash: -503766035</p></div><div id="embedding-720" style="margin:50px"><p> Sentence#: 720
Task hash: -268204281</p></div><div id="embedding-721" style="margin:50px"><p> Sentence#: 721
Task hash: 1587877816</p></div><div id="embedding-722" style="margin:50px"><p> Sentence#: 722
Task hash: 1191559429</p></div><div id="embedding-723" style="margin:50px"><p> Sentence#: 723
Task hash: 1597199106</p></div><div id="embedding-724" style="margin:50px"><p> Sentence#: 724
Task hash: -395316900</p></div><div id="embedding-725" style="margin:50px"><p> Sentence#: 725
Task hash: 410642594</p></div><div id="embedding-726" style="margin:50px"><p> Sentence#: 726
Task hash: 1706040961</p></div><div id="embedding-727" style="margin:50px"><p> Sentence#: 727
Task hash: -463014197</p></div><div id="embedding-728" style="margin:50px"><p> Sentence#: 728
Task hash: -1579595693</p></div><div id="embedding-729" style="margin:50px"><p> Sentence#: 729
Task hash: -189191230</p></div><div id="embedding-730" style="margin:50px"><p> Sentence#: 730
Task hash: 99133399</p></div><div id="embedding-731" style="margin:50px"><p> Sentence#: 731
Task hash: -844295739</p></div><div id="embedding-732" style="margin:50px"><p> Sentence#: 732
Task hash: 143724592</p></div><div id="embedding-733" style="margin:50px"><p> Sentence#: 733
Task hash: 237804820</p></div><div id="embedding-734" style="margin:50px"><p> Sentence#: 734
Task hash: 537046779</p></div><div id="embedding-735" style="margin:50px"><p> Sentence#: 735
Task hash: 255524343</p></div><div id="embedding-736" style="margin:50px"><p> Sentence#: 736
Task hash: -1226039729</p></div><div id="embedding-737" style="margin:50px"><p> Sentence#: 737
Task hash: 1926534568</p></div><div id="embedding-738" style="margin:50px"><p> Sentence#: 738
Task hash: -1421281608</p></div><div id="embedding-739" style="margin:50px"><p> Sentence#: 739
Task hash: 491251259</p></div><div id="embedding-740" style="margin:50px"><p> Sentence#: 740
Task hash: 94307791</p></div><div id="embedding-741" style="margin:50px"><p> Sentence#: 741
Task hash: -510977865</p></div><div id="embedding-742" style="margin:50px"><p> Sentence#: 742
Task hash: 1053646419</p></div><div id="embedding-743" style="margin:50px"><p> Sentence#: 743
Task hash: 1986675880</p></div><div id="embedding-744" style="margin:50px"><p> Sentence#: 744
Task hash: -1681894427</p></div><div id="embedding-745" style="margin:50px"><p> Sentence#: 745
Task hash: 1791055839</p></div><div id="embedding-746" style="margin:50px"><p> Sentence#: 746
Task hash: -1492956489</p></div><div id="embedding-747" style="margin:50px"><p> Sentence#: 747
Task hash: -1783596599</p></div><div id="embedding-748" style="margin:50px"><p> Sentence#: 748
Task hash: 581283236</p></div><div id="embedding-749" style="margin:50px"><p> Sentence#: 749
Task hash: -1945819792</p></div><div id="embedding-750" style="margin:50px"><p> Sentence#: 750
Task hash: -1976099226</p></div><div id="embedding-751" style="margin:50px"><p> Sentence#: 751
Task hash: -2141797910</p></div><div id="embedding-752" style="margin:50px"><p> Sentence#: 752
Task hash: -1596582845</p></div><div id="embedding-753" style="margin:50px"><p> Sentence#: 753
Task hash: -1768172943</p></div><div id="embedding-754" style="margin:50px"><p> Sentence#: 754
Task hash: 747101472</p></div><div id="embedding-755" style="margin:50px"><p> Sentence#: 755
Task hash: -956408914</p></div><div id="embedding-756" style="margin:50px"><p> Sentence#: 756
Task hash: 1246242703</p></div><div id="embedding-757" style="margin:50px"><p> Sentence#: 757
Task hash: -919932496</p></div><div id="embedding-758" style="margin:50px"><p> Sentence#: 758
Task hash: 313142513</p></div><div id="embedding-759" style="margin:50px"><p> Sentence#: 759
Task hash: -363296993</p></div><div id="embedding-760" style="margin:50px"><p> Sentence#: 760
Task hash: -1279016724</p></div><div id="embedding-761" style="margin:50px"><p> Sentence#: 761
Task hash: -1957354240</p></div><div id="embedding-762" style="margin:50px"><p> Sentence#: 762
Task hash: 1672167300</p></div><div id="embedding-763" style="margin:50px"><p> Sentence#: 763
Task hash: -636220364</p></div><div id="embedding-764" style="margin:50px"><p> Sentence#: 764
Task hash: -737595093</p></div><div id="embedding-765" style="margin:50px"><p> Sentence#: 765
Task hash: -643478175</p></div><div id="embedding-766" style="margin:50px"><p> Sentence#: 766
Task hash: 1760903771</p></div><div id="embedding-767" style="margin:50px"><p> Sentence#: 767
Task hash: -468192777</p></div><div id="embedding-768" style="margin:50px"><p> Sentence#: 768
Task hash: 1532828384</p></div><div id="embedding-769" style="margin:50px"><p> Sentence#: 769
Task hash: -2012165954</p></div><div id="embedding-770" style="margin:50px"><p> Sentence#: 770
Task hash: 177589350</p></div><div id="embedding-771" style="margin:50px"><p> Sentence#: 771
Task hash: -490798470</p></div><div id="embedding-772" style="margin:50px"><p> Sentence#: 772
Task hash: -620854663</p></div><div id="embedding-773" style="margin:50px"><p> Sentence#: 773
Task hash: 1646083099</p></div><div id="embedding-774" style="margin:50px"><p> Sentence#: 774
Task hash: 2070371762</p></div><div id="embedding-775" style="margin:50px"><p> Sentence#: 775
Task hash: -1925447195</p></div><div id="embedding-776" style="margin:50px"><p> Sentence#: 776
Task hash: 1168573367</p></div><div id="embedding-777" style="margin:50px"><p> Sentence#: 777
Task hash: -966672889</p></div><div id="embedding-778" style="margin:50px"><p> Sentence#: 778
Task hash: 1721836977</p></div><div id="embedding-779" style="margin:50px"><p> Sentence#: 779
Task hash: 18988758</p></div><div id="embedding-780" style="margin:50px"><p> Sentence#: 780
Task hash: 294447082</p></div><div id="embedding-781" style="margin:50px"><p> Sentence#: 781
Task hash: -1518592950</p></div><div id="embedding-782" style="margin:50px"><p> Sentence#: 782
Task hash: 2050021278</p></div><div id="embedding-783" style="margin:50px"><p> Sentence#: 783
Task hash: 911855969</p></div><div id="embedding-784" style="margin:50px"><p> Sentence#: 784
Task hash: -293227811</p></div><div id="embedding-785" style="margin:50px"><p> Sentence#: 785
Task hash: 1054444800</p></div><div id="embedding-786" style="margin:50px"><p> Sentence#: 786
Task hash: -2089736362</p></div><div id="embedding-787" style="margin:50px"><p> Sentence#: 787
Task hash: -990841031</p></div><div id="embedding-788" style="margin:50px"><p> Sentence#: 788
Task hash: 108875095</p></div><div id="embedding-789" style="margin:50px"><p> Sentence#: 789
Task hash: -1750679566</p></div><div id="embedding-790" style="margin:50px"><p> Sentence#: 790
Task hash: -646395875</p></div><div id="embedding-791" style="margin:50px"><p> Sentence#: 791
Task hash: 1310564952</p></div><div id="embedding-792" style="margin:50px"><p> Sentence#: 792
Task hash: -85808772</p></div><div id="embedding-793" style="margin:50px"><p> Sentence#: 793
Task hash: 1534791356</p></div><div id="embedding-794" style="margin:50px"><p> Sentence#: 794
Task hash: -471714460</p></div><div id="embedding-795" style="margin:50px"><p> Sentence#: 795
Task hash: 1741556342</p></div><div id="embedding-796" style="margin:50px"><p> Sentence#: 796
Task hash: -1449778914</p></div><div id="embedding-797" style="margin:50px"><p> Sentence#: 797
Task hash: -625681390</p></div><div id="embedding-798" style="margin:50px"><p> Sentence#: 798
Task hash: -758948945</p></div><div id="embedding-799" style="margin:50px"><p> Sentence#: 799
Task hash: 2071128997</p></div><div id="embedding-800" style="margin:50px"><p> Sentence#: 800
Task hash: 338392077</p></div><div id="embedding-801" style="margin:50px"><p> Sentence#: 801
Task hash: 1676593421</p></div><div id="embedding-802" style="margin:50px"><p> Sentence#: 802
Task hash: -310567717</p></div><div id="embedding-803" style="margin:50px"><p> Sentence#: 803
Task hash: 2119525620</p></div><div id="embedding-804" style="margin:50px"><p> Sentence#: 804
Task hash: 406900846</p></div><div id="embedding-805" style="margin:50px"><p> Sentence#: 805
Task hash: 2045861739</p></div><div id="embedding-806" style="margin:50px"><p> Sentence#: 806
Task hash: -1593004335</p></div><div id="embedding-807" style="margin:50px"><p> Sentence#: 807
Task hash: 278947975</p></div><div id="embedding-808" style="margin:50px"><p> Sentence#: 808
Task hash: 613176618</p></div><div id="embedding-809" style="margin:50px"><p> Sentence#: 809
Task hash: -344043407</p></div><div id="embedding-810" style="margin:50px"><p> Sentence#: 810
Task hash: 695523754</p></div><div id="embedding-811" style="margin:50px"><p> Sentence#: 811
Task hash: 1548965226</p></div><div id="embedding-812" style="margin:50px"><p> Sentence#: 812
Task hash: -1304948069</p></div><div id="embedding-813" style="margin:50px"><p> Sentence#: 813
Task hash: -1209061510</p></div><div id="embedding-814" style="margin:50px"><p> Sentence#: 814
Task hash: 1741855652</p></div><div id="embedding-815" style="margin:50px"><p> Sentence#: 815
Task hash: -1338780399</p></div><div id="embedding-816" style="margin:50px"><p> Sentence#: 816
Task hash: 1564359266</p></div><div id="embedding-817" style="margin:50px"><p> Sentence#: 817
Task hash: -2103337167</p></div><div id="embedding-818" style="margin:50px"><p> Sentence#: 818
Task hash: 1665843108</p></div><div id="embedding-819" style="margin:50px"><p> Sentence#: 819
Task hash: 1027970028</p></div><div id="embedding-820" style="margin:50px"><p> Sentence#: 820
Task hash: -1101059441</p></div><div id="embedding-821" style="margin:50px"><p> Sentence#: 821
Task hash: -247825801</p></div><div id="embedding-822" style="margin:50px"><p> Sentence#: 822
Task hash: 1264040284</p></div><div id="embedding-823" style="margin:50px"><p> Sentence#: 823
Task hash: 711673108</p></div><div id="embedding-824" style="margin:50px"><p> Sentence#: 824
Task hash: 1157467548</p></div><div id="embedding-825" style="margin:50px"><p> Sentence#: 825
Task hash: -1545377396</p></div><div id="embedding-826" style="margin:50px"><p> Sentence#: 826
Task hash: 1365591667</p></div><div id="embedding-827" style="margin:50px"><p> Sentence#: 827
Task hash: -309889734</p></div><div id="embedding-828" style="margin:50px"><p> Sentence#: 828
Task hash: 899713305</p></div><div id="embedding-829" style="margin:50px"><p> Sentence#: 829
Task hash: -1248053455</p></div><div id="embedding-830" style="margin:50px"><p> Sentence#: 830
Task hash: -1700536629</p></div><div id="embedding-831" style="margin:50px"><p> Sentence#: 831
Task hash: -57254806</p></div><div id="embedding-832" style="margin:50px"><p> Sentence#: 832
Task hash: -1855782755</p></div><div id="embedding-833" style="margin:50px"><p> Sentence#: 833
Task hash: -1952976899</p></div><div id="embedding-834" style="margin:50px"><p> Sentence#: 834
Task hash: 233086083</p></div><div id="embedding-835" style="margin:50px"><p> Sentence#: 835
Task hash: 1990681847</p></div><div id="embedding-836" style="margin:50px"><p> Sentence#: 836
Task hash: 1347429268</p></div><div id="embedding-837" style="margin:50px"><p> Sentence#: 837
Task hash: -1576260829</p></div><div id="embedding-838" style="margin:50px"><p> Sentence#: 838
Task hash: -1297528418</p></div><div id="embedding-839" style="margin:50px"><p> Sentence#: 839
Task hash: -31077396</p></div><div id="embedding-840" style="margin:50px"><p> Sentence#: 840
Task hash: 2050378196</p></div><div id="embedding-841" style="margin:50px"><p> Sentence#: 841
Task hash: 1078049662</p></div><div id="embedding-842" style="margin:50px"><p> Sentence#: 842
Task hash: -1731182865</p></div><div id="embedding-843" style="margin:50px"><p> Sentence#: 843
Task hash: -1183522067</p></div><div id="embedding-844" style="margin:50px"><p> Sentence#: 844
Task hash: 1257951844</p></div><div id="embedding-845" style="margin:50px"><p> Sentence#: 845
Task hash: 1015581938</p></div><div id="embedding-846" style="margin:50px"><p> Sentence#: 846
Task hash: -310781357</p></div><div id="embedding-847" style="margin:50px"><p> Sentence#: 847
Task hash: 928113899</p></div><div id="embedding-848" style="margin:50px"><p> Sentence#: 848
Task hash: 1972163467</p></div><div id="embedding-849" style="margin:50px"><p> Sentence#: 849
Task hash: 210173044</p></div><div id="embedding-850" style="margin:50px"><p> Sentence#: 850
Task hash: -1610658364</p></div><div id="embedding-851" style="margin:50px"><p> Sentence#: 851
Task hash: 2122640440</p></div><div id="embedding-852" style="margin:50px"><p> Sentence#: 852
Task hash: 1942900826</p></div><div id="embedding-853" style="margin:50px"><p> Sentence#: 853
Task hash: -746196914</p></div><div id="embedding-854" style="margin:50px"><p> Sentence#: 854
Task hash: -1824184458</p></div><div id="embedding-855" style="margin:50px"><p> Sentence#: 855
Task hash: 1201104267</p></div><div id="embedding-856" style="margin:50px"><p> Sentence#: 856
Task hash: -276994944</p></div><div id="embedding-857" style="margin:50px"><p> Sentence#: 857
Task hash: 1401657559</p></div><div id="embedding-858" style="margin:50px"><p> Sentence#: 858
Task hash: 454513455</p></div><div id="embedding-859" style="margin:50px"><p> Sentence#: 859
Task hash: 443713364</p></div><div id="embedding-860" style="margin:50px"><p> Sentence#: 860
Task hash: 987663559</p></div><div id="embedding-861" style="margin:50px"><p> Sentence#: 861
Task hash: 1762205310</p></div><div id="embedding-862" style="margin:50px"><p> Sentence#: 862
Task hash: 1076991410</p></div><div id="embedding-863" style="margin:50px"><p> Sentence#: 863
Task hash: 981932098</p></div><div id="embedding-864" style="margin:50px"><p> Sentence#: 864
Task hash: 906254762</p></div><div id="embedding-865" style="margin:50px"><p> Sentence#: 865
Task hash: -1057036120</p></div><div id="embedding-866" style="margin:50px"><p> Sentence#: 866
Task hash: -792217289</p></div><div id="embedding-867" style="margin:50px"><p> Sentence#: 867
Task hash: 966429111</p></div><div id="embedding-868" style="margin:50px"><p> Sentence#: 868
Task hash: 1339551658</p></div><div id="embedding-869" style="margin:50px"><p> Sentence#: 869
Task hash: 1322195766</p></div><div id="embedding-870" style="margin:50px"><p> Sentence#: 870
Task hash: 1776493182</p></div><div id="embedding-871" style="margin:50px"><p> Sentence#: 871
Task hash: -1060627951</p></div><div id="embedding-872" style="margin:50px"><p> Sentence#: 872
Task hash: -837855320</p></div><div id="embedding-873" style="margin:50px"><p> Sentence#: 873
Task hash: -349435788</p></div><div id="embedding-874" style="margin:50px"><p> Sentence#: 874
Task hash: 1664622193</p></div><div id="embedding-875" style="margin:50px"><p> Sentence#: 875
Task hash: -1886196831</p></div><div id="embedding-876" style="margin:50px"><p> Sentence#: 876
Task hash: 1201897598</p></div><div id="embedding-877" style="margin:50px"><p> Sentence#: 877
Task hash: 1189161433</p></div><div id="embedding-878" style="margin:50px"><p> Sentence#: 878
Task hash: 272899251</p></div><div id="embedding-879" style="margin:50px"><p> Sentence#: 879
Task hash: 326280679</p></div><div id="embedding-880" style="margin:50px"><p> Sentence#: 880
Task hash: -1506604103</p></div><div id="embedding-881" style="margin:50px"><p> Sentence#: 881
Task hash: -274447476</p></div><div id="embedding-882" style="margin:50px"><p> Sentence#: 882
Task hash: -457586386</p></div><div id="embedding-883" style="margin:50px"><p> Sentence#: 883
Task hash: 1545604187</p></div><div id="embedding-884" style="margin:50px"><p> Sentence#: 884
Task hash: -1340275620</p></div><div id="embedding-885" style="margin:50px"><p> Sentence#: 885
Task hash: 585137641</p></div><div id="embedding-886" style="margin:50px"><p> Sentence#: 886
Task hash: 1603623055</p></div><div id="embedding-887" style="margin:50px"><p> Sentence#: 887
Task hash: -112422943</p></div><div id="embedding-888" style="margin:50px"><p> Sentence#: 888
Task hash: 575391962</p></div><div id="embedding-889" style="margin:50px"><p> Sentence#: 889
Task hash: -1208262191</p></div><div id="embedding-890" style="margin:50px"><p> Sentence#: 890
Task hash: -2120535105</p></div><div id="embedding-891" style="margin:50px"><p> Sentence#: 891
Task hash: 188373212</p></div><div id="embedding-892" style="margin:50px"><p> Sentence#: 892
Task hash: 1130052428</p></div><div id="embedding-893" style="margin:50px"><p> Sentence#: 893
Task hash: -464410252</p></div><div id="embedding-894" style="margin:50px"><p> Sentence#: 894
Task hash: 1340287274</p></div><div id="embedding-895" style="margin:50px"><p> Sentence#: 895
Task hash: 488572527</p></div><div id="embedding-896" style="margin:50px"><p> Sentence#: 896
Task hash: 2104081629</p></div><div id="embedding-897" style="margin:50px"><p> Sentence#: 897
Task hash: 1828131553</p></div><div id="embedding-898" style="margin:50px"><p> Sentence#: 898
Task hash: 1773724587</p></div><div id="embedding-899" style="margin:50px"><p> Sentence#: 899
Task hash: -582613921</p></div><div id="embedding-900" style="margin:50px"><p> Sentence#: 900
Task hash: -610053778</p></div><div id="embedding-901" style="margin:50px"><p> Sentence#: 901
Task hash: 15868320</p></div><div id="embedding-902" style="margin:50px"><p> Sentence#: 902
Task hash: -694270459</p></div><div id="embedding-903" style="margin:50px"><p> Sentence#: 903
Task hash: 1293947339</p></div><div id="embedding-904" style="margin:50px"><p> Sentence#: 904
Task hash: 1027371649</p></div><div id="embedding-905" style="margin:50px"><p> Sentence#: 905
Task hash: 1223155538</p></div><div id="embedding-906" style="margin:50px"><p> Sentence#: 906
Task hash: -473995608</p></div><div id="embedding-907" style="margin:50px"><p> Sentence#: 907
Task hash: -1897292650</p></div><div id="embedding-908" style="margin:50px"><p> Sentence#: 908
Task hash: 1755309756</p></div><div id="embedding-909" style="margin:50px"><p> Sentence#: 909
Task hash: -1319959797</p></div><div id="embedding-910" style="margin:50px"><p> Sentence#: 910
Task hash: 2108486638</p></div><div id="embedding-911" style="margin:50px"><p> Sentence#: 911
Task hash: 1979122051</p></div><div id="embedding-912" style="margin:50px"><p> Sentence#: 912
Task hash: 1794287193</p></div><div id="embedding-913" style="margin:50px"><p> Sentence#: 913
Task hash: -2015950392</p></div><div id="embedding-914" style="margin:50px"><p> Sentence#: 914
Task hash: 659507683</p></div><div id="embedding-915" style="margin:50px"><p> Sentence#: 915
Task hash: 1652630987</p></div><div id="embedding-916" style="margin:50px"><p> Sentence#: 916
Task hash: -959141866</p></div><div id="embedding-917" style="margin:50px"><p> Sentence#: 917
Task hash: 413991972</p></div><div id="embedding-918" style="margin:50px"><p> Sentence#: 918
Task hash: 1606387754</p></div><div id="embedding-919" style="margin:50px"><p> Sentence#: 919
Task hash: 155176934</p></div><div id="embedding-920" style="margin:50px"><p> Sentence#: 920
Task hash: 1958088280</p></div><div id="embedding-921" style="margin:50px"><p> Sentence#: 921
Task hash: -1421589597</p></div><div id="embedding-922" style="margin:50px"><p> Sentence#: 922
Task hash: -1698879313</p></div><div id="embedding-923" style="margin:50px"><p> Sentence#: 923
Task hash: 1798311740</p></div><div id="embedding-924" style="margin:50px"><p> Sentence#: 924
Task hash: 1766293150</p></div><div id="embedding-925" style="margin:50px"><p> Sentence#: 925
Task hash: -1861602871</p></div><div id="embedding-926" style="margin:50px"><p> Sentence#: 926
Task hash: -1356636697</p></div><div id="embedding-927" style="margin:50px"><p> Sentence#: 927
Task hash: -2068375045</p></div><div id="embedding-928" style="margin:50px"><p> Sentence#: 928
Task hash: 1814548259</p></div><div id="embedding-929" style="margin:50px"><p> Sentence#: 929
Task hash: 2006811153</p></div><div id="embedding-930" style="margin:50px"><p> Sentence#: 930
Task hash: -1171100371</p></div><div id="embedding-931" style="margin:50px"><p> Sentence#: 931
Task hash: 1588136228</p></div><div id="embedding-932" style="margin:50px"><p> Sentence#: 932
Task hash: 1405683981</p></div><div id="embedding-933" style="margin:50px"><p> Sentence#: 933
Task hash: -1222961202</p></div><div id="embedding-934" style="margin:50px"><p> Sentence#: 934
Task hash: -1549466637</p></div><div id="embedding-935" style="margin:50px"><p> Sentence#: 935
Task hash: -621876135</p></div><div id="embedding-936" style="margin:50px"><p> Sentence#: 936
Task hash: -383127636</p></div><div id="embedding-937" style="margin:50px"><p> Sentence#: 937
Task hash: 1226119001</p></div><div id="embedding-938" style="margin:50px"><p> Sentence#: 938
Task hash: -1255398837</p></div><div id="embedding-939" style="margin:50px"><p> Sentence#: 939
Task hash: 392818406</p></div><div id="embedding-940" style="margin:50px"><p> Sentence#: 940
Task hash: -934642690</p></div><div id="embedding-941" style="margin:50px"><p> Sentence#: 941
Task hash: -567585052</p></div><div id="embedding-942" style="margin:50px"><p> Sentence#: 942
Task hash: 716431561</p></div><div id="embedding-943" style="margin:50px"><p> Sentence#: 943
Task hash: 250590014</p></div><div id="embedding-944" style="margin:50px"><p> Sentence#: 944
Task hash: -1903418538</p></div><div id="embedding-945" style="margin:50px"><p> Sentence#: 945
Task hash: -1688572656</p></div><div id="embedding-946" style="margin:50px"><p> Sentence#: 946
Task hash: -1622101341</p></div><div id="embedding-947" style="margin:50px"><p> Sentence#: 947
Task hash: 808707243</p></div><div id="embedding-948" style="margin:50px"><p> Sentence#: 948
Task hash: -352580434</p></div><div id="embedding-949" style="margin:50px"><p> Sentence#: 949
Task hash: -566938450</p></div><div id="embedding-950" style="margin:50px"><p> Sentence#: 950
Task hash: -144197884</p></div><div id="embedding-951" style="margin:50px"><p> Sentence#: 951
Task hash: -1905290727</p></div><div id="embedding-952" style="margin:50px"><p> Sentence#: 952
Task hash: 742025143</p></div><div id="embedding-953" style="margin:50px"><p> Sentence#: 953
Task hash: -80907958</p></div><div id="embedding-954" style="margin:50px"><p> Sentence#: 954
Task hash: -1261803835</p></div><div id="embedding-955" style="margin:50px"><p> Sentence#: 955
Task hash: 1117315234</p></div><div id="embedding-956" style="margin:50px"><p> Sentence#: 956
Task hash: -709320724</p></div><div id="embedding-957" style="margin:50px"><p> Sentence#: 957
Task hash: -524962873</p></div><div id="embedding-958" style="margin:50px"><p> Sentence#: 958
Task hash: 1407003057</p></div><div id="embedding-959" style="margin:50px"><p> Sentence#: 959
Task hash: 1533258816</p></div><div id="embedding-960" style="margin:50px"><p> Sentence#: 960
Task hash: -605452527</p></div><div id="embedding-961" style="margin:50px"><p> Sentence#: 961
Task hash: 354788465</p></div><div id="embedding-962" style="margin:50px"><p> Sentence#: 962
Task hash: -586129330</p></div><div id="embedding-963" style="margin:50px"><p> Sentence#: 963
Task hash: -1512350671</p></div><div id="embedding-964" style="margin:50px"><p> Sentence#: 964
Task hash: 1862317801</p></div><div id="embedding-965" style="margin:50px"><p> Sentence#: 965
Task hash: 835534191</p></div><div id="embedding-966" style="margin:50px"><p> Sentence#: 966
Task hash: -1242578126</p></div><div id="embedding-967" style="margin:50px"><p> Sentence#: 967
Task hash: 1072660936</p></div><div id="embedding-968" style="margin:50px"><p> Sentence#: 968
Task hash: -187249324</p></div><div id="embedding-969" style="margin:50px"><p> Sentence#: 969
Task hash: 709856478</p></div><div id="embedding-970" style="margin:50px"><p> Sentence#: 970
Task hash: 607354155</p></div><div id="embedding-971" style="margin:50px"><p> Sentence#: 971
Task hash: 2122674236</p></div><div id="embedding-972" style="margin:50px"><p> Sentence#: 972
Task hash: -182370665</p></div><div id="embedding-973" style="margin:50px"><p> Sentence#: 973
Task hash: -362287785</p></div><div id="embedding-974" style="margin:50px"><p> Sentence#: 974
Task hash: 1174568465</p></div><div id="embedding-975" style="margin:50px"><p> Sentence#: 975
Task hash: 550323258</p></div><div id="embedding-976" style="margin:50px"><p> Sentence#: 976
Task hash: -1565393988</p></div><div id="embedding-977" style="margin:50px"><p> Sentence#: 977
Task hash: -499005829</p></div><div id="embedding-978" style="margin:50px"><p> Sentence#: 978
Task hash: 926222776</p></div><div id="embedding-979" style="margin:50px"><p> Sentence#: 979
Task hash: -26976372</p></div><div id="embedding-980" style="margin:50px"><p> Sentence#: 980
Task hash: 1371521118</p></div><div id="embedding-981" style="margin:50px"><p> Sentence#: 981
Task hash: -97730022</p></div><div id="embedding-982" style="margin:50px"><p> Sentence#: 982
Task hash: 722728763</p></div><div id="embedding-983" style="margin:50px"><p> Sentence#: 983
Task hash: -1656632824</p></div><div id="embedding-984" style="margin:50px"><p> Sentence#: 984
Task hash: -1566090199</p></div><div id="embedding-985" style="margin:50px"><p> Sentence#: 985
Task hash: 954584292</p></div><div id="embedding-986" style="margin:50px"><p> Sentence#: 986
Task hash: -231178956</p></div><div id="embedding-987" style="margin:50px"><p> Sentence#: 987
Task hash: -181987425</p></div><div id="embedding-988" style="margin:50px"><p> Sentence#: 988
Task hash: -1084591110</p></div><div id="embedding-989" style="margin:50px"><p> Sentence#: 989
Task hash: -1317816317</p></div><div id="embedding-990" style="margin:50px"><p> Sentence#: 990
Task hash: 558510998</p></div><div id="embedding-991" style="margin:50px"><p> Sentence#: 991
Task hash: 203163462</p></div><div id="embedding-992" style="margin:50px"><p> Sentence#: 992
Task hash: -762541150</p></div><script type="text/javascript"> head.ready(function() { 
    Util.embed(
    'embedding-0',
    collData,
    {
        text: "Only limited cycle 4 PK data were available (n=3; 20MI arm); however, the ratio of AUC (cycle 4/cycle 1) for these few patients was close to 1, suggesting no drug accumulation.",
        entities: [['T0', 'PK', [[74, 104]]], ['T1', 'VALUE', [[141, 142]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-1',
    collData,
    {
        text: "The geometric mean ratios for Cmax and AUC in fed versus fasted subjects were 66% (90% CI 60.7–71.7) and 80% (90% CI 72.6–88.1), respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-2',
    collData,
    {
        text: "The initial volume of distribution was 22 ml and the postdistribution volume of distribution was 1076 ml, which indicated an extensive distribution of radioactivity.",
        entities: [['T0', 'UNITS', [[42, 44]]], ['T1', 'VALUE', [[39, 41]]], ['T2', 'UNITS', [[102, 104]]], ['T3', 'VALUE', [[97, 101]]], ['T4', 'PK', [[12, 34]]], ['T5', 'PK', [[70, 92]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-3',
    collData,
    {
        text: "A total of 2,665 peginesatide plasma samples collected from 672 CKD patients on or not on dialysis enrolled in five clinical trials (one phase 3 trial: AFX01-14 [9] and four Phase 2 trials [AFX01-02 [data on file], AFX01-03 [7], AFX01-04 [8], AFX01-07 [data on file]]) were used in the population PK analysis.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-4',
    collData,
    {
        text: "There was prolonged elimination half-life of formulation 2 (7.50+-0.94) than formulation 3 (7.43+-0.54) while product 1 (4.54+-0.15) showed lowest half-life.",
        entities: [['T0', 'VALUE', [[66, 70]]], ['T1', 'VALUE', [[60, 64]]], ['T2', 'VALUE', [[98, 102]]], ['T3', 'VALUE', [[92, 96]]], ['T4', 'VALUE', [[127, 131]]], ['T5', 'VALUE', [[121, 125]]], ['T6', 'PK', [[20, 41]]]],
        relations: [['R0', 'D_VAL', [['Entity', 'T0'], ['D_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T3']]], ['R2', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T5']]], ['R3', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T3']]], ['R5', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-5',
    collData,
    {
        text: "Temozolomide was unstable at 37 degrees C in human plasma with a degradation t1/2 of 15 min; however, it was stable at 4 degrees C for at least 30 min.",
        entities: [['T0', 'UNITS', [[88, 91]]], ['T1', 'VALUE', [[85, 87]]], ['T2', 'PK', [[65, 81]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-6',
    collData,
    {
        text: "The AUC(0→ t ) of DTX and RES in mPEG-PDLA micelles after i.v. administration to rats were 3.0-fold and 1.6-fold higher than that of i.v. injections of the individual drugs.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-7',
    collData,
    {
        text: "The 90% confidence intervals for test/reference mean ratio of the plasma pharmacokinetic variables Cmax and AUC0-inf were 103.7–118.3 and 97.1–110.0, respectively, which is within the accepted bioequivalence range of 80–125%.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-8',
    collData,
    {
        text: "The longest half-life occurred with ESRD (6 h), which was four times that of subjects with normal renal function.",
        entities: [['T0', 'UNITS', [[44, 45]]], ['T1', 'VALUE', [[42, 43]]], ['T2', 'PK', [[12, 21]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-9',
    collData,
    {
        text: "Ka for binding to ACE of each inhibitor was significantly higher in right and left atrium than in lung (P less than 0.05) or the right and left ventricle (P less than 0.005).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-10',
    collData,
    {
        text: "A total of 85 patients received amikacin treatment, of whom 71 (83.5%) achieved a Cmax/MIC >6, 66 (77.6%) a Cmax/MIC >8, 64 (75.3%) a Cmax/MIC >10 and 72 (84.7%) an AUC/MIC >65.",
        entities: [['T0', 'PK', [[82, 90]]], ['T1', 'VALUE', [[92, 93]]], ['T2', 'COMPARE', [[91, 92]]], ['T3', 'COMPARE', [[117, 118]]], ['T4', 'VALUE', [[118, 119]]], ['T5', 'PK', [[108, 116]]], ['T6', 'PK', [[134, 142]]], ['T7', 'VALUE', [[144, 146]]], ['T8', 'COMPARE', [[143, 144]]], ['T9', 'PK', [[165, 172]]], ['T10', 'VALUE', [[174, 176]]], ['T11', 'COMPARE', [[173, 174]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]], ['R6', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T10']]], ['R7', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T10']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-11',
    collData,
    {
        text: "In calcium imaging experiments on mouse muscle type α1β1εδ nAChR, Az showed a high inhibitory activity in nanomolar range (IC50 = 19 ± 8 nM, Figure 2a).",
        entities: [['T0', 'PK', [[123, 127]]], ['T1', 'VALUE', [[130, 132]]], ['T2', 'VALUE', [[135, 136]]], ['T3', 'UNITS', [[137, 139]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-12',
    collData,
    {
        text: "Time to maximum plasma concentration was significantly shorter for the nasogastric tube suspension and apple puree vs. the whole tablet [Hodges–Lehmann estimate of median difference (90% confidence interval): −0.75 (−1.25, −0.28); p = 0.0003 and −0.62 (−0.99, −0.26); p = 0.0024, respectively].",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-13',
    collData,
    {
        text: "The geometric mean ratios (triple combination relative to pemetrexed/carboplatin alone) for pemetrexed Cmax and AUC∞ were 1.20 and 1.03, respectively; for total platinum Cmax and AUC24 they were 0.97 and 1.00; and for free platinum Cmax and AUC24 they were 0.94 and 0.95 (Table 5).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-14',
    collData,
    {
        text: "For MISO the product of the plasma concentration and survival time (area under the curve (AUC) was constant and equal to approximately 50-mM-hrs.",
        entities: [['T0', 'UNITS', [[138, 144]]], ['T1', 'VALUE', [[135, 137]]], ['T2', 'PK', [[68, 94]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-15',
    collData,
    {
        text: "Because of the substantial increase in potency conferred by GalNAc3 conjugation for reducing RNA targets expressed in the hepatocyte, and the elimination half-lives from tissues for these agents range from 3 to 4 weeks, we also evaluated monthly administration of the GalNAc3-conjugated 2′MOE ASOs.",
        entities: [['T0', 'UNITS', [[213, 218]]], ['T1', 'RANGE', [[206, 212]]], ['T2', 'PK', [[142, 177]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-16',
    collData,
    {
        text: "Figure 9B (inset) shows the peak:trough ratio at steady state for the data shown in Figure 9B, and for data from a parallel experiment (not shown) in which a stomach volume of 35 ml was used.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-17',
    collData,
    {
        text: "When combined with binimetinib, Cmax and AUCtau of buparlisib were reduced by >50% in many patients, but this reduction is within the variability of buparlisib exposure and clinical relevance is unclear.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-18',
    collData,
    {
        text: "The chromatographic responses (ratio of peak area of DBT to IS versus DBT concentration) were found to be linear over an analytical range of 50–2000 ng/mL with correlation coefficient (r2) value of 0.9992, which showed reproducibility.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-19',
    collData,
    {
        text: "At steady state, rufinamide reached a peak plasma concentration with a mean time (Tmax) of 3.4 h and a mean half-life (t1/2) of 7.3 h. No autoinduction of rufinamide metabolism occurred.",
        entities: [['T0', 'UNITS', [[95, 96]]], ['T1', 'VALUE', [[91, 94]]], ['T2', 'UNITS', [[132, 133]]], ['T3', 'VALUE', [[128, 131]]], ['T4', 'PK', [[76, 87]]], ['T5', 'PK', [[108, 124]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-20',
    collData,
    {
        text: "These trends were replicated in vivo where danazol bioavailability in beagle dogs was higher after oral administration of self-emulsifying formulations employing 55% (w/w) CrRH when compared with CrEL.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-21',
    collData,
    {
        text: "The time to reach 80% of the MPA was 68.2 ± 44.2 and 123.5 ± 56.2 minutes for prasugrel and clopidogrel, respectively.",
        entities: [['T0', 'PK', [[4, 21]]], ['T1', 'VALUE', [[37, 41]]], ['T2', 'VALUE', [[53, 58]]], ['T3', 'UNITS', [[66, 73]]], ['T4', 'VALUE', [[44, 48]]], ['T5', 'VALUE', [[61, 65]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R4', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R6', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T2']]], ['R7', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-22',
    collData,
    {
        text: "Monte Carlo simulations were used to determine that administration of a 5.08 mg/kg dose of oseltamivir phosphate to ferret every 12 h for 5 days results in the same median OC area under the plasma concentration-time curve 0–12 h (i.e., 3220 mg h/mL) as that observed in humans during steady state at the approved dose of 75 mg twice daily for 5 days.",
        entities: [['T0', 'UNITS', [[241, 248]]], ['T1', 'VALUE', [[236, 240]]], ['T2', 'PK', [[175, 228]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-23',
    collData,
    {
        text: "Median lopinavir trough (C0) concentrations were above the recommended lower limit for ART-naïve patients of 1 μg/ [23].",
        entities: [['T0', 'PK', [[17, 43]]], ['T1', 'VALUE', [[109, 110]]], ['T2', 'COMPARE', [[49, 54]]], ['T3', 'UNITS', [[111, 114]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-24',
    collData,
    {
        text: "In vivo fraction absorbed plots indicated that the three generic formulations were absorbed more rapidly than the innovator product, and the mean time of maximum plasma concentration was 6-7 hr sooner for the generic formulations.",
        entities: [['T0', 'PK', [[146, 182]]], ['T1', 'RANGE', [[187, 190]]], ['T2', 'UNITS', [[191, 193]]], ['T3', 'COMPARE', [[194, 200]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-25',
    collData,
    {
        text: "The best LC peak symmetry was achieved when less than 20% of any organic solvent was used as the mobile phase and the retention time of AACA under these conditions showed only an increase of about 0.5 min compared to cases of using 40% of the same solvent for the mobile phase.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-26',
    collData,
    {
        text: "Throughout the treatment period, mean trough plasma forodesine concentrations at each time point remained within a range of 460 to 540 ng/mL. The AUClast values after dosing on days 1 and 15 were 3540 and 6520 ng h/mL, indicating an accumulation ratio of 1.8.",
        entities: [['T0', 'PK', [[38, 77]]], ['T1', 'RANGE', [[124, 134]]], ['T2', 'PK', [[146, 153]]], ['T3', 'VALUE', [[196, 200]]], ['T4', 'VALUE', [[205, 209]]], ['T5', 'UNITS', [[210, 217]]], ['T6', 'UNITS', [[135, 140]]], ['T7', 'PK', [[233, 251]]], ['T8', 'VALUE', [[255, 258]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T1']]], ['R6', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T8']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-27',
    collData,
    {
        text: "Relative bioavailability:(2)F%=AUC0–t,Pue−CCMsAUC0–t,puerarin×100%.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-28',
    collData,
    {
        text: "The ibandronate dialysis plasma clearance was determined at 92+-19 ml/min.",
        entities: [['T0', 'PK', [[25, 41]]], ['T1', 'VALUE', [[60, 62]]], ['T2', 'VALUE', [[64, 66]]], ['T3', 'UNITS', [[67, 73]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-29',
    collData,
    {
        text: "N-desmethyl enzalutamide and the carboxylic acid metabolite appeared to be formed slowly, with median tmax in plasma of 132 and 96 h (5.5 and 4.0 days) postdose, respectively.",
        entities: [['T0', 'PK', [[102, 106]]], ['T1', 'VALUE', [[120, 123]]], ['T2', 'VALUE', [[128, 130]]], ['T3', 'VALUE', [[142, 145]]], ['T4', 'UNITS', [[131, 132]]], ['T5', 'UNITS', [[146, 150]]], ['T6', 'VALUE', [[134, 137]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R5', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T6']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T6']]], ['R7', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-30',
    collData,
    {
        text: "In contrast, IPCS (2005, page 39) states its default position for dosimetric choice in the absence of data is to use the area under the curve (or AUC).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-31',
    collData,
    {
        text: "For propofol, halothane anaesthesia was associated with a statistically significant reduction in clearance (50% of awake), a slower initial half-life (247% of awake), and the emergence of a second slower half-life in some sheep.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-32',
    collData,
    {
        text: "During submaximal exercise, liver blood flow fell on average 71, 68 and 70%, respectively, during the three procedures, while calculated t-PA clearance decreased on average 59, 59 and 53%.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-33',
    collData,
    {
        text: "However, with an AUC24/MIC >345, only 33% of all patients with staphylococcal infection attained the target.",
        entities: [['T0', 'PK', [[17, 26]]], ['T1', 'VALUE', [[28, 31]]], ['T2', 'COMPARE', [[27, 28]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-34',
    collData,
    {
        text: "Upon repeated dosing, steady state was attained within 2–3 days, with no significant accumulation in exposure beyond that expected for repeat-dosing (ARAUCtau = 2.7; Table 1).",
        entities: [['T0', 'PK', [[150, 158]]], ['T1', 'VALUE', [[161, 164]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-35',
    collData,
    {
        text: "Plasma concentrations reached a mean Cmax of 23.4 μg/mL (range, 14.7-46.0 μg/mL) at 1.8 hours (range, 0.5-6 hours), with a terminal half-life of 7.4 hours (range, 1.4-40.9 hours).",
        entities: [['T0', 'PK', [[37, 41]]], ['T1', 'VALUE', [[45, 49]]], ['T2', 'PK', [[123, 141]]], ['T3', 'VALUE', [[145, 148]]], ['T4', 'UNITS', [[50, 55]]], ['T5', 'UNITS', [[149, 154]]], ['T6', 'RANGE', [[64, 73]]], ['T7', 'UNITS', [[74, 79]]], ['T8', 'RANGE', [[163, 171]]], ['T9', 'UNITS', [[172, 177]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T3']]], ['R7', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-36',
    collData,
    {
        text: "Also, Tmax was smaller in the self-emulsifying formulation group (1.25 h) compared with market products (2 h) and the dissolved amount from self-emulsifying formulations in water at 15 min was much higher (more than 80%) than that of the market products (less than 5%).",
        entities: [['T0', 'PK', [[6, 10]]], ['T1', 'VALUE', [[66, 70]]], ['T2', 'VALUE', [[105, 106]]], ['T3', 'UNITS', [[71, 72]]], ['T4', 'UNITS', [[107, 108]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-37',
    collData,
    {
        text: "Peak concentrations of IVM were 15.7, 23.3 and 1.9 µg/kg, observed 2, 5 and 4 days after I/V, S/C and oral administration, respectively.",
        entities: [['T0', 'UNITS', [[51, 56]]], ['T1', 'VALUE', [[47, 50]]], ['T2', 'VALUE', [[38, 42]]], ['T3', 'VALUE', [[32, 36]]], ['T4', 'PK', [[0, 19]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T2']]], ['R5', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-38',
    collData,
    {
        text: "Empirical mean concentrations are not within the confidence intervals for the steady state minimum estimated from the popPK model except perhaps for the 250 mg group.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-39',
    collData,
    {
        text: "For the combined group (corrected for the patient effect) the oldest third (mean age 70 years) had a mean clearance of 0.53 versus 0.72 for the middle third (mean age 47 years) and 0.73 ml/min/kg CBW for the youngest third (mean age 26 years).",
        entities: [['T0', 'PK', [[106, 115]]], ['T1', 'VALUE', [[119, 123]]], ['T2', 'VALUE', [[131, 135]]], ['T3', 'VALUE', [[181, 185]]], ['T4', 'UNITS', [[186, 195]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]], ['R5', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-40',
    collData,
    {
        text: "Allometric scaling9 was added a priori along with a fixed sigmoidal maturation function on clearance based on glomerular filtration maturation for ceftriaxone10 and CYP2A6 maturation11 for metronidazole.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-41',
    collData,
    {
        text: "However, peak concentrations for nicotinamide alone were significantly lower than in plasma, and very variable, whereas for nicotinamide plus nicotinic acid saliva levels were 20-30% higher, but more consistent.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-42',
    collData,
    {
        text: "VU0409106 emerged as a lead compound within a biaryl ether series, displaying potent and selective inhibition of mGlu₅. Despite its high clearance and short half-life, VU0409106 demonstrated efficacy in rodent models of anxiety after extravascular administration.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-43',
    collData,
    {
        text: "Although the mean trough concentrations of NFV remained above the stated minimum effective concentration of 0.4 microg/ml, there is nevertheless concern that some patients will fall below this value when NVP is added to treatment regimens.",
        entities: [['T0', 'UNITS', [[112, 121]]], ['T1', 'VALUE', [[108, 111]]], ['T2', 'PK', [[73, 104]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-44',
    collData,
    {
        text: "The plasma elimination half-life was estimated to be 6.37 h (1.7 h).",
        entities: [['T0', 'UNITS', [[58, 59]]], ['T1', 'VALUE', [[53, 57]]], ['T2', 'VALUE', [[61, 64]]], ['T3', 'UNITS', [[65, 66]]], ['T4', 'PK', [[4, 32]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-45',
    collData,
    {
        text: "Elimination rate constant (k(dial)), elimination half-life (t1/2beta, dial)) and clearance (CL(dial)) during 3.5-4 hours of dialysis were also determined from the pre- and post-plasma concentrations.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-46',
    collData,
    {
        text: "Bioequivalence between the products was determined by calculating 90% confidence intervals (90% CI) for the ratio of C(max), AUC(0-t) and AUC(0-infinity) values for the test and reference products, using logarithmic transformed data.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-47',
    collData,
    {
        text: "Peak serum concentrations were reached in a median time of 36 hours postdose, and a mean apparent clearance of 3.51 mL/h/kg was comparable to that observed previously in this patient population.",
        entities: [['T0', 'UNITS', [[116, 123]]], ['T1', 'VALUE', [[111, 115]]], ['T2', 'PK', [[89, 107]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-48',
    collData,
    {
        text: "Calibration curves were plotted as the peak area ratio (tolterodine/tolterodine-d6) versus (tolterodine) concentration for tolterodine and the peak area ratio (5-hydroxy methyl tolterodine/5-hydroxy methyl tolterodine-d14) versus (5-hydroxy methyl tolterodine) concentration for 5-hydroxy methyl tolterodine.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-49',
    collData,
    {
        text: "However, Cmax was higher following the administration of recrystallized MBZ (0.073±0.009 μg/mL) versus MBZ alone (0.052±0.014 μg/mL), this difference being statistically significant (P=0.016).",
        entities: [['T0', 'UNITS', [[89, 94]]], ['T1', 'VALUE', [[77, 82]]], ['T2', 'UNITS', [[126, 131]]], ['T3', 'VALUE', [[114, 119]]], ['T4', 'VALUE', [[83, 88]]], ['T5', 'VALUE', [[120, 125]]], ['T6', 'PK', [[9, 13]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T3']]], ['R5', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T5']]], ['R6', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]], ['R7', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-50',
    collData,
    {
        text: "However, clearance was inhibited over time to 76.4% of its original value, dependent on the concentration in an empirical inhibition compartment.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-51',
    collData,
    {
        text: "The point estimate and 90% CI of the ratios of the geometric means (after RG intake/before RG intake) of Cmax and AUClast of midazolam were 0.947 (0.756–1.186) and 1.128 (1.000–1.271), respectively, and that of the midazolam metabolic ratio, i.e., 1-hydroxymidazolam AUC/midazolam AUC, for the evaluation of CYP3A4 enzyme activity was 0.824 (0.658–1.032).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-52',
    collData,
    {
        text: "Ritonavir was a very potent inhibitor of CYP3A4 mediated testosterone 6beta-hydroxylation (mean K(i) = 0.019 +- 0.004 microM, mean +- s.d.; n = 6) and also inhibited tolbutamide hydroxylation (IC50 = 4.2 +- 1.3 microM, mean +- s.d.; n = 6).",
        entities: [['T0', 'UNITS', [[118, 124]]], ['T1', 'VALUE', [[103, 108]]], ['T2', 'UNITS', [[211, 217]]], ['T3', 'VALUE', [[200, 203]]], ['T4', 'VALUE', [[207, 210]]], ['T5', 'VALUE', [[112, 117]]], ['T6', 'PK', [[193, 197]]], ['T7', 'PK', [[96, 100]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T5']]], ['R6', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T3']]], ['R7', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-53',
    collData,
    {
        text: "The prospective PBPK modeling predicted an 11% increase and 12% decrease in M4 AUC0‐∞ in subjects with moderate and severe hepatic impairment, respectively, relative to matched healthy subjects.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-54',
    collData,
    {
        text: "Compared with warfarin alone, mean AUCPT;0–168 h values showed no difference with amenamevir at a dosage of 200 mg once daily and were slightly lower with amenamevir at a dosage of 400 mg once daily.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-55',
    collData,
    {
        text: "At steady-state, apparent volume of distribution (Vd/fm) was 1.5 ± 1.1 L/kg.",
        entities: [['T0', 'UNITS', [[71, 75]]], ['T1', 'VALUE', [[61, 64]]], ['T2', 'VALUE', [[67, 70]]], ['T3', 'PK', [[17, 56]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-56',
    collData,
    {
        text: "Half the patients had an ECOG score of 0, with the other half having an ECOG score of 1.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-57',
    collData,
    {
        text: "The geometric mean ratio (90% confidence interval) of AUC0–4 for subjects with severe renal impairment compared to healthy subjects was 135% (94%–195%), and for Cmax was 137% (84%–222%).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-58',
    collData,
    {
        text: "Harmonic mean terminal half-lives for FLU were 3.42, 4.48, and 5.39 h for intravenous, intramuscular, and subcutaneous injection, respectively.",
        entities: [['T0', 'UNITS', [[68, 69]]], ['T1', 'VALUE', [[47, 51]]], ['T2', 'VALUE', [[53, 57]]], ['T3', 'PK', [[14, 33]]], ['T4', 'VALUE', [[63, 67]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R4', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R5', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-59',
    collData,
    {
        text: "The mean +- SD ng/ml x h single-day lactone SN-38 area under the concentration-time curve (AUC(0-->6) was 90.9 +- 96.4, 103.7 +- 62.4, and 95.3 +- 63.9 at IRN doses of 20, 24, and 29 mg/m2, respectively.",
        entities: [['T0', 'PK', [[50, 101]]], ['T1', 'VALUE', [[106, 110]]], ['T2', 'VALUE', [[120, 125]]], ['T3', 'VALUE', [[139, 143]]], ['T4', 'VALUE', [[114, 118]]], ['T5', 'UNITS', [[15, 24]]], ['T6', 'VALUE', [[129, 133]]], ['T7', 'VALUE', [[147, 151]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T2']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T6']]], ['R7', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T3']]], ['R8', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T7']]], ['R9', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T2']]], ['R10', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R11', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-60',
    collData,
    {
        text: "Linear regression analyses, conducted to examine the relationships between PK parameters and hepatic measurements, revealed a trend toward a positive linear relationship between the CL of micafungin and Child–Pugh score (P = 0.0568), and positive linear relationships between both Cmax and AUC∞ of M-5 metabolite and total bilirubin (P < 0.05 in each).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-61',
    collData,
    {
        text: "Absorption is very rapid (half-life close to 15 min) and in accordance with the rapid appearance (tmax 0.3 to 2.6 h) of the plasma’s peak DON concentration (Cmax).",
        entities: [['T0', 'PK', [[26, 35]]], ['T1', 'VALUE', [[45, 47]]], ['T2', 'PK', [[98, 102]]], ['T3', 'RANGE', [[103, 113]]], ['T4', 'UNITS', [[48, 51]]], ['T5', 'UNITS', [[114, 115]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-62',
    collData,
    {
        text: "At steady state, once-daily itopride ER at 150 mg has a bioavailability comparable with that of itopride IR at 50 mg given three times a day under fasting conditions.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-63',
    collData,
    {
        text: "Single-dose Mean AUC0-t and AUC0-inf for ER formulation were 116.14 ± 21.54 mg·h/l and 117.60 ± 22.27 mg·h/l, and for IR formulation, were 107.25 ± 23.48 mg·h/l and 108.18 ± 23.93 mg·h/l, with the 90% CI within the limits accepted for bioequivalence.",
        entities: [['T0', 'PK', [[17, 23]]], ['T1', 'VALUE', [[61, 67]]], ['T2', 'VALUE', [[139, 145]]], ['T3', 'PK', [[28, 36]]], ['T4', 'VALUE', [[87, 93]]], ['T5', 'VALUE', [[165, 171]]], ['T6', 'VALUE', [[174, 179]]], ['T7', 'UNITS', [[180, 186]]], ['T8', 'VALUE', [[148, 153]]], ['T9', 'UNITS', [[154, 160]]], ['T10', 'VALUE', [[96, 101]]], ['T11', 'UNITS', [[102, 108]]], ['T12', 'VALUE', [[70, 75]]], ['T13', 'UNITS', [[76, 82]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T5']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T5']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T2']]], ['R7', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]], ['R8', 'D_VAL', [['Entity', 'T10'], ['D_VAL', 'T4']]], ['R9', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T10']]], ['R10', 'D_VAL', [['Entity', 'T12'], ['D_VAL', 'T1']]], ['R11', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T12']]], ['R12', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T5']]], ['R13', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T2']]], ['R14', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T4']]], ['R15', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-64',
    collData,
    {
        text: "WBH increased peak plasma concentrations of the Ro 03-8799 N-oxide metabolite Ro 31-0313 by 61% and the beta-phase AUC of i.v. administered Ro 31-0313 by 36%.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-65',
    collData,
    {
        text: "Pairwise t tests did not reject the null hypothesis that the mean Cl/F for the three doses are different from each other, demonstrating that RP5063 elimination is linear with respect to dose in this patient population over this dose range (P values were: 0.384, 0.789, and 0.508 for the comparisons dose 15 vs 30 mg, dose 15 vs 50 mg, and dose 30 vs 50 mg, respectively).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-66',
    collData,
    {
        text: "Cmax synovial was 2397 µg/mL (95%CI: 1161-3634 µg/mL) at 1.2 hours (95%CI: 0.5-1.8 hours).",
        entities: [['T0', 'PK', [[0, 4]]], ['T1', 'VALUE', [[18, 22]]], ['T2', 'RANGE', [[37, 46]]], ['T3', 'UNITS', [[47, 52]]], ['T4', 'UNITS', [[23, 28]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-67',
    collData,
    {
        text: "A saturable inhibitory Emax model found the exposure over 12 weeks produced by single-dose eptinezumab 100 and 300 mg exceeded the exposure estimates required to achieve 90% of the maximal efficacy (EC90 ).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-68',
    collData,
    {
        text: "Mean residence time values after IM administration were 200.4 +- 17.5 minutes and 198.4 +- 19.9 minutes at dosages of 10 and 20 mg/kg, respectively.",
        entities: [['T0', 'PK', [[0, 19]]], ['T1', 'VALUE', [[56, 61]]], ['T2', 'VALUE', [[82, 87]]], ['T3', 'VALUE', [[65, 69]]], ['T4', 'UNITS', [[70, 77]]], ['T5', 'VALUE', [[91, 95]]], ['T6', 'UNITS', [[96, 103]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T2']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-69',
    collData,
    {
        text: "Liposomes decorated with mPEG114-Chol had 3.2- and ~2.1-fold higher area under curve (AUC) than naked liposomes and branched (mPEG114)2-DSPE-coated liposomes, respectively, which reflects the high stability of this coating agent.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-70',
    collData,
    {
        text: "Table 2 includes the values of the pharmacokinetic parameters Cmax, tmax, and AUC determined for insulin in the 6 groups studied.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-71',
    collData,
    {
        text: "Following a single intravenous dose, the maximum concentration of the drug in serum, the time to maximum concentration of the drug in serum, the terminal elimination half-life in the CSF, and the percent penetration by fluconazole were 6.12 micrograms/ml, 1 h, 9.0 h, and 84.3%, respectively.",
        entities: [['T0', 'UNITS', [[276, 277]]], ['T1', 'VALUE', [[272, 276]]], ['T2', 'UNITS', [[265, 266]]], ['T3', 'VALUE', [[261, 264]]], ['T4', 'UNITS', [[258, 259]]], ['T5', 'VALUE', [[256, 257]]], ['T6', 'UNITS', [[241, 254]]], ['T7', 'VALUE', [[236, 240]]], ['T8', 'PK', [[41, 62]]], ['T9', 'PK', [[89, 118]]], ['T10', 'PK', [[145, 175]]], ['T11', 'PK', [[196, 215]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R3', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R4', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T7']]], ['R5', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T5']]], ['R6', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T3']]], ['R7', 'C_VAL', [['Entity', 'T11'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-72',
    collData,
    {
        text: "Maximum blood concentrations were 1.6 and 1.4μg D4 or D5/g blood at 24h post-dosing, with elimination half-lives of 39h (D4) and 70h (D5).",
        entities: [['T0', 'PK', [[90, 112]]], ['T1', 'VALUE', [[116, 118]]], ['T2', 'VALUE', [[129, 131]]], ['T3', 'UNITS', [[118, 119]]], ['T4', 'UNITS', [[131, 132]]], ['T5', 'PK', [[0, 28]]], ['T6', 'VALUE', [[34, 37]]], ['T7', 'VALUE', [[42, 45]]], ['T8', 'UNITS', [[45, 47]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]], ['R4', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T6']]], ['R5', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T7']]], ['R6', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]], ['R7', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-73',
    collData,
    {
        text: "The distribution half-lives t(1/2alpha) (days) of NNAL (1.32 +- 0.85 versus 3.35 +- 1.86) and NNAL-Gluc (1.53 +- 1.22 versus 3.89 +- 2.43) were significantly shorter in smokeless tobacco users than in smokers.",
        entities: [['T0', 'PK', [[4, 39]]], ['T1', 'VALUE', [[56, 60]]], ['T2', 'VALUE', [[76, 80]]], ['T3', 'VALUE', [[105, 109]]], ['T4', 'VALUE', [[125, 129]]], ['T5', 'VALUE', [[64, 68]]], ['T6', 'UNITS', [[41, 45]]], ['T7', 'VALUE', [[84, 88]]], ['T8', 'VALUE', [[113, 117]]], ['T9', 'VALUE', [[133, 137]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T2']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R8', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T3']]], ['R9', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T8']]], ['R10', 'D_VAL', [['Entity', 'T9'], ['D_VAL', 'T4']]], ['R11', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T9']]], ['R12', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T1']]], ['R13', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T2']]], ['R14', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T3']]], ['R15', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-74',
    collData,
    {
        text: "The blood/plasma ratio (0.708) in the rat dosed with CTGF was higher than in the animals not dosed with CTGF, suggesting that the CTGF/FG-3019 complex associates slightly more with the cellular components of blood than FG-3019 in the absence of CTGF.",
        entities: [['T0', 'PK', [[4, 22]]], ['T1', 'VALUE', [[24, 29]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-75',
    collData,
    {
        text: "In an LVAD mock flow-loop (1:1, PBS:human plasma:heparin) operating at maximal flow rate, 99mTc-F4A bound well to phantom clots in 2 min (p<0.05), whereas 99mTc-F1A had negligible targeting.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-76',
    collData,
    {
        text: "The Cmax of LY256548 in rats, mice, dogs, and monkeys was 0.17, 0.30, 0.04, and 0.02 microgram/ml, respectively.",
        entities: [['T0', 'PK', [[4, 8]]], ['T1', 'VALUE', [[58, 62]]], ['T2', 'VALUE', [[64, 68]]], ['T3', 'VALUE', [[70, 74]]], ['T4', 'VALUE', [[80, 84]]], ['T5', 'UNITS', [[85, 97]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-77',
    collData,
    {
        text: "The terminal half-life of lesogaberan was between 11 and 13 hours.",
        entities: [['T0', 'PK', [[4, 22]]], ['T1', 'RANGE', [[50, 59]]], ['T2', 'UNITS', [[60, 65]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-78',
    collData,
    {
        text: "The biological half-life of dibekacin ranged from 2.13 to 3.45 hours, and from 1.57 to 3.55 hours, with these 2 methods.",
        entities: [['T0', 'PK', [[4, 24]]], ['T1', 'RANGE', [[50, 62]]], ['T2', 'RANGE', [[79, 91]]], ['T3', 'UNITS', [[63, 68]]], ['T4', 'UNITS', [[92, 97]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-79',
    collData,
    {
        text: "Azithromycin elimination half-life was 20.3 hours, body clearance was 10.4 ml/min x kg, and apparent volume of distribution at steady state was 18.6 L/kg.",
        entities: [['T0', 'UNITS', [[44, 49]]], ['T1', 'VALUE', [[39, 43]]], ['T2', 'UNITS', [[75, 86]]], ['T3', 'VALUE', [[70, 74]]], ['T4', 'UNITS', [[149, 153]]], ['T5', 'VALUE', [[144, 148]]], ['T6', 'PK', [[13, 34]]], ['T7', 'PK', [[51, 65]]], ['T8', 'PK', [[92, 139]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R3', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T3']]], ['R5', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-80',
    collData,
    {
        text: "However, the percentage of IDV protein binding at Cmax was significantly lower compared with 12 h in each arm, possibly suggesting that IDV protein binding is concentration-dependent.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-81',
    collData,
    {
        text: "Crucially, compound 4 displayed only marginal inhibition of the hERG channel up to a concentration of 30 μM, whereas compound 7 was a moderate hERG inhibitor (IC50 = 3.1 μM, Table 2).",
        entities: [['T0', 'PK', [[159, 163]]], ['T1', 'VALUE', [[166, 169]]], ['T2', 'UNITS', [[170, 172]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-82',
    collData,
    {
        text: "Mean maximum plasma gabapentin concentration was 5.77 μg/mL in patients with moderate and severe renal impairment, and 5.59 μg/mL in patients with end-stage renal disease who were undergoing hemodialysis.",
        entities: [['T0', 'PK', [[5, 44]]], ['T1', 'VALUE', [[49, 53]]], ['T2', 'VALUE', [[119, 123]]], ['T3', 'UNITS', [[54, 59]]], ['T4', 'UNITS', [[124, 129]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-83',
    collData,
    {
        text: "AUCliver from 0 to 15 min was significantly lower in rifampicin-treated animals (103.6 ± 15.2 SUV.min) as compared with the control animals (129.4 ± 10.1 SUV.min, p < 0.05).",
        entities: [['T0', 'VALUE', [[89, 93]]], ['T1', 'VALUE', [[81, 86]]], ['T2', 'UNITS', [[94, 101]]], ['T3', 'VALUE', [[149, 153]]], ['T4', 'VALUE', [[141, 146]]], ['T5', 'UNITS', [[154, 161]]], ['T6', 'PK', [[0, 25]]]],
        relations: [['R0', 'D_VAL', [['Entity', 'T0'], ['D_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T0']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]], ['R5', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T4']]], ['R6', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-84',
    collData,
    {
        text: "0.765CHF; and Vd/F (L) for all ages = 9.27 * WT (kg) * 1.75CHF.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-85',
    collData,
    {
        text: "Thus, plasma concentration-time profiles in rats dosed with nanoemulsion showed a 1.6-fold enhancement in the area under the curve of natural vitamin E compared with the marketed soft capsule.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-86',
    collData,
    {
        text: "We performed population pharmacokinetic (PK) analysis using 117 nonbaseline blood samples from 34 patients collected over a period up to 135 d. The population model PK parameters do not specifically represent steady-state values, as they were determined from multiple repeated single doses taken by individual patients during their period of participation in the study.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-87',
    collData,
    {
        text: "After oral administration at 6 mg/kg, a visual inspection of the profiles showed that lotilaner blood concentrations decreased bi-exponentially after Tmax, with a rapid distribution phase within the first day of administration and a long elimination phase (Fig. 1).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-88',
    collData,
    {
        text: "Half‐maximal effective concentration (EC50) values for pAKT inhibition in stimulated B cells and monocytes were 50.4 and 85.0 ng/mL, respectively; EC50 values for pS6RP inhibition in stimulated B cells and monocytes were 20.3 and 174 ng/mL, respectively.",
        entities: [['T0', 'PK', [[0, 43]]], ['T1', 'VALUE', [[112, 116]]], ['T2', 'VALUE', [[121, 125]]], ['T3', 'PK', [[147, 151]]], ['T4', 'VALUE', [[221, 225]]], ['T5', 'VALUE', [[230, 233]]], ['T6', 'UNITS', [[126, 131]]], ['T7', 'UNITS', [[234, 239]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T5']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T2']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T1']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T5']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-89',
    collData,
    {
        text: "At this dose, the combined male and female Cmax was 1360 µg/mL and the AUC168 was 115,000 µg h/mL on day 8 (Table 5).",
        entities: [['T0', 'PK', [[43, 47]]], ['T1', 'VALUE', [[52, 56]]], ['T2', 'PK', [[71, 77]]], ['T3', 'VALUE', [[82, 89]]], ['T4', 'UNITS', [[57, 62]]], ['T5', 'UNITS', [[90, 97]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-90',
    collData,
    {
        text: "Of the 12 dogs with Cmax at 12 hours, the reported Cmax ranged from 51% to 98% of the 12 hour concentration: 5 were at > 90%, 8 were > 80%, 10 were > 75% of the 12 hour concentration.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-91',
    collData,
    {
        text: "Subsequent modification of the 2- and 5-positions led to improvement in potency and intrinsic clearance.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-92',
    collData,
    {
        text: "Specifically, Cmax, 5−FU and AUC0−24 h, 5−FU for CYP2A6 variant types were 70% (90% CI: 55–88%) and 74% (90% CI: 56–98%) those for *1 homozygotes (Table 4).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-93',
    collData,
    {
        text: "It is shown that Cmax significantly increased by 28%, whereas AUClast and AUCinf were not significantly changed.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-94',
    collData,
    {
        text: "Pharmacokinetic studies showed that the plasma half-life of the immunoconjugate was 67 h; whole-body retention, however, was prolonged with a biological half-life of 258 h. Serial gamma camera imaging localized known tumor in all patients, and also demonstrated prolonged Lu retention in the reticuloendothelial system (RES).",
        entities: [['T0', 'UNITS', [[170, 171]]], ['T1', 'VALUE', [[166, 169]]], ['T2', 'UNITS', [[87, 88]]], ['T3', 'VALUE', [[84, 86]]], ['T4', 'PK', [[40, 56]]], ['T5', 'PK', [[142, 162]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-95',
    collData,
    {
        text: "The absolute recoveries of glucocorticoids were above 94.6%.",
        entities: [['T0', 'UNITS', [[58, 59]]], ['T1', 'VALUE', [[54, 58]]], ['T2', 'PK', [[4, 23]]], ['T3', 'COMPARE', [[48, 53]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-96',
    collData,
    {
        text: "The AUC0–∞ after oral administration of NMP-NLC was 73.546±8.933 µg/mL*h, which was roughly 1.6-fold higher than that of NMP suspension 45.691±7.667 µg/mL*h.",
        entities: [['T0', 'UNITS', [[65, 72]]], ['T1', 'VALUE', [[52, 58]]], ['T2', 'UNITS', [[149, 156]]], ['T3', 'VALUE', [[136, 142]]], ['T4', 'VALUE', [[59, 64]]], ['T5', 'VALUE', [[143, 148]]], ['T6', 'PK', [[4, 10]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T3']]], ['R5', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T5']]], ['R6', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]], ['R7', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-97',
    collData,
    {
        text: "The tmax also increased with dose from 1-8 hr in rats, 8-24 hr in rabbits, and 3-7 hr in dogs.",
        entities: [['T0', 'UNITS', [[60, 62]]], ['T1', 'RANGE', [[55, 59]]], ['T2', 'UNITS', [[43, 45]]], ['T3', 'RANGE', [[39, 42]]], ['T4', 'UNITS', [[83, 85]]], ['T5', 'RANGE', [[79, 82]]], ['T6', 'PK', [[4, 8]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R3', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]], ['R5', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-98',
    collData,
    {
        text: "Comparing Treatment B to Treatment A, the geometric mean ratios of nilotinib C(max), AUC(0-tlast), and AUC(0-inf) were 0.966, 0.984, and 0.911, respectively (90% confidence intervals (CIs), 0.875-1.066, 0.905-1.069, and 0.798-1.039, respectively).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-99',
    collData,
    {
        text: "The flow rate of the method was 0.1 mL/min.",
        entities: [['T0', 'UNITS', [[36, 42]]], ['T1', 'VALUE', [[32, 35]]], ['T2', 'PK', [[4, 13]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-100',
    collData,
    {
        text: "Retention times of lenvatinib and propranolol (IS) were approximately 6.8 min and 7.1 min, respectively (Figure 2).",
        entities: [['T0', 'UNITS', [[74, 77]]], ['T1', 'VALUE', [[70, 73]]], ['T2', 'UNITS', [[86, 89]]], ['T3', 'VALUE', [[82, 85]]], ['T4', 'PK', [[0, 15]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-101',
    collData,
    {
        text: "The mean Cmax and AUClast of dextromethorphan were 3.623 ng/mL and 18.962 h*ng/mL, respectively, on Day 1 (before RG intake); these values on Day 15 (after RG intake) were 3.334 ng/mL and 17.351 h*ng/mL, respectively.",
        entities: [['T0', 'PK', [[9, 13]]], ['T1', 'VALUE', [[51, 56]]], ['T2', 'VALUE', [[172, 177]]], ['T3', 'PK', [[18, 25]]], ['T4', 'VALUE', [[67, 73]]], ['T5', 'VALUE', [[188, 194]]], ['T6', 'UNITS', [[57, 62]]], ['T7', 'UNITS', [[74, 81]]], ['T8', 'UNITS', [[178, 183]]], ['T9', 'UNITS', [[195, 202]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T5']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T1']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T4']]], ['R6', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-102',
    collData,
    {
        text: "The cumulative volume of whole saliva secreted during the first 3 h post-dose was linearly related to the area under the plasma concentration-time curve.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-103',
    collData,
    {
        text: "The maximum arterial plasma thiopental concentration achieved at EEG burst suppression was higher in the sheep (221.8 +- 27.9 micrograms/ml) than the dog (164.7 +- 29.9 micrograms/ml) or the rabbit (112.3 +- 15.1 micrograms/ml).",
        entities: [['T0', 'PK', [[4, 52]]], ['T1', 'VALUE', [[112, 117]]], ['T2', 'VALUE', [[155, 160]]], ['T3', 'VALUE', [[199, 204]]], ['T4', 'VALUE', [[121, 125]]], ['T5', 'UNITS', [[126, 139]]], ['T6', 'VALUE', [[164, 168]]], ['T7', 'UNITS', [[169, 182]]], ['T8', 'VALUE', [[208, 212]]], ['T9', 'UNITS', [[213, 226]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T2']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R7', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T3']]], ['R8', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]], ['R9', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]], ['R10', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T2']]], ['R11', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-104',
    collData,
    {
        text: "Nicorandil (3 mg kg(-1), p.o.) was rapidly absorbed and caused a significant reduction in blood pressure, lasting for at least 1 h, increases in heart rate and femoral blood flow, and decreases in femoral vascular resistance.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-105',
    collData,
    {
        text: "The equations for the CL and INH are as follows:CL = CL0 × INH,(1)(2)INH=RCLF+(1−RCLF)·(1−CInhIC50+CInh)(RCLF is the remaining CL fraction reflecting the CL at a steady state and the fraction that cannot be inhibited, CInh is the concentration in the inhibition compartment, and IC50 is the CInh yielding 50% of maximum CL inhibition).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-106',
    collData,
    {
        text: "The most extreme failure was “batch 1” vs. “batch 2,” for which bio‐inequivalence5 (defined as a 90% geometric mean ratio confidence interval entirely excluded from the 80–125% bioequivalence zone) was demonstrated for both FP Cmax and salmeterol Cmax.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-107',
    collData,
    {
        text: "The elimination half-life of BAL9141 was about 3 h.",
        entities: [['T0', 'PK', [[4, 25]]], ['T1', 'VALUE', [[47, 48]]], ['T2', 'UNITS', [[49, 50]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-108',
    collData,
    {
        text: "The mean residence time was 167.3 +- 21.1 minutes and 201.4 +- 16.8 minutes after IV and IM administrations, respectively.",
        entities: [['T0', 'PK', [[4, 23]]], ['T1', 'VALUE', [[28, 33]]], ['T2', 'VALUE', [[54, 59]]], ['T3', 'VALUE', [[37, 41]]], ['T4', 'UNITS', [[42, 49]]], ['T5', 'VALUE', [[63, 67]]], ['T6', 'UNITS', [[68, 75]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T2']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-109',
    collData,
    {
        text: "Deferoxamine was administered when serum-ferritin levels were greater than 500 ng/mL and used until the infusion day in patients whose ferritin levels continued to be above 500 ng/mL. Deferoxamine metabolites were detected in the high-AUC group, likely attributable to high ferritin levels.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-110',
    collData,
    {
        text: "A small Cmax reduction for omeprazole and its metabolite was observed, possibly reflecting an effect either on the activity of CYP2C19 or omeprazole absorption.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-111',
    collData,
    {
        text: "In the group administered 5,7-DMF, the area under the curve (AUC) of midazolam increased by 130% and its biological half-life was extended by approximately 100 min compared to the control group.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-112',
    collData,
    {
        text: "Although the maximum azimilide concentration (Cmax) was 27% higher in women, time to maximum concentration or area under the azimilide concentration-time curve were not different from those for men.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-113',
    collData,
    {
        text: "Th and AR did not differ significantly in their bronchodilating effect at 3 and 12 hours after intake.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-114',
    collData,
    {
        text: "The IC50 (for suppression) estimate was 0.73 ng/ml for SD, and EC50 (surge delay) was 1.42 ng/ml for MD.",
        entities: [['T0', 'PK', [[4, 8]]], ['T1', 'VALUE', [[40, 44]]], ['T2', 'PK', [[63, 67]]], ['T3', 'VALUE', [[86, 90]]], ['T4', 'UNITS', [[45, 50]]], ['T5', 'UNITS', [[91, 96]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-115',
    collData,
    {
        text: "As a result, the mean time of piperacillin stay in the body (MRS = Vdss/Cl) was practically doubled in elderly subjects (2.09 +- 0.15 h as against 1.15 +- 0.04 h in young adults (P less than 0.01).",
        entities: [['T0', 'VALUE', [[129, 133]]], ['T1', 'VALUE', [[121, 125]]], ['T2', 'UNITS', [[134, 135]]], ['T3', 'VALUE', [[155, 159]]], ['T4', 'VALUE', [[147, 151]]], ['T5', 'UNITS', [[160, 161]]], ['T6', 'PK', [[17, 64]]]],
        relations: [['R0', 'D_VAL', [['Entity', 'T0'], ['D_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T0']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R4', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R6', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]], ['R7', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-116',
    collData,
    {
        text: "Pharmacokinetic similarity between two drugs can be declared if the 90% CIs of the ratios for the geometric least-squares (LS) means of the primary PK parameters (AUC0-∞, AUC0-t, and Cmax) are within the range 80.00–125.00%.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-117',
    collData,
    {
        text: "Mean half-lives of SBT and ABPC in the serum following oral administration were about 1.33 and 1.61 hours respectively.",
        entities: [['T0', 'UNITS', [[100, 105]]], ['T1', 'VALUE', [[95, 99]]], ['T2', 'VALUE', [[86, 90]]], ['T3', 'PK', [[5, 15]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-118',
    collData,
    {
        text: "Food intake had no effect on filgotinib AUC∞ , but a high-fat meal reduced Cmax by 20%.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-119',
    collData,
    {
        text: "As depicted in figure 1, the trial consisted of a screening visit (Visit 1, V1), a randomization visit (baseline, V2), four treatment visits (V3–V6), and a final visit after 6 months of treatment (V7).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-120',
    collData,
    {
        text: "Steady-state plasma concentrations were reached by day 8 for both the dose-escalation and dose-expansion cohorts.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-121',
    collData,
    {
        text: "In HCV GT1-infected subjects with compensated cirrhosis, there was an increase in Cmax and AUC0–last for AL-335 (up to ~2.1- and ~1.5-fold increase on Day 1 and Day 7, respectively) and ALS-022399 (up to ~1.6- and ~1.3-fold increase on Day 1 and Day 7, respectively), compared with HCV GT1-infected subjects without compensated cirrhosis.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-122',
    collData,
    {
        text: "The relative bioavailabilities of CuB for CuB-MMs-CPs were 3.43 times and 2.14 times greater than that of free CuB and CuB-MMs, respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-123',
    collData,
    {
        text: "Based on visual inspection of the mean trough concentrations of selexipag and ACT-333679, concentrations on Day 8 were at steady state (data not shown).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-124',
    collData,
    {
        text: "At 13 mg/kg, the mean Cmax was 259 μg/mL and the mean AUC(0-∞) was 651 μg.h/mL.",
        entities: [['T0', 'UNITS', [[35, 40]]], ['T1', 'VALUE', [[31, 34]]], ['T2', 'UNITS', [[71, 78]]], ['T3', 'VALUE', [[67, 70]]], ['T4', 'PK', [[22, 26]]], ['T5', 'PK', [[54, 62]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-125',
    collData,
    {
        text: "The peak concentrations of 3-oxo desogestrel after a 150 micrograms dose of desogestrel in three subjects were between 0.48-0.71 ng/ml, and in two subjects 3-oxo desogestrel was still detectable 24 h after dosing.",
        entities: [['T0', 'UNITS', [[129, 134]]], ['T1', 'RANGE', [[119, 128]]], ['T2', 'PK', [[4, 23]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-126',
    collData,
    {
        text: "The 90% CIs for the ratio of the geometric means (AI/ PFS) for Cmax (1.01 [0.94–1.08]), AUC0–tlast (1.01 [0.95–1.07]), and AUC0–inf (1.01 [0.96–1.07]) were within the predefined bioequivalence range of 0.80–1.25 (Table 2].",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-127',
    collData,
    {
        text: "Four analytes, including PCA, CAA, SIN and EUP, showed a relatively short t1/2z (<1.89 h), indicating their rapid elimination.",
        entities: [['T0', 'PK', [[74, 79]]], ['T1', 'VALUE', [[82, 86]]], ['T2', 'UNITS', [[87, 88]]], ['T3', 'COMPARE', [[81, 82]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-128',
    collData,
    {
        text: "In five of six healthy volunteers therapeutic doses of cimetidine prolonged the half-life of antipyrine (range 12-37%; p < 0.05).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-129',
    collData,
    {
        text: "A slightly greater tmax for ASA of the micronized aspirin formulation compared to Aspirin Migraine® effervescent tablet, but identical to Alka Seltzer® and Aspro® effervescent tablets was observed (19.8 min vs. 17.4, 19.8 and 19.8 min, respectively) (Table 2).",
        entities: [['T0', 'PK', [[19, 23]]], ['T1', 'VALUE', [[198, 202]]], ['T2', 'VALUE', [[211, 215]]], ['T3', 'VALUE', [[217, 221]]], ['T4', 'VALUE', [[226, 230]]], ['T5', 'UNITS', [[231, 234]]], ['T6', 'UNITS', [[203, 206]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-130',
    collData,
    {
        text: "Due to the statistical significance of the effect of weight and dose on V2/F, the maximum plasma concentration (Cmax) of fedratinib would increase in slightly more than dose-proportional manner and would be inversely correlated to body weight (Fig. 2b).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-131',
    collData,
    {
        text: "The geometric LSM ratio values for AUC0−24 and Cmax of edoxaban plus quinidine versus edoxaban alone were 176.7 % (90 % CI, 165.0–189.2) and 185.4 % (90 % CI, 164.8–208.5), respectively (Fig. 1); increases of 76.7 and 85.4 %, respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-132',
    collData,
    {
        text: "Naringenin's maximal concentration, Cmax, increased from 0.3±0.1 µg/ml to 4.3±1.2 µg/ml representing a 14.6-fold increase (p = 0.002, n = 3).",
        entities: [['T0', 'UNITS', [[82, 87]]], ['T1', 'VALUE', [[74, 77]]], ['T2', 'UNITS', [[65, 70]]], ['T3', 'VALUE', [[57, 60]]], ['T4', 'PK', [[13, 40]]], ['T5', 'VALUE', [[61, 64]]], ['T6', 'VALUE', [[78, 81]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T3']]], ['R5', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T5']]], ['R6', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T1']]], ['R7', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-133',
    collData,
    {
        text: "Two acylcarnitines (carnitine C9:1 and carnitine C12:1-OH) and phenylacetylglutamine were down-regulated in the high-AUC group (Fig. 2E,F).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-134',
    collData,
    {
        text: "This resulted in a change in the estimate of the power associated with body‐weight on CL (from 0.767 to 0.12), and the power estimate for V2 was above 4.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-135',
    collData,
    {
        text: "In accordance with findings based on phase 3 semaglutide data investigating covariate effects on CL/F [6], body weight was found to be the only important covariate with respect to CL and, hence, average semaglutide concentrations under steady-state conditions with 90% CIs outside the equivalence interval.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-136',
    collData,
    {
        text: "The percentage of subjects that achieved the Cavg target of 500 to 2500 ng/mL on Day 7 ranged from 31% to 80%, with the lowest proportion in subjects 2 to <7 years receiving 12 mg/kg/day BID (AG2/DC1) and the highest proportion in subjects 7 to <18 years receiving 18 mg/kg/day TID (AG1/DC3).",
        entities: [['T0', 'PK', [[45, 49]]], ['T1', 'RANGE', [[60, 71]]], ['T2', 'UNITS', [[72, 77]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-137',
    collData,
    {
        text: "Food had no effect on alogliptin area under the concentration-time curve (AUC) from 0 h to infinity and a small, clinically insignificant effect on maximum plasma concentration (C(max)) (fed/fasted least squares (LS) geometric mean ratio, 0.856; 90% confidence interval (CI), 0.798 - 0.917).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-138',
    collData,
    {
        text: "Although their increased fold was different (25.28 times of S-HM-3 and 5.54 times of PTX, respectively), both of t1/2 were about 10 hours, indicating that S-HM-3 and PTX were loaded into one micelle on another side.",
        entities: [['T0', 'UNITS', [[132, 137]]], ['T1', 'VALUE', [[129, 131]]], ['T2', 'PK', [[113, 117]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-139',
    collData,
    {
        text: "These dose levels had AUCs corresponding to the 360 mg, 750 mg and 900 mg flat dose of MCLA-128 given q3wk in the First-In-Human study, and demonstrated profound tumor stasis at day 21.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-140',
    collData,
    {
        text: "The mean metabolic clearance of piretanide was 107.7 +- 47.6 ml/min/1.73 m2 body surface area and was the same as that reported for healthy subjects.",
        entities: [['T0', 'UNITS', [[61, 75]]], ['T1', 'VALUE', [[47, 52]]], ['T2', 'VALUE', [[56, 60]]], ['T3', 'PK', [[9, 28]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-141',
    collData,
    {
        text: "The maximum concentration was 3.2 times higher, the area under the concentration curve was 1.6 times higher, and the terminal disposition half-life was prolonged by 60%.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-142',
    collData,
    {
        text: "Terminal elimination half-life was 5.68 +- 5.05 h for the test and 6.11 +- 6.15 h for the reference formulations.",
        entities: [['T0', 'UNITS', [[80, 81]]], ['T1', 'VALUE', [[67, 71]]], ['T2', 'UNITS', [[48, 49]]], ['T3', 'VALUE', [[35, 39]]], ['T4', 'VALUE', [[43, 47]]], ['T5', 'VALUE', [[75, 79]]], ['T6', 'PK', [[0, 30]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T5']]], ['R6', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T3']]], ['R7', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-143',
    collData,
    {
        text: "The primary endpoint of this trial is the area under the plasma concentration-time curve (AUC(0–12)) for ticagrelor for the first 12 hours after the loading dose of ticagrelor.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-144',
    collData,
    {
        text: "Cmax was 9·6 (sd 0·9) nmol/l and was observed at Tmax, 4·4 (sd 1·8) h (Figs. 1 and 2).",
        entities: [['T0', 'PK', [[0, 4]]], ['T1', 'VALUE', [[9, 12]]], ['T2', 'PK', [[49, 53]]], ['T3', 'VALUE', [[55, 58]]], ['T4', 'VALUE', [[17, 20]]], ['T5', 'UNITS', [[22, 28]]], ['T6', 'VALUE', [[63, 66]]], ['T7', 'UNITS', [[68, 69]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T3']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-145',
    collData,
    {
        text: "The carbidopa half‐life harmonic mean was 1.9 and 2.0 hour, respectively, for the LCIG‐HV and LCIG‐LV formulations.",
        entities: [['T0', 'PK', [[14, 23]]], ['T1', 'VALUE', [[42, 45]]], ['T2', 'VALUE', [[50, 53]]], ['T3', 'UNITS', [[54, 58]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-146',
    collData,
    {
        text: "Dasatinib significantly reduced the maximum blood concentration (Cmax) of cyclosporine by 85.7%, and increased hepatic and intestinal CYP3A2 mRNA and protein expression levels by 2.4- and 1.25-fold, respectively, compared to those in the controls (p < 0.05).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-147',
    collData,
    {
        text: "The 86Y-CHX-A’’-DTPA-panitumumab tumor AUC[0→4]: liver AUC[0→4] ratio values were 1.7, 2.5 and 1.4 times greater than values obtained from 86Y-CHX-A’’-DTPA-cetuximab in mice bearing NCI-H226, MSTO-211H and NCI-H2052, respectively (Table 2).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-148',
    collData,
    {
        text: "A comparison of the pharmacokinetic parameters of the NI-LN suspensions with those of the NI solution prepared using only the surfactant polysorbate 80 revealed that although the AUC and bioavailability (59%) values were almost identical, a rapid absorption rate was still observed in the NI-LN suspensions.",
        entities: [['T0', 'PK', [[187, 202]]], ['T1', 'VALUE', [[204, 206]]], ['T2', 'UNITS', [[206, 207]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-149',
    collData,
    {
        text: "The arterial clearances of diacetylmorphine, monoacetylmorphine, and morphine-d3 were 8.7 +- 2.6, 6.7 +- 1.6, and 2.3 +- 0.3 L/min, respectively.",
        entities: [['T0', 'UNITS', [[125, 130]]], ['T1', 'VALUE', [[114, 117]]], ['T2', 'VALUE', [[98, 101]]], ['T3', 'VALUE', [[86, 89]]], ['T4', 'PK', [[4, 23]]], ['T5', 'VALUE', [[93, 96]]], ['T6', 'VALUE', [[105, 108]]], ['T7', 'VALUE', [[121, 124]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R5', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T2']]], ['R6', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T3']]], ['R7', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T5']]], ['R8', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T2']]], ['R9', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T6']]], ['R10', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T1']]], ['R11', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-150',
    collData,
    {
        text: "The mean t1/2 of KRN23 was 8-12 days after i.v. administration and 13-19 days after s.c. administration.",
        entities: [['T0', 'PK', [[9, 13]]], ['T1', 'RANGE', [[27, 31]]], ['T2', 'RANGE', [[67, 72]]], ['T3', 'UNITS', [[32, 36]]], ['T4', 'UNITS', [[73, 77]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-151',
    collData,
    {
        text: "Borneol did not alter the AUC0-12 (plasma) of PUE, but α-asarone significantly enhanced AUC0-12 (plasma) of PUE by 1.48-fold.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-152',
    collData,
    {
        text: "Paromomycin showed good PK properties after intravenous dose in male BALB/c mice which included low plasma clearance, i.e., <10% of hepatic blood flow in mice, high volume of distribution (Vd), and half-life (T½) of 2.6 h. Following per oral dose, it exhibits low oral bioavailability (0.3%) with carboxymethyl cellulose formulation.",
        entities: [['T0', 'PK', [[198, 212]]], ['T1', 'VALUE', [[216, 219]]], ['T2', 'PK', [[264, 284]]], ['T3', 'VALUE', [[286, 289]]], ['T4', 'UNITS', [[289, 290]]], ['T5', 'UNITS', [[220, 221]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-153',
    collData,
    {
        text: "The aim of this study was to compare the bioavailability of IP and its metabolites M1, M2, M3, and M5 at steady-state after administration of 200 mg tablets three times daily and 300 mg Scherer capsules twice daily during meals.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-154',
    collData,
    {
        text: "The volume of distribution at steady state (Vss) in the respective groups was 3.1+-0.7, 2.2+-0.6 and 1.3+-0.2 L/kg.",
        entities: [['T0', 'PK', [[4, 48]]], ['T1', 'VALUE', [[78, 81]]], ['T2', 'VALUE', [[88, 91]]], ['T3', 'VALUE', [[101, 104]]], ['T4', 'VALUE', [[83, 86]]], ['T5', 'UNITS', [[110, 114]]], ['T6', 'VALUE', [[93, 96]]], ['T7', 'VALUE', [[106, 109]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T2']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T6']]], ['R7', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T3']]], ['R8', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T7']]], ['R9', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R10', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T2']]], ['R11', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-155',
    collData,
    {
        text: "When measured by AUC∞, exposure to tolvaptan, on average, was 90% higher in the CrCL <30-ml/min group and 83% higher in the CrCL 30- to 60-ml/min group than in the CrCL >60-ml/min group (Table 2).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-156',
    collData,
    {
        text: "CYP1A2, CYP3A4, and to a minor extent CYP2C19 and CYP2D6, have all been shown to contribute to pomalidomide metabolism.14,16 The mean half-life (t1/2) of pomalidomide is approximately 7.5 hours in patients with MM, and apparent clearance (CL/F) generally ranges from 6.5 to 10.8 L/h.14 Both CL/F and t1/2 in plasma appeared to be independent of dose and dosing duration (Celgene, data on file).",
        entities: [['T0', 'PK', [[134, 150]]], ['T1', 'VALUE', [[184, 187]]], ['T2', 'PK', [[219, 244]]], ['T3', 'RANGE', [[267, 278]]], ['T4', 'UNITS', [[188, 193]]], ['T5', 'UNITS', [[279, 282]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-157',
    collData,
    {
        text: "The mean irinotecan systemic clearance and steady-state volume of distribution values were 14.3 l/h/m(2) and 211 l/m(2), respectively.",
        entities: [['T0', 'PK', [[20, 38]]], ['T1', 'VALUE', [[91, 95]]], ['T2', 'PK', [[43, 78]]], ['T3', 'VALUE', [[109, 112]]], ['T4', 'UNITS', [[113, 119]]], ['T5', 'UNITS', [[96, 104]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-158',
    collData,
    {
        text: "There were no meaningful differences in PK profiles between males and females (data not shown), and exposures (based on AUC) following repeated daily oral administration for 28 days tended to be slightly higher (<2-fold change) than the exposures observed after a single administration.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-159',
    collData,
    {
        text: "In a separate study on the orally active acyloxymethyl esters (1) of 7-[2-(2-aminothiazol-4-yl)acetamido]-3-[[[1-(2-dimethylaminoethyl) - 1H-tetrazol-5-yl]thio]methyl]ceph-3-em-4-carboxylic acid (cefotiam, CTM), we have shown, by quantitative structure-oral bioavailability (BA) relation analysis, that the R2 group in the acyl group R2CO must have both an adequate lipophilicity (Hansch's lipophilic parameter, pi) and steric hindrance (Taft's Es value).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-160',
    collData,
    {
        text: "The 2-sample model suggested that the predicted AUC0-12 of twice-daily intravenous busulfan could be calculated using the following equation: AUC0-12 = 40.017 + 0.955 × C3 + 1.088 × C6 with r2 = 0.919.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-161',
    collData,
    {
        text: "The AUC values of the parasitised group (143.0 +- 18 ng d/mL) were significantly lower (P<0.05) than those observed in the parasitically naïve animals (229.6 +- 21.7 ng d/mL).",
        entities: [['T0', 'PK', [[4, 7]]], ['T1', 'VALUE', [[41, 46]]], ['T2', 'VALUE', [[152, 157]]], ['T3', 'VALUE', [[50, 52]]], ['T4', 'UNITS', [[53, 60]]], ['T5', 'VALUE', [[161, 165]]], ['T6', 'UNITS', [[166, 173]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T2']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-162',
    collData,
    {
        text: "Estimated free plasma concentrations of regorafenib and M‐2, but not M‐5, exceeded the IC50 at human and murine VEGFR2, suggesting that regorafenib and M‐2 are the primary contributors to the pharmacologic activity of regorafenib in vivo.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-163',
    collData,
    {
        text: "This was further confirmed during comparison of the pharmacokinetic parameters, as the resultant mean AUClast ratio(Obs/Pred) values after intravenous application were 1.12 (95 % CI 1.01–1.22) and 0.97 (95 % CI 0.78–1.16), using models 1 and 2, respectively, and after oral application they were 0.80 (95 % CI 0.51–1.11) and 0.94 (95 % CI 0.65–1.23), using models 1 and 2, respectively.",
        entities: [['T0', 'PK', [[102, 115]]], ['T1', 'VALUE', [[168, 172]]], ['T2', 'VALUE', [[197, 201]]], ['T3', 'VALUE', [[296, 300]]], ['T4', 'VALUE', [[325, 329]]], ['T5', 'RANGE', [[182, 191]]], ['T6', 'RANGE', [[211, 220]]], ['T7', 'RANGE', [[310, 319]]], ['T8', 'RANGE', [[339, 348]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T1']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T2']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T3']]], ['R7', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-164',
    collData,
    {
        text: "The optimum compound was 1-(3-[5-(1,2, 4-triazol-4-yl)-1H-indol-3-yl]propyl)-4-(2-(3-fluorophenyl)ethyl)p ipe razine (7f) which has excellent selectivity for h5-HT1D receptors over other 5-HT receptor subtypes and good oral bioavailability in three species.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-165',
    collData,
    {
        text: "Cocaine administered by inhalation was eliminated with a half-life of 1.6 +- 0.5 min (mean +- SE) compared to 3.4 +- 0.9 following intravenous administration (p less than 0.03).",
        entities: [['T0', 'PK', [[57, 66]]], ['T1', 'VALUE', [[70, 73]]], ['T2', 'VALUE', [[110, 113]]], ['T3', 'VALUE', [[77, 80]]], ['T4', 'UNITS', [[81, 84]]], ['T5', 'VALUE', [[117, 120]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T2']]], ['R5', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-166',
    collData,
    {
        text: "Renal clearances were a small fraction of total clearance at 0.042, and 0.114 liter/hr/kg for the rat and dog, respectively, suggesting extensive nonrenal clearance.",
        entities: [['T0', 'PK', [[0, 16]]], ['T1', 'VALUE', [[61, 66]]], ['T2', 'VALUE', [[72, 77]]], ['T3', 'UNITS', [[78, 89]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-167',
    collData,
    {
        text: "It is adapted from Potts and Guy39, who found Kp linearly correlated with molecular size and lipophilicity (R2 = 0.67).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-168',
    collData,
    {
        text: "The Amax of the plasma anti-thrombin activity after reviparin administration was also slightly but significantly lower than that observed after enoxaparin administration, (difference between treatments of 0.018 95% CI[0.01-0.025] iu ml-1) whereas the AUC(0, 24h) of anti-thrombin activity vs time was not.",
        entities: [['T0', 'PK', [[4, 8]]], ['T1', 'VALUE', [[205, 210]]], ['T2', 'RANGE', [[218, 228]]], ['T3', 'UNITS', [[230, 237]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-169',
    collData,
    {
        text: "All Cl(int) values of S(-) were higher than of R(+) talinolol; 0.1 microM ketoconazole inhibited the formation of all metabolites.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-170',
    collData,
    {
        text: "Target AUC ranged from 3 to 7 mg ml(-1) min, and Ccr was measured by 24-h urine collection.",
        entities: [['T0', 'PK', [[7, 10]]], ['T1', 'RANGE', [[23, 29]]], ['T2', 'UNITS', [[30, 43]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-171',
    collData,
    {
        text: "Seven of 46 (15%) had a half-life of <130 min, suggesting that 84.8% of participants would conventionally be classified as the slow acetylator phenotype.",
        entities: [['T0', 'PK', [[24, 33]]], ['T1', 'VALUE', [[38, 41]]], ['T2', 'UNITS', [[42, 45]]], ['T3', 'COMPARE', [[37, 38]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-172',
    collData,
    {
        text: "The %T>4×MIC and ATB-CL were significantly correlated with CLCr at the first (r=-0.41, P=0.002; r=0.56, P<0.001, respectively) and second (r=-0.61, P<0.001; r=0.63, P<0.001, respectively) TDM.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-173',
    collData,
    {
        text: "Nonparametric Friedman test was performed on Tmax using Kinetics 2000 software (Lawrence Livermore National Laboratory, Livermore, California).25, 26",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-174',
    collData,
    {
        text: "The absolute bioavailability is 16.2%, which represented the existing of the obvious first-pass effect.",
        entities: [['T0', 'PK', [[4, 28]]], ['T1', 'VALUE', [[32, 36]]], ['T2', 'UNITS', [[36, 37]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-175',
    collData,
    {
        text: "The half-lives for 5-HNMP, MSI, and 2-HMSI in urine were approximately 4, 8, and 17 hr, respectively.",
        entities: [['T0', 'PK', [[4, 14]]], ['T1', 'VALUE', [[74, 75]]], ['T2', 'VALUE', [[81, 83]]], ['T3', 'UNITS', [[84, 86]]], ['T4', 'VALUE', [[71, 72]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R5', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-176',
    collData,
    {
        text: "Mean +- SD values for C(max) were 96 +- 25, 11 +- 7 and 16 +- 6 ng/ml for subcutaneous, intranasal 10 mg and intranasal 20 mg formulations, respectively.",
        entities: [['T0', 'VALUE', [[40, 42]]], ['T1', 'VALUE', [[34, 36]]], ['T2', 'UNITS', [[64, 69]]], ['T3', 'VALUE', [[62, 63]]], ['T4', 'VALUE', [[56, 58]]], ['T5', 'VALUE', [[50, 51]]], ['T6', 'VALUE', [[44, 46]]], ['T7', 'PK', [[22, 28]]]],
        relations: [['R0', 'D_VAL', [['Entity', 'T0'], ['D_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T0']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T6']]], ['R5', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T5']]], ['R6', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T1']]], ['R7', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T6']]], ['R8', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T4']]], ['R9', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T4']]], ['R10', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T6']]], ['R11', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-177',
    collData,
    {
        text: "The half-life of the drug in the beta-phase, computed from the mean blood concentrations up to 8 hours postdosing, was 2.61 hours.",
        entities: [['T0', 'UNITS', [[124, 129]]], ['T1', 'VALUE', [[119, 123]]], ['T2', 'PK', [[4, 13]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-178',
    collData,
    {
        text: "Belinostat AUC was increased (P = .003), and t1/2 increased (P = .0009) in UGT1A1*28 and UGT1A1*60 carriers who received more than 400 mg/m(2) /24 h.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-179',
    collData,
    {
        text: "In contrast, the tumor accumulation of boron species in the PM micelles (AUC: 268.6) was 7-fold higher than the NPM micelles (AUC: 37.1), determined by ICP-AES.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-180',
    collData,
    {
        text: "By comparing the areas under serum concentration-time curves (AUCs), the bioavailability of cisplatin was estimated to be 31%.",
        entities: [['T0', 'UNITS', [[124, 125]]], ['T1', 'VALUE', [[122, 124]]], ['T2', 'PK', [[73, 88]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-181',
    collData,
    {
        text: "Lithium has been used to treat mania and depression since the mid-20th century5 and, despite the advent of newer medications, it is still considered the gold standard for the treatment of bipolar disorder.6, 7 Although lithium is currently FDA approved as a mood stabilizer for the treatment of bipolar disorder, it is also commonly prescribed off-label for other neuropsychiatric symptoms, including suicidality and impulsive aggression,6 as well as neurodegenerative diseases such as AD.8 Nunes and colleagues observed in a 18-month clinical study that AD patients treated daily with micro-doses of lithium performed at a consistent level on the mini-mental status exam, indicating arrested cognitive decline compared with the placebo-group.9 Moreover, Forlenza and colleagues reported in their 1-year clinical trial study that patients with amnestic mild cognitive impairment treated with chronic low-dose lithium progressed less to AD compared with the placebo-group.7 The treated patients performed higher on the cognition subscale of the AD Assessment Scale and had decreased concentrations of phosphorylated tau in their cerebrospinal fluid (CSF), indicating lithium as a potential therapeutic for AD.7",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-182',
    collData,
    {
        text: "On the other hand, administration of the levodopa preparation with a commercial beverage containing 10% banana juice resulted in no significant change in C(max) or AUC.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-183',
    collData,
    {
        text: "The sustained-release manner of MCNs could prolong the time of drug absorption in the gastrointestinal tract, which might be beneficial to enhanced bioavailability of MIF [31,34].",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-184',
    collData,
    {
        text: "After ethanol ingestion and patch removal the half-life of E2 was calculated to be 378 minutes, and after carbohydrate punch and patch removal 245 minutes.",
        entities: [['T0', 'UNITS', [[87, 94]]], ['T1', 'VALUE', [[83, 86]]], ['T2', 'UNITS', [[147, 154]]], ['T3', 'VALUE', [[143, 146]]], ['T4', 'PK', [[46, 55]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-185',
    collData,
    {
        text: "PFOS has longer half-life and had respective values of 13.6 mg/(h kg), 0.023 mg/L, and 0.025.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-186',
    collData,
    {
        text: "In regorafenib‐treated mice, the sum of the total AUC(0–24)ss of regorafenib and its active major human metabolites was 46,911 μg × h/L, with the majority of exposure attributed to regorafenib (82%), while M‐2 and M‐5 accounted for 16% and 2% of total exposure, respectively (Table 2).",
        entities: [['T0', 'UNITS', [[127, 135]]], ['T1', 'VALUE', [[120, 126]]], ['T2', 'PK', [[44, 61]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-187',
    collData,
    {
        text: "Samples were predominantly trough concentrations taken around 48 h (52.2%) and 72 h (36.8%) after Erwinia asparaginase administration.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-188',
    collData,
    {
        text: "Various forms of homocysteine completely dissolved in an aqueous solution were rapidly absorbed after peroral administration, and the bioavailability was estimated to be 0.53.",
        entities: [['T0', 'PK', [[134, 149]]], ['T1', 'VALUE', [[170, 174]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-189',
    collData,
    {
        text: "The administration of ATZ daily by gavage at doses of 50 or 100 mg/kg to female SD rats for 4 days statistically significantly reduced the LH surge, as indicated by a statistically significant treatment effect shown by ANOVA, with significant reductions in LH at 11:00 and 13:00 hr, based on the Bonferroni t test, and with statistically significant reduced peak LH and LH AUC, based on the Student’s t test.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-190',
    collData,
    {
        text: "Trough and peak serum digoxin concentrations were determined after 10 days of digitalisation, or when signs of toxicity became apparent.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-191',
    collData,
    {
        text: "The peak plasma concentration and AUC for N-desmethylavitriptan and the AUC for methoxypyrimidinyl piperazine also showed statistically significant increases (about 25%) when avitriptan was coadministered with propranolol.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-192',
    collData,
    {
        text: "AUC was increased by 53% (90% CI 43.9, 63.3), and Cmax was increased by 26% (90% CI 9.9, 43.4) (Table 2).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-193',
    collData,
    {
        text: "Following administration of the first natalizumab dose, the median Tmax was 24.7 hours (range, 1.1–29.0 hours).",
        entities: [['T0', 'PK', [[67, 71]]], ['T1', 'VALUE', [[76, 80]]], ['T2', 'RANGE', [[95, 103]]], ['T3', 'UNITS', [[104, 109]]], ['T4', 'UNITS', [[81, 86]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-194',
    collData,
    {
        text: "Following this addition, a 5% reduction of BSV on Vc was observed.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-195',
    collData,
    {
        text: "Liposomes with 25% TEL could improve the oral bioavailability of octreotide 4.1-fold and one formulation with a cationic TEL derivative 4.6-fold.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-196',
    collData,
    {
        text: "Stiripentol area under the plasma concentration-time curve (AUC) values and trough concentrations were simulated for 7000 theoretical children weighing between 10 and 70 kg for the 25 mg/kg twice-daily dose.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-197',
    collData,
    {
        text: "Intravenous administration of 0.1 mg/kg yielded half-lives of 12.3-13.4 min and 130 min.",
        entities: [['T0', 'PK', [[48, 58]]], ['T1', 'RANGE', [[62, 71]]], ['T2', 'VALUE', [[80, 83]]], ['T3', 'UNITS', [[84, 87]]], ['T4', 'UNITS', [[72, 75]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-198',
    collData,
    {
        text: "The mean area under the concentration-time curve by the intraosseous route was similar to the intravenous route for all 3 drugs and similar to the intramuscular route for atropine and pralidoxime.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-199',
    collData,
    {
        text: "In volunteers and the Parkinson's disease participants, the serum half‐life of BIIB054 was 28 to 35 days; the cerebrospinal fluid–to‐serum ratio ranged from 0.13% to 0.56%.",
        entities: [['T0', 'PK', [[60, 75]]], ['T1', 'RANGE', [[91, 99]]], ['T2', 'UNITS', [[100, 104]]], ['T3', 'UNITS', [[161, 162]]], ['T4', 'VALUE', [[157, 161]]], ['T5', 'UNITS', [[170, 171]]], ['T6', 'VALUE', [[166, 170]]], ['T7', 'PK', [[110, 144]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T6']]], ['R4', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T4']]], ['R5', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-200',
    collData,
    {
        text: "In a model in which common half-times for all subjects were used, the best fit for B-Hg was obtained with half-times of 3.1 d for a fast phase and 18 d for a slow phase.",
        entities: [['T0', 'PK', [[106, 116]]], ['T1', 'VALUE', [[120, 123]]], ['T2', 'VALUE', [[147, 149]]], ['T3', 'UNITS', [[124, 125]]], ['T4', 'UNITS', [[150, 151]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-201',
    collData,
    {
        text: "Nanoparticle formulation enhances both Caco-2 monolayer permeability and rat oral bioavailability of the poorly soluble 301029.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-202',
    collData,
    {
        text: "Intersubject variability in Ctrough values for enzalutamide and N-desmethyl enzalutamide were ≤29 percent coefficient of variation (%CV), and 80 %CV for the carboxylic acid metabolite.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-203',
    collData,
    {
        text: "Tables 7 and 8 summarise the ≥ 80% PTA when considering AUC/MIC ratio targets for either prophylaxis or treatment.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-204',
    collData,
    {
        text: "Peak mobilization at the 500 µg/kg dose was observed 1 h after the end of the balixafortide infusion/after reaching Cmax (Figs. 1b, 2a).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-205',
    collData,
    {
        text: "The regional distribution and the kinetics of haloperidol uptake in human brain were examined using [18F]haloperidol and PET in 9 controls and 5 schizophrenics while on haloperidol medication and after haloperidol washout.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-206',
    collData,
    {
        text: "The strong correlation between the predicted values and the measured actual values of AUC0−30 min (linear regression coefficients: 0.833 at the low dose, and 0.673 at the high dose [Figure 4J, 4L]) suggests the potential prediction ability based on the baseline data.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-207',
    collData,
    {
        text: "After four or five doses, blood samples were drawn before the next dosage for serum trough vancomycin concentration (Cmin), and target concentration was defined between 15 mg/L and 20 mg/L. The urine creatinine (UCr) was measured, and CLCR was calculated.",
        entities: [['T0', 'UNITS', [[184, 188]]], ['T1', 'VALUE', [[181, 183]]], ['T2', 'UNITS', [[172, 176]]], ['T3', 'VALUE', [[169, 171]]], ['T4', 'PK', [[128, 148]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-208',
    collData,
    {
        text: "The mean serum half-lives ranged from 5 to 7 h. Cerebrospinal fluid levels in patients with meningitis ranged from 2.8 to 9.5 micrograms/ml and in patients without meningitis from 1 to 7 micrograms/ml.",
        entities: [['T0', 'PK', [[9, 25]]], ['T1', 'RANGE', [[38, 44]]], ['T2', 'PK', [[48, 74]]], ['T3', 'RANGE', [[115, 125]]], ['T4', 'RANGE', [[180, 186]]], ['T5', 'UNITS', [[45, 46]]], ['T6', 'UNITS', [[126, 139]]], ['T7', 'UNITS', [[187, 200]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T3']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-209',
    collData,
    {
        text: "EM1 resulted in TDF half-life of 23.6 ± 2.3 and 4.7 ± 0.4 min in human and rat S9, respectively; PP resulted in TDF half-life of 20.1 ± 1.8 and 3.5 ± 0.4 min in human and rat S9, respectively.",
        entities: [['T0', 'PK', [[20, 29]]], ['T1', 'VALUE', [[33, 37]]], ['T2', 'VALUE', [[48, 51]]], ['T3', 'PK', [[116, 125]]], ['T4', 'VALUE', [[129, 133]]], ['T5', 'VALUE', [[144, 147]]], ['T6', 'VALUE', [[150, 153]]], ['T7', 'UNITS', [[154, 157]]], ['T8', 'VALUE', [[136, 139]]], ['T9', 'VALUE', [[40, 43]]], ['T10', 'UNITS', [[58, 61]]], ['T11', 'VALUE', [[54, 57]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T5']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T5']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T4']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T8']]], ['R8', 'D_VAL', [['Entity', 'T9'], ['D_VAL', 'T1']]], ['R9', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T9']]], ['R10', 'D_VAL', [['Entity', 'T11'], ['D_VAL', 'T2']]], ['R11', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T11']]], ['R12', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T5']]], ['R13', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T4']]], ['R14', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T2']]], ['R15', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-210',
    collData,
    {
        text: "Both the calculated area under the plasma concentration versus time curve up to 24 h and Cmax values were 3- to 4-fold higher in the dermal application group administered 12 mg/kg dapsone in 25 versus 10% DGME gel, whereas the calculated area under the plasma concentration versus time curve up to 24 h and Cmax values for the 60 mg/kg group were only 3.3- and 2.3-fold greater than those obtained after application of 12 mg/kg in 25% DGME.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-211',
    collData,
    {
        text: "After p.o. administration toloxatone was rapidly absorbed, peak plasma concentrations (Cmax) ranging from 0.384 to 0.640 mg/l occurred between 0.53 and 1.00 h. Plasma curves were fitted according to a one-compartment open model.",
        entities: [['T0', 'PK', [[59, 92]]], ['T1', 'RANGE', [[106, 120]]], ['T2', 'UNITS', [[121, 125]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-212',
    collData,
    {
        text: "Through the oral gavage to KM mice, the Cmax of tryptanthrin was reached among plasma and tissues within 2.5 hours after dosing.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-213',
    collData,
    {
        text: "The mean maternal baboon steady-state clearance of fluoxetine (42 mL/min/kg) was considerably higher than that in humans.",
        entities: [['T0', 'PK', [[25, 47]]], ['T1', 'VALUE', [[63, 65]]], ['T2', 'UNITS', [[66, 75]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-214',
    collData,
    {
        text: "Median clearance (CL) was 13.6 (range 3.7-78.2) ml.min(-1).kg(-1) and median apparent volume of distribution at steady state (V(ss)) was 3.7 (1.33-7.96) l.kg(-1).",
        entities: [['T0', 'PK', [[77, 132]]], ['T1', 'VALUE', [[137, 140]]], ['T2', 'RANGE', [[142, 151]]], ['T3', 'UNITS', [[153, 161]]], ['T4', 'UNITS', [[48, 65]]], ['T5', 'VALUE', [[26, 30]]], ['T6', 'PK', [[7, 21]]], ['T7', 'RANGE', [[38, 46]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R4', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R5', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T5']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T5']]], ['R7', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-215',
    collData,
    {
        text: "Taking into account the increasing resistance to ciprofloxacin worldwide, a ciprofloxacin dose of 1200 mg i.v. daily in patients with normal renal function is necessary to reach the targeted AUC : MIC > 125.",
        entities: [['T0', 'PK', [[191, 200]]], ['T1', 'VALUE', [[203, 206]]], ['T2', 'COMPARE', [[201, 202]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-216',
    collData,
    {
        text: "When differences among three genotypes (wild‐type (*1/*1), 1/*2, and *1/*3) were analyzed by anova, there was no significant difference in Cmax (P = 0.1785), but there was a difference in AUCinf (P < 0.0001).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-217',
    collData,
    {
        text: "[area under the plasma unbound (1%) drug concentration-time curve over 24 h/MIC (fAUC/MIC) = 10 and 20] and an effective concentration target against Aspergillus spp.",
        entities: [['T0', 'PK', [[1, 90]]], ['T1', 'VALUE', [[93, 95]]], ['T2', 'VALUE', [[100, 102]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-218',
    collData,
    {
        text: "Similarly buccal films has shown enhanced half-life (9.91hr vs 2.51 hr), AUC 0-t (1043.4 ng/ml*h vs 149.1 ng/ml*h) and Cmax (91.92 ng/ml vs 42.29 ng/ml) from oral solution.",
        entities: [['T0', 'PK', [[42, 51]]], ['T1', 'VALUE', [[53, 57]]], ['T2', 'VALUE', [[63, 67]]], ['T3', 'PK', [[73, 80]]], ['T4', 'VALUE', [[82, 88]]], ['T5', 'VALUE', [[100, 105]]], ['T6', 'PK', [[119, 123]]], ['T7', 'VALUE', [[125, 130]]], ['T8', 'VALUE', [[140, 145]]], ['T9', 'UNITS', [[146, 151]]], ['T10', 'UNITS', [[131, 136]]], ['T11', 'UNITS', [[106, 113]]], ['T12', 'UNITS', [[89, 96]]], ['T13', 'UNITS', [[68, 70]]], ['T14', 'UNITS', [[57, 59]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T5']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R5', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T8']]], ['R6', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]], ['R7', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T7']]], ['R8', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T5']]], ['R9', 'RELATED', [['Entity', 'T12'], ['RELATED', 'T4']]], ['R10', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T2']]], ['R11', 'RELATED', [['Entity', 'T14'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-219',
    collData,
    {
        text: "The ratios of geometric means, using a 90% confidence interval, between coadministration of digoxin with levetiracetam or placebo were 103.96% (99.18%, 108.95%) for AUC(ss), 100.87% (89.52%, 113.66%) for C(max), 97.67% (82.76%, 115.26%) for PTF, and 99.04% (90.98%, 109.00%) for C(min).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-220',
    collData,
    {
        text: "At steady state (Day 14), total and maximum systemic exposure (AUC0-24, Cmax) to NVA237 and urinary excretion of unchanged drug (Ae0-24) was approximately dose proportional over the 50 - 200 μg dose range.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-221',
    collData,
    {
        text: "The median time of peak concentrations in serum following oral doses was 0.75 h (range, 0.25 to 3 h).",
        entities: [['T0', 'PK', [[11, 38]]], ['T1', 'VALUE', [[73, 77]]], ['T2', 'RANGE', [[88, 97]]], ['T3', 'UNITS', [[98, 99]]], ['T4', 'UNITS', [[78, 79]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-222',
    collData,
    {
        text: "Edoxaban administered alone resulted in a range of mean [±standard deviation (SD)] Cmax values of 223.4 (±75.0) to 295.6 (±83.6) ng/mL across the 6 studies, indicating consistent exposure of edoxaban (Tables 2, 3).",
        entities: [['T0', 'PK', [[83, 87]]], ['T1', 'VALUE', [[98, 103]]], ['T2', 'VALUE', [[115, 120]]], ['T3', 'VALUE', [[106, 110]]], ['T4', 'UNITS', [[129, 134]]], ['T5', 'VALUE', [[123, 127]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T2']]], ['R5', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-223',
    collData,
    {
        text: "The volumes of distribution were small (mean VC, 8.5 to 14.1 L; VSS, 12.8 to 28.4 L) and elimination fairly fast (mean t1/2 beta, 0.83 to 1.77 hours).",
        entities: [['T0', 'PK', [[45, 47]]], ['T1', 'RANGE', [[49, 60]]], ['T2', 'PK', [[64, 67]]], ['T3', 'RANGE', [[69, 81]]], ['T4', 'PK', [[119, 128]]], ['T5', 'RANGE', [[130, 142]]], ['T6', 'UNITS', [[143, 148]]], ['T7', 'UNITS', [[82, 83]]], ['T8', 'UNITS', [[61, 62]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R3', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R4', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T3']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-224',
    collData,
    {
        text: "The turning point of Ke from WPI-stabilized nanoemulsions was also at the 25% fraction; however, the changing trend of Ke was the opposite (Figure 4B); it was ascribed to the change of size distribution in particle size.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-225',
    collData,
    {
        text: "Using NCA to analyse datasets with the same design as the original study, but simulated by the final model, the median (2.5 and 97.5 percentiles) GMRs of AUC0–14d in the 100 datasets were, for bedaquiline, 40.6% (34.5%–47.7%) with rifampicin and 47.8% (41.9%–54.3%) for rifapentine, and those for M2 were 76.7% (64.7%–90.7%) and 89.0% (76.4%–104.6%), respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-226',
    collData,
    {
        text: "Differences between treatment groups in ratios for area under the concentration-time curve for blister fluid and plasma (AUC(blister fluid)/AUC(plasma) ratios) were evaluated using a t test (alpha = 0.05).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-227',
    collData,
    {
        text: "On the other hand, resveratrol showed inhibitory effect on CYP3A4*1, CYP2D6*1, human and rat microsomes, the IC50 of resveratrol was 6.771, 87.87, 45.11 and 35.59 μmol l(-1), respectively.",
        entities: [['T0', 'PK', [[109, 113]]], ['T1', 'VALUE', [[133, 138]]], ['T2', 'VALUE', [[140, 145]]], ['T3', 'VALUE', [[147, 152]]], ['T4', 'VALUE', [[157, 162]]], ['T5', 'UNITS', [[163, 173]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-228',
    collData,
    {
        text: "The 0 min post-dose fasting resulted in generally lower mean exposure of insulin 338 (Fig. 1 and Online Resource 1, Fig. S2), with a significant reduction of ~ 65% in AUCIns338,0–∞ and Cmax,Ins338 compared with 360 min post-dose fasting (Fig. 2).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-229',
    collData,
    {
        text: "CP-424391 accounts for about 40% of radioactivity area under the plasma concentration-time curve and C(max) in circulation.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-230',
    collData,
    {
        text: "The possibility that caffeine per se might elevate endogenous plasma F and calcium concentrations was excluded after caffeine (25 mg/kg) ig without F was given.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-231',
    collData,
    {
        text: "When the rats were administered with ginsenoside Rb1 (200 mg/kg), the Tmax of ginsenoside Rd was 10.6 ± 2.3 h and the Cmax and AUC of ginsenoside Rd were 72.4 ± 31.6 ng/mL and 663.9 ± 285.3ng h/mL, respectively (Table 1).",
        entities: [['T0', 'PK', [[70, 74]]], ['T1', 'VALUE', [[97, 101]]], ['T2', 'PK', [[118, 122]]], ['T3', 'VALUE', [[154, 158]]], ['T4', 'PK', [[127, 130]]], ['T5', 'VALUE', [[176, 181]]], ['T6', 'VALUE', [[104, 107]]], ['T7', 'UNITS', [[108, 109]]], ['T8', 'VALUE', [[161, 165]]], ['T9', 'UNITS', [[166, 171]]], ['T10', 'VALUE', [[184, 189]]], ['T11', 'UNITS', [[189, 196]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R3', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T1']]], ['R4', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R5', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T3']]], ['R6', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]], ['R7', 'D_VAL', [['Entity', 'T10'], ['D_VAL', 'T5']]], ['R8', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T10']]], ['R9', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T1']]], ['R10', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T3']]], ['R11', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-232',
    collData,
    {
        text: "We also examined the correlation between the 123I-IMP imaging and the 123I-ioflupane early-phase image for 14 cases in which both dopamine transporter (DaT) imaging by 123I-ioflupane and cerebral blood flow imaging by 123I-IMP were performed on the same camera.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-233',
    collData,
    {
        text: "Mean t1/2 ranged from 18 to 21 h and was found to be independent of dose.",
        entities: [['T0', 'PK', [[5, 9]]], ['T1', 'RANGE', [[22, 30]]], ['T2', 'UNITS', [[31, 32]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-234',
    collData,
    {
        text: "Bioavailability was significantly higher in foals (57.8 ± 19.3%) than in adult horses (32.0 ± 18.0%).",
        entities: [['T0', 'PK', [[0, 15]]], ['T1', 'VALUE', [[51, 55]]], ['T2', 'VALUE', [[87, 91]]], ['T3', 'VALUE', [[58, 62]]], ['T4', 'UNITS', [[62, 63]]], ['T5', 'VALUE', [[94, 98]]], ['T6', 'UNITS', [[98, 99]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T2']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-235',
    collData,
    {
        text: "The skin clearance rate following exposure was estimated at 0.4 μg/cm²/h.",
        entities: [['T0', 'PK', [[4, 23]]], ['T1', 'VALUE', [[60, 63]]], ['T2', 'UNITS', [[64, 72]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-236',
    collData,
    {
        text: "Median time to Cmax was ~74–76 hours (~2–4 hours after patch removal), and mean t1/2β was ~63.77–93.07 hours.",
        entities: [['T0', 'PK', [[7, 19]]], ['T1', 'RANGE', [[25, 30]]], ['T2', 'RANGE', [[39, 42]]], ['T3', 'PK', [[80, 85]]], ['T4', 'RANGE', [[91, 102]]], ['T5', 'UNITS', [[103, 108]]], ['T6', 'UNITS', [[43, 48]]], ['T7', 'UNITS', [[31, 36]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T2']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-237',
    collData,
    {
        text: "Artemisinin half-life was approximately 0.5 h after both routes of administration in both sexes.",
        entities: [['T0', 'PK', [[12, 21]]], ['T1', 'VALUE', [[40, 43]]], ['T2', 'UNITS', [[44, 45]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-238',
    collData,
    {
        text: "A higher concentration of IB in plasma (Cmax 48.5 μg/ml) was found after injection of IB compared with ibuprofen–OHB, despite administration of a lower dose of IB (25 mg/kg versus 40 mg/kg in case of ibuprofen-OHB).",
        entities: [['T0', 'PK', [[40, 44]]], ['T1', 'VALUE', [[45, 49]]], ['T2', 'UNITS', [[50, 55]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-239',
    collData,
    {
        text: "The bioavailability was estimated from the cumulative amount excreted unchanged in urine over 48 h (Du48).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-240',
    collData,
    {
        text: "The ability of b-LMB to induce nuclear retention of Rev-GFP in U2OS cells was similar to unmodified LMB (IC50 0.11 nM vs. 0.16 nM, respectively; Table 1) and was 360-fold more potent than selinexor (IC50 40 nM; Table 1).",
        entities: [['T0', 'PK', [[105, 109]]], ['T1', 'VALUE', [[110, 114]]], ['T2', 'VALUE', [[122, 126]]], ['T3', 'PK', [[199, 203]]], ['T4', 'VALUE', [[204, 206]]], ['T5', 'UNITS', [[127, 129]]], ['T6', 'UNITS', [[115, 117]]], ['T7', 'UNITS', [[207, 209]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T2']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T1']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-241',
    collData,
    {
        text: "The regression analyses between AUC0-9 of CyA and anthropometric parameters indicated that IBW was potentially the superior predictor for dose adjustment of CyA in an empiric strategy using TBW (IBW; r=0.5181, TBW; r=0.3192); however, this finding seems to lack the pharmacokinetic rationale and thus warrants further basic and clinical investigations.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-242',
    collData,
    {
        text: "The possible mechanism of AEs increasing oral bioavailability of poorly permeated therapeutic molecules includes the transcellular route, enhancing the transport across the epithelial membrane, the paracellular route or modifying the epithelial intercellular tight junctions [33,34,35,36].",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-243',
    collData,
    {
        text: "The plasma half-life of 5-AZA-CdR in humans is approximately 20 minutes due to the high levels in the liver of cytidine deaminase, the enzyme that inactivates this analogue.",
        entities: [['T0', 'PK', [[4, 20]]], ['T1', 'VALUE', [[61, 63]]], ['T2', 'UNITS', [[64, 71]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-244',
    collData,
    {
        text: "In the case of the female dosed at 10 mg/kg, the peak serum concentrations were found to be 6.38 micrograms/ml for AMPC and 1.83 micrograms/ml for CVA at 1 hour following administration.",
        entities: [['T0', 'PK', [[49, 74]]], ['T1', 'VALUE', [[92, 96]]], ['T2', 'VALUE', [[124, 128]]], ['T3', 'UNITS', [[97, 110]]], ['T4', 'UNITS', [[129, 142]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-245',
    collData,
    {
        text: "The bioavailability was found to be 70.5%, and the mean terminal elimination half-life was 82 hours.",
        entities: [['T0', 'PK', [[4, 19]]], ['T1', 'VALUE', [[36, 40]]], ['T2', 'PK', [[56, 86]]], ['T3', 'VALUE', [[91, 93]]], ['T4', 'UNITS', [[40, 41]]], ['T5', 'UNITS', [[94, 99]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-246',
    collData,
    {
        text: "Data for the first 4 days of treatment were analysed with linear regression to obtain a mean value for the apparent volume of distribution of ATG (Vd) of 0.12 l/kg body weight (range 0.07 to 0.17, n = 5).",
        entities: [['T0', 'PK', [[107, 150]]], ['T1', 'VALUE', [[154, 158]]], ['T2', 'RANGE', [[183, 195]]], ['T3', 'UNITS', [[159, 163]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-247',
    collData,
    {
        text: "Subjects with ADA titer above 128 were estimated to have increased risankizumab clearance by 43% corresponding to an AUC decrease by 30%, on average (Figure 2).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-248',
    collData,
    {
        text: "An open-label, four-way crossover, single dose pharmacokinetic study comparing the bioavailability of 10 mg selegiline hydrochloride administered to healthy young males as a solution by the oral route (in the stomach) and by a nasoenteric tube to the following three sites: duodenum, jejunum and terminal ileum was conducted.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-249',
    collData,
    {
        text: "Maximal MetHb concentrations did not exceed 3.0 % in any subject, nor were any changes in SaO2 observed in any subject in the three trials presented.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-250',
    collData,
    {
        text: "Accordingly, the AUC0−∞ values were significantly higher (p ≤ 0.001) in dalarelin receiving groups, both for solution and suspension forms (Fig. 4)",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-251',
    collData,
    {
        text: "The median time to maximum concentration of drug in serum (Tmax) was 2.2 h, ranging from 0.4 to 5.7 h.",
        entities: [['T0', 'PK', [[11, 64]]], ['T1', 'VALUE', [[69, 72]]], ['T2', 'RANGE', [[89, 99]]], ['T3', 'UNITS', [[100, 101]]], ['T4', 'UNITS', [[73, 74]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-252',
    collData,
    {
        text: "Overall, vilaprisan exposure was higher in participants with hepatic impairment compared with the matched control participants; geometric mean AUC values of 162, 142, 187 and 195 μg·h L−1 were observed in the control mild hepatic impairment, control moderate hepatic impairment, mild hepatic impairment and moderate hepatic impairment cohorts, respectively (Table 3).",
        entities: [['T0', 'UNITS', [[179, 187]]], ['T1', 'VALUE', [[175, 178]]], ['T2', 'VALUE', [[167, 170]]], ['T3', 'VALUE', [[162, 165]]], ['T4', 'VALUE', [[157, 160]]], ['T5', 'PK', [[143, 146]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T3']]], ['R3', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]], ['R5', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T3']]], ['R6', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T2']]], ['R7', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-253',
    collData,
    {
        text: "We observed increased sufentanil volume of distribution (11.6 vs 5.6 L/kg) and decreased sufentanil clearance (0.535 vs 0.746 L/h/kg) in extracorporeal membrane oxygenation period.",
        entities: [['T0', 'PK', [[33, 55]]], ['T1', 'VALUE', [[57, 61]]], ['T2', 'VALUE', [[65, 68]]], ['T3', 'UNITS', [[69, 73]]], ['T4', 'PK', [[100, 109]]], ['T5', 'VALUE', [[111, 116]]], ['T6', 'VALUE', [[120, 125]]], ['T7', 'UNITS', [[126, 132]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T6']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-254',
    collData,
    {
        text: "Total phenoxodiol had a longer plasma elimination half-life than free phenoxodiol, but both were relatively short (mean values 3.19 ± 1.93 h and 0.67 ± 0.53 h, respectively).",
        entities: [['T0', 'PK', [[31, 59]]], ['T1', 'VALUE', [[127, 131]]], ['T2', 'VALUE', [[145, 149]]], ['T3', 'UNITS', [[139, 140]]], ['T4', 'UNITS', [[157, 158]]], ['T5', 'VALUE', [[134, 138]]], ['T6', 'VALUE', [[152, 156]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T5']]], ['R6', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T2']]], ['R7', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-255',
    collData,
    {
        text: "Urine iohexol clearance was poorly correlated (r=0.770) with GFR(9) owing to variability in urine collections (median CV=24%).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-256',
    collData,
    {
        text: "Based on these data, an FG of 0.56 was assumed for EE with the estimated unbound intrinsic clearance for the gut back‐calculated using the “QGut” model17; of which ~70% was assigned to sulfation, ~20% to hydroxylation, and the rest to glucuronidation (see details in the Methods).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-257',
    collData,
    {
        text: "The central volume (V1/F) was found to decrease (30 %) with increasing age (41–84 years), to be lower (12 %) in females, and to be increased with smoking (34 %).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-258',
    collData,
    {
        text: "The mean peak concentration in erythrocytes was 131% and the AUC 145% of that found in plasma.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-259',
    collData,
    {
        text: "In addition, regarding t1/2 andMRT0–24, there were no statistical differences between CsA alone and CsA withCLM.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-260',
    collData,
    {
        text: "The Vz and Cl of NC-6004 were smaller than those of cisplatin, 52 l and 350 ml h−1, respectively (Calvert et al, 1993).",
        entities: [['T0', 'UNITS', [[76, 82]]], ['T1', 'VALUE', [[72, 75]]], ['T2', 'VALUE', [[63, 65]]], ['T3', 'UNITS', [[66, 67]]], ['T4', 'PK', [[4, 6]]], ['T5', 'PK', [[11, 13]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T2']]], ['R4', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-261',
    collData,
    {
        text: "Theophylline oral clearance increased from 2.67 +- 1.01 L/hour to 2.69 +- 0.93 L/hour, when given alone and with temafloxacin, respectively (p = 0.92).",
        entities: [['T0', 'PK', [[13, 27]]], ['T1', 'VALUE', [[43, 47]]], ['T2', 'VALUE', [[51, 55]]], ['T3', 'UNITS', [[56, 62]]], ['T4', 'VALUE', [[66, 70]]], ['T5', 'VALUE', [[74, 78]]], ['T6', 'UNITS', [[79, 85]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T4']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T4']]], ['R7', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-262',
    collData,
    {
        text: "The half-life of the absorption phase (mean +- standard deviation) was 0.35 +- 0.10 h, and the half-life of the elimination phase was 0.75 +- 0.06 h. This is 54% less than the half-life of elimination of 1.38 h previously reported for the intravenous dose.",
        entities: [['T0', 'PK', [[4, 37]]], ['T1', 'VALUE', [[71, 75]]], ['T2', 'VALUE', [[79, 83]]], ['T3', 'UNITS', [[84, 85]]], ['T4', 'VALUE', [[142, 146]]], ['T5', 'VALUE', [[134, 138]]], ['T6', 'UNITS', [[147, 148]]], ['T7', 'PK', [[95, 129]]], ['T8', 'PK', [[176, 200]]], ['T9', 'VALUE', [[204, 208]]], ['T10', 'UNITS', [[209, 210]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T5']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T4']]], ['R5', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T5']]], ['R6', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T9']]], ['R7', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T9']]], ['R8', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R9', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-263',
    collData,
    {
        text: "Similarly, rats in the fed state exhibited decreasing mean AUCs with increasing concentrations (4%, 16%, and 40%) of intragastrically administered ethanol (1.0 g/kg).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-264',
    collData,
    {
        text: "The absorption of [14C]apremilast was relatively rapid (Tmax of 1.5 h) and the plasma half-life was moderate (approximately 7h), while plasma radioactivity had a much longer half-life (approximately 50 h) (Tables 1 and 2, Figure 3), suggesting the presence of metabolites that are longer-lived than parent compound.",
        entities: [['T0', 'PK', [[56, 60]]], ['T1', 'VALUE', [[64, 67]]], ['T2', 'UNITS', [[68, 69]]], ['T3', 'PK', [[79, 95]]], ['T4', 'VALUE', [[124, 125]]], ['T5', 'UNITS', [[125, 126]]], ['T6', 'PK', [[174, 183]]], ['T7', 'VALUE', [[199, 201]]], ['T8', 'UNITS', [[202, 203]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-265',
    collData,
    {
        text: "The oral bioavailability of elvitegravir and tenofovir is affected by food intake.3,7 A food interaction study showed that the mean AUCinf and Cmax of these components of EVG/COBI/FTC/TDF STR administered orally were increased by 34% and 24%, respectively, when administered with a meal (373 kcal, 20% fat), as compared with fasting conditions.7 Therefore, in a clinical setting, it is recommended that EVG/COBI/FTC/TDF STR be taken with a meal.3 Although EVG/COBI/FTC/TDF STR has been approved for marketing in Japan and has already been administered to HIV-1-infected patients, the pharmacokinetics of these components have not yet been evaluated in Japanese subjects.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-266',
    collData,
    {
        text: "In these mouse PK studies of NDAT, the plasma NDAT level declined biophysically with a distributive T1/2α of 0.4 hours.",
        entities: [['T0', 'PK', [[100, 105]]], ['T1', 'VALUE', [[109, 112]]], ['T2', 'UNITS', [[113, 118]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-267',
    collData,
    {
        text: "The mean maximum concentration in plasma of hydroxyitraconazole after fasting was about 72% the postmeal concentration (287 and 397 ng/ml, respectively).",
        entities: [['T0', 'UNITS', [[132, 137]]], ['T1', 'VALUE', [[128, 131]]], ['T2', 'VALUE', [[120, 123]]], ['T3', 'PK', [[9, 30]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-268',
    collData,
    {
        text: "The median time to Emax after a single dose of alogliptin ranged from 2 to 4 h across all three treatment groups.",
        entities: [['T0', 'UNITS', [[77, 78]]], ['T1', 'RANGE', [[70, 76]]], ['T2', 'PK', [[11, 23]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-269',
    collData,
    {
        text: "IL‐7 concentration reached peak levels during days 2–15, and returned to baseline by day 22.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-270',
    collData,
    {
        text: "After oral administration, the mean half-life for total radioactivity was 27.5 hours.",
        entities: [['T0', 'PK', [[36, 45]]], ['T1', 'VALUE', [[74, 78]]], ['T2', 'UNITS', [[79, 84]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-271',
    collData,
    {
        text: "The absorption rate of PBCD (5/h) was faster than Feldene (1.41/h).",
        entities: [['T0', 'PK', [[4, 19]]], ['T1', 'VALUE', [[29, 30]]], ['T2', 'UNITS', [[30, 32]]], ['T3', 'VALUE', [[59, 63]]], ['T4', 'UNITS', [[63, 65]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-272',
    collData,
    {
        text: "For Cmax, the geometric mean ratios showed a decrease of 8% to 14%; all ratios were slightly below 1, and the lower bounds of the 90% CIs were below 0.80: Day 4, 0.863 (0.746, 0.997); Day 7, 0.922 (0.793, 1.071); and Day 11, 0.856 (0.709, 1.034).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-273',
    collData,
    {
        text: "On the other hand, the peak plasma concentration and AUC of ofloxacin after co-administration with sucralfate while fasting fell by 70 and 61% compared with ofloxacin alone; the changes non-fasting were 39 and 31% respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-274',
    collData,
    {
        text: "The mean total calcitriol exposure (area under the concentration versus time curve) in the prostate was 297.6 (+-159) pg/hr/mL (intact) and 272.7 (+-123.6) pg/hr/mL (castrated).",
        entities: [['T0', 'UNITS', [[118, 126]]], ['T1', 'VALUE', [[104, 109]]], ['T2', 'VALUE', [[113, 116]]], ['T3', 'VALUE', [[149, 154]]], ['T4', 'VALUE', [[140, 145]]], ['T5', 'UNITS', [[156, 164]]], ['T6', 'PK', [[36, 82]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R3', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R6', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]], ['R7', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-275',
    collData,
    {
        text: "Administration of velnacrine with food resulted in slightly lower peak plasma levels of unconjugated velnacrine, (175 vs 213 ng/ml) and delayed times-to-peak plasma levels, (2.5 vs 1.5 h) without affecting the AUCs and the t 1/2 of the drug.",
        entities: [['T0', 'PK', [[66, 84]]], ['T1', 'VALUE', [[114, 117]]], ['T2', 'VALUE', [[121, 124]]], ['T3', 'UNITS', [[125, 130]]], ['T4', 'PK', [[144, 171]]], ['T5', 'VALUE', [[174, 177]]], ['T6', 'VALUE', [[181, 184]]], ['T7', 'UNITS', [[185, 186]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R5', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T6']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-276',
    collData,
    {
        text: "The bioavailability revealed moderate inter-patient variation and was 30% +- 7.7% (range 21-45%).",
        entities: [['T0', 'PK', [[4, 19]]], ['T1', 'VALUE', [[70, 72]]], ['T2', 'VALUE', [[77, 80]]], ['T3', 'UNITS', [[80, 81]]], ['T4', 'UNITS', [[72, 73]]], ['T5', 'RANGE', [[89, 94]]], ['T6', 'UNITS', [[94, 95]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-277',
    collData,
    {
        text: "There were no statistically significant differences between 5 mg IY-81149 and 20 mg omeprazole in terms of AUC(0-24), pHmedian, tpH, 4, AUC(0-8), and AUC(8-16).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-278',
    collData,
    {
        text: "However, the peak plasma ketoconazole levels were significantly diminished when taken in conjunction with rifampicin, compared to when taken alone (P less than 0.015).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-279',
    collData,
    {
        text: "Pharmacokinetic parameters (Cmax, tmax, AUC, t1/2, Cl, aVd, UEx) were not affected by food administration, but significant differences were found in t1/2 calculated from the decay of plasma concentrations in response to oral administration of 25 mg and 50 mg treatment doses.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-280',
    collData,
    {
        text: "The elimination half-lives (T1/2) of S-diniconazole were 2.87, 3.85, 5.29, and 4.42 h in blood, heart, liver, and kidney, respectively; the T1/2 of R-diniconazole were 2.44, 3.42, 146.23, and 74.02 h in blood, heart, liver, and kidney, respectively.",
        entities: [['T0', 'PK', [[4, 33]]], ['T1', 'VALUE', [[57, 61]]], ['T2', 'VALUE', [[63, 67]]], ['T3', 'VALUE', [[69, 73]]], ['T4', 'VALUE', [[79, 83]]], ['T5', 'UNITS', [[84, 85]]], ['T6', 'PK', [[140, 144]]], ['T7', 'VALUE', [[168, 172]]], ['T8', 'VALUE', [[174, 178]]], ['T9', 'VALUE', [[180, 186]]], ['T10', 'VALUE', [[192, 197]]], ['T11', 'UNITS', [[198, 199]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]], ['R8', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R9', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T8']]], ['R10', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T9']]], ['R11', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T10']]], ['R12', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T10']]], ['R13', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T9']]], ['R14', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T8']]], ['R15', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-281',
    collData,
    {
        text: "We administered homemade PEGylated microbubbles multiple times over a 28-d period and observed dramatically accelerated clearance (4.2 × reduction in half-life), which was associated with robust anti-PEG IgM and anti-PEG IgG antibody production.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-282',
    collData,
    {
        text: "Since adefovir is essentially completely unbound in plasma or serum, these data indicate that active tubular secretion accounted for approximately 60% of the clearance of adefovir.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-283',
    collData,
    {
        text: "In our assay, the absolute bioavailabilities of Compound 1 at 45, 180 and 720 mg/kg groups were 23.68%, 14.67% and 11.93% respectively.",
        entities: [['T0', 'PK', [[18, 44]]], ['T1', 'VALUE', [[96, 101]]], ['T2', 'VALUE', [[104, 109]]], ['T3', 'VALUE', [[115, 120]]], ['T4', 'UNITS', [[101, 102]]], ['T5', 'UNITS', [[120, 121]]], ['T6', 'UNITS', [[109, 110]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-284',
    collData,
    {
        text: "The incorporation of the covariate “Asian” into the basic model did not improve it significantly: the difference in mean objective function value for the model with Asian as covariate on clearance and volume of distribution of central compartment compared to the basic model without other covariates was 0.002 and 0.099 points, respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-285',
    collData,
    {
        text: "Results of the statistical analysis for the oral dispersion gave values for β (95% CI) of 0.89 (0.47, 1.32) and 0.56 (0.29, 0.83) for AUC(0,∞) and Cmax, respectively, indicating dose proportionality for AUC(0,∞) but not for Cmax.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-286',
    collData,
    {
        text: "Secondary endpoints included 0-24 h weighted mean FEV(1) and serial FEV(1) values over 28 h. Safety measures and pharmacokinetics were assessed.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-287',
    collData,
    {
        text: "Following administration to the DSB, the relative bioavailability was approximately 52% and 30% for the salt form and free acid form, respectively.",
        entities: [['T0', 'PK', [[41, 65]]], ['T1', 'VALUE', [[84, 86]]], ['T2', 'VALUE', [[92, 94]]], ['T3', 'UNITS', [[86, 87]]], ['T4', 'UNITS', [[94, 95]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-288',
    collData,
    {
        text: "Table 2 in particular shows that the mean values for blood flow did not significantly differ between the two groups (approximately 100–120 mL/min), which confirmed that both procedures were performed under similar conditions.",
        entities: [['T0', 'UNITS', [[139, 145]]], ['T1', 'RANGE', [[131, 138]]], ['T2', 'PK', [[53, 63]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-289',
    collData,
    {
        text: "The t1/2 was similar for all the four treatment groups, with the mean t1/2 values ranging from 4.6 to 4.9 h (Table 1).",
        entities: [['T0', 'UNITS', [[106, 107]]], ['T1', 'RANGE', [[95, 105]]], ['T2', 'PK', [[70, 74]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-290',
    collData,
    {
        text: "DCV AUC∞ was higher in ESRD subjects versus controls (GMR 1.264, 90% CI 0.989, 1.616).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-291',
    collData,
    {
        text: "The absorption of the mixture (AMB/GLYK = 1/9) was about 35 times greater in the area under the serum concentration-time curve (0-24 h) than that of lyophilized AMB alone.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-292',
    collData,
    {
        text: "This compound inhibited AChE ~32-fold more strongly than the standard neostigmine, and nine-fold as effective against AChE as the second standard donepezil (IC50 = 7.23 ± 0.12 μM).",
        entities: [['T0', 'PK', [[157, 161]]], ['T1', 'VALUE', [[164, 168]]], ['T2', 'VALUE', [[171, 175]]], ['T3', 'UNITS', [[176, 178]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-293',
    collData,
    {
        text: "After multiple doses, mean (range) dose-normalized pharmacokinetic parameters were similar for adult versus pediatric patients receiving 60 Units/kg: Cmax expressed in ng/mL/mg was 42.4 (14.5–95.4) in adults and 46.6 (34.4–68.4) in pediatric patients, AUC0 t expressed in ng•h/mL/mg was 63.4 (26.3–156) in adults and 63.9 (39.8–85.1) in pediatric patients, t1/2 expressed in minutes was 34.8 (11.3–104) in adults and 31.5 (18.0–42.9) in pediatric patients and total body clearance expressed in L/h was 19.9 (6.25–37.9) in adults and 17.0 (11.7–24.9) in pediatric patients.",
        entities: [['T0', 'PK', [[150, 154]]], ['T1', 'VALUE', [[181, 185]]], ['T2', 'VALUE', [[212, 216]]], ['T3', 'PK', [[252, 258]]], ['T4', 'VALUE', [[287, 291]]], ['T5', 'UNITS', [[272, 282]]], ['T6', 'VALUE', [[317, 321]]], ['T7', 'PK', [[357, 361]]], ['T8', 'VALUE', [[387, 391]]], ['T9', 'UNITS', [[375, 382]]], ['T10', 'VALUE', [[417, 421]]], ['T11', 'PK', [[460, 480]]], ['T12', 'VALUE', [[502, 506]]], ['T13', 'UNITS', [[494, 497]]], ['T14', 'VALUE', [[533, 537]]], ['T15', 'UNITS', [[168, 176]]], ['T16', 'RANGE', [[187, 196]]], ['T17', 'RANGE', [[218, 227]]], ['T18', 'RANGE', [[293, 301]]], ['T19', 'RANGE', [[323, 332]]], ['T20', 'RANGE', [[393, 401]]], ['T21', 'RANGE', [[423, 432]]], ['T22', 'RANGE', [[508, 517]]], ['T23', 'RANGE', [[539, 548]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T6']]], ['R5', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T8']]], ['R6', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]], ['R7', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T10']]], ['R8', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T10']]], ['R9', 'C_VAL', [['Entity', 'T11'], ['C_VAL', 'T12']]], ['R10', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T12']]], ['R11', 'C_VAL', [['Entity', 'T11'], ['C_VAL', 'T14']]], ['R12', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T14']]], ['R13', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T1']]], ['R14', 'D_VAL', [['Entity', 'T16'], ['D_VAL', 'T1']]], ['R15', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T16']]], ['R16', 'D_VAL', [['Entity', 'T17'], ['D_VAL', 'T2']]], ['R17', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T17']]], ['R18', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T2']]], ['R19', 'D_VAL', [['Entity', 'T18'], ['D_VAL', 'T4']]], ['R20', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T18']]], ['R21', 'D_VAL', [['Entity', 'T19'], ['D_VAL', 'T6']]], ['R22', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T19']]], ['R23', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T6']]], ['R24', 'D_VAL', [['Entity', 'T20'], ['D_VAL', 'T8']]], ['R25', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T20']]], ['R26', 'D_VAL', [['Entity', 'T21'], ['D_VAL', 'T10']]], ['R27', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T21']]], ['R28', 'D_VAL', [['Entity', 'T22'], ['D_VAL', 'T12']]], ['R29', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T22']]], ['R30', 'D_VAL', [['Entity', 'T23'], ['D_VAL', 'T14']]], ['R31', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T23']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-294',
    collData,
    {
        text: "Step 2: Calculating true volume of distribution V:",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-295',
    collData,
    {
        text: "A significant dose-dependent increase in the area under the serum concentration-time curve from zero to 35 days (AUC0-35 days) from 541.7 to 1653.9 ng/ml.h was also noted (p less than 0.01).",
        entities: [['T0', 'UNITS', [[148, 155]]], ['T1', 'RANGE', [[132, 147]]], ['T2', 'PK', [[45, 126]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-296',
    collData,
    {
        text: "On the other hand, Cmin-ss was significantly lower in Group-II compared to Group I. Furthermore, total clearances (CL/F) and volumes of distribution (V/F, Vz/F) were found to be significantly greater and t1/2e was significantly longer in Group II patients with all values being 120%.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-297',
    collData,
    {
        text: "Upon inhalation of cromolyn single dose, the cromolyn plasma concentration reached a mean (±SD) Cmax of 46.69 ± 32.97 ng/ml at 22.8 ± 16.6 min.",
        entities: [['T0', 'PK', [[96, 100]]], ['T1', 'VALUE', [[104, 109]]], ['T2', 'UNITS', [[118, 123]]], ['T3', 'VALUE', [[112, 117]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-298',
    collData,
    {
        text: "GLPG1690 (2‐[[2‐ethyl‐6‐[4‐[2‐(3‐hydroxyazetidin‐1‐yl)‐2‐oxoethyl]piperazin‐1‐yl]‐8‐methylimidazo[1,2‐α]pyridin‐3‐yl]‐(methyl)amino]‐4‐(4‐fluorophenyl)thiazole‐5‐carbonitrile; compound code G451990; Supplemental Figure S1) is a first‐in‐class inhibitor of autotaxin being investigated as a novel therapy for IPF.18 GLPG1690 selectively inhibits autotaxin, with ex vivo human plasma LPA release assays indicating a half maximal inhibitory concentration (IC50) of approximately 100 nM.19 In preclinical studies, GLPG1690 has demonstrated efficacy in a mouse bleomycin‐induced pulmonary fibrosis model (therapeutic setting): GLPG1690 was superior to pirfenidone and similar to nintedanib in reducing the Ashcroft fibrotic score and collagen content.19, 20 Furthermore, a recent phase 2a study (FLORA study) in 23 patients with IPF demonstrated that GLPG1690 was well tolerated, reduced plasma LPA C18:2 levels, and stabilized forced vital capacity (FVC) after 12 weeks of treatment.21",
        entities: [['T0', 'PK', [[414, 458]]], ['T1', 'VALUE', [[476, 479]]], ['T2', 'UNITS', [[480, 482]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-299',
    collData,
    {
        text: "At the RP2D, the geometric mean (%CV [coefficient of variation]) Cmax was 33·5 (57) ng/ml and 58·7 (32) ng/ml on days 1 and 11, respectively.",
        entities: [['T0', 'UNITS', [[84, 89]]], ['T1', 'VALUE', [[74, 78]]], ['T2', 'PK', [[65, 69]]], ['T3', 'VALUE', [[94, 98]]], ['T4', 'UNITS', [[104, 109]]], ['T5', 'VALUE', [[100, 102]]], ['T6', 'VALUE', [[80, 82]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T3']]], ['R5', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R6', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T1']]], ['R7', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-300',
    collData,
    {
        text: "The pharmacokinetic (PK) data for cycle 1 demonstrated that the time to peak concentration (tmax) occurred shortly after the end of the infusion (3–6 hours) in all cohorts (Supplementary Table 1; Figure 1).",
        entities: [['T0', 'UNITS', [[150, 155]]], ['T1', 'RANGE', [[146, 149]]], ['T2', 'PK', [[64, 97]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-301',
    collData,
    {
        text: "The bioavailability of the two i.n. dosage forms (relative to that of the i.m. injection) were 94% (microsphere) and 54% (gel).",
        entities: [['T0', 'PK', [[4, 19]]], ['T1', 'VALUE', [[95, 97]]], ['T2', 'VALUE', [[117, 119]]], ['T3', 'UNITS', [[119, 120]]], ['T4', 'UNITS', [[97, 98]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-302',
    collData,
    {
        text: "The dose was calculated using Calvert's formula with 24 h creatinine clearance (Ccr, ml/min) as a substitute for glomerular filtration rate (GFR): carboplatin (mg) = AUC X (Ccr+25), where AUC denotes the area under the concentration versus time curve (mg ml–1 min).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-303',
    collData,
    {
        text: "Elimination constant after an oral administration of 50 μg/kg in Wistar rat was 1.81 h−1, absorption constant was 3.05 h−1, Cmax was 3.57 μg/mL at 0.33 h, AUC0–α was 956.54 μ/mL·h and distribution volume was 419.4 mL. To IV administration at the same dose, ke was 1.21 h−1, Vd was 399.6 mL and AUC0–α was 747.81 μ/mL·h.",
        entities: [['T0', 'UNITS', [[85, 88]]], ['T1', 'VALUE', [[80, 84]]], ['T2', 'PK', [[0, 20]]], ['T3', 'PK', [[90, 109]]], ['T4', 'VALUE', [[114, 118]]], ['T5', 'UNITS', [[119, 122]]], ['T6', 'UNITS', [[138, 143]]], ['T7', 'VALUE', [[133, 137]]], ['T8', 'PK', [[124, 128]]], ['T9', 'UNITS', [[173, 179]]], ['T10', 'VALUE', [[166, 172]]], ['T11', 'PK', [[155, 161]]], ['T12', 'PK', [[184, 203]]], ['T13', 'VALUE', [[208, 213]]], ['T14', 'UNITS', [[214, 216]]], ['T15', 'PK', [[257, 259]]], ['T16', 'VALUE', [[264, 268]]], ['T17', 'UNITS', [[269, 272]]], ['T18', 'PK', [[274, 276]]], ['T19', 'VALUE', [[281, 286]]], ['T20', 'UNITS', [[287, 289]]], ['T21', 'PK', [[294, 300]]], ['T22', 'VALUE', [[305, 311]]], ['T23', 'UNITS', [[312, 318]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R5', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T7']]], ['R6', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T10']]], ['R7', 'C_VAL', [['Entity', 'T11'], ['C_VAL', 'T10']]], ['R8', 'C_VAL', [['Entity', 'T12'], ['C_VAL', 'T13']]], ['R9', 'RELATED', [['Entity', 'T14'], ['RELATED', 'T13']]], ['R10', 'C_VAL', [['Entity', 'T15'], ['C_VAL', 'T16']]], ['R11', 'RELATED', [['Entity', 'T17'], ['RELATED', 'T16']]], ['R12', 'C_VAL', [['Entity', 'T18'], ['C_VAL', 'T19']]], ['R13', 'RELATED', [['Entity', 'T20'], ['RELATED', 'T19']]], ['R14', 'C_VAL', [['Entity', 'T21'], ['C_VAL', 'T22']]], ['R15', 'RELATED', [['Entity', 'T23'], ['RELATED', 'T22']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-304',
    collData,
    {
        text: "Out of the three CHEM-based pH-sensitive formulas, 4%PEG-HS-CHEM was selected to proceed with the tissue distribution and clearance study, due to its better stability with serum compared to 1% and 2%PEG-HS-CHEM.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-305',
    collData,
    {
        text: "After single intravenously administration of 250, 500 and 1000 mg mildronate, the elimination half-life (t(1/2)) were (5.56+-1.55), (6.46+-1.07) and (6.55+-1.17) h, respectively.",
        entities: [['T0', 'VALUE', [[125, 129]]], ['T1', 'VALUE', [[119, 123]]], ['T2', 'UNITS', [[162, 163]]], ['T3', 'VALUE', [[139, 143]]], ['T4', 'VALUE', [[133, 137]]], ['T5', 'VALUE', [[156, 160]]], ['T6', 'VALUE', [[150, 154]]], ['T7', 'PK', [[82, 112]]]],
        relations: [['R0', 'D_VAL', [['Entity', 'T0'], ['D_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T0']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T6']]], ['R5', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T5']]], ['R6', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T6']]], ['R7', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T4']]], ['R8', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R9', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T6']]], ['R10', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T4']]], ['R11', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-306',
    collData,
    {
        text: "Comparison of areas under the time-concentration curves (AUC) with reference to the three administration routes indicates that after oral administration only 0.2%-17.4% (mean 5.7%; SD 3.77; 40 patients) of the administered dose is absorbed; after IM treatment a daily absorption of 0.7%-7.7% (mean 2.5%; SD 1.66; 30 patients) of the administered dose per injection site was computed.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-307',
    collData,
    {
        text: "Estimated mean age group ratios (elderly/younger) for AUCIDeg,τ,SS and Cmax,IDeg,SS and corresponding two-sided 95 % CIs were 1.04 (95 % CI 0.73–1.47) and 1.02 (95 % CI 0.74–1.39), respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-308',
    collData,
    {
        text: "Furthermore, power model analysis displayed dose-proportional increases in the AUClast and Cmax of oseltamivir and OC within a dose range of 2.5 to 10 mg.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-309',
    collData,
    {
        text: "On the other hand, compound 2l was the most potent compound against SK-Mel-5 [melanoma], A498 [renal], PC-3 [prostate], and MDA-MB-468 [breast] with an IC50 values of 1.23, 0.33, 1.74, and 1.16 µM, respectively.",
        entities: [['T0', 'PK', [[152, 156]]], ['T1', 'VALUE', [[167, 171]]], ['T2', 'VALUE', [[173, 177]]], ['T3', 'VALUE', [[179, 183]]], ['T4', 'VALUE', [[189, 193]]], ['T5', 'UNITS', [[194, 196]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-310',
    collData,
    {
        text: "The CV in Ae and CLR was higher in subjects with moderate hepatic impairment, with values ranging from 72.8 to 84.6 %, compared with subjects with normal hepatic function, with values ranging from 39.4 to 46.5 %.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-311',
    collData,
    {
        text: "Two methods of estimating the steady-state concentration response relationship from the single dose data were examined: 1) the relationship of descending limb Cp vs. E and 2) the relationship of estimated effect site concentrations (Ce) vs. E. When compared to experimental steady-state measurements, the absolute errors of predictions from the Ce vs. E method were less than those from the Cp vs. E predictions (6.8 +- 4.4 vs. 9.6 +- 6.6, mean +- S.D.).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-312',
    collData,
    {
        text: "Though 60 μg⋅h/mL was not a useful threshold, a relationship was still seen between AUC and adverse effects.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-313',
    collData,
    {
        text: "Bradycardic response was similar in both groups; metoprolol chronotropic potency was greater in fructose-fed rats (IC50: 123 +- 15 ng/mL, P < 0.05 vs. control) compared to control animals (IC50: 216 +- 36 ng/mL) after administration of 3 mg/kg.",
        entities: [['T0', 'PK', [[115, 119]]], ['T1', 'VALUE', [[121, 124]]], ['T2', 'VALUE', [[128, 130]]], ['T3', 'UNITS', [[131, 136]]], ['T4', 'PK', [[189, 193]]], ['T5', 'VALUE', [[195, 198]]], ['T6', 'VALUE', [[202, 204]]], ['T7', 'UNITS', [[205, 210]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T5']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-314',
    collData,
    {
        text: "The mean terminal phase half-life was approximately 3.2 hours for both parent drug and total radioactivity.",
        entities: [['T0', 'UNITS', [[56, 61]]], ['T1', 'VALUE', [[52, 55]]], ['T2', 'PK', [[9, 33]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-315',
    collData,
    {
        text: "The key PK characteristics of cebranopadol after single oral dosing were determined in the relative bioavailability trial comparing the 4 × 50 μg and 1 × 400 μg film-coated tablets with the oral solution (Table 1).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-316',
    collData,
    {
        text: "The mean time of peak concentration was 1.63 +- 0.74 h (range 1-4 h).",
        entities: [['T0', 'UNITS', [[53, 54]]], ['T1', 'VALUE', [[40, 44]]], ['T2', 'PK', [[9, 35]]], ['T3', 'VALUE', [[48, 52]]], ['T4', 'RANGE', [[62, 65]]], ['T5', 'UNITS', [[66, 67]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-317',
    collData,
    {
        text: "There was no difference in APAP half‐life or AUC(0‐20.25h) (CYP/total(%)) between SNAP trial conventional and modified NAC treatment (half‐life: 2.19 h (1.97–2.54) vs. 2.44 h (2.08–2.84), P = 0.08.",
        entities: [['T0', 'PK', [[134, 143]]], ['T1', 'VALUE', [[145, 149]]], ['T2', 'UNITS', [[150, 151]]], ['T3', 'UNITS', [[173, 174]]], ['T4', 'VALUE', [[168, 172]]], ['T5', 'RANGE', [[176, 185]]], ['T6', 'RANGE', [[153, 162]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T4']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-318',
    collData,
    {
        text: "The average value for the absorption half-lives in the dogs were 19.3 and 12.2 min, showing that even lipophobic solutes such as the fluorescein dianion, are absorbed extremely rapidly via the lung.",
        entities: [['T0', 'PK', [[26, 47]]], ['T1', 'VALUE', [[65, 69]]], ['T2', 'VALUE', [[74, 78]]], ['T3', 'UNITS', [[79, 82]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-319',
    collData,
    {
        text: "The geometric mean values with 90% CIs for dose-normalized AUC0–last (Table 7), demonstrate a more than linear increase in AUC0–last with dose (no overlap in the 90% CIs) in the 40–80 μg/kg range.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-320',
    collData,
    {
        text: "After i.v. administration, the concentration of bivalirudin was eliminated with a half-life (t1/2) of 20.2±1.7 min and the clearance 5.8±0.9 mL/min/kg.",
        entities: [['T0', 'PK', [[82, 98]]], ['T1', 'VALUE', [[102, 106]]], ['T2', 'PK', [[123, 132]]], ['T3', 'VALUE', [[133, 136]]], ['T4', 'VALUE', [[107, 110]]], ['T5', 'UNITS', [[111, 114]]], ['T6', 'VALUE', [[137, 140]]], ['T7', 'UNITS', [[141, 150]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T3']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-321',
    collData,
    {
        text: "Pharmacokinetic and metabolite identification studies were conducted to understand the clearance pathways of EPZ011652 [(2-aminoethyl)(methyl)({3-[4-(propan-2-yloxy)phenyl]-1H-pyrazol-4-yl}methyl)amine], a potent protein arginine N-methyltransferase inhibitor.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-322',
    collData,
    {
        text: "Total plasma concentrations of cefuroxime were 154.4+-41.6, 73.3+-20.7, 67.1+-20.4, 59.2+-21.0, 49.0+-16.4, 110.9+-33.6 (mg l(-1)) and concentrations of free plasma fraction were 110.7+-37.1, 62.2+-18.8, 58.9+-18.6, 48.4+-16.6, 41.7+-15.6, 97.6+-28.6 (mg l(-1)).",
        entities: [['T0', 'PK', [[0, 27]]], ['T1', 'VALUE', [[47, 52]]], ['T2', 'VALUE', [[54, 58]]], ['T3', 'UNITS', [[121, 129]]], ['T4', 'VALUE', [[66, 70]]], ['T5', 'VALUE', [[60, 64]]], ['T6', 'VALUE', [[72, 76]]], ['T7', 'VALUE', [[78, 82]]], ['T8', 'VALUE', [[84, 88]]], ['T9', 'VALUE', [[90, 94]]], ['T10', 'VALUE', [[96, 100]]], ['T11', 'VALUE', [[108, 113]]], ['T12', 'VALUE', [[102, 106]]], ['T13', 'VALUE', [[115, 119]]], ['T14', 'PK', [[135, 173]]], ['T15', 'VALUE', [[179, 184]]], ['T16', 'VALUE', [[192, 196]]], ['T17', 'VALUE', [[204, 208]]], ['T18', 'VALUE', [[216, 220]]], ['T19', 'VALUE', [[228, 232]]], ['T20', 'VALUE', [[240, 244]]], ['T21', 'VALUE', [[186, 190]]], ['T22', 'UNITS', [[252, 260]]], ['T23', 'VALUE', [[198, 202]]], ['T24', 'VALUE', [[210, 214]]], ['T25', 'VALUE', [[222, 226]]], ['T26', 'VALUE', [[234, 238]]], ['T27', 'VALUE', [[246, 250]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T5']]], ['R4', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R5', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R6', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T6']]], ['R7', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T6']]], ['R8', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T6']]], ['R9', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T7']]], ['R10', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T8']]], ['R11', 'D_VAL', [['Entity', 'T9'], ['D_VAL', 'T8']]], ['R12', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T9']]], ['R13', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T8']]], ['R14', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T10']]], ['R15', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T11']]], ['R16', 'D_VAL', [['Entity', 'T12'], ['D_VAL', 'T10']]], ['R17', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T12']]], ['R18', 'D_VAL', [['Entity', 'T13'], ['D_VAL', 'T11']]], ['R19', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T13']]], ['R20', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T11']]], ['R21', 'C_VAL', [['Entity', 'T14'], ['C_VAL', 'T15']]], ['R22', 'C_VAL', [['Entity', 'T14'], ['C_VAL', 'T16']]], ['R23', 'C_VAL', [['Entity', 'T14'], ['C_VAL', 'T17']]], ['R24', 'C_VAL', [['Entity', 'T14'], ['C_VAL', 'T18']]], ['R25', 'C_VAL', [['Entity', 'T14'], ['C_VAL', 'T19']]], ['R26', 'C_VAL', [['Entity', 'T14'], ['C_VAL', 'T20']]], ['R27', 'D_VAL', [['Entity', 'T21'], ['D_VAL', 'T15']]], ['R28', 'RELATED', [['Entity', 'T22'], ['RELATED', 'T21']]], ['R29', 'D_VAL', [['Entity', 'T23'], ['D_VAL', 'T16']]], ['R30', 'RELATED', [['Entity', 'T22'], ['RELATED', 'T23']]], ['R31', 'D_VAL', [['Entity', 'T24'], ['D_VAL', 'T17']]], ['R32', 'RELATED', [['Entity', 'T22'], ['RELATED', 'T24']]], ['R33', 'D_VAL', [['Entity', 'T25'], ['D_VAL', 'T18']]], ['R34', 'RELATED', [['Entity', 'T22'], ['RELATED', 'T25']]], ['R35', 'D_VAL', [['Entity', 'T26'], ['D_VAL', 'T19']]], ['R36', 'RELATED', [['Entity', 'T22'], ['RELATED', 'T26']]], ['R37', 'D_VAL', [['Entity', 'T27'], ['D_VAL', 'T20']]], ['R38', 'RELATED', [['Entity', 'T22'], ['RELATED', 'T27']]], ['R39', 'RELATED', [['Entity', 'T22'], ['RELATED', 'T20']]], ['R40', 'RELATED', [['Entity', 'T22'], ['RELATED', 'T19']]], ['R41', 'RELATED', [['Entity', 'T22'], ['RELATED', 'T18']]], ['R42', 'RELATED', [['Entity', 'T22'], ['RELATED', 'T17']]], ['R43', 'RELATED', [['Entity', 'T22'], ['RELATED', 'T16']]], ['R44', 'RELATED', [['Entity', 'T22'], ['RELATED', 'T15']]], ['R45', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T10']]], ['R46', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T5']]], ['R47', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-323',
    collData,
    {
        text: "h/L) and dose 3 (C(max3) = 4.9 +- 2 mg/L and AUC(24-36) = 17.5 +- 11 mg.h/L).",
        entities: [['T0', 'PK', [[17, 24]]], ['T1', 'VALUE', [[27, 30]]], ['T2', 'PK', [[45, 55]]], ['T3', 'VALUE', [[58, 62]]], ['T4', 'UNITS', [[36, 40]]], ['T5', 'UNITS', [[69, 75]]], ['T6', 'VALUE', [[34, 35]]], ['T7', 'VALUE', [[66, 68]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T6']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T3']]], ['R7', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-324',
    collData,
    {
        text: "In addition, maintaining the column temperature at 60°C and the flow rate at 0.55 ml/min yielded sharp and symmetrical peaks (Fig 2A).",
        entities: [['T0', 'PK', [[64, 73]]], ['T1', 'VALUE', [[77, 81]]], ['T2', 'UNITS', [[82, 88]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-325',
    collData,
    {
        text: "The area under the ROC curve was 0.83 and the cut-off value of penicillin G Cmin/MIC for clinical efficacy was 60 (sensitivity 68 %, specificity 100 %).",
        entities: [['T0', 'PK', [[76, 84]]], ['T1', 'VALUE', [[111, 113]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-326',
    collData,
    {
        text: "Geometric LSM ratios and 90% CI for metformin CL/F and AUC12 were 80% (75%, 85%) and 125% (117%, 134%), respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-327',
    collData,
    {
        text: "Geometric mean t1/2 of both silybin A andsilybin B was ~5 hours (Table 2).",
        entities: [['T0', 'PK', [[15, 19]]], ['T1', 'VALUE', [[56, 57]]], ['T2', 'UNITS', [[58, 63]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-328',
    collData,
    {
        text: "The harmonic mean terminal half-life decreased from 17 h to 13 h during concomitant ritonavir.",
        entities: [['T0', 'PK', [[18, 36]]], ['T1', 'VALUE', [[52, 54]]], ['T2', 'UNITS', [[55, 56]]], ['T3', 'UNITS', [[63, 64]]], ['T4', 'VALUE', [[60, 62]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-329',
    collData,
    {
        text: "In Trial 2, systemic exposure for albuterol was lower for CVT‐R 20/100 compared with CVT‐MDI 36/206; the GMRs for AUC0–6 and Cmax were 0.74 and 0.76, respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-330',
    collData,
    {
        text: "After administration of multiple doses, the GMRs (90% CIs) for Cmax,ss and AUCτ,ss of fimasartan with or without rosuvastatin were 0.94 (0.74–1.20) and 1.07 (0.90–1.16), respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-331',
    collData,
    {
        text: "Patients with probable AD based on the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association (NINCDS/ADRDA) and the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) criteria, having a Mini-Mental State Exam (MMSE) score of 17–26 inclusive, and a modified Hachinski Ischemia Scale score ≤4 were enroled in the study.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-332',
    collData,
    {
        text: "In both orthotopic and metastatic lung tumor models, BA-SD produced superior anticancer effects compared to BA free drug groups, in terms of lung tumor weights and tumor volumes show 1.49 and 1.90 fold superior in BA-SD treated groups.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-333',
    collData,
    {
        text: "Total cysteamine exposure, expressed as area under the curve (AUC(0, infinity)) was greatest when the drug was infused into the small intestine (4331.3 +- 1907.6 min x microM) followed by stomach (3901.9 +- 1591.9 min x microM) and caecum (3141.4 +- 1627.6 min x microM).",
        entities: [['T0', 'PK', [[40, 79]]], ['T1', 'VALUE', [[145, 151]]], ['T2', 'VALUE', [[197, 203]]], ['T3', 'VALUE', [[240, 246]]], ['T4', 'UNITS', [[162, 174]]], ['T5', 'UNITS', [[214, 226]]], ['T6', 'UNITS', [[257, 269]]], ['T7', 'VALUE', [[155, 161]]], ['T8', 'VALUE', [[207, 213]]], ['T9', 'VALUE', [[250, 256]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T2']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T3']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T1']]], ['R7', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T7']]], ['R8', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T2']]], ['R9', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T8']]], ['R10', 'D_VAL', [['Entity', 'T9'], ['D_VAL', 'T3']]], ['R11', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T9']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-334',
    collData,
    {
        text: "Peak plasma levels of the two compounds after their subcutaneous administration were obtained within 10 min.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-335',
    collData,
    {
        text: "The carbamazepine hemoperfusion clearance rate was 80-90 ml/min, but due to a probable ongoing absorption from the gut the effect of hemoperfusion was limited.",
        entities: [['T0', 'UNITS', [[57, 63]]], ['T1', 'RANGE', [[51, 56]]], ['T2', 'PK', [[32, 46]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-336',
    collData,
    {
        text: "Lu et al (2008)also observed that AST could be linked to bevacizumab clearance, but found it unlikely that impaired hepatic enzymes would actually alter clearance.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-337',
    collData,
    {
        text: "Over the 15-week trial, pUA in PR averaged 1.0 ± 0.4 mg/dL; T½ for pUox was approximately 13 days, and area under the curve after dose 5 was approximately 30% higher than after dose 1.",
        entities: [['T0', 'PK', [[60, 62]]], ['T1', 'VALUE', [[90, 92]]], ['T2', 'UNITS', [[93, 97]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-338',
    collData,
    {
        text: "The R isomer was then converted to a biologically active compound (34) that had a Ke of 36 nM. The most potent compound displayed enhanced aqueous solubility compared with the prototypical antagonist SHA-68 and demonstrated favorable pharmacokinetic properties for behavioral assessment.",
        entities: [['T0', 'PK', [[82, 84]]], ['T1', 'VALUE', [[88, 90]]], ['T2', 'UNITS', [[91, 93]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-339',
    collData,
    {
        text: "Peak plasma concentrations, AUCs, and times with plasma concentration above 1 micrograms/mL correlated significantly with the relative decrease in leukocyte but not platelet counts.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-340',
    collData,
    {
        text: "The pyridine N-oxide series is exemplified by L-372,662 (30), which possessed good potency in vitro (Ki = 4.1 nM, cloned human oxytocin receptor) and in vivo (intravenous AD50 = 0.71 mg/kg in the rat), excellent oral bioavailability (90% in the rat, 96% in the dog), good aqueous solubility (>8.5 mg/mL at pH 5.2) which should facilitate formulation for iv administration, and excellent selectivity against the human arginine vasopressin receptors.",
        entities: [['T0', 'UNITS', [[110, 112]]], ['T1', 'VALUE', [[106, 109]]], ['T2', 'PK', [[101, 103]]], ['T3', 'UNITS', [[183, 188]]], ['T4', 'VALUE', [[178, 182]]], ['T5', 'PK', [[171, 175]]], ['T6', 'PK', [[212, 232]]], ['T7', 'VALUE', [[234, 236]]], ['T8', 'UNITS', [[236, 237]]], ['T9', 'VALUE', [[250, 252]]], ['T10', 'UNITS', [[252, 253]]], ['T11', 'UNITS', [[297, 302]]], ['T12', 'VALUE', [[293, 296]]], ['T13', 'PK', [[280, 290]]], ['T14', 'COMPARE', [[292, 293]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]], ['R6', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T9']]], ['R7', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T9']]], ['R8', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T12']]], ['R9', 'C_VAL', [['Entity', 'T13'], ['C_VAL', 'T12']]], ['R10', 'RELATED', [['Entity', 'T14'], ['RELATED', 'T12']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-341',
    collData,
    {
        text: "Based on the results shown in Table S4, D1203_5A3 was selected as the base model, an Emax‐Tmax model with Cminss as the measure of exposure affecting only the magnitude of the DAS28 response, with a full block matrix IIV on E0, Emax,aba and T50, with additive residual error.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-342',
    collData,
    {
        text: "Interestingly, the blank sHDL also showed some antitumor activity but at a significantly higher concentration of 5A (IC50=0.21 mg/mL of 5A) than that of HCPT-sHDL (IC50=0.012 mg/mL of 5A and 0.17 µg/mL of HCPT).",
        entities: [['T0', 'PK', [[117, 121]]], ['T1', 'VALUE', [[122, 126]]], ['T2', 'PK', [[164, 168]]], ['T3', 'VALUE', [[169, 174]]], ['T4', 'VALUE', [[191, 195]]], ['T5', 'UNITS', [[127, 132]]], ['T6', 'UNITS', [[175, 180]]], ['T7', 'UNITS', [[196, 201]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T3']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-343',
    collData,
    {
        text: "Bmax,C, estimated by the model, which was likely to be a reflection of the plasma DPP-4 concentration, correlated with the pre-dose DPP-4 activity (∆OBJF 68), dose (∆OBJF 69) and age (∆OBJF 14).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-344',
    collData,
    {
        text: "In 5 patients, peak time was detected at 240 or even 360 minutes after the end of nebulization.",
        entities: [['T0', 'PK', [[15, 24]]], ['T1', 'VALUE', [[41, 44]]], ['T2', 'VALUE', [[53, 56]]], ['T3', 'UNITS', [[57, 64]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-345',
    collData,
    {
        text: "The area under the curve (AUC) in plasma was 14.1 and 14.7 μg·h/mL in male and female rats, whereas in blood it was 25.0 and 23.1 μg·h/mL in male and female rats, respectively (Table 1; Figures 2 and 3).",
        entities: [['T0', 'PK', [[4, 30]]], ['T1', 'VALUE', [[45, 49]]], ['T2', 'VALUE', [[54, 58]]], ['T3', 'VALUE', [[116, 120]]], ['T4', 'VALUE', [[125, 129]]], ['T5', 'UNITS', [[59, 66]]], ['T6', 'UNITS', [[130, 137]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T2']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]], ['R6', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T4']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-346',
    collData,
    {
        text: "Mean accumulation ratios for plasma AG10 Cmax ranged from 1.3 to 1.6.",
        entities: [['T0', 'PK', [[5, 24]]], ['T1', 'RANGE', [[58, 68]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-347',
    collData,
    {
        text: "A very similar area-specific flow or clearance rate of 1.6 microliters.h-1.mm-2 was calculated for the interface area between the serum compartment and either the small or large blisters.",
        entities: [['T0', 'PK', [[37, 51]]], ['T1', 'VALUE', [[55, 58]]], ['T2', 'UNITS', [[59, 79]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-348',
    collData,
    {
        text: "The pharmacokinetic study demonstrated a significant correlation between trough concentration (C0) and area under the concentration-time curve of tacrolimus after discontinuation of clotrimazole (R2 = 0.60, P < 0.05) but not before its discontinuation.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-349',
    collData,
    {
        text: "However, the mean tmax was generally comparable for patients receiving GFF MDI (mean tmax [CV%]: 0.92 h [102%] and 0.92 h [137%] on Day 1 and at Week 12, respectively), compared with patients receiving FF MDI (mean tmax [CV%]: 1.24 h [133%] and 1.06 h [106%] on Day 1 and at Week 12, respectively).",
        entities: [['T0', 'PK', [[85, 89]]], ['T1', 'VALUE', [[97, 101]]], ['T2', 'UNITS', [[102, 103]]], ['T3', 'VALUE', [[115, 119]]], ['T4', 'UNITS', [[120, 121]]], ['T5', 'PK', [[215, 219]]], ['T6', 'VALUE', [[227, 231]]], ['T7', 'UNITS', [[232, 233]]], ['T8', 'UNITS', [[250, 251]]], ['T9', 'VALUE', [[245, 249]]], ['T10', 'VALUE', [[105, 108]]], ['T11', 'UNITS', [[108, 109]]], ['T12', 'VALUE', [[123, 126]]], ['T13', 'UNITS', [[126, 127]]], ['T14', 'VALUE', [[235, 238]]], ['T15', 'UNITS', [[238, 239]]], ['T16', 'VALUE', [[253, 256]]], ['T17', 'UNITS', [[256, 257]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T6']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T9']]], ['R7', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T9']]], ['R8', 'D_VAL', [['Entity', 'T10'], ['D_VAL', 'T1']]], ['R9', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T10']]], ['R10', 'D_VAL', [['Entity', 'T12'], ['D_VAL', 'T3']]], ['R11', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T12']]], ['R12', 'D_VAL', [['Entity', 'T14'], ['D_VAL', 'T6']]], ['R13', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T14']]], ['R14', 'D_VAL', [['Entity', 'T16'], ['D_VAL', 'T9']]], ['R15', 'RELATED', [['Entity', 'T17'], ['RELATED', 'T16']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-350',
    collData,
    {
        text: "Cranberry significantly increased the area under the INR-time curve by 30% when administered with warfarin compared with treatment with warfarin alone.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-351',
    collData,
    {
        text: "However, when these tablets were enteric coated, PCC improved CEF bioavailability from 2.44 +- 1.84 to 29.0 +- 13.4%.",
        entities: [['T0', 'PK', [[66, 81]]], ['T1', 'VALUE', [[87, 91]]], ['T2', 'VALUE', [[95, 99]]], ['T3', 'UNITS', [[115, 116]]], ['T4', 'VALUE', [[111, 115]]], ['T5', 'VALUE', [[103, 107]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T5']]], ['R4', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R5', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T5']]], ['R6', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T5']]], ['R7', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-352',
    collData,
    {
        text: "The relative bioavailability of phenylephrine 10 mg was doubled (Fbio 2.11, 95%CI 1.89, 2.31) when combined with acetaminophen 1000 mg, while the absorption half-time was reduced by 50 %.",
        entities: [['T0', 'PK', [[4, 28]]], ['T1', 'VALUE', [[70, 74]]], ['T2', 'RANGE', [[82, 92]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-353',
    collData,
    {
        text: "The levodopa pharmacokinetics of the new DRF showed rapid absorption (tmax=1.1 h), followed by sustained levodopa plasma concentrations, similar to the SRF.",
        entities: [['T0', 'UNITS', [[79, 80]]], ['T1', 'VALUE', [[75, 78]]], ['T2', 'PK', [[70, 74]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-354',
    collData,
    {
        text: "Furthermore, the pharmacokinetic simulation based on the estimated pharmacokinetic parameters from the final model demonstrated that TM-α administered at a dose of 0.06 mg/kg every 24 hr also failed to achieve the target trough concentration at steady state in the majority of pediatric patients.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-355',
    collData,
    {
        text: "Higher MPA Cmax was associated with increasing IMPDH activity, expressed as AUC0–9 h (r = 0.80, P = 0.058, n = 6) and Amax (r = 0.88, P = 0.051, n = 6).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-356',
    collData,
    {
        text: "Plasma concentration peaked at 3-4 hours after administration of 3 mg/kg of CFDN with Cmax ranging from 0.57-0.89 microgram/ml except 1 case in which the absorption of the drug was poor.",
        entities: [['T0', 'PK', [[86, 90]]], ['T1', 'RANGE', [[104, 113]]], ['T2', 'UNITS', [[114, 126]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-357',
    collData,
    {
        text: "In study part 2, the mean value of Cmin on cycle 2, day 15 for ontuxizumab 12 mg/kg biweekly administration was between the trough concentrations of 4 mg/kg and 8 mg/kg weekly administration in patients with gastric cancer or HCC.",
        entities: [['T0', 'UNITS', [[151, 156]]], ['T1', 'VALUE', [[149, 150]]], ['T2', 'UNITS', [[163, 168]]], ['T3', 'VALUE', [[161, 162]]], ['T4', 'PK', [[124, 145]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-358',
    collData,
    {
        text: "Intravenous infusions resulted in mean Cmax values of 26,709.6 ng/mL (FDC-IV) and 26,236 ng/mL (paracetamol IV) immediately after the 15-min infusion.",
        entities: [['T0', 'UNITS', [[63, 68]]], ['T1', 'VALUE', [[54, 62]]], ['T2', 'PK', [[39, 43]]], ['T3', 'VALUE', [[82, 88]]], ['T4', 'UNITS', [[89, 94]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-359',
    collData,
    {
        text: "Renal clearance based on 24 h urinary recovery was determined to be insignificant (< 1% of CL(tot)).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-360',
    collData,
    {
        text: "The initial burst release could be attributed to AE probably adsorbed on LCNPs surface and/or the high surface area-to-volume ratio of the nano-LCNPs.37 On the other hand, the delayed release of AE from both AE-LCNPs and AE-PEGylated LCNPs may be attributed to the diffusion of entrapped drug through the tortuous regular channels of the lipidic matrix.14 AE-PEGylated LCNPs demonstrated slower release profile at initial time points with only 2% drug released after a lag time of 2 hours when compared with AE-LCNPs.",
        entities: [['T0', 'UNITS', [[483, 488]]], ['T1', 'VALUE', [[481, 482]]], ['T2', 'PK', [[469, 477]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-361',
    collData,
    {
        text: "The plasma unbound fraction of disopyramide enantiomers was constant at a concentration range of 1.44-28.9 microM. An intravenous infusion study of the disopyramide enantiomer or racemate suggested that the S-enantiomer had a pharmacological effect, determined by linear regression analysis, approximately 3.3-times more potent than that of the R-enantiomer.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-362',
    collData,
    {
        text: "AGene gave the highest AUC value (0.776, p < 0.001) and the best sensitivity (Figure 2), demonstrating that gene factors might improve predictive accuracy of RRR.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-363',
    collData,
    {
        text: "The authors exploited the ability of Annexin V to cross the corneal epithelium cell membrane in the presence of Ca2+ [26,27,29,35] and achieved a remarkable ocular bioavailability of bevacizumab.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-364',
    collData,
    {
        text: "Sensitivity of morphine CL to changes in cardiac output increased with age up to 3 years, whereas sensitivity to changes in UGT2B7 activity decreased.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-365',
    collData,
    {
        text: "The unbound clearance (CLu/F) of quinine, which reflects the activity of the drug-metabolizing enzymes, was considerably greater (6.9-fold) in subjects when rifampicin was coadministered with quinine than that of quinine alone (6.9 +- 3.6 vs 1.0 +- 0.5 1 h-1 kg-1; the 95% C.I. for the mean difference was 3.3 to 8.5).",
        entities: [['T0', 'UNITS', [[253, 263]]], ['T1', 'VALUE', [[242, 245]]], ['T2', 'VALUE', [[228, 231]]], ['T3', 'PK', [[4, 29]]], ['T4', 'VALUE', [[235, 238]]], ['T5', 'VALUE', [[249, 252]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]], ['R4', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T2']]], ['R5', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T4']]], ['R6', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T1']]], ['R7', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-366',
    collData,
    {
        text: "Half the adult OC clearance was reached at a PMA of 45.6 weeks (95% confidence interval (CI) 41.6-49.6) with a Hill coefficient of 2.35 (95% CI 1.67-3.04).",
        entities: [['T0', 'PK', [[111, 127]]], ['T1', 'VALUE', [[131, 135]]], ['T2', 'RANGE', [[144, 153]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-367',
    collData,
    {
        text: "Bioavailability tests (single dosage, crossover design) and several investigations into the dissolution profile were carried out on three test batches of a sustained release carbamazepine preparation (Timonil 300 retard).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-368',
    collData,
    {
        text: "In the case of the variant allele ABCC3 rs4793665 (OR = 0.2, 95% CI = 0.1–0.9, p = 0.03), as well as the homozygous variant genotype allele ABCC2 rs3740066 (OR = 0.1, 95% CI = 0.01–0.8, p = 0.01), AUC0-48 was lower.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-369',
    collData,
    {
        text: "ASP3026 demonstrated both linear pharmacokinetics and dose-proportional exposure for area under the plasma concentration–time curve and maximum concentration observed with a median terminal half-life of 35 h, supporting the daily dosing.",
        entities: [['T0', 'UNITS', [[206, 207]]], ['T1', 'VALUE', [[203, 205]]], ['T2', 'PK', [[181, 199]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-370',
    collData,
    {
        text: "The absolute bioavailability, however, was increased because of a dose- and duration of treatment-dependent reduction in hepatic elimination (absolute bioavailability changing from 0.25 +- 0.18 at 1 mg/kg to 0.40 +- 0.22 at 6 mg/kg and 0.48 +- 0.14 after multiple dosing, P < .05).",
        entities: [['T0', 'VALUE', [[189, 193]]], ['T1', 'VALUE', [[181, 185]]], ['T2', 'VALUE', [[216, 220]]], ['T3', 'VALUE', [[208, 212]]], ['T4', 'PK', [[142, 166]]], ['T5', 'VALUE', [[236, 240]]], ['T6', 'VALUE', [[244, 248]]]],
        relations: [['R0', 'D_VAL', [['Entity', 'T0'], ['D_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-371',
    collData,
    {
        text: "The oral absolute bioavailability of DDI was 47.2% and 7.9% after compound 4a and DDI were orally administered to rats at a dose of 15 mg/kg, respectively.",
        entities: [['T0', 'PK', [[4, 33]]], ['T1', 'VALUE', [[45, 49]]], ['T2', 'VALUE', [[55, 58]]], ['T3', 'UNITS', [[58, 59]]], ['T4', 'UNITS', [[49, 50]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-372',
    collData,
    {
        text: "Corresponding median Tmax were 5.0 h and 6.0 h, respectively.",
        entities: [['T0', 'PK', [[21, 25]]], ['T1', 'VALUE', [[31, 34]]], ['T2', 'VALUE', [[41, 44]]], ['T3', 'UNITS', [[35, 36]]], ['T4', 'UNITS', [[45, 46]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-373',
    collData,
    {
        text: "These results indicated that preadministration of 4.0 g/kg RLQ (twice a day) substantially changed the pharmacokinetics of ciprofloxacin in rats, leading to the reduction of the ciprofloxacin AUC(0–t), AUC(0–∞), and Cmax and the simultaneous elevation of t1/2z, CLz/F, and Vz/F.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-374',
    collData,
    {
        text: "The greatest changes after beta 2 agonist were established by plethysmographic parameters SGaw (mean increase 117%) and Raw (mean decrease 45%), than by the expiratory flow rates from flow-volume curve: FEF25%-75% and FEF50% (mean increase 26%), than the FEV1 (+ 15%), the PEF (also + 15%), the RV (mean decrease 17%) and the FVC (mean increase 8%).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-375',
    collData,
    {
        text: "The half-life was 1.13 h, apparent volume of distribution was 33 liters, serum clearance 341 ml/min per 1.73 m2, and renal clearance was 130 ml/min per 1.73 m2.",
        entities: [['T0', 'UNITS', [[23, 24]]], ['T1', 'VALUE', [[18, 22]]], ['T2', 'UNITS', [[65, 71]]], ['T3', 'VALUE', [[62, 64]]], ['T4', 'UNITS', [[93, 111]]], ['T5', 'VALUE', [[89, 92]]], ['T6', 'UNITS', [[141, 159]]], ['T7', 'VALUE', [[137, 140]]], ['T8', 'PK', [[4, 13]]], ['T9', 'PK', [[26, 57]]], ['T10', 'PK', [[73, 88]]], ['T11', 'PK', [[117, 132]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R3', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R4', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T1']]], ['R5', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T3']]], ['R6', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T5']]], ['R7', 'C_VAL', [['Entity', 'T11'], ['C_VAL', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-376',
    collData,
    {
        text: "The GMRs of Cmax,ss and AUCτ,ss were 1.037 and 1.037, with 90% CIs of 0.945–1.137 and 0.977–1.101, respectively (Table 1 and Figure 2A).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-377',
    collData,
    {
        text: "The areas under the concentration-time curves (AUC) were 21.92 and 34.38 microg x h/mL for IM and IV administration, respectively.",
        entities: [['T0', 'UNITS', [[73, 86]]], ['T1', 'VALUE', [[67, 72]]], ['T2', 'VALUE', [[57, 62]]], ['T3', 'PK', [[4, 51]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-378',
    collData,
    {
        text: "The mean values for TBC and T1/2 or Kd of the two birth weight groups were significantly different from each other on the 4th day of treatment, suggesting a less maturity of renal functions in the less than 1,500 g group.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-379',
    collData,
    {
        text: "Metformin renal clearance increased significantly in mid (723 +- 243 ml/min, P < 0.01) and late pregnancy (625 +- 130 ml/min, P < 0.01) compared with postpartum (477 +- 132 ml/min).",
        entities: [['T0', 'PK', [[10, 25]]], ['T1', 'VALUE', [[58, 61]]], ['T2', 'VALUE', [[107, 110]]], ['T3', 'VALUE', [[162, 165]]], ['T4', 'VALUE', [[65, 68]]], ['T5', 'UNITS', [[69, 75]]], ['T6', 'VALUE', [[114, 117]]], ['T7', 'UNITS', [[118, 124]]], ['T8', 'VALUE', [[169, 172]]], ['T9', 'UNITS', [[173, 179]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T2']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R7', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T3']]], ['R8', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]], ['R9', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]], ['R10', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T2']]], ['R11', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-380',
    collData,
    {
        text: "The AUC0–4 and AUC0–∞ values obtained were 7,060.72 ± 1,337.51 h·ng/mL and 7,135.79 ± 1,346.40 h·ng/mL for salidroside, and 122.77 ± 25.90 h·ng/mL and 146.83 ± 32.49 h·ng/mL for p-tyrosol, respectively, which implied that only about 2% salidroside was present as the aglycone metabolite, p-tyrosol, in plasma.",
        entities: [['T0', 'PK', [[4, 10]]], ['T1', 'VALUE', [[43, 51]]], ['T2', 'VALUE', [[54, 62]]], ['T3', 'UNITS', [[63, 70]]], ['T4', 'VALUE', [[133, 138]]], ['T5', 'VALUE', [[124, 130]]], ['T6', 'UNITS', [[139, 146]]], ['T7', 'VALUE', [[86, 94]]], ['T8', 'VALUE', [[75, 83]]], ['T9', 'UNITS', [[95, 102]]], ['T10', 'PK', [[15, 21]]], ['T11', 'VALUE', [[151, 157]]], ['T12', 'VALUE', [[160, 165]]], ['T13', 'UNITS', [[166, 173]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T5']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T4']]], ['R5', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T8']]], ['R6', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T7']]], ['R7', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T8']]], ['R8', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T5']]], ['R9', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T11']]], ['R10', 'D_VAL', [['Entity', 'T12'], ['D_VAL', 'T11']]], ['R11', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T12']]], ['R12', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R13', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]], ['R14', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R15', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T11']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-381',
    collData,
    {
        text: "The within-subject CV of the Cmax for fimasartan was 67.95% and the expanded BE limit was 0.6894–1.4319.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-382',
    collData,
    {
        text: "In the galunisertib 160 mg/day plus sorafenib group, 5 patients had T2 tumor/node/metastasis (TNM) classification, 1 patient had T3b, and 1 patient had T4, and in the galunisertib 300 mg/day plus sorafenib group, 3 patients had T2, 1 patient had T3a, 1 patient had T3b, and 2 patients had Tx.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-383',
    collData,
    {
        text: "We did not observe any differences between the CSA-AUC0-12 (p = 0.84) and the CSA-AUC0-4 (p = 0.88) during remission (1538±517 ng.h/ml and 925±304 ng.h/ml, respectively) and relapse (1574±602 ng.h/ml and 925±458 ng.h/ml, respectively).",
        entities: [['T0', 'PK', [[51, 58]]], ['T1', 'VALUE', [[118, 122]]], ['T2', 'PK', [[82, 88]]], ['T3', 'VALUE', [[139, 142]]], ['T4', 'UNITS', [[127, 134]]], ['T5', 'UNITS', [[147, 154]]], ['T6', 'VALUE', [[143, 146]]], ['T7', 'VALUE', [[123, 126]]], ['T8', 'VALUE', [[208, 211]]], ['T9', 'VALUE', [[204, 207]]], ['T10', 'UNITS', [[212, 219]]], ['T11', 'VALUE', [[188, 191]]], ['T12', 'VALUE', [[183, 187]]], ['T13', 'UNITS', [[192, 199]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T3']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T6']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T1']]], ['R7', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T7']]], ['R8', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T9']]], ['R9', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T8']]], ['R10', 'D_VAL', [['Entity', 'T11'], ['D_VAL', 'T12']]], ['R11', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T11']]], ['R12', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T9']]], ['R13', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T12']]], ['R14', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T12']]], ['R15', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T9']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-384',
    collData,
    {
        text: "Comparisons of exposure (AUC0–24 hours and Cmax) revealed similarity between QD and BID regimens and between 1 × 1,000-mg and 2 × 500-mg formulations (Figure 3; group 1 versus group 3, AUC0–24 hours for total EPA in plasma, unesterified EPA and total EPA in RBCs, with observed differences in maximum concentration expected based on dosing regimen; group 1 versus group 4, AUC0–24 hours and maximum concentration for total plasma and unesterified EPA).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-385',
    collData,
    {
        text: "Mazindol plasma concentrations at a steady state (ie, 24 on day 7) ranged from <0.5 to 2.09 ng/mL. The maximum concentration (Cmax) measured after the first dose was 2.99±0.73 ng/mL (range 1.56–4.23 ng/mL).",
        entities: [['T0', 'PK', [[103, 131]]], ['T1', 'VALUE', [[166, 170]]], ['T2', 'UNITS', [[92, 97]]], ['T3', 'RANGE', [[80, 91]]], ['T4', 'PK', [[9, 48]]], ['T5', 'UNITS', [[176, 181]]], ['T6', 'VALUE', [[171, 175]]], ['T7', 'RANGE', [[189, 198]]], ['T8', 'UNITS', [[199, 204]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T6']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T1']]], ['R7', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-386',
    collData,
    {
        text: "An analysis of variance regression analysis showed that female gender (P < 0.001) and the time to maximum concentration of drug in serum (T(max)) at 2 h (P = 0.012) were independently correlated with increased exposure to rifampin.",
        entities: [['T0', 'UNITS', [[151, 152]]], ['T1', 'VALUE', [[149, 150]]], ['T2', 'PK', [[90, 145]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-387',
    collData,
    {
        text: "Bioavailability of phenformin administered as a single oral dose of 100 mg/kg, which is comparable to the therapeutic dose in humans (Bando et al., 2010), was assessed by comparing with the plasma profiles of this drug following intravenous administration of phenformin.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-388',
    collData,
    {
        text: "The VDR BsmIG > A (rs1544410) polymorphism was significantly associated with CYP3A4 jejunal expression/activity, with CYP3A4 duodenal mRNA, and with midazolam area under the curve (AUC).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-389',
    collData,
    {
        text: "The average plasma half-life of PTX after iv administration was 2.6 +- 0.3 hr, and the average total body clearance was 0.33 +- 0.13 liter/hr/kg.",
        entities: [['T0', 'PK', [[12, 28]]], ['T1', 'VALUE', [[64, 67]]], ['T2', 'UNITS', [[75, 77]]], ['T3', 'VALUE', [[71, 74]]], ['T4', 'PK', [[95, 115]]], ['T5', 'VALUE', [[120, 124]]], ['T6', 'VALUE', [[128, 132]]], ['T7', 'UNITS', [[133, 144]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T5']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-390',
    collData,
    {
        text: "Bioequivalence in 3TC-TP PK following the administration of 300 and 150 mg was not demonstrated: the GMRs for AUC(0-24), C(24), and C(max) were 0.73 (0.64 to 0.83), 0.82 (0.68 to 0.99), and 0.70 (0.61 to 0.82), respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-391',
    collData,
    {
        text: "Average Intra-individual variation for each individual between the 3 visits (for males and females, respectively) was 5.6% and 8% for Co, 12% and 13% for Cmax, 42% and 37% for Tmax and 11% and 13% for ß.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-392',
    collData,
    {
        text: "Following oral administration, all three metabolites were well absorbed with peak blood concentrations being attained between 1 and 3h post-dosing.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-393',
    collData,
    {
        text: "When compared to the results from the intra-nasally administered 1.04 mg-azelastine in 29 healthy subjects (24), Tmax (2~3 h) was shorter than the present data (5.6~5.9 h), resulting in very speedy absorption into the bloodstream, even though Cmax was similar to the present data.",
        entities: [['T0', 'UNITS', [[123, 124]]], ['T1', 'RANGE', [[119, 122]]], ['T2', 'PK', [[113, 117]]], ['T3', 'RANGE', [[161, 168]]], ['T4', 'UNITS', [[169, 170]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-394',
    collData,
    {
        text: "Mean terminal half-lives, volumes of distribution, and total body clearances for the normal controls and the morbidly obese subjects were 4.8 h, 0.39 liter/kg, and 1.085 ml/min per kg versus 3.2 h, 0.26 liter/kg TBW, and 1.112 ml/min per kg TBW.",
        entities: [['T0', 'UNITS', [[142, 143]]], ['T1', 'VALUE', [[138, 141]]], ['T2', 'UNITS', [[150, 158]]], ['T3', 'VALUE', [[145, 149]]], ['T4', 'PK', [[5, 24]]], ['T5', 'PK', [[26, 49]]], ['T6', 'PK', [[55, 76]]], ['T7', 'VALUE', [[164, 169]]], ['T8', 'VALUE', [[191, 194]]], ['T9', 'VALUE', [[198, 202]]], ['T10', 'VALUE', [[221, 226]]], ['T11', 'UNITS', [[227, 240]]], ['T12', 'UNITS', [[203, 211]]], ['T13', 'UNITS', [[195, 196]]], ['T14', 'UNITS', [[170, 183]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R5', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T8']]], ['R6', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T9']]], ['R7', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T10']]], ['R8', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T10']]], ['R9', 'RELATED', [['Entity', 'T12'], ['RELATED', 'T9']]], ['R10', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T8']]], ['R11', 'RELATED', [['Entity', 'T14'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-395',
    collData,
    {
        text: "Coadministration of dolutegravir with boceprevir had no effect on dolutegravir area under the plasma concentration–time curve (AUC) and maximal plasma concentration (Cmax) and caused a small increase in concentration at the end of the dosing interval (Cτ; 8%).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-396',
    collData,
    {
        text: "The total body clearance was 12,0, 9.2, and 6.4 liters/h for the three doses of azlocillin and 14.4 liters/h for 2.",
        entities: [['T0', 'UNITS', [[48, 56]]], ['T1', 'VALUE', [[44, 47]]], ['T2', 'VALUE', [[35, 38]]], ['T3', 'VALUE', [[29, 33]]], ['T4', 'UNITS', [[100, 108]]], ['T5', 'VALUE', [[95, 99]]], ['T6', 'PK', [[4, 24]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T3']]], ['R5', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T2']]], ['R6', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]], ['R7', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-397',
    collData,
    {
        text: "After oral administration of 3 mL/kg E. ulmoides extract in rats, the maximum plasma concentrations of pinoresinol glucoside and chlorogenic acid were 57.44 and 61.04 ng/mL, respectively.",
        entities: [['T0', 'UNITS', [[167, 172]]], ['T1', 'VALUE', [[161, 166]]], ['T2', 'VALUE', [[151, 156]]], ['T3', 'PK', [[70, 99]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-398',
    collData,
    {
        text: "Interestingly, the IC50 valuesagainst other kinases did not correlate with a sequence similarityto the Mer protein.26 On the basis of proteinsequence within the kinase domain, Met is the closest kinase to theTAM family, and many Met inhibitors also inhibit the TAMs.26 However, 11 was more than 700-foldless active against Met compared to Mer, while it was equally potentagainst Flt3.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-399',
    collData,
    {
        text: "Regarding urinary excretion, the fraction of unchanged drug excreted in urine (fe) of DA-8031 was 0.09–0.18, and the mean renal clearance (CLR) was 3.7–5.6 L/h.",
        entities: [['T0', 'UNITS', [[156, 159]]], ['T1', 'RANGE', [[148, 155]]], ['T2', 'PK', [[122, 143]]], ['T3', 'PK', [[33, 82]]], ['T4', 'RANGE', [[98, 107]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-400',
    collData,
    {
        text: "The majority of the estimated standard errors were well below 50%, with the exception of Vp (52%) and IIV on ka (64%).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-401',
    collData,
    {
        text: "The mean ratio of the AUC for R-IBU, S-IBU or total IBU after the first and last dose, as calculated according to Eq. 1, was lower than 1 for all four age groups.",
        entities: [['T0', 'PK', [[9, 25]]], ['T1', 'VALUE', [[136, 137]]], ['T2', 'COMPARE', [[125, 130]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-402',
    collData,
    {
        text: "In this study, BPR1J-340 was identified as a novel potent FLT3 inhibitor by biochemical kinase activity (IC50 approximately 25 nM) and cellular proliferation (GC50 approximately 5 nM) assays.",
        entities: [['T0', 'PK', [[105, 109]]], ['T1', 'VALUE', [[124, 126]]], ['T2', 'UNITS', [[127, 129]]], ['T3', 'PK', [[159, 163]]], ['T4', 'VALUE', [[178, 179]]], ['T5', 'UNITS', [[180, 182]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-403',
    collData,
    {
        text: "WinNonlin parameters revealed significant differences in cmax and AUClast (W: 4.80 ± 1.12 g/dl/h, AS: 4.61 ± 0.92 g/dl/h, 15CHO: 4.10 ± 0.86 g/dl/h, 50CHO: 3.11 ± 0.58 g/dL/h) when CHO-containing beverages were consumed compared to W and AS treatments.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-404',
    collData,
    {
        text: "Regression analyses demonstrated increased glecaprevir and pibrentasvir plasma exposures, as determined by the area under the curve, with decreasing renal function, up to 56% and 46%, respectively, in subjects with an eGFR of <15 ml/min/1.73 m2 In dialysis-dependent subjects, glecaprevir and pibrentasvir exposures were similar (≤18% difference) when study drugs were administered before hemodialysis or on a nondialysis day.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-405',
    collData,
    {
        text: "This led to the discovery of compound 12x, a highly potent (IC(50) = 1.0 nM) and selective CRF(1) receptor antagonist with good oral bioavailability (F = 52%) in rats and efficacy in the defensive withdrawal anxiety test in rats.",
        entities: [['T0', 'UNITS', [[73, 75]]], ['T1', 'VALUE', [[69, 72]]], ['T2', 'PK', [[60, 66]]], ['T3', 'PK', [[128, 151]]], ['T4', 'VALUE', [[154, 156]]], ['T5', 'UNITS', [[156, 157]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-406',
    collData,
    {
        text: "Mean pharmacokinetic parameters obtained using a 2-compartmental model included a volume of distribution at steady-state (V(ss)) of 1.759+-0.3149L/kg, a total clearance (Cl) of 3.045+-0.5264mL/kg/min and an elimination half-life (t(1/2beta)) of 7.027+-1.128h.",
        entities: [['T0', 'PK', [[82, 128]]], ['T1', 'VALUE', [[132, 137]]], ['T2', 'UNITS', [[145, 149]]], ['T3', 'VALUE', [[139, 145]]], ['T4', 'PK', [[153, 173]]], ['T5', 'VALUE', [[177, 182]]], ['T6', 'UNITS', [[190, 199]]], ['T7', 'VALUE', [[184, 190]]], ['T8', 'PK', [[207, 241]]], ['T9', 'VALUE', [[245, 250]]], ['T10', 'VALUE', [[252, 257]]], ['T11', 'UNITS', [[257, 258]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T5']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R8', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T9']]], ['R9', 'D_VAL', [['Entity', 'T10'], ['D_VAL', 'T9']]], ['R10', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T10']]], ['R11', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T9']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-407',
    collData,
    {
        text: "Median plasma clearance time (t1/2) of acetazolamide in hypoxia-exposed rabbits was significantly (P<0.05) prolonged (28%), as compared to control rabbits (Fig. 1).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-408',
    collData,
    {
        text: "The metabolism of AMD via cytochrome P-450 was best described using a Vmax of 1.6 mg/h/kg and a Km of 10 mg/L, while the metabolism of AMD via GST was described using a second-order rate constant of 0.55 L/h-mmol GSH.",
        entities: [['T0', 'PK', [[70, 74]]], ['T1', 'VALUE', [[78, 81]]], ['T2', 'UNITS', [[82, 89]]], ['T3', 'PK', [[96, 98]]], ['T4', 'VALUE', [[102, 104]]], ['T5', 'UNITS', [[105, 109]]], ['T6', 'PK', [[169, 195]]], ['T7', 'VALUE', [[199, 203]]], ['T8', 'UNITS', [[204, 212]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-409',
    collData,
    {
        text: "For doses > or = 200 mg, an Emax pharmacodynamic model was used to describe the relationship between zifrosilone plasma concentration and red blood cell acetylcholinesterase inhibition (Emax = 83.8%; EC50 = 0.65 ng/ml).",
        entities: [['T0', 'UNITS', [[197, 198]]], ['T1', 'VALUE', [[193, 197]]], ['T2', 'UNITS', [[212, 217]]], ['T3', 'VALUE', [[207, 211]]], ['T4', 'PK', [[186, 190]]], ['T5', 'PK', [[200, 204]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-410',
    collData,
    {
        text: "Equation (11) can also be expressed in terms of apparent oral clearance.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-411',
    collData,
    {
        text: "Sulphadimidine (SDD) plasma clearance, urinary excretion of 6-hydroxy-SDD and the in vitro microsomal SDD-hydroxylations were only inhibited when rBST was given in three injections per 24 hours.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-412',
    collData,
    {
        text: "MIBI Cl(biliary) in vivo was 5.5+-1.2 mL/min/kg (mean+-SD).",
        entities: [['T0', 'PK', [[5, 16]]], ['T1', 'VALUE', [[29, 32]]], ['T2', 'VALUE', [[34, 37]]], ['T3', 'UNITS', [[38, 47]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-413',
    collData,
    {
        text: "The linearity of each calibration curve was determined by plotting the peak area ratio (y) of analytes to IS versus the nominal concentration (x) of analytes with weighted (1/x2) least square linear regression.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-414',
    collData,
    {
        text: "The population pharmacokinetics parameters were: clearance, 1.2 mL/min/kg; half-life, 16.8 hours; and volume of distribution, 1.5 L/kg.",
        entities: [['T0', 'PK', [[49, 58]]], ['T1', 'VALUE', [[60, 63]]], ['T2', 'UNITS', [[64, 73]]], ['T3', 'PK', [[75, 84]]], ['T4', 'VALUE', [[86, 90]]], ['T5', 'UNITS', [[91, 96]]], ['T6', 'PK', [[102, 124]]], ['T7', 'VALUE', [[126, 129]]], ['T8', 'UNITS', [[130, 134]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-415',
    collData,
    {
        text: "Peak plasma concentrations of propranolol glucuronide were 6-8 times those of the corresponding peak propranolol plasma concentrations.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-416',
    collData,
    {
        text: "The 521 T>C polymorphism has been correlated earlier with higher plasma concentrations of several drugs and the aim of this study was to determine whether this polymorphism influences trough concentrations of maraviroc.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-417',
    collData,
    {
        text: "The geometric mean ratios of the maximum concentration and AUC comparing the new 25 and 50 mg capsule formulations to the reference tablet did not exceed 0.25 and 0.50, respectively, indicating that the new capsule formulation did not increase the maximum concentration of or the total exposure to almorexant.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-418',
    collData,
    {
        text: "After rectal administration of suppositories, the rate and extent of carprofen absorption increased with the hydroxyl value of the suppository base; the mean absorption times (MAT) and tmax were shorter with MEA (2.15 and 1.7 h, respectively) than with the less hydrophilic vehicles (MEB: 4.09 and 2.1 h, respectively; ME299: 4.22 and 2.4 h, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)",
        entities: [['T0', 'UNITS', [[226, 227]]], ['T1', 'VALUE', [[222, 225]]], ['T2', 'VALUE', [[213, 217]]], ['T3', 'PK', [[153, 180]]], ['T4', 'PK', [[185, 189]]], ['T5', 'VALUE', [[289, 293]]], ['T6', 'VALUE', [[298, 301]]], ['T7', 'UNITS', [[302, 303]]], ['T8', 'VALUE', [[326, 330]]], ['T9', 'VALUE', [[335, 338]]], ['T10', 'UNITS', [[339, 340]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T5']]], ['R5', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T6']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T5']]], ['R8', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T8']]], ['R9', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T9']]], ['R10', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T9']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-419',
    collData,
    {
        text: "In patients with severe liver cirrhosis, the decreased rate of metabolism results in a half-life of 7-9 h. The clearance of pantoprazole is only slightly affected by age, its half-life being approximately 1.25 h in the elderly.",
        entities: [['T0', 'PK', [[87, 96]]], ['T1', 'RANGE', [[100, 103]]], ['T2', 'UNITS', [[104, 105]]], ['T3', 'PK', [[175, 184]]], ['T4', 'VALUE', [[205, 209]]], ['T5', 'UNITS', [[210, 211]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-420',
    collData,
    {
        text: "Moreover, pharmacokinetic analysis showed significantly higher (p ≤ 0.05) AUC, Cmax, and shorter Tmax.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-421',
    collData,
    {
        text: "Elimination half-life was about 50 h (50.3 ± 3.1 vs. 52.9 ± 2.8 h) without differences between the formulations.",
        entities: [['T0', 'UNITS', [[35, 36]]], ['T1', 'VALUE', [[32, 34]]], ['T2', 'PK', [[0, 21]]], ['T3', 'UNITS', [[64, 65]]], ['T4', 'VALUE', [[53, 57]]], ['T5', 'VALUE', [[38, 42]]], ['T6', 'VALUE', [[45, 48]]], ['T7', 'VALUE', [[60, 63]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T5']]], ['R4', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T5']]], ['R5', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T4']]], ['R6', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T5']]], ['R7', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T6']]], ['R8', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T4']]], ['R9', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-422',
    collData,
    {
        text: "Within- and between-patient coefficients of variation were estimated as 29 and 42 %, respectively, for AUC(0-∞) at steady state, and 31 and 55 %, respectively, for Cmax,ss, all pooled across the 5 cohorts from the dose-proportionality analysis.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-423',
    collData,
    {
        text: "Based on the fitting result using the Ritger–Peppas model (ln R = k ln t + C; Mo et al., 2011), the values of k were 0.8121 and 0.6954, respectively (0.45 < k < 0.85), which indicated that LPM release from SLNs was due to drug diffusion and lipid matrix corrosion.",
        entities: [['T0', 'PK', [[110, 111]]], ['T1', 'VALUE', [[117, 123]]], ['T2', 'VALUE', [[128, 134]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-424',
    collData,
    {
        text: "In Fig. 2a and b, both Cmax and AUCpo had a liner correlation between 30 and 100 mg/kg, and F was approximately 0.22.",
        entities: [['T0', 'PK', [[92, 93]]], ['T1', 'VALUE', [[112, 116]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-425',
    collData,
    {
        text: "ATI mice were faster (n = 6), to identify the sticky dot compared to both SAL (n = 4), and YOH (n = 6); (respectively: p = 0.0095; p = 0.0087 and AUC = 1; AUC = 0.97 [0.8 1], very strong effects).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-426',
    collData,
    {
        text: "Clearance of DMI was considerably slower than that of IMI (0.67 +- 0.45 vs. 2.18 +- 1.33 l(kg.h), p less than 0.001).",
        entities: [['T0', 'UNITS', [[89, 96]]], ['T1', 'VALUE', [[76, 80]]], ['T2', 'VALUE', [[59, 63]]], ['T3', 'VALUE', [[84, 88]]], ['T4', 'VALUE', [[67, 71]]], ['T5', 'PK', [[0, 9]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T2']]], ['R5', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T4']]], ['R6', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T2']]], ['R7', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-427',
    collData,
    {
        text: "As expected, the geometric mean maximum observed plasma concentration (Cmax) and area under the plasma concentration time curve from 0 to 24 hours (AUC0‐24 h) values were dose‐dependent following single and multiple SC doses of 30, 70, and 200 mg mipomersen (Table 2).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-428',
    collData,
    {
        text: "Taking the area under the curve divided by time as the average IGF-1 concentration, it became clear that on 120 µg/kg, some children had an average IGF-1 SDS of greater than +2.5, while other children had appropriate concentrations.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-429',
    collData,
    {
        text: "Plasma pharmacokinetics were described by a triexponential function, with a terminal half-life of 4.2 h. Up to 1.5 h after injection, the initial rapid decline of MTX concentrations in bone marrow, kidney, and liver roughly paralleled that in plasma.",
        entities: [['T0', 'PK', [[76, 94]]], ['T1', 'VALUE', [[98, 101]]], ['T2', 'UNITS', [[102, 103]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-430',
    collData,
    {
        text: "Although no changes in the rate of dexamethasone absorption were noted on coadministration with valspodar (Cmax 88+-23 vs 91+-20 ng/ml), overall exposure was significantly increased by 24% on average (AUC 400+-87 vs 494+-90 ng x hr/ml).",
        entities: [['T0', 'UNITS', [[224, 234]]], ['T1', 'VALUE', [[216, 219]]], ['T2', 'VALUE', [[205, 208]]], ['T3', 'VALUE', [[210, 212]]], ['T4', 'VALUE', [[221, 223]]], ['T5', 'PK', [[201, 204]]], ['T6', 'UNITS', [[129, 134]]], ['T7', 'VALUE', [[122, 124]]], ['T8', 'VALUE', [[112, 114]]], ['T9', 'VALUE', [[116, 118]]], ['T10', 'VALUE', [[126, 128]]], ['T11', 'PK', [[107, 111]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T2']]], ['R3', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T4']]], ['R6', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T2']]], ['R7', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T1']]], ['R8', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R9', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T8']]], ['R10', 'D_VAL', [['Entity', 'T9'], ['D_VAL', 'T8']]], ['R11', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T9']]], ['R12', 'D_VAL', [['Entity', 'T10'], ['D_VAL', 'T7']]], ['R13', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T10']]], ['R14', 'C_VAL', [['Entity', 'T11'], ['C_VAL', 'T8']]], ['R15', 'C_VAL', [['Entity', 'T11'], ['C_VAL', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-431',
    collData,
    {
        text: "When women taking no OCS were compared with men, all pharmacokinetic parameters were similar except for volume of distribution, which was significantly larger in the women (p less than 0.05).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-432',
    collData,
    {
        text: "In addition, the area under the curve to the last measurable concentration and area under the curve to infinite time were decreased, by 21 and 16%, 30 and 33%, and 33 and 34% (P<0.01), respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-433',
    collData,
    {
        text: "Linear regression models of log-corrected AUC0-12 h versus individual log calcitriol serum levels in the hour 1, 2, 3, 4, 6, and 8 samples were established using the training data set of 17 patients.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-434',
    collData,
    {
        text: "As a consequence, the area under the curve of DOX calculated in tumour tissue after DOX-GA3 (13.1 μmol min–1g–1) was 10-fold higher than after DOX (1.31 μmol min–1g–1).",
        entities: [['T0', 'PK', [[22, 42]]], ['T1', 'VALUE', [[93, 97]]], ['T2', 'UNITS', [[98, 111]]], ['T3', 'UNITS', [[153, 166]]], ['T4', 'VALUE', [[148, 152]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-435',
    collData,
    {
        text: "To compare the oral bolus and diet groups at the same external dose, we scaled the dose of the diet-exposed group to 20 mg/kg BW, and the AUC(0–24hr) was modestly greater (but not statistically significant) in the diet group compared with the oral bolus group (227.4 ± 41.1 and 201.0 ± 20.6 ng-hr/mL, respectively), indicating a relative bioavailability of 113% for the diet group.",
        entities: [['T0', 'PK', [[329, 353]]], ['T1', 'VALUE', [[357, 360]]], ['T2', 'UNITS', [[360, 361]]], ['T3', 'UNITS', [[291, 299]]], ['T4', 'VALUE', [[278, 283]]], ['T5', 'VALUE', [[261, 266]]], ['T6', 'VALUE', [[286, 290]]], ['T7', 'VALUE', [[269, 273]]], ['T8', 'PK', [[138, 149]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T5']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T4']]], ['R5', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T6']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T5']]], ['R7', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T7']]], ['R8', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T5']]], ['R9', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-436',
    collData,
    {
        text: "Pharmacokinetic values obtained from the sheep with normal serum protein were 5.94 +- 1.78 ml/kg/min for clearance, 1.32 +- 0.16 L/kg for the steady-state volume of distribution, and 3.89 +- 0.80 hours for mean residence time.",
        entities: [['T0', 'UNITS', [[91, 100]]], ['T1', 'VALUE', [[78, 82]]], ['T2', 'VALUE', [[86, 90]]], ['T3', 'VALUE', [[124, 128]]], ['T4', 'VALUE', [[116, 120]]], ['T5', 'UNITS', [[129, 133]]], ['T6', 'PK', [[105, 114]]], ['T7', 'PK', [[142, 177]]], ['T8', 'PK', [[206, 225]]], ['T9', 'VALUE', [[183, 187]]], ['T10', 'UNITS', [[196, 201]]], ['T11', 'VALUE', [[191, 195]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R3', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R6', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]], ['R7', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T4']]], ['R8', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T9']]], ['R9', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T9']]], ['R10', 'D_VAL', [['Entity', 'T11'], ['D_VAL', 'T9']]], ['R11', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T11']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-437',
    collData,
    {
        text: "The presence of fostamatinib doubled the Cmax of simvastatin [treatment difference 212.5 % (90 % CI 164.7–274.3)], with a marginal change in tmax.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-438',
    collData,
    {
        text: "For the calibration and regression, the non-zero point calibration curve (12.5, 25, 50, 100, 200, 400 ng/mL) was calculated by regressing the peak ratio of largazole thiol to the internal standard.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-439',
    collData,
    {
        text: "NK105 exhibited slower clearance from the plasma than PTX, while NK105 was present in the plasma for up to 72 h after injection; PTX was not detected after 24 h or later of injection.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-440',
    collData,
    {
        text: "The 600% interindividual variation in elimination t1/2 and the 300% variation in total body clearance of pemoline may explain the unpredictable nature of its dynamics and associated neurotoxicity in some cases.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-441',
    collData,
    {
        text: "The first-order rate constant associated with the terminal log-linear portion of the concentration versus time curve λz (h−1) was calculated from individual concentration versus time data using the following formula (minimum of final three data points):λz=−1(slopeelimination).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-442',
    collData,
    {
        text: "The highest AUC0-6 was 246 ng/mL, observed at 4.5 mg b.d.",
        entities: [['T0', 'UNITS', [[27, 32]]], ['T1', 'VALUE', [[23, 26]]], ['T2', 'PK', [[12, 18]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-443',
    collData,
    {
        text: "In the XG-102 PK evaluation, XG-102 body weight-normalized Vss (geometric mean ranging from 168 to 217 mL/kg in the different doses [Table 6]) is similar or slightly higher (13.7–29.8%) than the expected value of 19% of total body weight for extracellular water and higher than the expected values of 4% and 8% of body weight expected for the plasma and the blood volume, respectively (Gibaldi 1991) suggesting a relatively wide extravascular distribution.",
        entities: [['T0', 'UNITS', [[103, 108]]], ['T1', 'RANGE', [[92, 102]]], ['T2', 'PK', [[36, 62]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-444',
    collData,
    {
        text: "AZD4831 distributed rapidly into plasma, with a half‐life of 38.2–50.0 hours.",
        entities: [['T0', 'UNITS', [[71, 76]]], ['T1', 'RANGE', [[61, 70]]], ['T2', 'PK', [[48, 57]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-445',
    collData,
    {
        text: "The time to achieve complete neuromuscular blockade (after the initial dose of 0.15 mg.kg-1 followed by repeated injections of 0.03 mg.kg-1 every four minutes) was much longer in ICU patients when compared to surgical patients: 34 ± 21 versus 4 ± 2 minutes respectively (P < 0.0001; Figure 1) and the total cumulative dose of cisatracurium was significantly higher in ICU patients when compared to surgical patients: 38 ± 14 mg versus 11 ± 2 mg respectively (P < 0.0001; Figure 2).",
        entities: [['T0', 'PK', [[4, 51]]], ['T1', 'VALUE', [[228, 230]]], ['T2', 'VALUE', [[243, 244]]], ['T3', 'PK', [[301, 322]]], ['T4', 'VALUE', [[417, 419]]], ['T5', 'VALUE', [[435, 437]]], ['T6', 'VALUE', [[233, 235]]], ['T7', 'UNITS', [[249, 256]]], ['T8', 'VALUE', [[247, 248]]], ['T9', 'VALUE', [[422, 424]]], ['T10', 'UNITS', [[425, 427]]], ['T11', 'VALUE', [[440, 441]]], ['T12', 'UNITS', [[442, 444]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T5']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T2']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T8']]], ['R8', 'D_VAL', [['Entity', 'T9'], ['D_VAL', 'T4']]], ['R9', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T9']]], ['R10', 'D_VAL', [['Entity', 'T11'], ['D_VAL', 'T5']]], ['R11', 'RELATED', [['Entity', 'T12'], ['RELATED', 'T11']]], ['R12', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T2']]], ['R13', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T1']]], ['R14', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T4']]], ['R15', 'RELATED', [['Entity', 'T12'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-446',
    collData,
    {
        text: "Their in vivo half-lives (t(1/2)) were 11, 5, 22, 11, 32, 15, 37, 38, and 17 hours, respectively.",
        entities: [['T0', 'PK', [[14, 33]]], ['T1', 'VALUE', [[39, 41]]], ['T2', 'VALUE', [[43, 44]]], ['T3', 'VALUE', [[46, 48]]], ['T4', 'VALUE', [[50, 52]]], ['T5', 'VALUE', [[54, 56]]], ['T6', 'VALUE', [[58, 60]]], ['T7', 'VALUE', [[62, 64]]], ['T8', 'VALUE', [[66, 68]]], ['T9', 'VALUE', [[74, 76]]], ['T10', 'UNITS', [[77, 82]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T5']]], ['R5', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T6']]], ['R6', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T7']]], ['R7', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T8']]], ['R8', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T9']]], ['R9', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T9']]], ['R10', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T8']]], ['R11', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T7']]], ['R12', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T6']]], ['R13', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T5']]], ['R14', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T4']]], ['R15', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T3']]], ['R16', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T2']]], ['R17', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-447',
    collData,
    {
        text: "For individual patients on these days, tmax was in the range of 1 to 6 hours postdose.",
        entities: [['T0', 'PK', [[39, 43]]], ['T1', 'RANGE', [[64, 70]]], ['T2', 'UNITS', [[71, 76]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-448',
    collData,
    {
        text: "Elimination half-lives of this metabolite averaged 3.6 hr.",
        entities: [['T0', 'PK', [[0, 22]]], ['T1', 'VALUE', [[51, 54]]], ['T2', 'UNITS', [[55, 57]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-449',
    collData,
    {
        text: "Cmax were 1.32±0.62 and 1.40±0.58 μg.ml-1; Tmax were 3.51±0.54 and 2.01±0.42 h; AUC were 7.65±2.54 and 7.12±2.10 μg.h.ml-1.",
        entities: [['T0', 'PK', [[0, 4]]], ['T1', 'VALUE', [[10, 14]]], ['T2', 'VALUE', [[24, 28]]], ['T3', 'PK', [[43, 47]]], ['T4', 'VALUE', [[53, 57]]], ['T5', 'VALUE', [[67, 71]]], ['T6', 'PK', [[80, 83]]], ['T7', 'VALUE', [[89, 93]]], ['T8', 'VALUE', [[103, 107]]], ['T9', 'VALUE', [[15, 19]]], ['T10', 'UNITS', [[34, 41]]], ['T11', 'VALUE', [[29, 33]]], ['T12', 'VALUE', [[58, 62]]], ['T13', 'UNITS', [[77, 78]]], ['T14', 'VALUE', [[72, 76]]], ['T15', 'VALUE', [[94, 98]]], ['T16', 'UNITS', [[113, 122]]], ['T17', 'VALUE', [[108, 112]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T5']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R5', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T8']]], ['R6', 'D_VAL', [['Entity', 'T9'], ['D_VAL', 'T1']]], ['R7', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T9']]], ['R8', 'D_VAL', [['Entity', 'T11'], ['D_VAL', 'T2']]], ['R9', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T11']]], ['R10', 'D_VAL', [['Entity', 'T12'], ['D_VAL', 'T4']]], ['R11', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T12']]], ['R12', 'D_VAL', [['Entity', 'T14'], ['D_VAL', 'T5']]], ['R13', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T14']]], ['R14', 'D_VAL', [['Entity', 'T15'], ['D_VAL', 'T7']]], ['R15', 'RELATED', [['Entity', 'T16'], ['RELATED', 'T15']]], ['R16', 'D_VAL', [['Entity', 'T17'], ['D_VAL', 'T8']]], ['R17', 'RELATED', [['Entity', 'T16'], ['RELATED', 'T17']]], ['R18', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T2']]], ['R19', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T1']]], ['R20', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T5']]], ['R21', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T4']]], ['R22', 'RELATED', [['Entity', 'T16'], ['RELATED', 'T8']]], ['R23', 'RELATED', [['Entity', 'T16'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-450',
    collData,
    {
        text: "Although there were no age differences in the AUC for plasma phylloquinone adjusted for triglycerides, older adults had significantly higher plasma phylloquinone concentrations (both unadjusted and adjusted) at 0 and 24 h than the younger adults (P < 0.001).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-451',
    collData,
    {
        text: "Preliminary pharmacokinetic investigations of AMI allowed estimation of AMI clearance to be 0.017 mL kg(-1) min(-1) in the rat and 0.043 mL kg(-1) min(-1) in the mouse.",
        entities: [['T0', 'PK', [[76, 85]]], ['T1', 'VALUE', [[92, 97]]], ['T2', 'VALUE', [[131, 136]]], ['T3', 'UNITS', [[98, 115]]], ['T4', 'UNITS', [[137, 154]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-452',
    collData,
    {
        text: "Further, there was a statistically significant decrease in clearance (P value = 0.0156) from day 1 to day 28.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-453',
    collData,
    {
        text: "The results were as follows: the volume ratio of organic phase/water phase was 1:3, emulsification temperature was 80°C ± 2°C, stirring velocity was 1000 rpm, volume ratio of the nanoemulsion/ice-water bath was 1:3, and a proportion of concentrated original volume is 1:2.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-454',
    collData,
    {
        text: "Pregnant subjects had significantly lower area under the plasma concentration-time curve for both CQ (35,750 versus 47,892 microg.h/liter, P < 0.001) and DECQ (23,073 versus 41,584 microg.h/liter, P < 0.001), reflecting significant differences in elimination half-lives and in volumes of distribution and clearances relative to bioavailability.",
        entities: [['T0', 'PK', [[42, 88]]], ['T1', 'VALUE', [[102, 108]]], ['T2', 'VALUE', [[116, 122]]], ['T3', 'VALUE', [[160, 166]]], ['T4', 'VALUE', [[174, 180]]], ['T5', 'UNITS', [[181, 195]]], ['T6', 'UNITS', [[123, 137]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R6', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-455',
    collData,
    {
        text: "After oral administration, the peak concentration of niclosamide was observed at the first sampling time (5 min), followed by a fast distribution phase.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-456',
    collData,
    {
        text: "The pharmacokinetic profiles show that t1/2α is only about 7 min and t1/2β is about 69 min, which means that the elimination is very fast in the central compartment and the elimination of the tissue is relatively slow.",
        entities: [['T0', 'PK', [[39, 44]]], ['T1', 'VALUE', [[59, 60]]], ['T2', 'PK', [[69, 74]]], ['T3', 'VALUE', [[84, 86]]], ['T4', 'UNITS', [[87, 90]]], ['T5', 'UNITS', [[61, 64]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-457',
    collData,
    {
        text: "A significant inverse correlation was observed between the percent change in neutrophil count and TFT Cmax (r=−0.678, P<0.001) or AUC0–10 (r=−0.753, P<0.001; Figure 2).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-458',
    collData,
    {
        text: "The pharmacokinetics results showed Cmax (7.039 μg/mL) and Tmax (2 h) after oral administration of vicenin-1.",
        entities: [['T0', 'PK', [[36, 40]]], ['T1', 'VALUE', [[42, 47]]], ['T2', 'PK', [[59, 63]]], ['T3', 'VALUE', [[65, 66]]], ['T4', 'UNITS', [[67, 68]]], ['T5', 'UNITS', [[48, 53]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-459',
    collData,
    {
        text: "Our research found that AUC0→t of genipin-1-o-glucuronic acid and genipin-monosulfate in blood of diabetic group were 17.68 and 7.58 times than those in normal group, respectively, and AUC0→t of genipin-1-o-glucuronic acid was 2.28 times than that of genipin-monosulfate in blood of diabetic group, which revealed the effect of diabetes on the pharmacokinetic properties of the two metabolites.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-460',
    collData,
    {
        text: "The geometric least-squares mean estimates (90% CI) for the Cmax ratio (COC coadministered with erenumab vs COC alone) were 1.04 (0.88–1.22) for ethinylestradiol, 1.06 (0.97–1.16) for norgestrel, and 1.05 (0.90–1.23) for norelgestromin.",
        entities: [['T0', 'PK', [[60, 70]]], ['T1', 'VALUE', [[124, 128]]], ['T2', 'VALUE', [[163, 167]]], ['T3', 'VALUE', [[200, 204]]], ['T4', 'RANGE', [[130, 139]]], ['T5', 'RANGE', [[169, 178]]], ['T6', 'RANGE', [[206, 215]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T2']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-461',
    collData,
    {
        text: "Values of IC50 were 1.11 +- 0.07 micrograms I-1 (mean +- s.d.) in patients with severe renal failure and 1.81 +- 0.20 micrograms l-1 in patients with moderate renal failure.",
        entities: [['T0', 'PK', [[10, 14]]], ['T1', 'VALUE', [[20, 24]]], ['T2', 'VALUE', [[105, 109]]], ['T3', 'VALUE', [[113, 117]]], ['T4', 'UNITS', [[118, 132]]], ['T5', 'VALUE', [[28, 32]]], ['T6', 'UNITS', [[33, 47]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T2']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-462',
    collData,
    {
        text: "The time to reach the maximum concentration (Tmax) of zidovudine was two times higher in humans than in rabbits (0.75 h and 0.33 h, respectively), while for lamivudine and stavudine the values were similar (Table 4).",
        entities: [['T0', 'PK', [[4, 50]]], ['T1', 'VALUE', [[113, 117]]], ['T2', 'VALUE', [[124, 128]]], ['T3', 'UNITS', [[129, 130]]], ['T4', 'UNITS', [[118, 119]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-463',
    collData,
    {
        text: "The Vz/F of ertugliflozin following oral administration was 215.3 L vs. 85.5 L for the Vss following i.v. administration.",
        entities: [['T0', 'PK', [[4, 8]]], ['T1', 'VALUE', [[60, 65]]], ['T2', 'PK', [[87, 90]]], ['T3', 'VALUE', [[72, 76]]], ['T4', 'UNITS', [[66, 67]]], ['T5', 'UNITS', [[77, 78]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-464',
    collData,
    {
        text: "When combined, the two haplotypes explained 17% of the variability in busulfan clearance.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-465',
    collData,
    {
        text: "The mean areas under the bactericidal titer-time curve (AUBC24s) +- SD for MSSA 1199 were 528 +- 263 for CD therapy and 547 +- 390 for CI therapy.",
        entities: [['T0', 'PK', [[9, 64]]], ['T1', 'VALUE', [[90, 93]]], ['T2', 'VALUE', [[120, 123]]], ['T3', 'VALUE', [[97, 100]]], ['T4', 'VALUE', [[127, 130]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-466',
    collData,
    {
        text: "Steady-state minimum concentration (Cmin) and overall exposure (AUC0–24) for intravenous carbamazepine infused over 30, 15, or 2–5 min were similar to oral carbamazepine.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-467',
    collData,
    {
        text: "Although elimination half-life was prolonged for the reference (4.17 hr), this was not statistically different from other products.",
        entities: [['T0', 'PK', [[9, 30]]], ['T1', 'VALUE', [[64, 68]]], ['T2', 'UNITS', [[69, 71]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-468',
    collData,
    {
        text: "Estimated Km and Vmax values were 38.49 +- 3.71 mg l-1 and 1.24 +- 0.06 mg l-1 min-1, respectively.",
        entities: [['T0', 'PK', [[10, 12]]], ['T1', 'VALUE', [[34, 39]]], ['T2', 'PK', [[17, 21]]], ['T3', 'VALUE', [[59, 63]]], ['T4', 'VALUE', [[67, 71]]], ['T5', 'UNITS', [[72, 84]]], ['T6', 'VALUE', [[43, 47]]], ['T7', 'UNITS', [[48, 54]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-469',
    collData,
    {
        text: "After intravenous infusion, the pharmacokinetic profiles of the plasma concentrations showed a biphasic decline, with half-lives (mean +- SD) of 8.55 +- 4.20 min and 11.50 +- 1.75 h, respectively.",
        entities: [['T0', 'PK', [[118, 128]]], ['T1', 'VALUE', [[145, 149]]], ['T2', 'VALUE', [[166, 171]]], ['T3', 'VALUE', [[175, 179]]], ['T4', 'UNITS', [[180, 181]]], ['T5', 'VALUE', [[153, 157]]], ['T6', 'UNITS', [[158, 161]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T2']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-470',
    collData,
    {
        text: "The 90% CI for the test/reference geometric means ratio for the parent compound, itraconazole, was in the range from 85.29% to 116.07% for AUC0-72h.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-471',
    collData,
    {
        text: "The gMean volume of distribution of volasertib ranged from 3540 to 4720 L, suggesting extensive distribution of volasertib into tissues and/or organs.",
        entities: [['T0', 'PK', [[10, 32]]], ['T1', 'RANGE', [[59, 71]]], ['T2', 'UNITS', [[72, 73]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-472',
    collData,
    {
        text: "Only 25% of the patients attained the therapeutic range for MPA-AUC under standard EC-MPS dose during the early-phase post-transplantation.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-473',
    collData,
    {
        text: "Accounting for the correlation between CLRAL/F and VRAL/F (correlation coefficient = 0.567) in the raltegravir model significantly improved the model.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-474',
    collData,
    {
        text: "The flow rate was 0.15 mL/min under ambient temperature.",
        entities: [['T0', 'UNITS', [[23, 29]]], ['T1', 'VALUE', [[18, 22]]], ['T2', 'PK', [[4, 13]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-475',
    collData,
    {
        text: "Because different actual amounts of insulin were being administered to the patient of weight 65 kg vs the diabetes patient of 80 kg, the resulting insulin profiles showed that the overall shape of the profiles are comparable, and onset of the peak insulin concentrations tends to occur at approximately the same times, but actual peak concentrations between patients of different body weights tend to differ slightly despite the adoption of a weight‐based dosing approach.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-476',
    collData,
    {
        text: "Using the “worst case” of subjects with moderate renal insufficiency, the exposure to HPβCD after administration of HPβCD‐diclofenac 37.5 mg would still be expected to be 7.9‐fold lower based on AUC0–t and 3.9‐fold lower based on the average concentration at steady state (Cav) than in healthy subjects administered intravenous itraconazole.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-477',
    collData,
    {
        text: "The mean peak platinum plasma levels were reached within 45 to 60 minutes after perfusion was started.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-478',
    collData,
    {
        text: "According to the results of an in vivo pharmacokinetic study in rats, intranasal administration of udenafil-loaded microemulsion had a shorter T(max) value (1 min) compared with oral administration and improved bioavailability (85.71%) compared with oral and intranasal (solution) administration.",
        entities: [['T0', 'UNITS', [[159, 162]]], ['T1', 'VALUE', [[157, 158]]], ['T2', 'PK', [[143, 149]]], ['T3', 'PK', [[211, 226]]], ['T4', 'VALUE', [[228, 233]]], ['T5', 'UNITS', [[233, 234]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-479',
    collData,
    {
        text: "The mean terminal half-life of rIX-FP was 91.4 hours (h), 4.3-fold longer than previous FIX treatment and clearance was 1.11 ml/h/kg, 6.4-fold slower than previous FIX treatment.",
        entities: [['T0', 'UNITS', [[47, 56]]], ['T1', 'VALUE', [[42, 46]]], ['T2', 'PK', [[9, 27]]], ['T3', 'PK', [[106, 115]]], ['T4', 'VALUE', [[120, 124]]], ['T5', 'UNITS', [[125, 132]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-480',
    collData,
    {
        text: "Etelcalcetide (ONO-5163/AMG 416) is a novel peptide consisting of 7 D-amino acids, is administered i.v., is an agonist of CaSR,15 and has a long action in hemodialysis patients with limited or no kidney function because renal clearance is the main elimination pathway in healthy individuals.16 Etelcalcetide lowers the threshold for CaSR activation in response to extracellular calcium, and directly activates CaSR itself in the absence or presence of extracellular calcium as well as cinacalcet.17 Phase I and II studies demonstrated that etelcalcetide quickly reduced serum intact PTH (iPTH) and serum albumin-corrected calcium (cCa) in a dose-dependent manner in non-Japanese hemodialysis patients with SHPT.18, 19, 20 The effects were sustained during the interdialytic period when the drug was administered 3 times weekly for 4 weeks.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-481',
    collData,
    {
        text: "cancer patients may require higher than usual dosing regimens to ensure optimal therapeutic concentrations, since vancomycin CL and Vd is significantly higher in these patients, a dosing schedule as high as 60 mg/kg/day may be needed for cancer patients.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-482',
    collData,
    {
        text: "Further, the T(max) values associated with the 0.67 and 5.45 mg/L solutions did not differ significantly indicating that the absorption, distribution and elimination rates were not affected by the dose size.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-483',
    collData,
    {
        text: "Our data suggest that a minimum dosage, greater than 10 mg/kg, of cilastatin may be required to prolong the half-life of imipenem to adult values.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-484',
    collData,
    {
        text: "Concomitant use of morphine also resulted in greater variability in orally administered paracetamol exposures, plasma concentrations, and Tmax (Table 1; Figs. 1 and 2a).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-485',
    collData,
    {
        text: "The pharmacokinetic parameters evaluated were Cmax (maximum observed drug concentration during the study), AUC0–6.5 (area under the plasma concentration–time curve measured 6.5 h, using the trapezoidal rule), tmax (time to observe maximum drug concentration), Kel (apparent first order terminal rate constant calculated from a semi-log plot of the plasma concentration versus time curve, using the method of the least square regression) and t1/2 (terminal half-life as determined by the quotient 0.693/Kel, Table 4).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-486',
    collData,
    {
        text: "As shown in Table 2, the control inhibitors T-20 and LP-52 inhibited six viruses with IC50s of 15,305.37 and 16.95 pM, respectively, whereas LP-80 and LP-90 had their IC50s of 7.09 and 23.71 pM, respectively.",
        entities: [['T0', 'PK', [[86, 91]]], ['T1', 'VALUE', [[95, 104]]], ['T2', 'VALUE', [[109, 114]]], ['T3', 'UNITS', [[115, 117]]], ['T4', 'PK', [[167, 172]]], ['T5', 'VALUE', [[176, 180]]], ['T6', 'VALUE', [[185, 190]]], ['T7', 'UNITS', [[191, 193]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R5', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T6']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-487',
    collData,
    {
        text: "The tmax of martynoside and crenatoside were at 3.1 ± 3.6 h and 6.8 ± 1.1 h, respectively, which were longer than those of acteoside and isoacteoside.",
        entities: [['T0', 'UNITS', [[58, 59]]], ['T1', 'VALUE', [[48, 51]]], ['T2', 'UNITS', [[74, 75]]], ['T3', 'VALUE', [[64, 67]]], ['T4', 'PK', [[4, 8]]], ['T5', 'VALUE', [[54, 57]]], ['T6', 'VALUE', [[70, 73]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T5']]], ['R6', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T3']]], ['R7', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-488',
    collData,
    {
        text: "According to the pharmacokinetic analysis, the absorption rate of mosapride was 3.14 ± 1.14 hr-1 and oral bioavailability of mosapride was approximately 1%.",
        entities: [['T0', 'PK', [[47, 62]]], ['T1', 'VALUE', [[80, 84]]], ['T2', 'UNITS', [[92, 96]]], ['T3', 'VALUE', [[87, 91]]], ['T4', 'PK', [[101, 121]]], ['T5', 'VALUE', [[153, 154]]], ['T6', 'UNITS', [[154, 155]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-489',
    collData,
    {
        text: "The CL/F ratios (children to adults) indicated that doses of 1 mg for > or =6 months- <1 year and 1.25 mg for > or =1 year- < or =2 years would result in similar systemic exposure to that observed in adults receiving the recommended 5 mg dose.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-490',
    collData,
    {
        text: "In T4, these trough values were 4, 4, and 6 μg/ml.",
        entities: [['T0', 'UNITS', [[44, 49]]], ['T1', 'VALUE', [[42, 43]]], ['T2', 'VALUE', [[35, 36]]], ['T3', 'VALUE', [[32, 33]]], ['T4', 'PK', [[13, 19]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T2']]], ['R5', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-491',
    collData,
    {
        text: "Considerable accumulation was observed between day 0 and day 14 (see Figure 5), with the AUC0–8 being 179‐ and 228‐fold higher after multiple than after first dosing in the tid regimens in Cohorts 3 and 4 (RAAUC0–8), respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-492',
    collData,
    {
        text: "Peak levels of free silibinin were observed at 0.5 h after administration in liver, lung, stomach and pancreas, accounting for 8.8 +- 1.6, 4.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-493',
    collData,
    {
        text: "Elimination half-life ranged from 9.0 hours after 100 mg to 22.6 hours after 200 mg.",
        entities: [['T0', 'UNITS', [[38, 43]]], ['T1', 'VALUE', [[34, 37]]], ['T2', 'UNITS', [[65, 70]]], ['T3', 'VALUE', [[60, 64]]], ['T4', 'PK', [[0, 21]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-494',
    collData,
    {
        text: "The elimination half-life in mice was dramatically increased from 3 min for BNP to 12-19 h for AlbuBNP.",
        entities: [['T0', 'UNITS', [[68, 71]]], ['T1', 'VALUE', [[66, 67]]], ['T2', 'UNITS', [[89, 90]]], ['T3', 'RANGE', [[83, 88]]], ['T4', 'PK', [[4, 25]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-495',
    collData,
    {
        text: "Individual patient peak concentrations averaged 1.0+-0.7 and 2.2+-1.1 microg/mL in the same two groups, 19+-16 and 10+-15 min after lidocaine administration, respectively.",
        entities: [['T0', 'UNITS', [[70, 79]]], ['T1', 'VALUE', [[61, 64]]], ['T2', 'VALUE', [[48, 51]]], ['T3', 'PK', [[19, 38]]], ['T4', 'VALUE', [[53, 56]]], ['T5', 'VALUE', [[66, 69]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]], ['R4', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T2']]], ['R5', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T4']]], ['R6', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T1']]], ['R7', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-496',
    collData,
    {
        text: "The abemaciclib concentration–time data were best described by a one-compartment structural model parameterized in terms of CL/F and Vd/F. This model adequately described the disposition of abemaciclib in cancer patients over a range of doses (50–275 mg) and dosing regimens (q12h vs. q24h), as indicated by the goodness-of-fit plots (Electronic Supplementary Material [ESM] Fig. 1) and VPCs (Fig. 1 and ESM Fig. 2).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-497',
    collData,
    {
        text: "Mean Cl for the cis-trans, trans-trans and cis-cis isomers were 19.98, 13.53 and 3.47 mL min(-1) kg(-1) respectively and the corresponding mean Vdss were 0.29, 0.24 and 1.00 L kg(-1).",
        entities: [['T0', 'PK', [[5, 7]]], ['T1', 'VALUE', [[64, 69]]], ['T2', 'VALUE', [[71, 76]]], ['T3', 'VALUE', [[81, 85]]], ['T4', 'UNITS', [[86, 103]]], ['T5', 'UNITS', [[174, 182]]], ['T6', 'VALUE', [[169, 173]]], ['T7', 'PK', [[144, 148]]], ['T8', 'VALUE', [[154, 158]]], ['T9', 'VALUE', [[160, 164]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]], ['R5', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T6']]], ['R7', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T8']]], ['R8', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T9']]], ['R9', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-498',
    collData,
    {
        text: "After introduction of SRL, TAC half-life did not change (11.6 +- 3.9-14.0 +- 10.4, n = 10, P = 0.52) in all the groups analyzed together.",
        entities: [['T0', 'PK', [[31, 40]]], ['T1', 'VALUE', [[57, 61]]], ['T2', 'VALUE', [[69, 73]]], ['T3', 'VALUE', [[65, 68]]], ['T4', 'VALUE', [[77, 81]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-499',
    collData,
    {
        text: "As compared to control group, area under curve (AUC, 17.35 ± 1.04 μg∙h/mL) and peak concentration (Cmax, 1.79 ± 0.13 μg/mL) were decreased and drug clearance rate were increased (CL, 563.45 ± 29.76 mL/h/kg) when high concentration (60 mg/kg) of quercetin was administered (P < 0.05).",
        entities: [['T0', 'PK', [[30, 51]]], ['T1', 'VALUE', [[53, 58]]], ['T2', 'UNITS', [[66, 73]]], ['T3', 'VALUE', [[61, 65]]], ['T4', 'PK', [[79, 103]]], ['T5', 'VALUE', [[105, 109]]], ['T6', 'UNITS', [[117, 122]]], ['T7', 'VALUE', [[112, 116]]], ['T8', 'PK', [[179, 181]]], ['T9', 'VALUE', [[183, 189]]], ['T10', 'UNITS', [[198, 205]]], ['T11', 'VALUE', [[192, 197]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T5']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R8', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T9']]], ['R9', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T9']]], ['R10', 'D_VAL', [['Entity', 'T11'], ['D_VAL', 'T9']]], ['R11', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T11']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-500',
    collData,
    {
        text: "Cmax of BGC9331 after day 1 administration at 40 mg m−2 was 11.21 μg ml−1±2.51.",
        entities: [['T0', 'PK', [[0, 4]]], ['T1', 'VALUE', [[60, 65]]], ['T2', 'VALUE', [[74, 78]]], ['T3', 'UNITS', [[66, 73]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-501',
    collData,
    {
        text: "At clinically relevant concentrations, ertugliflozin is a substrate for the P‐glycoprotein and breast cancer resistance protein efflux transporters; however, no clinically relevant interaction is expected with inhibitors of these transporters based on the oral bioavailability of ertugliflozin of approximately 100%, and dose‐proportional increases in exposure over the dose range of 0.5 mg to 300 mg.",
        entities: [['T0', 'UNITS', [[314, 315]]], ['T1', 'VALUE', [[311, 314]]], ['T2', 'PK', [[256, 276]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-502',
    collData,
    {
        text: "The mean areas under the plasma concentration–time curves were calculated to be 1,540.33 and 870.23 ng·h/mL, respectively.",
        entities: [['T0', 'UNITS', [[100, 107]]], ['T1', 'VALUE', [[93, 99]]], ['T2', 'VALUE', [[80, 88]]], ['T3', 'PK', [[9, 57]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-503',
    collData,
    {
        text: "The whole blood concentration declined in a bi-exponential manner, and the apparent terminal-phase half-life (t1/2) (obtained at up to 168 h after a single dose on Day 1) ranged from 55.8 to 58.0 h (harmonic mean).",
        entities: [['T0', 'PK', [[75, 115]]], ['T1', 'RANGE', [[183, 195]]], ['T2', 'UNITS', [[196, 197]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-504',
    collData,
    {
        text: "The peak urinary concentration in the fasting state was observed at 0-2 hours after dosing, and in non-fasting individuals it occurred at 2-4 hours after dosing.(ABSTRACT TRUNCATED AT 400 WORDS)",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-505',
    collData,
    {
        text: "Composite Ctrough (i.e., the geometric mean of all trough concentrations over the 48 weeks), population inhibitory quotient ([IQ], i.e., Ctrough divided population estimated protein binding adjusted effective concentration at 90% [EC90 , 14 ng/ml]), composite population IQ (i.e., ATV composite trough divided by population estimated protein binding adjusted EC90 ), HIV RNA, CD4 cell counts, and metabolic and safety parameters were also assessed.",
        entities: [['T0', 'PK', [[231, 235]]], ['T1', 'VALUE', [[238, 240]]], ['T2', 'UNITS', [[241, 246]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-506',
    collData,
    {
        text: "The results revealed that: (i) the efficiency of acetylcholinesterase inhibition of GH was greatly enhanced by intranasal administration compared with oral administration, especially GH loaded in flexible liposomes; (ii) the C(max) and AUC(0→10) for intranasal administration of GH loaded flexible liposomes were 3.52 and 3.36 times higher than those of orally administered GH, moreover, the T(max) was greatly shortened from 1.5h for oral administration to 0.75h for intranasal administration of GH loaded flexible liposomes; and (iii) PC-12 cells viability tests showed that the flexible liposome carrier is not toxic to the cultured cells and the cytotoxicity of GH to cells was clearly decreased by loading in flexible liposomes.",
        entities: [['T0', 'UNITS', [[429, 430]]], ['T1', 'VALUE', [[426, 429]]], ['T2', 'PK', [[392, 398]]], ['T3', 'VALUE', [[458, 462]]], ['T4', 'UNITS', [[462, 463]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-507',
    collData,
    {
        text: "The tablet with largest particle size (102 mu) showed markedly lower bioavailability than the reference solution, namely 39%.",
        entities: [['T0', 'PK', [[69, 84]]], ['T1', 'VALUE', [[121, 123]]], ['T2', 'UNITS', [[123, 124]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-508',
    collData,
    {
        text: "The AUC(0®96), AUC(0®∞) and Cmax of HBUP were significantly different between CYP2B6*1/*1 and CYP2B6*1/*6 participants, CYP2B6*1/*1 and CYP2B6*1/*4 participants, CYP2B6*1/*6 and CYP2B6*4/*6 participants, CYP2B6*1/*6 and CYP2B6*1/*4 participants, or CYP2B6*4/*6 and CYP2B6*1/*4 participants (all P values were below 0.05).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-509',
    collData,
    {
        text: "The mean values for AUC0‐t, where t = 48 h post‐dose, were 736, 1250, 2380 and 3300 µg*h/ml for the doses of 10, 20, 40 and 60 mg/kg respectively.",
        entities: [['T0', 'PK', [[20, 26]]], ['T1', 'VALUE', [[59, 62]]], ['T2', 'VALUE', [[64, 68]]], ['T3', 'VALUE', [[70, 74]]], ['T4', 'VALUE', [[79, 83]]], ['T5', 'UNITS', [[84, 91]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-510',
    collData,
    {
        text: "For hybrid coefficient A, hybrid first-order rate constant α, volume of the central compartment (Vc), terminal phase half-life (t1/2β), elimination rate constant from the central compartment (K21), and systemic clearance (CLs), peak value appeared following the administration of 2 μg/kg dose.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-511',
    collData,
    {
        text: "Mean Tmax at day 5 occurred slightly later after administration of Amgen filgrastim 10 µg/kg compared with Hospira filgrastim 10 µg/kg (4.37 vs. 3.55 h, respectively).",
        entities: [['T0', 'UNITS', [[150, 151]]], ['T1', 'VALUE', [[145, 149]]], ['T2', 'VALUE', [[136, 140]]], ['T3', 'PK', [[5, 9]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-512',
    collData,
    {
        text: "Dexmedetomidine is a selective and potent alpha2-adrenoceptor agonist licensed for use in the sedation of patients initially ventilated in intensive care units at a maximum dose rate of 0.7 μg/kg/h administered for up to 24 hours.",
        entities: [['T0', 'UNITS', [[190, 197]]], ['T1', 'VALUE', [[186, 189]]], ['T2', 'PK', [[165, 182]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-513',
    collData,
    {
        text: "Mean elimination half-life (t1/2) ranged from 1.6 to 6.8 h. Most patients had concentrations below the limit of quantitation 48 h post-end of infusion.",
        entities: [['T0', 'UNITS', [[57, 58]]], ['T1', 'RANGE', [[46, 56]]], ['T2', 'PK', [[5, 33]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-514',
    collData,
    {
        text: "A statistically significant period effect was observed for all parameters (AUC(0–t), p = 0.0010; AUC(0–inf), p = 0.0011; AUC(0–24), p = 0.0005; Cmax, p < 0.0001), which suggests that exposures in Treatment Period 1 were higher than those observed for Treatment Periods 2 through 4.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-515',
    collData,
    {
        text: "Equivalence was demonstrated on the PK endpoints (AUC0–inf, Cmax, and AUC0–last) based on bounds of 80–125% for the ratio of the geometric means (ONS-3010/Humira®).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-516',
    collData,
    {
        text: "The elimination half-life was prolonged (mean 5.4 vs. 2.3 hrs) and the volume of distribution was larger (3.1 vs. 0.9 L/kg) in patients vs. healthy volunteers.",
        entities: [['T0', 'PK', [[4, 25]]], ['T1', 'VALUE', [[46, 49]]], ['T2', 'UNITS', [[58, 61]]], ['T3', 'VALUE', [[54, 57]]], ['T4', 'UNITS', [[118, 122]]], ['T5', 'VALUE', [[114, 117]]], ['T6', 'VALUE', [[106, 109]]], ['T7', 'PK', [[71, 93]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R4', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R5', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T6']]], ['R6', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T6']]], ['R7', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-517',
    collData,
    {
        text: "The non-renal clearance of furosemide was significantly faster (55.9% increase) in rats pretreated with isoniazid, but slower in those pretreated with cimetidine or troleandomycin (38.5% and 22.7% decreases, respectively), than controls.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-518',
    collData,
    {
        text: "The elimination half-life was slightly longer than previous reports, with four subjects having t(1/2) above 3 h. The t(1/2) was found to correlate significantly (p < 0.01) with the mean residence time (MRT), an indication that MRT can be used where t(1/2) cannot be evaluated.",
        entities: [['T0', 'UNITS', [[110, 111]]], ['T1', 'VALUE', [[108, 109]]], ['T2', 'COMPARE', [[102, 107]]], ['T3', 'PK', [[95, 101]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-519',
    collData,
    {
        text: "Simplified methods included the slope intercept method using different combinations of blood samples (2 and 4 h; 2, 3 and 4 h; 1.5, 2, 3 and 4 h; 1.5, 2 and 3 h) and several single clearance methods (Constable 3 h; Groth 3 h; Groth 4 h).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-520',
    collData,
    {
        text: "The mean Tmax of milled TAK-228 increased from 2.0 hours in the fasted state to 6.0 hours in the fed state (figure 1).",
        entities: [['T0', 'UNITS', [[51, 56]]], ['T1', 'VALUE', [[47, 50]]], ['T2', 'UNITS', [[84, 89]]], ['T3', 'VALUE', [[80, 83]]], ['T4', 'PK', [[9, 13]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-521',
    collData,
    {
        text: "Uridine plasma decay curves were biphasic with a terminal half-life of 118 min.",
        entities: [['T0', 'UNITS', [[75, 78]]], ['T1', 'VALUE', [[71, 74]]], ['T2', 'PK', [[49, 67]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-522',
    collData,
    {
        text: "For Cmax, the CI criterion was strictly met (slope estimate, 0.97; 90%CI, 0.86–1.08), indicating that this parameter increased in a dose‐proportional manner from 4 to 24 mg/kg.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-523',
    collData,
    {
        text: "Total naproxen concentrations were significantly lower in active disease, together with a larger apparent volume of distribution (10.6 +- 1.8 L vs. 8.4 +- 1.3 L; P less than 0.05) and total body clearance (0.79 +- 1.8 L/hr vs. 0.59 +- 0.14 L/hr; P less than 0.001).",
        entities: [['T0', 'UNITS', [[142, 143]]], ['T1', 'VALUE', [[130, 134]]], ['T2', 'UNITS', [[159, 160]]], ['T3', 'VALUE', [[148, 151]]], ['T4', 'PK', [[97, 128]]], ['T5', 'VALUE', [[155, 158]]], ['T6', 'VALUE', [[138, 141]]], ['T7', 'UNITS', [[218, 222]]], ['T8', 'VALUE', [[206, 210]]], ['T9', 'UNITS', [[240, 244]]], ['T10', 'VALUE', [[227, 231]]], ['T11', 'VALUE', [[214, 217]]], ['T12', 'VALUE', [[235, 239]]], ['T13', 'PK', [[184, 204]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T3']]], ['R5', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T5']]], ['R6', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T1']]], ['R7', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T6']]], ['R8', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T8']]], ['R9', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T10']]], ['R10', 'D_VAL', [['Entity', 'T11'], ['D_VAL', 'T8']]], ['R11', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T11']]], ['R12', 'D_VAL', [['Entity', 'T12'], ['D_VAL', 'T10']]], ['R13', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T12']]], ['R14', 'C_VAL', [['Entity', 'T13'], ['C_VAL', 'T8']]], ['R15', 'C_VAL', [['Entity', 'T13'], ['C_VAL', 'T10']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-524',
    collData,
    {
        text: "The time to reach the peak concentration was 1 hour in all patients.",
        entities: [['T0', 'UNITS', [[47, 51]]], ['T1', 'VALUE', [[45, 46]]], ['T2', 'PK', [[4, 40]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-525',
    collData,
    {
        text: "The results shown in Figure 2 demonstrate that the blood clearance of the second dose was sharply accelerated (AUC ratio =0.10±0.06).",
        entities: [['T0', 'PK', [[111, 120]]], ['T1', 'VALUE', [[122, 126]]], ['T2', 'VALUE', [[127, 131]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-526',
    collData,
    {
        text: "Atorvastatin clearance increased by 78% when coadministered with CYP3A4 inducers.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-527',
    collData,
    {
        text: "At a low (50 nM) concentration of 25OHD3, 25OHD3-3-O-sulfate was the most abundant metabolite, with an intrinsic clearance approximately 8-fold higher than the next most efficient metabolic route.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-528',
    collData,
    {
        text: "In fasted subjects (N = 27), mean [SD] parameters were Cmax: 58.9 [12.5] ng/mL; tmax: 3.7 [1.5] h; area under concentration-time curve (AUC): 3,387 [1,328] ng/h/mL; Vλz/F: 2,829 [1,267] L; CL/F: 2.76 [1.28] L/h; and t½: 784 [347] h.",
        entities: [['T0', 'PK', [[55, 59]]], ['T1', 'VALUE', [[61, 65]]], ['T2', 'PK', [[80, 84]]], ['T3', 'VALUE', [[86, 89]]], ['T4', 'PK', [[99, 140]]], ['T5', 'VALUE', [[142, 147]]], ['T6', 'PK', [[165, 170]]], ['T7', 'VALUE', [[172, 177]]], ['T8', 'PK', [[189, 193]]], ['T9', 'VALUE', [[195, 199]]], ['T10', 'PK', [[216, 218]]], ['T11', 'VALUE', [[220, 223]]], ['T12', 'VALUE', [[67, 71]]], ['T13', 'UNITS', [[73, 78]]], ['T14', 'VALUE', [[91, 94]]], ['T15', 'UNITS', [[96, 97]]], ['T16', 'VALUE', [[149, 154]]], ['T17', 'UNITS', [[156, 163]]], ['T18', 'VALUE', [[179, 184]]], ['T19', 'UNITS', [[186, 187]]], ['T20', 'VALUE', [[201, 205]]], ['T21', 'UNITS', [[207, 210]]], ['T22', 'VALUE', [[225, 228]]], ['T23', 'UNITS', [[230, 231]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R3', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R4', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T9']]], ['R5', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T11']]], ['R6', 'D_VAL', [['Entity', 'T12'], ['D_VAL', 'T1']]], ['R7', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T12']]], ['R8', 'D_VAL', [['Entity', 'T14'], ['D_VAL', 'T3']]], ['R9', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T14']]], ['R10', 'D_VAL', [['Entity', 'T16'], ['D_VAL', 'T5']]], ['R11', 'RELATED', [['Entity', 'T17'], ['RELATED', 'T16']]], ['R12', 'D_VAL', [['Entity', 'T18'], ['D_VAL', 'T7']]], ['R13', 'RELATED', [['Entity', 'T19'], ['RELATED', 'T18']]], ['R14', 'D_VAL', [['Entity', 'T20'], ['D_VAL', 'T9']]], ['R15', 'RELATED', [['Entity', 'T21'], ['RELATED', 'T20']]], ['R16', 'D_VAL', [['Entity', 'T22'], ['D_VAL', 'T11']]], ['R17', 'RELATED', [['Entity', 'T23'], ['RELATED', 'T22']]], ['R18', 'RELATED', [['Entity', 'T23'], ['RELATED', 'T11']]], ['R19', 'RELATED', [['Entity', 'T21'], ['RELATED', 'T9']]], ['R20', 'RELATED', [['Entity', 'T19'], ['RELATED', 'T7']]], ['R21', 'RELATED', [['Entity', 'T17'], ['RELATED', 'T5']]], ['R22', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T3']]], ['R23', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-529',
    collData,
    {
        text: "Compared with fasted subjects, fed subjects (N = 27) exhibited a 34% increase in Cmax, delay in tmax to 5.3 [2.1] h, 44% increase in AUC, 40% decrease in Vλz/F, and a 35% decrease in CL/F.",
        entities: [['T0', 'PK', [[96, 100]]], ['T1', 'VALUE', [[104, 107]]], ['T2', 'VALUE', [[109, 112]]], ['T3', 'UNITS', [[114, 115]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-530',
    collData,
    {
        text: "Oral clearance of clozapine and the ratio AUC(0, 12h) for desmethyl-clozapine/AUC(0,12h) for clozapine were correlated with the paraxanthine/caffeine ratio in serum after intake of caffeine (rs=0.62; P=0.03 and rs=0.77; P=0.003, respectively).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-531',
    collData,
    {
        text: "These data agree well with the estimated t1/2λz of scFv7F9Cys (1.3 ± 0.3 hr) and dendribodies (26 ± 2.6 hr) in rats.",
        entities: [['T0', 'PK', [[41, 47]]], ['T1', 'VALUE', [[63, 66]]], ['T2', 'VALUE', [[69, 72]]], ['T3', 'UNITS', [[73, 75]]], ['T4', 'VALUE', [[100, 103]]], ['T5', 'VALUE', [[95, 97]]], ['T6', 'UNITS', [[104, 106]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T5']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T4']]], ['R5', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T5']]], ['R6', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-532',
    collData,
    {
        text: "Total uptake (1,072,270, 1,182,498; 1,481,060; ng/ml/min), serum half-life (48.8; 34.0; 30.0 min) and relative bioavailability (1.0, 1.1; 1.4;) of mouse [D-Leu-4]OB3 were similar when the peptide was given by ip, sc, or im injection, respectively.",
        entities: [['T0', 'PK', [[59, 74]]], ['T1', 'VALUE', [[76, 80]]], ['T2', 'VALUE', [[82, 86]]], ['T3', 'VALUE', [[88, 92]]], ['T4', 'UNITS', [[93, 96]]], ['T5', 'PK', [[102, 126]]], ['T6', 'VALUE', [[128, 131]]], ['T7', 'VALUE', [[133, 136]]], ['T8', 'VALUE', [[138, 141]]], ['T9', 'PK', [[0, 12]]], ['T10', 'VALUE', [[14, 23]]], ['T11', 'VALUE', [[25, 34]]], ['T12', 'VALUE', [[36, 45]]], ['T13', 'UNITS', [[47, 56]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]], ['R5', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R6', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T6']]], ['R7', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T7']]], ['R8', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T8']]], ['R9', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T10']]], ['R10', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T11']]], ['R11', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T12']]], ['R12', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T12']]], ['R13', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T11']]], ['R14', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T10']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-533',
    collData,
    {
        text: "Percent of extrapolated AUC for S‐warfarin was > 20% in 15 of 16 patients and percent of extrapolated AUC for digoxin was > 20% in all 16 patients.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-534',
    collData,
    {
        text: "The mean Cmax and AUClast of paraxanthine, a metabolite of caffeine, were 1,461.2 ng/mL and 24,682.6 h*ng/mL, respectively, on Day 1 (before RG intake), and these values were 1,444.3 ng/mL and 23,835.0 h*ng/mL, respectively, on Day 15 (after RG intake).",
        entities: [['T0', 'UNITS', [[82, 87]]], ['T1', 'VALUE', [[74, 81]]], ['T2', 'UNITS', [[101, 108]]], ['T3', 'VALUE', [[92, 100]]], ['T4', 'PK', [[9, 13]]], ['T5', 'PK', [[18, 25]]], ['T6', 'UNITS', [[183, 188]]], ['T7', 'VALUE', [[175, 182]]], ['T8', 'UNITS', [[202, 209]]], ['T9', 'VALUE', [[193, 201]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T3']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T9']]], ['R6', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T7']]], ['R7', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T9']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-535',
    collData,
    {
        text: "Nevirapine significantly reduced median indinavir Cmin (47.5%) and AUC (27.4%) and, to a lesser extent, Cmax (11%).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-536',
    collData,
    {
        text: "Mean T1/2 was 6.8 and 8.6 hours following a single 30-mg and repeat 180-mg BID dose, respectively (Table 1, Additional file 1: Table S2).",
        entities: [['T0', 'UNITS', [[26, 31]]], ['T1', 'VALUE', [[22, 25]]], ['T2', 'VALUE', [[14, 17]]], ['T3', 'PK', [[5, 9]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-537',
    collData,
    {
        text: "mL−1), cingulate (Cmax = 0.033% ID .",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-538',
    collData,
    {
        text: "These and other pharmacokinetic data analyses support the use of the recommended dose regimen of daratumumab (16 mg/kg weekly for 8 weeks, every 2 weeks for 16 weeks, and every 4 weeks thereafter) to rapidly saturate target-mediated clearance during weekly dosing and maintain saturation when dosing every 2 or 4 weeks.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-539',
    collData,
    {
        text: "By 6 hours, the change from baseline was approximately half of maximum.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-540',
    collData,
    {
        text: "Two patients in group I (200 mg b.i.d. cohort) showed high exposure to nintedanib (AUCτ,ss 6170 and 5700 ng·h/mL, respectively), the cause of which was unknown.",
        entities: [['T0', 'UNITS', [[105, 112]]], ['T1', 'VALUE', [[100, 104]]], ['T2', 'VALUE', [[91, 95]]], ['T3', 'PK', [[83, 90]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-541',
    collData,
    {
        text: "The median terminal half-lives (t1/2) were 7.1 h and 11.5 h in the ropivacaine group and the bupivacaine group, respectively (P = 0.07).",
        entities: [['T0', 'UNITS', [[47, 48]]], ['T1', 'VALUE', [[43, 46]]], ['T2', 'UNITS', [[58, 59]]], ['T3', 'VALUE', [[53, 57]]], ['T4', 'PK', [[11, 37]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-542',
    collData,
    {
        text: "In pharmacokinetic studies, cefiderocol manifested similar pharmacokinetics across tested doses (4, 100 and 250 mg/kg) with a mean half-life of 0.86 h. In pharmacodynamic studies, the change in CFU after 24 h from the initial inoculum ranged from +3.4 to -3.1 log10 with doses of 4.2-166.7 mg/kg q8h.",
        entities: [['T0', 'UNITS', [[149, 150]]], ['T1', 'VALUE', [[144, 148]]], ['T2', 'PK', [[131, 140]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-543',
    collData,
    {
        text: "The present study in 7 normal volunteers and 8 adult male patients with iron deficiency anaemia (IDA) was done to investigate the effect of iron deficiency and its treatment with total dose iron (TDI) on the bioavailability of a single dose of phenytoin.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-544',
    collData,
    {
        text: "The half-lives (t1/2) for AZT-Iso were 1.19, 1.13 and 0.30 h for human, rat and rabbit plasma, respectively, and 14.91 and 25.49 h for potassium phosphate buffer (pH 7.4) and human serum albumin solution, respectively.",
        entities: [['T0', 'UNITS', [[59, 60]]], ['T1', 'VALUE', [[39, 43]]], ['T2', 'PK', [[4, 21]]], ['T3', 'VALUE', [[113, 118]]], ['T4', 'UNITS', [[129, 130]]], ['T5', 'VALUE', [[123, 128]]], ['T6', 'VALUE', [[54, 58]]], ['T7', 'VALUE', [[45, 49]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R5', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T6']]], ['R6', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T7']]], ['R7', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T7']]], ['R8', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T6']]], ['R9', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-545',
    collData,
    {
        text: "Through previous in vitro testing of DB 1192 against T. evansi, an IC50 value of 10.5 ng/ml was obtained for a 72 hour assay.",
        entities: [['T0', 'UNITS', [[86, 91]]], ['T1', 'VALUE', [[81, 85]]], ['T2', 'PK', [[67, 71]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-546',
    collData,
    {
        text: "Cmax ranged from 140 to 230 μg/L and AUC0-∞ was 110–210 μg.h/L. The T1/2 of puerarin ranged from 0.86–0.88 h, with no significant difference between doses.",
        entities: [['T0', 'UNITS', [[28, 32]]], ['T1', 'RANGE', [[17, 27]]], ['T2', 'PK', [[0, 4]]], ['T3', 'UNITS', [[107, 108]]], ['T4', 'RANGE', [[97, 106]]], ['T5', 'UNITS', [[56, 62]]], ['T6', 'RANGE', [[48, 55]]], ['T7', 'PK', [[37, 43]]], ['T8', 'PK', [[68, 72]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T6']]], ['R4', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T6']]], ['R5', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-547',
    collData,
    {
        text: "Consistent with the known biology of SYK, RO9021 blocked anti-IgM-activated calcium flux in Ramos B-cell line with an IC50 value of 78 ± 21 nM. This effect is specific to BCR signaling because RO9021 showed about 12-fold potency shift (IC50 = 910 ± 270 nM) in blocking T-cell receptor (anti-CD3)-induced calcium flux in Jurkat, a human T-cell line (Figure 2B).",
        entities: [['T0', 'PK', [[118, 122]]], ['T1', 'VALUE', [[132, 134]]], ['T2', 'UNITS', [[140, 142]]], ['T3', 'VALUE', [[137, 139]]], ['T4', 'PK', [[236, 240]]], ['T5', 'VALUE', [[243, 246]]], ['T6', 'VALUE', [[249, 252]]], ['T7', 'UNITS', [[253, 255]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T5']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-548',
    collData,
    {
        text: "It was rapidly eliminated, with a mean total plasma clearance of 39.3 l.h-1, and a mean terminal-phase half-life of 2.0 h.",
        entities: [['T0', 'UNITS', [[120, 121]]], ['T1', 'VALUE', [[116, 119]]], ['T2', 'UNITS', [[70, 75]]], ['T3', 'VALUE', [[65, 69]]], ['T4', 'PK', [[39, 61]]], ['T5', 'PK', [[88, 112]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-549',
    collData,
    {
        text: "Bioavailability after i.m. injection was 89%.",
        entities: [['T0', 'UNITS', [[43, 44]]], ['T1', 'VALUE', [[41, 43]]], ['T2', 'PK', [[0, 15]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-550',
    collData,
    {
        text: "The hypnotic effect coincided with a remarkable hysteresis between serum concentration and biophase, determined by an equilibration half-life of 8 min (ke0 = 0.087 +- 0.013 min-1).",
        entities: [['T0', 'UNITS', [[147, 150]]], ['T1', 'VALUE', [[145, 146]]], ['T2', 'PK', [[132, 141]]], ['T3', 'UNITS', [[173, 178]]], ['T4', 'VALUE', [[158, 163]]], ['T5', 'PK', [[152, 155]]], ['T6', 'VALUE', [[167, 172]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T4']]], ['R5', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-551',
    collData,
    {
        text: "After the distribution phase, blood levels declined with a half-life near 10 hr.",
        entities: [['T0', 'UNITS', [[77, 79]]], ['T1', 'VALUE', [[74, 76]]], ['T2', 'PK', [[59, 68]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-552',
    collData,
    {
        text: "The AUC for grade 3 renal insufficiency increased by approximately 60% versus grade 0 (P < .01) but was not significantly different between other grades of renal function.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-553',
    collData,
    {
        text: "Steady-state conditions were established with the second dose of nisoldipine coat-core and accumulation from first dose to steady-state accounted for 46% as expected due to the contribution of AUC beyond 24 h. At steady-state the coat-core formulation produced a plateau-shaped profile of nisoldipine plasma concentrations throughout the 24 h dosing interval and the peak-trough fluctuation was reduced by approximately 4-fold, compared to the immediate-release tablet in a b.i.d. regimen.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-554',
    collData,
    {
        text: "Oral coadministration of quinidine (10 and 30 mg/kg) increased both the extent and the first-order rate of absorption of MRK-1 (2 mg/kg) by approximately 40 to 50% and approximately 100 to 300%, respectively, in rats, thus further substantiating the role of P-gp in modulating the intestinal absorption of MRK-1 in this species.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-555',
    collData,
    {
        text: "After reaching Cmax at 0.25 h, coinciding with the end of the 15 min infusion time, the plasma concentrations of total 14C-radioactivity were slowly eliminated in a biphasic manner.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-556',
    collData,
    {
        text: "Pharmacokinetic results of the two administrations show that from both products, testosterone was rapidly absorbed with a total testosterone Tmax between 12 and 16 minutes (0.201–0.256 h) and a half-life between 36 and 44 minutes (0.598–0.726 h).",
        entities: [['T0', 'PK', [[141, 145]]], ['T1', 'RANGE', [[154, 163]]], ['T2', 'UNITS', [[164, 171]]], ['T3', 'UNITS', [[222, 229]]], ['T4', 'RANGE', [[212, 221]]], ['T5', 'PK', [[194, 203]]], ['T6', 'RANGE', [[173, 184]]], ['T7', 'UNITS', [[185, 186]]], ['T8', 'RANGE', [[231, 242]]], ['T9', 'UNITS', [[243, 244]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T4']]], ['R7', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-557',
    collData,
    {
        text: "The maximum serum concentration after the first dose was 6.46 +- 1.06 (mean +- SEM) micrograms/ml and was reached in 4.3 +- 0.8 h after the first administration.",
        entities: [['T0', 'PK', [[4, 31]]], ['T1', 'VALUE', [[57, 61]]], ['T2', 'UNITS', [[84, 97]]], ['T3', 'VALUE', [[65, 69]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-558',
    collData,
    {
        text: "In vivo VD3 bioavailability was evaluated by a large randomized, double blind, placebo-controlled clinical trial, measuring serum 25(OH)D increase in subjects who consumed fat-free yogurt with 50,000 IU of either VD3-rCM, VD3-PS80, or VD3-free placebo yogurt.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-559',
    collData,
    {
        text: "Dipraglurant was rapidly absorbed (tmax = 1 hour).",
        entities: [['T0', 'UNITS', [[44, 48]]], ['T1', 'VALUE', [[42, 43]]], ['T2', 'PK', [[35, 39]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-560',
    collData,
    {
        text: "Some predose samples had measurable concentrations due to incomplete washout; however, the majority of the measurable concentration values were <0.1% of the following Cmax and hence were included in the non-compartmental PK analysis.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-561',
    collData,
    {
        text: "Isavuconazole has demonstrated weak inhibition of the transporters P‐glycoprotein (P‐gp; in P‐gp–transfected porcine kidney epithelial cell monolayers, inhibition constant [IC50] with [3H]digoxin substrate, 25.7 μmol/L), organic cation transporters 1 and 2 (OCT1 and OCT2; in stably transfected human embryonic kidney [HEK293] cells, IC50 for OCT1 with [14C]tetraethylammonium bromide substrate, 3.74 μmol/L; IC50 for OCT2 with [14C]metformin substrate, 1.97 μmol/L), and multidrug and toxin extrusion protein 1 (in stably transfected HEK293 cells, IC50 with 14C‐metformin substrate, 6.31 μmol/L; see also Yamazaki et al11), as well as weak inhibition of uridine diphosphateglucuronosyl transferase (in human liver microsomes, IC50 for 17β‐estradiol 3‐glucuronidation [UGT1A1], 9.0 μmol/L; propofol glucuronidation [UGT1A9], 19 μmol/L; morphine 3‐glucuronidation [UGT2B7], 44 μmol/L; see also Groll et al12).",
        entities: [['T0', 'UNITS', [[212, 218]]], ['T1', 'VALUE', [[207, 211]]], ['T2', 'PK', [[152, 178]]], ['T3', 'UNITS', [[401, 407]]], ['T4', 'VALUE', [[396, 400]]], ['T5', 'PK', [[334, 338]]], ['T6', 'UNITS', [[459, 465]]], ['T7', 'VALUE', [[454, 458]]], ['T8', 'PK', [[409, 413]]], ['T9', 'PK', [[549, 553]]], ['T10', 'VALUE', [[584, 588]]], ['T11', 'UNITS', [[589, 595]]], ['T12', 'PK', [[727, 731]]], ['T13', 'VALUE', [[778, 781]]], ['T14', 'UNITS', [[782, 788]]], ['T15', 'UNITS', [[828, 834]]], ['T16', 'VALUE', [[825, 827]]], ['T17', 'UNITS', [[876, 882]]], ['T18', 'VALUE', [[873, 875]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R5', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T7']]], ['R6', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T10']]], ['R7', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T10']]], ['R8', 'C_VAL', [['Entity', 'T12'], ['C_VAL', 'T13']]], ['R9', 'RELATED', [['Entity', 'T14'], ['RELATED', 'T13']]], ['R10', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T16']]], ['R11', 'RELATED', [['Entity', 'T17'], ['RELATED', 'T18']]], ['R12', 'C_VAL', [['Entity', 'T12'], ['C_VAL', 'T16']]], ['R13', 'C_VAL', [['Entity', 'T12'], ['C_VAL', 'T18']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-562',
    collData,
    {
        text: "Peak serum concentrations, area under the curve, and 24 h urinary recovery values were unchanged in the fed and fasted states.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-563',
    collData,
    {
        text: "The mean AUCT (mean ± SD ng/mL ∗ hr) of test and reference were 196.172 ± 12.01 and 193.172 ± 12.01 while mean AUCI (mean ± SD ng/mL ∗ hr) of test and reference formulations were 211.468 ± 13.51 and 196.468 ± 13.51, respectively.",
        entities: [['T0', 'PK', [[9, 13]]], ['T1', 'VALUE', [[64, 71]]], ['T2', 'PK', [[111, 115]]], ['T3', 'VALUE', [[179, 186]]], ['T4', 'VALUE', [[84, 91]]], ['T5', 'VALUE', [[199, 206]]], ['T6', 'VALUE', [[94, 99]]], ['T7', 'UNITS', [[25, 35]]], ['T8', 'VALUE', [[189, 194]]], ['T9', 'UNITS', [[127, 137]]], ['T10', 'VALUE', [[209, 214]]], ['T11', 'VALUE', [[74, 79]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T5']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T4']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T3']]], ['R7', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]], ['R8', 'D_VAL', [['Entity', 'T10'], ['D_VAL', 'T5']]], ['R9', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T10']]], ['R10', 'D_VAL', [['Entity', 'T11'], ['D_VAL', 'T1']]], ['R11', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T11']]], ['R12', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T1']]], ['R13', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-564',
    collData,
    {
        text: "The highest excretion rate of TP (50 +- 8 mumol/h) occurring at 0-6 h after the load and rapidly declining thereafter, indicated the lower excretion of TP compared with its metabolites.",
        entities: [['T0', 'PK', [[12, 26]]], ['T1', 'VALUE', [[34, 36]]], ['T2', 'VALUE', [[40, 41]]], ['T3', 'UNITS', [[42, 49]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-565',
    collData,
    {
        text: "In contrast, the maximum amounts taken up by bone were 18 and 13% of the dose for 111In-SOD-ALN(32) and LZM-ALN(9), respectively, because of their high renal clearance.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-566',
    collData,
    {
        text: "BET specific surface area (SBET), total pore volume (Vt), and Barrett–Joyner–Halenda pore diameter (wBJH) were calculated (Table 1), and the mean pore size of 6.5 nm is consistent with the value measured from the TEM images.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-567',
    collData,
    {
        text: "The bioavailability of enalapril and its active metabolite enalaprilat in the different age subsets (1 months to less than 12months, 12 months to less than 6 years, 6 years to less than 12 years) of the paediatric population (AUC within a dosing interval of 12 h, Cmax and Tmax); descriptive PK investigation.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-568',
    collData,
    {
        text: "PCP absorption was rapid with maximum measured plasma concentrations ranging from 559 to 1450 ng/ml at 10-30 min after dosing, which corresponded to the time of maximum PCP stimulus effects in the drug discrimination studies.",
        entities: [['T0', 'UNITS', [[94, 99]]], ['T1', 'RANGE', [[82, 93]]], ['T2', 'PK', [[30, 68]]], ['T3', 'UNITS', [[109, 112]]], ['T4', 'RANGE', [[103, 108]]], ['T5', 'PK', [[153, 168]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-569',
    collData,
    {
        text: "The half-life of CCK-58 was 4.4 +- 0.6 minutes compared with 1.3 +- 0.1 minutes for CCK-8.",
        entities: [['T0', 'UNITS', [[39, 46]]], ['T1', 'VALUE', [[28, 31]]], ['T2', 'UNITS', [[72, 79]]], ['T3', 'VALUE', [[61, 64]]], ['T4', 'VALUE', [[35, 38]]], ['T5', 'VALUE', [[68, 71]]], ['T6', 'PK', [[4, 13]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T3']]], ['R5', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T5']]], ['R6', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]], ['R7', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-570',
    collData,
    {
        text: "Mean apparent terminal t½ increased with worsening renal function (for IV delafloxacin and IV placebo, respectively, 1.8 and 1.7 hours in normal renal function and 10.8 and 9.7 hours in severe renal impairment).",
        entities: [['T0', 'UNITS', [[129, 134]]], ['T1', 'VALUE', [[125, 128]]], ['T2', 'VALUE', [[117, 120]]], ['T3', 'PK', [[5, 25]]], ['T4', 'VALUE', [[164, 168]]], ['T5', 'VALUE', [[173, 176]]], ['T6', 'UNITS', [[177, 182]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R5', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T5']]], ['R6', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-571',
    collData,
    {
        text: "Median Time to GIRmax was approximately 13 hours for all treatments.",
        entities: [['T0', 'UNITS', [[43, 48]]], ['T1', 'VALUE', [[40, 42]]], ['T2', 'PK', [[7, 21]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-572',
    collData,
    {
        text: "We observed that the serum EPO Cmax values ranged from 14.4 mIU/L for ZYAN1 100 mg to 60.5 mIU/L for ZYAN1 300 mg while it was 11.0 mIU/L for subjects who received placebo.",
        entities: [['T0', 'UNITS', [[60, 65]]], ['T1', 'VALUE', [[55, 59]]], ['T2', 'UNITS', [[132, 137]]], ['T3', 'VALUE', [[127, 131]]], ['T4', 'UNITS', [[91, 96]]], ['T5', 'VALUE', [[86, 90]]], ['T6', 'PK', [[31, 35]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R3', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T5']]], ['R5', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-573',
    collData,
    {
        text: "On a daily dosing regimen, skipped or missed doses can be replaced with minimal impact on plasma IgG levels: simulated steady-state concentration profiles showed that the influence of up to three consecutive skipped doses resulted in only a 4% reduction in average concentrations relative to consistent daily dosing (Fig. 3a, b).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-574',
    collData,
    {
        text: "The apparent average half-life in the ten volunteers (5 men and 5 women) is about 17 hours for secnidazole and 13 hours for tinidazole.",
        entities: [['T0', 'UNITS', [[85, 90]]], ['T1', 'VALUE', [[82, 84]]], ['T2', 'UNITS', [[114, 119]]], ['T3', 'VALUE', [[111, 113]]], ['T4', 'PK', [[4, 30]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-575',
    collData,
    {
        text: "Pharmacodynamic bioequivalence for WBC and ANC between AVI-014 and filgrastim was met, as 90% confidence intervals for the point estimate of the geometric mean ratios of AUC and Cmax lay within the a priori 0.5–2.0 bounds.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-576',
    collData,
    {
        text: "Peak triamcinolone concentrations (Cmax) of 5.4 ng/mL (median value) were detected within 22.1 hours (Tmax) of administration (Table 1).",
        entities: [['T0', 'UNITS', [[48, 53]]], ['T1', 'VALUE', [[44, 47]]], ['T2', 'PK', [[0, 40]]], ['T3', 'PK', [[102, 106]]], ['T4', 'VALUE', [[90, 94]]], ['T5', 'UNITS', [[95, 100]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-577',
    collData,
    {
        text: "For the parent drug, risperidone, the 90% CIs of the relative values (test vs. reference) of the Cmax, AUC from time zero to time t (AUCt), and AUC from time zero to infinity (AUC∞) were 97.0–124.0%, 92.7–115.1%, and 92.8–114.2%, respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-578',
    collData,
    {
        text: "By contrast, RT at 2 Gy increased drug clearances of 5-FU by 28.2% when compared with those of non-RT controls.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-579',
    collData,
    {
        text: "The AUC ratios of buprenorphine glucuronide to BUP, indicative of UGT activity, were 0.71, 2.07, and 0.3 at first/second trimesters, third trimester, and postpartum, respectively.",
        entities: [['T0', 'PK', [[4, 14]]], ['T1', 'VALUE', [[85, 89]]], ['T2', 'VALUE', [[91, 95]]], ['T3', 'VALUE', [[101, 104]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-580',
    collData,
    {
        text: "Further analysis indicated that the ratio of geometric mean Cmax, C24 h, AUC0–24 h (Day 7/Day 1) and the corresponding 95% confidence interval were 0·76 (0·61–0·95), 0·91 (0·78–1·06) and 1·04 (0·97–1·11), suggesting no apparent accumulation in the body when steady state was reached following once-daily administration of levofloxacin for 7 days.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-581',
    collData,
    {
        text: "The results were compared to that of standard oral solution, which showed average Cmax 42.2 ng/ml, 39.98 ng/ml and 44.38 ng/ml in A, B and C respectively and the average t½ about 2.5hr.",
        entities: [['T0', 'PK', [[82, 86]]], ['T1', 'VALUE', [[87, 91]]], ['T2', 'VALUE', [[99, 104]]], ['T3', 'VALUE', [[115, 120]]], ['T4', 'UNITS', [[92, 97]]], ['T5', 'UNITS', [[105, 110]]], ['T6', 'UNITS', [[121, 126]]], ['T7', 'UNITS', [[182, 184]]], ['T8', 'VALUE', [[179, 182]]], ['T9', 'PK', [[170, 172]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T2']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T3']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T8']]], ['R7', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T8']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-582',
    collData,
    {
        text: "Following intramuscular administration some pharmacokinetic differences were recorded between the cephalexin preparations: lysine cephalexin was more rapidly eliminated (t1/2kel = 55.2 min) than sodium cephalexin (t1/2kel = 89.8 min), although the peak blood level was higher and attained after a longer time with lysine cephalexin.",
        entities: [['T0', 'PK', [[170, 177]]], ['T1', 'VALUE', [[180, 184]]], ['T2', 'PK', [[214, 221]]], ['T3', 'VALUE', [[224, 228]]], ['T4', 'UNITS', [[185, 188]]], ['T5', 'UNITS', [[229, 232]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-583',
    collData,
    {
        text: "The PK profile of rVWF was not influenced by rFVIII (mean VWF:RCo terminal half-life: 21.9 hours for rVWF and 19.6 hours for rVWF:rFVIII).",
        entities: [['T0', 'UNITS', [[91, 96]]], ['T1', 'VALUE', [[86, 90]]], ['T2', 'UNITS', [[115, 120]]], ['T3', 'VALUE', [[110, 114]]], ['T4', 'PK', [[66, 84]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-584',
    collData,
    {
        text: "AUC0–24h for IV and SC palonosetron were respectively 14.1 and 12.7 ng × h/ml (p = 0.160).",
        entities: [['T0', 'UNITS', [[68, 77]]], ['T1', 'VALUE', [[63, 67]]], ['T2', 'VALUE', [[54, 58]]], ['T3', 'PK', [[0, 8]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-585',
    collData,
    {
        text: "Dermorphin rapidly disappeared from plasma (half-life: 1.3 min).",
        entities: [['T0', 'UNITS', [[59, 62]]], ['T1', 'VALUE', [[55, 58]]], ['T2', 'PK', [[44, 53]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-586',
    collData,
    {
        text: "The plasma metformin concentrations of the groups, over 24 hours post 500 mg dose, were not significantly different, with median AUC0–24 16.9 and 13.9 mg/L*h in the tolerant and intolerant cohorts, respectively (P = .72), as shown in Figure 2.",
        entities: [['T0', 'UNITS', [[151, 157]]], ['T1', 'VALUE', [[146, 150]]], ['T2', 'VALUE', [[137, 141]]], ['T3', 'PK', [[129, 136]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-587',
    collData,
    {
        text: "Subcutaneous gantenerumab injections at speeds of 5 and 15 s were well tolerated in healthy volunteers and could enable at-home administration by patients with AD or their caregivers.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-588',
    collData,
    {
        text: "The mean residence time (MRT) was (4.99 ± 0.84) hours.",
        entities: [['T0', 'PK', [[4, 29]]], ['T1', 'VALUE', [[35, 39]]], ['T2', 'UNITS', [[48, 53]]], ['T3', 'VALUE', [[42, 46]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-589',
    collData,
    {
        text: "The results showed a statistically significant median reduction of 2944% in the quinidine total apparent oral clearance, partial clearances by 3-hydroxylation and N-oxidation and residual clearance during fluvoxamine treatment.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-590',
    collData,
    {
        text: "Besides signifying clarity of the formulation, a percentage transmittance closer to 100% also implied that the size of the globules approximated the nanometric range, which in turn indicated that the formula had a large surface area for drug release, high capacity to undergo enhanced absorption in biological matrix and thus had the ability for increased oral bioavailability [56].",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-591',
    collData,
    {
        text: "Plasma concentration versus time data demonstrated biexponential decay; mean steady-state terminal half-life was 7 h. Concentrations of inactive metabolites 4′-DMHHT and cephalotaxine were approximately 10 % of omacetaxine and undetectable in most patients, respectively.",
        entities: [['T0', 'UNITS', [[115, 116]]], ['T1', 'VALUE', [[113, 114]]], ['T2', 'PK', [[77, 108]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-592',
    collData,
    {
        text: "MRT0→∞ and t1/2 values suggested that the 12 alkaloids were not eliminated rapidly in vivo, which indicated that absorptions were the major obstacle to their systemic exposure level.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-593',
    collData,
    {
        text: "Maximum plasma concentration (C(max)) and area under the plasma-concentration curve (AUC) values were derived after administration of single doses (60 mg) of test product and reference product, both approved for once-a-day administration, to 24 healthy male volunteers either after an overnight fast or immediately after a high-fat American breakfast.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-594',
    collData,
    {
        text: "The blood EVL concentration – time profiles after oral administration of EVL alone and coadministrations with 50 or 100 mg/kg of curcumin are shown in Figure 1.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-595',
    collData,
    {
        text: "This result is consistent with the poor precision of the estimation of BSV on V (large CI including 0) and the large eta‐shrinkage (62.3%) reflecting the poor degree of information available to estimate the random effect independently.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-596',
    collData,
    {
        text: "The typical values of oral clearance were 10.2 L/h, 7.33 L/h, and 2.38 L/h and simulation results suggested that the optimal daily oral doses are 550 mg, 350 mg, and 100 mg for the GG, GT, and TT populations, respectively.",
        entities: [['T0', 'UNITS', [[47, 50]]], ['T1', 'VALUE', [[42, 46]]], ['T2', 'UNITS', [[57, 60]]], ['T3', 'VALUE', [[52, 56]]], ['T4', 'UNITS', [[71, 74]]], ['T5', 'VALUE', [[66, 70]]], ['T6', 'PK', [[22, 36]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R3', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T3']]], ['R5', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-597',
    collData,
    {
        text: "The mean half-life (T½) for garenoxacin appeared to be independent of dose (13.9 ± 2.2hr and 13.7 ± 1.9 hr at the 200 and 400 mg dose).",
        entities: [['T0', 'UNITS', [[104, 106]]], ['T1', 'VALUE', [[93, 97]]], ['T2', 'UNITS', [[86, 88]]], ['T3', 'VALUE', [[76, 80]]], ['T4', 'PK', [[9, 23]]], ['T5', 'VALUE', [[83, 86]]], ['T6', 'VALUE', [[100, 103]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T3']]], ['R5', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T5']]], ['R6', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T1']]], ['R7', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-598',
    collData,
    {
        text: "Similarly, exposure based on the observed Cmax was 19% greater in the lenvatinib plus ketoconazole treatment.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-599',
    collData,
    {
        text: "The pharmacokinetic parameters and relative bioavailability of orally administrated silymarin pure (SP), silymarin-Gelucire 44/14 SD (GL) capsules were assessed and compared to that of Hepaticum (silybin-cyclodextrin) capsules (CP) as a reference standard (RF) using New Zealand albino rabbits.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-600',
    collData,
    {
        text: "(6) Clearance rate constants of 4-hydroxy-TEMPO and 3-carbamoyl-PROXYL, that were estimated by X- and L-band ESR for the collected blood of mice and rats, were found to be remarkably smaller than those in whole living animals observed by in vivo L-band ESR method.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-601',
    collData,
    {
        text: "AUC0–7 was more than dose proportional to MEDI-546 dose from 0.3 to 1.0 mg/kg/week, and proportional from 1.0 to 5.0 mg/kg/week (Figure 2B, Table 3).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-602',
    collData,
    {
        text: "However, 1 and 2 mg/kg treated rats were significantly more active than VEH at both the 15 min testing-onset, minimum t(11) = 2.98, p = 0.00 (Figure 4A), and at the 60 min testing-onset after 1 mg/kg (bins 4–6: minimum t(18) = 2.54, p = 0.02), and after 2 mg/kg (bins 2–5: minimum t(18) = 2.11, p = 0.05 (Figure 4B).",
        entities: [['T0', 'PK', [[110, 123]]], ['T1', 'VALUE', [[126, 130]]], ['T2', 'PK', [[211, 224]]], ['T3', 'VALUE', [[227, 231]]], ['T4', 'PK', [[273, 286]]], ['T5', 'VALUE', [[289, 293]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-603',
    collData,
    {
        text: "Similarly, in case of the ABCC3 rs4793665 (0.48) and GGH rs3758149 (0.41) SNPs, the influence on the area under the curve could also be demonstrated using multivariate analysis.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-604',
    collData,
    {
        text: "RIF had no effect on PK of temsirolimus in healthy volunteers, but resulted in a decrease of Cmax by 36%, and did reduce the sirolimus AUC by 65% and Cmax by 56% [69].",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-605',
    collData,
    {
        text: "Following univariate logistic regression of PK parameters, mean individual predicted efavirenz logCL/F (odds ratio (OR) (95% CI): 0.037 (0.005–0.303), P = 0.002), logAUC0–24 (OR (95% CI): 17.56 (1.61–192.95), P = 0.019), logC24 (OR (95% CI): 7.53 (2.04–27.75), P = 0.002), and logC12 (OR (95% CI): 21.01 (2.94‐150.11), P = 0.002) were associated with pVL <200 copies/mL at 48 weeks, although confidence intervals (CIs) were generally wide.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-606',
    collData,
    {
        text: "The blood-circulation time of PLA-TPGS nanoparticles was significantly extended compared to that of Taxotere, with a 13.2-fold longer half-life (t½), 8.51-fold higher mean residence time (MRT), 2.23-fold higher area under the curve (AUC0–72), and substantially lower values of clearance (41.9%).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-607',
    collData,
    {
        text: "The correlation enabled the formulation of an equation by which effective renal plasma flow (ERPF) could be established from 99Tcm-EC clearance: ERPFOIH = 1.245 x ClEC + 51.52.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-608',
    collData,
    {
        text: "The CL/F of evacetrapib increased with dose, with estimated population values of 13.1, 17.0, and 25.4 l/hour at doses of 30, 100, and 500 mg, respectively (Supplementary Figure S3).",
        entities: [['T0', 'UNITS', [[102, 108]]], ['T1', 'VALUE', [[97, 101]]], ['T2', 'VALUE', [[87, 91]]], ['T3', 'VALUE', [[81, 85]]], ['T4', 'PK', [[4, 8]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T2']]], ['R5', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-609',
    collData,
    {
        text: "Co-administration of GHB (600 mg/kg iv) and L: -lactate (330 mg/kg iv bolus plus 121 mg/kg/h iv infusion), a known inhibitor of MCTs, resulted in a significant decrease in GHB plasma AUC and an increase in time-averaged renal clearance, consistent with the model simulations.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-610',
    collData,
    {
        text: "The 0.40-mg/kg PQ dose was associated with a higher AUC and Cmax compared to the 0.25-mg/kg dose (Table 3), although there was substantial variation within each study arm: Cmax estimates included values that were 6 to 10 times higher than the lowest model-derived Cmax in each study arm; a similar pattern was observed for the AUC.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-611',
    collData,
    {
        text: "In patients with 15-30 μg/ml of maximal Cmin during therapy, nephrotoxicity occurred in 13.1 %, and hepatotoxicity in 2.6 %, and these incidences were not significantly higher compared with those patients with <15 μg/ml.",
        entities: [['T0', 'PK', [[32, 44]]], ['T1', 'RANGE', [[17, 22]]], ['T2', 'UNITS', [[23, 28]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-612',
    collData,
    {
        text: "The regression equation of HI3h was the best to estimate AUCOPZ/AUC5OH-OPZ (AUCOPZ/AUC5OH-OPZ = 1.37 * HI3h + 0.18 * Age - 7.83, r2 = 0.883, p < 0.001).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-613',
    collData,
    {
        text: "The mean AUCGIR,0–24h,SD for IDegAsp was similar for elderly and younger adult subjects (mean ratio elderly/younger adults 1.01, 95 % confidence interval [CI] 0.69–1.47).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-614',
    collData,
    {
        text: "The volumes of distribution at steady state, calculated by model-dependent and -independent methods, compared very well with each other and were 6.5 L or 58% of body weight.",
        entities: [['T0', 'PK', [[4, 43]]], ['T1', 'VALUE', [[145, 148]]], ['T2', 'UNITS', [[149, 150]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-615',
    collData,
    {
        text: "The relative bioavailability of enteric-coated sodium fluoride (NaF) tablets (10 mg F-) has been assessed following administration with a standard calcium-rich breakfast or calcium-poor lunch, and 2 h before or simultaneously with antacid administration (2.4 g aluminum-magnesium hydroxide), versus intake on an empty stomach.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-616',
    collData,
    {
        text: "This investigation was carried out to evaluate the bioavailability of the generic product of digoxin 0.25 mg (cardixin) relative to a reference product, lanoxin (0.25 mg) tablets.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-617',
    collData,
    {
        text: "AUC0–t (area under the curve from 0 h to the time point of the last quantifiable concentration) was calculated according to the log linear trapezoidal method, μg mL−1;",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-618',
    collData,
    {
        text: "The linear regression equation was A = 0.233×d –1.33, r = 0.98, where d corresponded to the dose and A refered to the AUC0-24 of three dose groups of zaltoprofen.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-619',
    collData,
    {
        text: "Pharmacokinetic study performed in rabbit model showed that the relative oral bioavailability of MT after administration of oral solution, sustain release and optimized formulation was 51%, 67% and 87%, respectively.",
        entities: [['T0', 'UNITS', [[200, 201]]], ['T1', 'VALUE', [[198, 200]]], ['T2', 'UNITS', [[192, 193]]], ['T3', 'VALUE', [[190, 192]]], ['T4', 'UNITS', [[187, 188]]], ['T5', 'VALUE', [[185, 187]]], ['T6', 'PK', [[64, 93]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R3', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T5']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T3']]], ['R5', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-620',
    collData,
    {
        text: "This increase in exposure was observed in all subjects, with parameter ratios for AUCt and Cmax ranging from 1.03 to 5.35 %.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-621',
    collData,
    {
        text: "Based on plasma TCA concentrations in our patient, we calculated a terminal half-life of TCA of 33 days as opposed to 5 days observed after intra-articular administration of a therapeutic dose of 40 mg TCA.",
        entities: [['T0', 'UNITS', [[99, 103]]], ['T1', 'VALUE', [[96, 98]]], ['T2', 'UNITS', [[120, 124]]], ['T3', 'VALUE', [[118, 119]]], ['T4', 'PK', [[67, 85]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-622',
    collData,
    {
        text: "Elimination half-life was similar for the two populations (3.5 +- 0.9 hr in obese subjects vs 3.1 +- 0.9 hr in controls).",
        entities: [['T0', 'PK', [[0, 21]]], ['T1', 'VALUE', [[59, 62]]], ['T2', 'VALUE', [[94, 97]]], ['T3', 'VALUE', [[101, 104]]], ['T4', 'UNITS', [[105, 107]]], ['T5', 'VALUE', [[66, 69]]], ['T6', 'UNITS', [[70, 72]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T2']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-623',
    collData,
    {
        text: "However, lower peak concentrations were seen after the first dose, which suggested the need for a 1500 mg loading dose in order to achieve a rapid onset of maximum therapeutic efficacy (Fig. 4).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-624',
    collData,
    {
        text: "The aim of this study was to explore the bioavailability and stability of synthesized anserine by (1) performing in vitro stability experiments in human plasma and molecular modelling studies and by (2) evaluating the plasma and urinary pharmacokinetic profile in healthy volunteers following different doses of anserine (4-10-20 mg/kg body weight).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-625',
    collData,
    {
        text: "The pharmacokinetic parameter estimates for terminal half-life (1.54 +- 0.17 h [mean +- the standard deviation]) and volume of distribution (0.20 +- 0.02 liters/kg in patients with CF patients were not different from those in healthy subjects.",
        entities: [['T0', 'PK', [[44, 62]]], ['T1', 'VALUE', [[64, 68]]], ['T2', 'PK', [[117, 139]]], ['T3', 'VALUE', [[141, 145]]], ['T4', 'VALUE', [[72, 76]]], ['T5', 'UNITS', [[77, 78]]], ['T6', 'VALUE', [[149, 153]]], ['T7', 'UNITS', [[154, 163]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T3']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-626',
    collData,
    {
        text: "Analysis of colon tissue after oral dosing with 1 and 10 mg/kg indicated high peak concentrations (10 and 100 µg/g, respectively) that scale in a dose-proportional manner.",
        entities: [['T0', 'PK', [[78, 97]]], ['T1', 'VALUE', [[99, 101]]], ['T2', 'VALUE', [[106, 109]]], ['T3', 'UNITS', [[110, 114]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-627',
    collData,
    {
        text: "The GMR of AUCτ on Day 10 to AUC∞ on Day 1 was 1.28 (90 % CI 1.08–1.52) in the 100 mg group and 1.18 (90 % CI 0.99–1.40) in the 200 mg group.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-628',
    collData,
    {
        text: "The dose-limiting toxicities were found to be neutropenia, stomatitis and palmar plantar syndrome and the maximum tolerated dose was defined as; carboplatin AUC 5, paclitaxel 175 mg m−2 and doxil 30 mg m−2 q 21.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-629',
    collData,
    {
        text: "Pharmacokinetic analysis showed early absorption with a half-life of 9 hours.",
        entities: [['T0', 'PK', [[56, 65]]], ['T1', 'VALUE', [[69, 70]]], ['T2', 'UNITS', [[71, 76]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-630',
    collData,
    {
        text: "As a result of clearance from the blood pool, the ratio of SUVmax of AAT foci to blood pool increased over time to 120 min: 2.6 (range 1.5–3.9) at 60 min and 3.4 (range 2.0–6.3) at 120 min (p = 0.005).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-631',
    collData,
    {
        text: "AUC comparisons from 0-24 hr after administration indicated that 13-cis-RA treatment resulted in primarily cis metabolites and all-trans-RA treatment resulted in primarily trans metabolites, although low levels of isomerization products were observed.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-632',
    collData,
    {
        text: "The occurrence of racemization required the calculation of the pharmacokinetic parameters as enantiomeric mixtures of lorazepam (t(1/2a) 3.5h; K(a) 0.198 ngh(-1); t(1/2) 11.5h; beta 0.060 h(-1); AUC(0-infinity) 192.1ngh/ml; CLt/f 2.41ml/minkg; Vd/f 173.5l; Fel 0.41%, and Cl(R) 0.0099 ml/minkg) and its metabolite lorazepam-glucuronide (t(1/2f) 1.2h; K(f) 0.578 h(-1); t(1/2) 16.6h; beta 0.042 h(-1); AUC(0-infinity) 207.6 ngh/ml; Fel 51.80%, and Cl(R) 98.32 ml/minkg).",
        entities: [['T0', 'PK', [[129, 136]]], ['T1', 'VALUE', [[137, 140]]], ['T2', 'PK', [[143, 147]]], ['T3', 'VALUE', [[148, 153]]], ['T4', 'PK', [[163, 169]]], ['T5', 'VALUE', [[170, 174]]], ['T6', 'PK', [[177, 181]]], ['T7', 'VALUE', [[182, 187]]], ['T8', 'PK', [[195, 210]]], ['T9', 'VALUE', [[211, 216]]], ['T10', 'PK', [[224, 229]]], ['T11', 'VALUE', [[230, 234]]], ['T12', 'PK', [[244, 248]]], ['T13', 'VALUE', [[249, 254]]], ['T14', 'PK', [[272, 277]]], ['T15', 'VALUE', [[278, 284]]], ['T16', 'PK', [[337, 344]]], ['T17', 'VALUE', [[345, 348]]], ['T18', 'PK', [[351, 355]]], ['T19', 'VALUE', [[356, 361]]], ['T20', 'PK', [[369, 375]]], ['T21', 'VALUE', [[376, 380]]], ['T22', 'PK', [[401, 416]]], ['T23', 'VALUE', [[417, 422]]], ['T24', 'PK', [[447, 452]]], ['T25', 'VALUE', [[453, 458]]], ['T26', 'PK', [[383, 387]]], ['T27', 'VALUE', [[388, 393]]], ['T28', 'UNITS', [[140, 141]]], ['T29', 'UNITS', [[154, 161]]], ['T30', 'UNITS', [[174, 175]]], ['T31', 'UNITS', [[188, 193]]], ['T32', 'UNITS', [[216, 222]]], ['T33', 'UNITS', [[234, 242]]], ['T34', 'UNITS', [[254, 255]]], ['T35', 'UNITS', [[285, 293]]], ['T36', 'UNITS', [[348, 349]]], ['T37', 'UNITS', [[362, 367]]], ['T38', 'UNITS', [[380, 381]]], ['T39', 'UNITS', [[394, 399]]], ['T40', 'UNITS', [[423, 429]]], ['T41', 'UNITS', [[459, 467]]], ['T42', 'UNITS', [[265, 266]]], ['T43', 'VALUE', [[261, 265]]], ['T44', 'PK', [[257, 260]]], ['T45', 'UNITS', [[440, 441]]], ['T46', 'VALUE', [[435, 440]]], ['T47', 'PK', [[431, 434]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R3', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R4', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T9']]], ['R5', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T11']]], ['R6', 'C_VAL', [['Entity', 'T12'], ['C_VAL', 'T13']]], ['R7', 'C_VAL', [['Entity', 'T14'], ['C_VAL', 'T15']]], ['R8', 'C_VAL', [['Entity', 'T16'], ['C_VAL', 'T17']]], ['R9', 'C_VAL', [['Entity', 'T18'], ['C_VAL', 'T19']]], ['R10', 'C_VAL', [['Entity', 'T20'], ['C_VAL', 'T21']]], ['R11', 'C_VAL', [['Entity', 'T22'], ['C_VAL', 'T23']]], ['R12', 'C_VAL', [['Entity', 'T24'], ['C_VAL', 'T25']]], ['R13', 'C_VAL', [['Entity', 'T26'], ['C_VAL', 'T27']]], ['R14', 'RELATED', [['Entity', 'T28'], ['RELATED', 'T1']]], ['R15', 'RELATED', [['Entity', 'T29'], ['RELATED', 'T3']]], ['R16', 'RELATED', [['Entity', 'T30'], ['RELATED', 'T5']]], ['R17', 'RELATED', [['Entity', 'T31'], ['RELATED', 'T7']]], ['R18', 'RELATED', [['Entity', 'T32'], ['RELATED', 'T9']]], ['R19', 'RELATED', [['Entity', 'T33'], ['RELATED', 'T11']]], ['R20', 'RELATED', [['Entity', 'T34'], ['RELATED', 'T13']]], ['R21', 'RELATED', [['Entity', 'T35'], ['RELATED', 'T15']]], ['R22', 'RELATED', [['Entity', 'T36'], ['RELATED', 'T17']]], ['R23', 'RELATED', [['Entity', 'T37'], ['RELATED', 'T19']]], ['R24', 'RELATED', [['Entity', 'T38'], ['RELATED', 'T21']]], ['R25', 'RELATED', [['Entity', 'T39'], ['RELATED', 'T27']]], ['R26', 'RELATED', [['Entity', 'T40'], ['RELATED', 'T23']]], ['R27', 'RELATED', [['Entity', 'T41'], ['RELATED', 'T25']]], ['R28', 'RELATED', [['Entity', 'T42'], ['RELATED', 'T43']]], ['R29', 'C_VAL', [['Entity', 'T44'], ['C_VAL', 'T43']]], ['R30', 'RELATED', [['Entity', 'T45'], ['RELATED', 'T46']]], ['R31', 'C_VAL', [['Entity', 'T47'], ['C_VAL', 'T46']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-633',
    collData,
    {
        text: "The GMRs (90% CI) for maximum concentration and area under the concentration-time curve of raltegravir with vs without HCV therapy were 0.68 (0.38-1.19) and 0.82 (0.58-1.17), respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-634',
    collData,
    {
        text: "Elimination was triphasic, comprising two rapid early phases and a long terminal half-life (mean, 14.1 +- 7.8 h).",
        entities: [['T0', 'PK', [[72, 90]]], ['T1', 'VALUE', [[98, 102]]], ['T2', 'VALUE', [[106, 109]]], ['T3', 'UNITS', [[110, 111]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-635',
    collData,
    {
        text: "The intrinsic dissolution rate experiments indicated that the rate of dissolution of olanzapine pamoate in plasma (0.73 mg/hr·cm2) was approximately 6 times higher than in the phosphate buffer (pH 7.46 = 0.12 mg/hr·cm2).",
        entities: [['T0', 'PK', [[62, 81]]], ['T1', 'VALUE', [[115, 119]]], ['T2', 'VALUE', [[204, 208]]], ['T3', 'UNITS', [[209, 218]]], ['T4', 'UNITS', [[120, 129]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-636',
    collData,
    {
        text: "Mean systemic clearance (CL(S)) and elimination half-life (t(1/2)) of cefepime were 35.9 +- 6.0 ml/min and 12.9 +- 2.6 h during CVVH versus 46.8 +- 12.4 ml/min and 8.6 +- 1.4 h during CVVHDF, respectively.",
        entities: [['T0', 'PK', [[5, 31]]], ['T1', 'VALUE', [[84, 88]]], ['T2', 'VALUE', [[140, 144]]], ['T3', 'PK', [[36, 66]]], ['T4', 'VALUE', [[107, 111]]], ['T5', 'VALUE', [[164, 167]]], ['T6', 'VALUE', [[92, 95]]], ['T7', 'UNITS', [[96, 102]]], ['T8', 'VALUE', [[115, 118]]], ['T9', 'UNITS', [[119, 120]]], ['T10', 'VALUE', [[148, 152]]], ['T11', 'UNITS', [[153, 159]]], ['T12', 'VALUE', [[171, 174]]], ['T13', 'UNITS', [[175, 176]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T5']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T4']]], ['R7', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]], ['R8', 'D_VAL', [['Entity', 'T10'], ['D_VAL', 'T2']]], ['R9', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T10']]], ['R10', 'D_VAL', [['Entity', 'T12'], ['D_VAL', 'T5']]], ['R11', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T12']]], ['R12', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T1']]], ['R13', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T4']]], ['R14', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T2']]], ['R15', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-637',
    collData,
    {
        text: "The C-P score did not correlate with AUC0-24 (r = 0.03; P = 0.84), CL (r = -0.07; P = 0.68), or V1 (r = 0.19; P = 0.26), but there was a bilirubin-driven negative correlation with the elimination rate constant (r = -0.46; P = 0.004).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-638',
    collData,
    {
        text: "The average plasma clearance of TLI into the waste fluid was 2.4 +- 1.6 ml/min whereas TLE was below the measurable sensitivity.",
        entities: [['T0', 'PK', [[12, 28]]], ['T1', 'VALUE', [[61, 64]]], ['T2', 'VALUE', [[68, 71]]], ['T3', 'UNITS', [[72, 78]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-639',
    collData,
    {
        text: "When the two drugs were analyzed in a joint model, their random BSV or BOV in bioavailability was found to be correlated (r = 0.677), and the inclusion of this improved the model (ΔOFV = 76.2).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-640',
    collData,
    {
        text: "The half-life of the parent compound was prolonged after intragastric administration of prodrug 3, which was found to be a superior prodrug candidate for increasing myocardial contractility.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-641',
    collData,
    {
        text: "The total body clearance was approximately 1.81 l/h/kg.",
        entities: [['T0', 'PK', [[4, 24]]], ['T1', 'VALUE', [[43, 47]]], ['T2', 'UNITS', [[48, 54]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-642',
    collData,
    {
        text: "DLT criteria as defined per protocol prior to the study were not met with carboplatin AUC 2 in combination with FDR gemcitabine 300-800 mg/m(2) because of myelosuppressive dose-holds (especially thrombocytopenia and neutropenia).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-643',
    collData,
    {
        text: "Plasma 20:5n-3 and 22:5n-3 were lower in AD subjects, compared with controls (20:5n-3: -50%, 22:5n-3: -34%).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-644',
    collData,
    {
        text: "The flow rate was 0.3 mL/min.",
        entities: [['T0', 'UNITS', [[22, 28]]], ['T1', 'VALUE', [[18, 21]]], ['T2', 'PK', [[4, 13]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-645',
    collData,
    {
        text: "Digoxin AUC and Cmax increased by 30% and 32%, respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-646',
    collData,
    {
        text: "The nanoparticles (diamater < 100 nm) with relative high bioavailability were prepared using solvent-nonsolvent method.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-647',
    collData,
    {
        text: "The steady-state pharmacokinetic profiles of venlafaxine and O-desmethylvenlafaxine were evaluated during a 24-hour period after 5 days of treatment with venlafaxine (50 mg three times a day) and during a second 24-hour period after 5 days of combination treatment with venlafaxine (50 mg three times a day) and cimetidine (800 mg once a day).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-648',
    collData,
    {
        text: "Antiviral activity was greatest in the two groups that received a loading dose--viral clearance was accelerated (P≤0.05), and the AUC for viral load decreased by 85 to 88% as compared with the placebo group.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-649',
    collData,
    {
        text: "Praziquantel was found after half an hour post injection, and after 1 h, its maximum concentration was noticed.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-650',
    collData,
    {
        text: "The difference was greatest in P-gp-overexpressing P388/DOX cells, the DOX area under the curve being approximately seven times greater after PSC 833 and DOX than after DOX alone.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-651',
    collData,
    {
        text: "The Cmax and AUCall of memantine in the test and reference products were similar, with mean (SD) values of 27.7 (3.94) ng/mL and 1890 (266) ng h/mL, and 28.5 (3.70) ng/mL and 1880 (271) ng h/mL, respectively.",
        entities: [['T0', 'PK', [[4, 8]]], ['T1', 'VALUE', [[107, 111]]], ['T2', 'VALUE', [[153, 157]]], ['T3', 'PK', [[13, 19]]], ['T4', 'VALUE', [[129, 133]]], ['T5', 'VALUE', [[175, 179]]], ['T6', 'UNITS', [[119, 124]]], ['T7', 'UNITS', [[140, 147]]], ['T8', 'UNITS', [[165, 170]]], ['T9', 'UNITS', [[186, 193]]], ['T10', 'VALUE', [[113, 117]]], ['T11', 'VALUE', [[135, 138]]], ['T12', 'VALUE', [[159, 163]]], ['T13', 'VALUE', [[181, 184]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T5']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T1']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T4']]], ['R6', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T5']]], ['R8', 'D_VAL', [['Entity', 'T10'], ['D_VAL', 'T1']]], ['R9', 'D_VAL', [['Entity', 'T11'], ['D_VAL', 'T4']]], ['R10', 'D_VAL', [['Entity', 'T12'], ['D_VAL', 'T2']]], ['R11', 'D_VAL', [['Entity', 'T13'], ['D_VAL', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-652',
    collData,
    {
        text: "After intravenous administration, total body clearance of vincamine was equal for both dosage forms, but a longer half-life (X 2) and larger distribution volume (X 2) were observed with the suspension of nanoparticles.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-653',
    collData,
    {
        text: "The AUC0–t value for fucoxanthin was much lower than that for metabolite fucoxanthinol (191.1 and 5017.6 μg·h/L, respectively), indicating that fucoxanthinol was absorbed more easily than fucoxanthin in rats and supported the earlier conclusion from i.v. studies that fucoxanthinol appeared to play an important pharmacological role.",
        entities: [['T0', 'PK', [[4, 10]]], ['T1', 'VALUE', [[88, 93]]], ['T2', 'VALUE', [[98, 104]]], ['T3', 'UNITS', [[105, 111]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-654',
    collData,
    {
        text: "The IC50 values calculated from the dose response curves were in the range of 0.041–0.064 µM against 3D7 and 0.047–0.122 µM against D10.",
        entities: [['T0', 'UNITS', [[90, 92]]], ['T1', 'RANGE', [[78, 89]]], ['T2', 'UNITS', [[121, 123]]], ['T3', 'RANGE', [[109, 120]]], ['T4', 'PK', [[4, 8]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-655',
    collData,
    {
        text: "However, in terms of dose‐adjusted AUC, the three administrations (2 mg i.m., 2 × 2 mg i.n., 4 mg i.n.) were roughly equivalent.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-656',
    collData,
    {
        text: "Estimates of net changes in total body iron suggested that the overall bioavailability of carbonyl iron was high, about 70% that of ferrous sulfate.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-657',
    collData,
    {
        text: "The mean terminal half-life (T1/2) was 8.4 ± 3.6 h, with no dependency to dose level.",
        entities: [['T0', 'PK', [[9, 34]]], ['T1', 'VALUE', [[39, 42]]], ['T2', 'UNITS', [[49, 50]]], ['T3', 'VALUE', [[45, 48]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-658',
    collData,
    {
        text: "In Fig 12, we show the dependency of the peak-above-baseline amplitude of the outflowing insulin concentration on the fraction of low-binding cells for all 4096 cases, i.e., for the full range of 0 ≤ ηl ≤ 1.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-659',
    collData,
    {
        text: "Differences remain significant after normalization of the ln-transformed PK parameters considering the individual weight and dose (p value Cmax 0.0019, AUC0–T 0.0002, and AUC0–∞ 0.0002).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-660',
    collData,
    {
        text: "Median maximum plasma concentrations of quercetin (431 nmol/L) were observed 360 min after intake of 150 mg quercetin.",
        entities: [['T0', 'PK', [[7, 36]]], ['T1', 'VALUE', [[51, 54]]], ['T2', 'UNITS', [[55, 61]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-661',
    collData,
    {
        text: "In step 1 of covariate selection, BSA, height, weight, sex, breast cancer tumor type, ALT ratio, and inducers were all significant covariates for CL, and BSA, weight, Caucasian race, and gastrointestinal tumor type were all significant covariates for V1.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-662',
    collData,
    {
        text: "The aim of this study was to compare the bioavailability of 2 sublingual formulations of ketorolac 30-mg tablets in healthy Mexican adult volunteers.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-663',
    collData,
    {
        text: "However, the eRPF (PAH clearance) was significantly higher at 4 weeks and 6–7 months of age.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-664',
    collData,
    {
        text: "Post-treatment washout of posaconazole was slow in normals (mean half-life 31 hours), and further prolonged in obese subjects (53 hours).",
        entities: [['T0', 'UNITS', [[78, 83]]], ['T1', 'VALUE', [[75, 77]]], ['T2', 'PK', [[65, 74]]], ['T3', 'UNITS', [[130, 135]]], ['T4', 'VALUE', [[127, 129]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-665',
    collData,
    {
        text: "The peak concentration of carboxyprimaquine was 0.50 +- 0.08 microgram/ml at 1.67 +- 0.15 h after IV administration.",
        entities: [['T0', 'PK', [[4, 22]]], ['T1', 'VALUE', [[48, 52]]], ['T2', 'VALUE', [[56, 60]]], ['T3', 'UNITS', [[61, 73]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-666',
    collData,
    {
        text: "Both compounds proved orally bioavailable, affording plasma exposures above the half-maximal effective concentration (EC50) concentration for at least 12 hours.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-667',
    collData,
    {
        text: "The accepted target values of AUC/MIC and Cmax/MIC for quinolones are 125 and 10, respectively.",
        entities: [['T0', 'PK', [[30, 37]]], ['T1', 'VALUE', [[70, 73]]], ['T2', 'PK', [[42, 50]]], ['T3', 'VALUE', [[78, 80]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-668',
    collData,
    {
        text: "The disposition half-lives of loratadine in the distribution and elimination phases were 1.5 and 18.2 h, respectively.",
        entities: [['T0', 'UNITS', [[102, 103]]], ['T1', 'VALUE', [[97, 101]]], ['T2', 'VALUE', [[89, 92]]], ['T3', 'PK', [[4, 26]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-669',
    collData,
    {
        text: "The most labile prodrugs in dog intestinal homogenates, bis-(n-butyloxycarbonyloxymethyl) PMPA 5 and bis-(neo-pentyloxy-carbonyloxymethyl) PMPA 8 (t1/2 < 5 min) had the lowest oral bioavailabilities.",
        entities: [['T0', 'PK', [[147, 151]]], ['T1', 'VALUE', [[154, 155]]], ['T2', 'UNITS', [[156, 159]]], ['T3', 'COMPARE', [[152, 153]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-670',
    collData,
    {
        text: "The probability of exceeding the limits of acceptance for bioequivalence established by the US Food and Drug Administration (80%–125%) was obtained using two 1-sided t tests.15,16 The formulations were to be considered bioequivalent if calculations of a 90% CIs for the ratio of the means of the measures for the test and reference formulations fell within bioequivalence limits, 80% to 125%, for ln-transformation of Cmax AUC0–t, and AUC0–∞, and if 2 1-sided t tests showed P < 0.05.15,16",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-671',
    collData,
    {
        text: "In study 2, AR appeared in the plasma after 60 min, peaked at 180-240 min, and remained elevated after 960 min.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-672',
    collData,
    {
        text: "The highest Cmax and AUC values and the lowest clearance were achievedby 5 and 7.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-673',
    collData,
    {
        text: "The median tmax ranged from 1 to 4 hours for all doses.",
        entities: [['T0', 'UNITS', [[35, 40]]], ['T1', 'RANGE', [[28, 34]]], ['T2', 'PK', [[11, 15]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-674',
    collData,
    {
        text: "The linear regression slope (95% CI) was 1.07 (1.00–1.13), 1.05 (0.99–1.11), and 1.07 (1.01–1.13) for maximum plasma concentration (Cmax), area under the plasma drug concentration-time curve (AUC) from 0 to 24 h (AUC0–24), and AUC from 0 to infinity (AUC0–∞), respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-675',
    collData,
    {
        text: "The drug was rapidly distributed into the tissue compartment and was then eliminated from the body with a mean half-life t 1/2 beta of about 1 h (range 0.79-1.34 h).",
        entities: [['T0', 'UNITS', [[143, 144]]], ['T1', 'VALUE', [[141, 142]]], ['T2', 'PK', [[111, 131]]], ['T3', 'RANGE', [[152, 161]]], ['T4', 'UNITS', [[162, 163]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-676',
    collData,
    {
        text: "Thereby, to six kinds of the model compounds except disopyramide, the solubility was from 340 to 98,000 times that in water, and the AUCs in plasma concentration of the compound were equivalent to that of solution or O/W microemulsion administration, or was increased by 1.5 to 78 times that of suspension administration.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-677',
    collData,
    {
        text: "Plasma concentrations of 4PP declined slowly with a long terminal half-life (33.4 +- 17.1 h).",
        entities: [['T0', 'PK', [[57, 75]]], ['T1', 'VALUE', [[77, 81]]], ['T2', 'UNITS', [[90, 91]]], ['T3', 'VALUE', [[85, 89]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-678',
    collData,
    {
        text: "The typical value of the volume of the central compartment (V1) scaled to 70 kg was 52.0 L, whereas the volume of the peripheral compartment was slightly higher (V2 = 70.4 L).",
        entities: [['T0', 'UNITS', [[89, 90]]], ['T1', 'VALUE', [[84, 88]]], ['T2', 'PK', [[25, 63]]], ['T3', 'UNITS', [[172, 173]]], ['T4', 'VALUE', [[167, 171]]], ['T5', 'PK', [[162, 164]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-679',
    collData,
    {
        text: "Estrone and estrone sulfate maximum serum concentrations (Cmax) were significantly lower for the test product compared with the reference drug at both the 10-μg and the 25-μg doses (p < 0.05 for all comparisons; Table 2).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-680',
    collData,
    {
        text: "Area under the concentration-time curve, peak concentration (C(max)) and time to reach C(max) were 72,868.61 ng h/mL, 2133.93 ng/mL and 4.06 h for Mobic, and 78,352.52 ng h/mL, 2525.18 ng/mL and 3.61 h for Melocam.",
        entities: [['T0', 'UNITS', [[109, 116]]], ['T1', 'VALUE', [[99, 108]]], ['T2', 'UNITS', [[126, 131]]], ['T3', 'VALUE', [[118, 125]]], ['T4', 'UNITS', [[141, 142]]], ['T5', 'VALUE', [[136, 140]]], ['T6', 'UNITS', [[168, 175]]], ['T7', 'VALUE', [[158, 167]]], ['T8', 'UNITS', [[185, 190]]], ['T9', 'VALUE', [[177, 184]]], ['T10', 'UNITS', [[200, 201]]], ['T11', 'VALUE', [[195, 199]]], ['T12', 'PK', [[0, 39]]], ['T13', 'PK', [[41, 68]]], ['T14', 'PK', [[73, 93]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R3', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R4', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T9']]], ['R5', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T11']]], ['R6', 'C_VAL', [['Entity', 'T12'], ['C_VAL', 'T1']]], ['R7', 'C_VAL', [['Entity', 'T13'], ['C_VAL', 'T3']]], ['R8', 'C_VAL', [['Entity', 'T14'], ['C_VAL', 'T5']]], ['R9', 'C_VAL', [['Entity', 'T12'], ['C_VAL', 'T7']]], ['R10', 'C_VAL', [['Entity', 'T13'], ['C_VAL', 'T9']]], ['R11', 'C_VAL', [['Entity', 'T14'], ['C_VAL', 'T11']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-681',
    collData,
    {
        text: "The PPK analysis revealed that healthy participants and patients with MM have comparable CL/F and V2/F; however, V3/F in patients with MM was found to be 71.5 L, approximately 8-fold higher than was observed in healthy participants (8.45 L), and Q/F in patients with MM was 3.75 L/h, approximately 3.7-fold higher than observed in healthy participants (1.0 L/h).",
        entities: [['T0', 'UNITS', [[159, 160]]], ['T1', 'VALUE', [[154, 158]]], ['T2', 'UNITS', [[238, 239]]], ['T3', 'VALUE', [[233, 237]]], ['T4', 'UNITS', [[279, 282]]], ['T5', 'VALUE', [[274, 278]]], ['T6', 'UNITS', [[357, 360]]], ['T7', 'VALUE', [[353, 356]]], ['T8', 'PK', [[113, 117]]], ['T9', 'PK', [[246, 249]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R3', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R4', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T1']]], ['R5', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T3']]], ['R6', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T5']]], ['R7', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-682',
    collData,
    {
        text: "The areas under the plasma concentration-time curve (AUC) and the peak concentration of diltiazem were significantly increased (P < 0.05, 1.0 mg/kg) in the presence of lovastatin.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-683',
    collData,
    {
        text: "The median tmax for both the AAFP 500- and 625-mg doses (Table 3) compared with OAA was not statistically significant (AAFP 500 mg vs. OAA 1000 mg, P = 0.2301; AAFP 625 mg vs. OAA 1000 mg, P = 0.3041) as determined by the Wilcoxon signed rank test.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-684',
    collData,
    {
        text: "The CSF insulin profile was irregular with an early peak at 15 min, a Cmax of 17 μIU/ml (2.38 pmol/l) at 1 h, and clearance by 3 h. Insulin Cmax in cortex was substantially higher than in plasma at 53.0 μIU/ml (7.42 pmol/l) vs. 11.7 μIU/ml (1.64 pmol/l), respectively.",
        entities: [['T0', 'PK', [[70, 74]]], ['T1', 'VALUE', [[78, 80]]], ['T2', 'UNITS', [[81, 87]]], ['T3', 'PK', [[140, 144]]], ['T4', 'VALUE', [[198, 202]]], ['T5', 'UNITS', [[203, 209]]], ['T6', 'UNITS', [[233, 239]]], ['T7', 'VALUE', [[228, 232]]], ['T8', 'UNITS', [[246, 252]]], ['T9', 'VALUE', [[241, 245]]], ['T10', 'UNITS', [[94, 100]]], ['T11', 'VALUE', [[89, 93]]], ['T12', 'UNITS', [[216, 222]]], ['T13', 'VALUE', [[211, 215]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T9']]], ['R6', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T7']]], ['R7', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T9']]], ['R8', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T11']]], ['R9', 'RELATED', [['Entity', 'T12'], ['RELATED', 'T13']]], ['R10', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T13']]], ['R11', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T11']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-685',
    collData,
    {
        text: "To estimate k84 as transfer rate constant from gallbladder to the absorption compartment, the fraction of MPA that metabolised to MPAG was fixed to 85%20–22.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-686',
    collData,
    {
        text: "Although soybean milk isoflavones seem to be 85% degraded in the intestine, the bioavailability, especially of daidzein, may be sufficient to exert some health-protective effects.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-687',
    collData,
    {
        text: "In the metoprolol study, the 90% confidence intervals of Cmax and AUC(inf) were 98-118% and 92-115%, respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-688',
    collData,
    {
        text: "The contraction in volume of distribution and clearance diminished significantly after 48 hours of chronic quinine dosing in infected patients.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-689',
    collData,
    {
        text: "Fraction time above MIC (ft > MIC) for ceftriaxone free concentration over the first 24 hours was simulated for 50, 80, and 100 mg/kg once daily dosing (Figure3).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-690',
    collData,
    {
        text: "Half-life was 1.83 h for the kidney and 3.37 h for the spleen.",
        entities: [['T0', 'UNITS', [[19, 20]]], ['T1', 'VALUE', [[14, 18]]], ['T2', 'UNITS', [[45, 46]]], ['T3', 'VALUE', [[40, 44]]], ['T4', 'PK', [[0, 9]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-691',
    collData,
    {
        text: "According to the MMV (Medicines for Malaria Venture) compound progression criteria of August 2008 [14], a compound with oral bioavailability > 20% in rat after oral dosing is considered as a development candidate.",
        entities: [['T0', 'PK', [[120, 140]]], ['T1', 'VALUE', [[143, 145]]], ['T2', 'UNITS', [[145, 146]]], ['T3', 'COMPARE', [[141, 142]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-692',
    collData,
    {
        text: "Pharmacokinetic studies using LC-MS/MS analysis in male C57BL/6 mice showed that administration of NDAT improved the area under the drug concentration curve AUC(0–48 h) by 4-fold at a dose of 3 mg/kg when compared with DAT, and Cmax of NDAT (4363 ng/mL) was 8-fold greater than that of DAT (548 ng/mL).",
        entities: [['T0', 'UNITS', [[247, 252]]], ['T1', 'VALUE', [[242, 246]]], ['T2', 'PK', [[228, 232]]], ['T3', 'VALUE', [[291, 294]]], ['T4', 'UNITS', [[295, 300]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-693',
    collData,
    {
        text: "Previously published physiologically based pharmacokinetic (PBPK) models of tolbutamide are based on an assumption that its metabolic clearance is exclusively through CYP2C9; however, many studies indicate that CYP2C9 metabolism is only responsible for 80–90% of the total clearance.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-694',
    collData,
    {
        text: "Values determined for T(max) (0.25-1.0 h) and T(1/2) (3.8-6.4 h) of garenoxacin in plasma did not vary with dose or study day.",
        entities: [['T0', 'UNITS', [[39, 40]]], ['T1', 'RANGE', [[30, 38]]], ['T2', 'PK', [[22, 28]]], ['T3', 'PK', [[46, 52]]], ['T4', 'RANGE', [[54, 61]]], ['T5', 'UNITS', [[62, 63]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-695',
    collData,
    {
        text: "The 90% confidence intervals for the least squares means derived from an analysis of the log-transformed pharmacokinetic parameters maximum serum concentration (Cmax), area under the serum concentration-time curve (AUC) from 0 to the last measurable concentration (AUC(0-t)) and AUC from 0 to infinity (AUC(0-∞)) for etanercept were between the limits of 80 and 125%.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-696',
    collData,
    {
        text: "The elimination rate constant (kel) in goats was nearly twice as large as the value determined in sheep, and the urea under the i.v. plasma curve in goats was only 63% of the value in sheep indicating that goats are more effective in their capacity to eliminate clorsulon than are sheep.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-697',
    collData,
    {
        text: "The predicted results showed that DPT exhibited a high CL of 1.39 L/min (close to hepatic blood flow) in human, with a t1/2 of 70.22 min and a Vss close to total body volume (61.94 L).",
        entities: [['T0', 'UNITS', [[66, 71]]], ['T1', 'VALUE', [[61, 65]]], ['T2', 'PK', [[55, 57]]], ['T3', 'PK', [[119, 123]]], ['T4', 'VALUE', [[127, 132]]], ['T5', 'PK', [[143, 146]]], ['T6', 'VALUE', [[175, 180]]], ['T7', 'UNITS', [[181, 182]]], ['T8', 'UNITS', [[133, 136]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T6']]], ['R4', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-698',
    collData,
    {
        text: "Model L-PZQ AUC data from Studies 200661-001 and 200585-001 separately using a linear mixed effects model based on noncompartmental estimates (Eq. (1)).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-699',
    collData,
    {
        text: "In plasma, the IC50 of sorafenib for P-FLT3 inhibition shifts to approximately 308nM (Figure 1A).",
        entities: [['T0', 'UNITS', [[82, 84]]], ['T1', 'VALUE', [[79, 82]]], ['T2', 'PK', [[15, 19]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-700',
    collData,
    {
        text: "Group 2A patients were the main source of the paradoxical variability in C(min)/Dose (higher ratio of 2.7; CV = 100%), suggesting a lower clearance and difficulty in the recovery of stability.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-701',
    collData,
    {
        text: "The dose-normalised (to 1 mg) Cmax and AUC values at different dose levels and different study days appeared to be similar indicating linear pharmacokinetics.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-702',
    collData,
    {
        text: "Half the dose of cefpodoxime orally administered as cefpodoxime proxetil in tablet form reaches the systemic circulation, while 80% of the cefpodoxime absorbed is excreted unchanged in urine.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-703',
    collData,
    {
        text: "The mean volume of distribution at steady state ranged from 5.0 to 6.3 liters, indicating the limited distribution of the monoclonal antibody.",
        entities: [['T0', 'PK', [[9, 47]]], ['T1', 'RANGE', [[60, 70]]], ['T2', 'UNITS', [[71, 77]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-704',
    collData,
    {
        text: "Ara‐CTP could be determined at levels under 1μM. There was a close correlation between the elimination half‐life values of the plasma ara‐C and the intracellular ara‐CTP.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-705',
    collData,
    {
        text: "On the other hand, apparent oral clearance (CL/F) of FEX was significantly decreased by 41.3% (37.03 versus 21.75 L/h) and there was no significant change was observed in Tmax, T1/2, and CLr (renal clearance) upon treatment with DSN when compared to control.",
        entities: [['T0', 'PK', [[19, 49]]], ['T1', 'VALUE', [[95, 100]]], ['T2', 'VALUE', [[108, 113]]], ['T3', 'UNITS', [[114, 117]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-706',
    collData,
    {
        text: "Estimates of distribution volume (Vd, lambda z/F) for FCE 22,178 increased from 0.75 L/kg at the 100-mg dose to 3.00 L/kg at the 3200-mg dose, and renal clearance (CLr) also increased with dose.",
        entities: [['T0', 'PK', [[13, 49]]], ['T1', 'VALUE', [[80, 84]]], ['T2', 'VALUE', [[112, 116]]], ['T3', 'UNITS', [[85, 89]]], ['T4', 'UNITS', [[117, 121]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-707',
    collData,
    {
        text: "We retrospectively collected pharmacokinetic data of all patients treated for MAC lung disease in the Adult Care Unit at National Jewish Health, Denver, Colorado, in the January 2006 to January 2010 period; we retrospectively calculated areas under the time-concentration curve (AUC).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-708',
    collData,
    {
        text: "Formononetin was absorbed and eliminated the most slowly among four isoflavones with tmax at 2.5 h and t1/2 at 1.207 h (Table 2).",
        entities: [['T0', 'PK', [[85, 89]]], ['T1', 'VALUE', [[93, 96]]], ['T2', 'UNITS', [[97, 98]]], ['T3', 'PK', [[103, 107]]], ['T4', 'VALUE', [[111, 116]]], ['T5', 'UNITS', [[117, 118]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-709',
    collData,
    {
        text: "Following oral administration, the absolute bioavailability of VCD was 94 +- 14%, and the terminal half-life was similar to that obtained after iv administration.",
        entities: [['T0', 'PK', [[35, 59]]], ['T1', 'VALUE', [[71, 73]]], ['T2', 'VALUE', [[77, 79]]], ['T3', 'UNITS', [[79, 80]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-710',
    collData,
    {
        text: "PK parameters [Cmax, Tmax, and AUC(0–24h)] for LE in ocular tissues following ocular instillation of LE (submicron) gel 0.38% and the micronized comparators, LE gels 0.38%, 0.5%, and 0.75% are presented in Table 2.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-711',
    collData,
    {
        text: "The values of A, ka and ke for P1 were 1300 μg/ml, 0.75 hr-1, and 0.742 hr-1 respectively and for P2 it was 1350 μg/ml, 0.75 hr-1, and 0.742 hr-1 respectively.",
        entities: [['T0', 'PK', [[14, 15]]], ['T1', 'VALUE', [[39, 43]]], ['T2', 'PK', [[17, 19]]], ['T3', 'VALUE', [[51, 55]]], ['T4', 'PK', [[24, 26]]], ['T5', 'VALUE', [[66, 71]]], ['T6', 'UNITS', [[44, 49]]], ['T7', 'UNITS', [[56, 60]]], ['T8', 'UNITS', [[72, 76]]], ['T9', 'UNITS', [[141, 145]]], ['T10', 'VALUE', [[135, 140]]], ['T11', 'UNITS', [[125, 129]]], ['T12', 'VALUE', [[120, 124]]], ['T13', 'UNITS', [[113, 118]]], ['T14', 'VALUE', [[108, 112]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R3', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T1']]], ['R4', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T3']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T10']]], ['R7', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T12']]], ['R8', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T14']]], ['R9', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T14']]], ['R10', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T12']]], ['R11', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T10']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-712',
    collData,
    {
        text: "A slightly shorter median tmax was measured for Prolastin-C compared with Prolastin (0.673 hour versus 0.820 hour, respectively).",
        entities: [['T0', 'PK', [[26, 30]]], ['T1', 'VALUE', [[85, 90]]], ['T2', 'VALUE', [[103, 108]]], ['T3', 'UNITS', [[109, 113]]], ['T4', 'UNITS', [[91, 95]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-713',
    collData,
    {
        text: "Compared to control, consumption of GT with milk, caseinate, or soy protein significantly reduced the bioavailability (mean area under the plasma concentration-time curve) of total catechins (means ± SEM; GT + M, 87 ± 5%; GT + CS, 79 ± 5%; GT + S, 88 ± 4%), epigallocatechin gallate (GT + M, 68 ± 4%; GT + CS, 63 ± 5%; GT + S, 76 ± 5%), and epicatechin gallate (GT + M, 68 ± 5%; GT + CS, 66 ± 6%; GT + S, 77 ± 6%), while the bioavailability of non-galloylated catechins such as epigallocatechin (GT + M, 134 ± 9%; GT + CS, 118 ± 9 %; GT + S, 123 ± 8%) and epicatechin (GT + M, 125 ± 10%; GT + CS, 114 ± 11%; GT + S, 110 ± 8%) significantly increased.",
        entities: [['T0', 'PK', [[102, 117]]], ['T1', 'VALUE', [[213, 215]]], ['T2', 'VALUE', [[231, 233]]], ['T3', 'VALUE', [[248, 250]]], ['T4', 'VALUE', [[292, 294]]], ['T5', 'VALUE', [[310, 312]]], ['T6', 'VALUE', [[327, 329]]], ['T7', 'VALUE', [[370, 372]]], ['T8', 'VALUE', [[388, 390]]], ['T9', 'VALUE', [[405, 407]]], ['T10', 'PK', [[425, 440]]], ['T11', 'VALUE', [[504, 507]]], ['T12', 'VALUE', [[523, 526]]], ['T13', 'VALUE', [[542, 545]]], ['T14', 'VALUE', [[577, 580]]], ['T15', 'VALUE', [[597, 600]]], ['T16', 'VALUE', [[616, 619]]], ['T17', 'VALUE', [[622, 623]]], ['T18', 'UNITS', [[623, 624]]], ['T19', 'VALUE', [[603, 605]]], ['T20', 'UNITS', [[605, 606]]], ['T21', 'VALUE', [[583, 585]]], ['T22', 'UNITS', [[585, 586]]], ['T23', 'VALUE', [[548, 549]]], ['T24', 'UNITS', [[549, 550]]], ['T25', 'VALUE', [[529, 530]]], ['T26', 'UNITS', [[531, 532]]], ['T27', 'VALUE', [[510, 511]]], ['T28', 'UNITS', [[511, 512]]], ['T29', 'VALUE', [[410, 411]]], ['T30', 'UNITS', [[411, 412]]], ['T31', 'VALUE', [[393, 394]]], ['T32', 'UNITS', [[394, 395]]], ['T33', 'VALUE', [[375, 376]]], ['T34', 'UNITS', [[376, 377]]], ['T35', 'VALUE', [[332, 333]]], ['T36', 'UNITS', [[333, 334]]], ['T37', 'VALUE', [[315, 316]]], ['T38', 'UNITS', [[316, 317]]], ['T39', 'VALUE', [[297, 298]]], ['T40', 'UNITS', [[298, 299]]], ['T41', 'VALUE', [[253, 254]]], ['T42', 'UNITS', [[254, 255]]], ['T43', 'VALUE', [[236, 237]]], ['T44', 'UNITS', [[237, 238]]], ['T45', 'VALUE', [[218, 219]]], ['T46', 'UNITS', [[219, 220]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T5']]], ['R5', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T6']]], ['R6', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T7']]], ['R7', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T8']]], ['R8', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T9']]], ['R9', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T11']]], ['R10', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T12']]], ['R11', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T13']]], ['R12', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T14']]], ['R13', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T15']]], ['R14', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T16']]], ['R15', 'D_VAL', [['Entity', 'T17'], ['D_VAL', 'T16']]], ['R16', 'RELATED', [['Entity', 'T18'], ['RELATED', 'T17']]], ['R17', 'D_VAL', [['Entity', 'T19'], ['D_VAL', 'T15']]], ['R18', 'RELATED', [['Entity', 'T20'], ['RELATED', 'T19']]], ['R19', 'D_VAL', [['Entity', 'T21'], ['D_VAL', 'T14']]], ['R20', 'RELATED', [['Entity', 'T22'], ['RELATED', 'T21']]], ['R21', 'D_VAL', [['Entity', 'T23'], ['D_VAL', 'T13']]], ['R22', 'RELATED', [['Entity', 'T24'], ['RELATED', 'T23']]], ['R23', 'D_VAL', [['Entity', 'T25'], ['D_VAL', 'T12']]], ['R24', 'RELATED', [['Entity', 'T26'], ['RELATED', 'T25']]], ['R25', 'D_VAL', [['Entity', 'T27'], ['D_VAL', 'T11']]], ['R26', 'RELATED', [['Entity', 'T28'], ['RELATED', 'T27']]], ['R27', 'D_VAL', [['Entity', 'T29'], ['D_VAL', 'T9']]], ['R28', 'RELATED', [['Entity', 'T30'], ['RELATED', 'T29']]], ['R29', 'D_VAL', [['Entity', 'T31'], ['D_VAL', 'T8']]], ['R30', 'RELATED', [['Entity', 'T32'], ['RELATED', 'T31']]], ['R31', 'D_VAL', [['Entity', 'T33'], ['D_VAL', 'T7']]], ['R32', 'RELATED', [['Entity', 'T34'], ['RELATED', 'T33']]], ['R33', 'D_VAL', [['Entity', 'T35'], ['D_VAL', 'T6']]], ['R34', 'RELATED', [['Entity', 'T36'], ['RELATED', 'T35']]], ['R35', 'D_VAL', [['Entity', 'T37'], ['D_VAL', 'T5']]], ['R36', 'RELATED', [['Entity', 'T38'], ['RELATED', 'T37']]], ['R37', 'D_VAL', [['Entity', 'T39'], ['D_VAL', 'T4']]], ['R38', 'RELATED', [['Entity', 'T40'], ['RELATED', 'T39']]], ['R39', 'D_VAL', [['Entity', 'T41'], ['D_VAL', 'T3']]], ['R40', 'RELATED', [['Entity', 'T42'], ['RELATED', 'T41']]], ['R41', 'D_VAL', [['Entity', 'T43'], ['D_VAL', 'T2']]], ['R42', 'RELATED', [['Entity', 'T44'], ['RELATED', 'T43']]], ['R43', 'D_VAL', [['Entity', 'T45'], ['D_VAL', 'T1']]], ['R44', 'RELATED', [['Entity', 'T46'], ['RELATED', 'T45']]], ['R45', 'RELATED', [['Entity', 'T18'], ['RELATED', 'T16']]], ['R46', 'RELATED', [['Entity', 'T20'], ['RELATED', 'T15']]], ['R47', 'RELATED', [['Entity', 'T22'], ['RELATED', 'T14']]], ['R48', 'RELATED', [['Entity', 'T24'], ['RELATED', 'T13']]], ['R49', 'RELATED', [['Entity', 'T26'], ['RELATED', 'T12']]], ['R50', 'RELATED', [['Entity', 'T28'], ['RELATED', 'T11']]], ['R51', 'RELATED', [['Entity', 'T30'], ['RELATED', 'T9']]], ['R52', 'RELATED', [['Entity', 'T32'], ['RELATED', 'T8']]], ['R53', 'RELATED', [['Entity', 'T34'], ['RELATED', 'T7']]], ['R54', 'RELATED', [['Entity', 'T36'], ['RELATED', 'T6']]], ['R55', 'RELATED', [['Entity', 'T38'], ['RELATED', 'T5']]], ['R56', 'RELATED', [['Entity', 'T40'], ['RELATED', 'T4']]], ['R57', 'RELATED', [['Entity', 'T42'], ['RELATED', 'T3']]], ['R58', 'RELATED', [['Entity', 'T44'], ['RELATED', 'T2']]], ['R59', 'RELATED', [['Entity', 'T46'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-714',
    collData,
    {
        text: "The bioavailability of the exenatide-loaded microspheres, relative to subcutaneous injection of exenatide, reached 10.2%.",
        entities: [['T0', 'PK', [[4, 19]]], ['T1', 'VALUE', [[115, 119]]], ['T2', 'UNITS', [[119, 120]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-715',
    collData,
    {
        text: "To integrate the above predictors, we classified 39 patients into 4 patients with high OPRT/TS, high AUC0–24h of 5-FU, low DPD (ORR 50.0%, median PFS 7.00 m, median OS 13.90 m), and other 35 patients (ORR 40.0%, median PFS 4.10 m, median OS 9.17 m).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-716',
    collData,
    {
        text: "It was shown that the cleavage of vicagrel was almost completed in intestine with great different clearance (53.28 vs. 3.643 L⋅h-1⋅kg-1, p < 0.05) in rats and dogs.",
        entities: [['T0', 'PK', [[98, 107]]], ['T1', 'VALUE', [[109, 114]]], ['T2', 'VALUE', [[119, 124]]], ['T3', 'UNITS', [[125, 135]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-717',
    collData,
    {
        text: "In the current study, absorption of CBD from SEDDS-CBD was substantially faster compared to the reference with 87.5% of subjects showing peak concentration within 1 h, whereas the median of Tmax for the MCT-CBD was 3.0 h. A fast absorption of CBD is favorable in various conditions, especially in the therapeutic field.",
        entities: [['T0', 'PK', [[190, 194]]], ['T1', 'VALUE', [[215, 218]]], ['T2', 'UNITS', [[219, 220]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-718',
    collData,
    {
        text: "CLtotal and CLr in humans were predicted to be 10.6 L/h and 1.24 L/h.",
        entities: [['T0', 'UNITS', [[65, 68]]], ['T1', 'VALUE', [[60, 64]]], ['T2', 'UNITS', [[52, 55]]], ['T3', 'VALUE', [[47, 51]]], ['T4', 'PK', [[0, 7]]], ['T5', 'PK', [[12, 15]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-719',
    collData,
    {
        text: "Cl/F was 930 l/hr (95% CI 799-1061 l/hr) after intravenous administration, and 1939 l/hr (95% CI 1661-2217 l/hr) after inhalation.",
        entities: [['T0', 'PK', [[0, 4]]], ['T1', 'VALUE', [[9, 12]]], ['T2', 'UNITS', [[13, 17]]], ['T3', 'UNITS', [[84, 88]]], ['T4', 'VALUE', [[79, 83]]], ['T5', 'RANGE', [[26, 34]]], ['T6', 'UNITS', [[35, 39]]], ['T7', 'RANGE', [[97, 106]]], ['T8', 'UNITS', [[107, 111]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T4']]], ['R7', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-720',
    collData,
    {
        text: "Elimination half life, mean residence time and apparent volume of distribution at steady state were not different in the two groups of patients (mean values: 142.4 and 120.2 min; 128.5 and 136.0 min; and 40.5 and 27.6 L, respectively in chronic renal failure patients and patients with normal renal function).",
        entities: [['T0', 'PK', [[0, 21]]], ['T1', 'VALUE', [[158, 163]]], ['T2', 'VALUE', [[168, 173]]], ['T3', 'UNITS', [[174, 177]]], ['T4', 'PK', [[23, 42]]], ['T5', 'VALUE', [[179, 184]]], ['T6', 'VALUE', [[189, 194]]], ['T7', 'UNITS', [[195, 198]]], ['T8', 'PK', [[47, 94]]], ['T9', 'VALUE', [[204, 208]]], ['T10', 'VALUE', [[213, 217]]], ['T11', 'UNITS', [[218, 219]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R5', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T6']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T5']]], ['R8', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T9']]], ['R9', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T10']]], ['R10', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T10']]], ['R11', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T9']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-721',
    collData,
    {
        text: "Other pharmacokinetic parameters analyzed included the maximum observed concentration (Cmax); the time to reach Cmax (Tmax); the area under the concentration-time curve from time 0 to infinity, calculated as AUC0–inf = AUC0–last + Clast/λz, where last is the time of the last quantifiable concentration, and Clast is the last quantifiable concentration; the terminal elimination half-life (T1/2), calculated as T1/2 = ln(2)/λz, and the apparent clearance after extravascular administration (CL/F), calculated as CL/F = Dose/AUC0–inf after a single dose and as CL/F = Dose/AUC0–tau after multiple dosing (at steady state).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-722',
    collData,
    {
        text: "The maximum drug concentration (Cmax) and area under the receiver‐operating characteristic curve from 0 to infinity (AUC0–∞) increased dose‐dependently in the dose range 0.3 to 1.0 mg/kg (Table 2; Fig. 3B, C).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-723',
    collData,
    {
        text: "7.>0-t and AUC0-∞. Compared with the 3-months-old rats, ketamineexposure (AUC0-t) increased by factors of 1.98, 2.94, and 4.15 in the 6-, 12-,and 18-month-old rats, respectively, whereas xylazine exposure increased by factors of1.33, 1.85 and 2.78.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-724',
    collData,
    {
        text: "All other main effects and interactions, including the three-way drug × testing-onset × bins interaction were significant, minimum F(8, 183) = 3.23, p = 0.001.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-725',
    collData,
    {
        text: "In the first group of patients, mean +- s.d. values of clearance, half-life and total distribution volume were 21.41 +- 14.59 1 h-1, 19.83 +- 23.95 h, 165.89 +- 134.75 1 respectively.",
        entities: [['T0', 'PK', [[55, 64]]], ['T1', 'VALUE', [[111, 116]]], ['T2', 'PK', [[66, 75]]], ['T3', 'VALUE', [[142, 147]]], ['T4', 'PK', [[80, 105]]], ['T5', 'VALUE', [[151, 157]]], ['T6', 'UNITS', [[148, 149]]], ['T7', 'VALUE', [[133, 138]]], ['T8', 'VALUE', [[120, 125]]], ['T9', 'UNITS', [[126, 131]]], ['T10', 'VALUE', [[161, 167]]], ['T11', 'UNITS', [[168, 169]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R3', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T3']]], ['R5', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T1']]], ['R6', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]], ['R7', 'D_VAL', [['Entity', 'T10'], ['D_VAL', 'T5']]], ['R8', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T10']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-726',
    collData,
    {
        text: "Relative bioavailability was evaluated by comparing the log-transformed C(max) and AUC(0-672) of the 2 formulations; Korean regulatory requirements for the assumption of bioequivalence were met if the 90% CIs fell within the range of 0.80 to 1.25.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-727',
    collData,
    {
        text: "Area under the concentration curve (AUC) was 5.65 h X micrograms/mL and 10.37h X micrograms/mL. Serum clearance was 23L for both doses.",
        entities: [['T0', 'PK', [[0, 40]]], ['T1', 'VALUE', [[45, 49]]], ['T2', 'UNITS', [[50, 67]]], ['T3', 'VALUE', [[72, 77]]], ['T4', 'UNITS', [[77, 94]]], ['T5', 'UNITS', [[118, 119]]], ['T6', 'VALUE', [[116, 118]]], ['T7', 'PK', [[96, 111]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T6']]], ['R5', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-728',
    collData,
    {
        text: "The same dose infused over 4 h results in a peak concentration of 0.92 mg L-1, falling to 0.005 mg L-1 at 8 h. Simultaneous modelling of dihydroartemisinin showed that while its peak plasma concentration was reduced by 27% and the peak delayed by 2.5 h following artesunate administration by infusion, substantially higher concentrations were maintained compared with those predicted after bolus artesunate.",
        entities: [['T0', 'UNITS', [[71, 77]]], ['T1', 'VALUE', [[66, 70]]], ['T2', 'UNITS', [[96, 102]]], ['T3', 'VALUE', [[90, 95]]], ['T4', 'PK', [[44, 62]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-729',
    collData,
    {
        text: "Both parameters were significantly influenced by postnatal age and current body weight, whereas volume of distribution in infants > 28 weeks' gestational age was higher than that in more premature babies.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-730',
    collData,
    {
        text: "The oral and intravenous administrations of genaconazole yielded virtually superimposable plasma concentration-time curves, resulting in an absolute bioavailability of 100%.",
        entities: [['T0', 'UNITS', [[171, 172]]], ['T1', 'VALUE', [[168, 171]]], ['T2', 'PK', [[140, 164]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-731',
    collData,
    {
        text: "The median AUCs of CLA and 14-hydroxyclarithromycin (14OH-CLA) were 2.9 mg x h/liter (IQR, 1.5 to 3.8 mg x h/liter) and 8.0 mg x h/liter (IQR, 6.7 to 8.6 mg x h/liter), respectively.",
        entities: [['T0', 'UNITS', [[72, 84]]], ['T1', 'VALUE', [[68, 71]]], ['T2', 'UNITS', [[124, 136]]], ['T3', 'VALUE', [[120, 123]]], ['T4', 'RANGE', [[91, 101]]], ['T5', 'UNITS', [[102, 114]]], ['T6', 'PK', [[11, 15]]], ['T7', 'RANGE', [[143, 153]]], ['T8', 'UNITS', [[154, 166]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]], ['R5', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T3']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T3']]], ['R7', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-732',
    collData,
    {
        text: "Geometric mean ratios (90% confidence intervals) of the test to the reference formulation in Cmax and AUClast were 0.9652 (0.8302-1.1223) and 0.9891 (0.8541-1.1455), respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-733',
    collData,
    {
        text: "Simulations of treatment dosing using our new candidate algorithm for twice daily v-GCV dosing resulted in a low probability of achieving an AUC0–12 of 40–60 mg*h/L. In addition to twice daily dosing for treatment, doses should also be increased by an additional 20% for all age and eGFR ranges (Fig.5), i.e., 1.2 * prophylactic dose given twice daily.",
        entities: [['T0', 'UNITS', [[158, 164]]], ['T1', 'RANGE', [[152, 157]]], ['T2', 'PK', [[141, 148]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-734',
    collData,
    {
        text: "Compared with those in the IBU-CL-SF PM, the Cmax value of IBU was 2.95 times higher, and Tmax decreased by 15 min in the IBU-CL-SF SD.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-735',
    collData,
    {
        text: "The 90% CIs for the geometric mean ratios (4%, 20%, and 40% ethanol versus water) for Cmax and systemic exposure (AUC0-5, AUClast, and AUC0-∞) were within 80% to 125%.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-736',
    collData,
    {
        text: "The AUC0-infinity and Cmax values were proportional to doses (mg or mg/kg, P less than .001).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-737',
    collData,
    {
        text: "The molar AUC ratio of morphine-3-glucuronide/morphine was 1.8 +- 0.5 and the corresponding ratio for normorphine/morphine was 0.2 +- 0.06.",
        entities: [['T0', 'VALUE', [[134, 138]]], ['T1', 'VALUE', [[127, 130]]], ['T2', 'VALUE', [[66, 69]]], ['T3', 'VALUE', [[59, 62]]], ['T4', 'PK', [[4, 19]]]],
        relations: [['R0', 'D_VAL', [['Entity', 'T0'], ['D_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-738',
    collData,
    {
        text: "The same phenomenon may explain the markedly longer half-life of the AON in cardiac muscle tissue (~46 days).",
        entities: [['T0', 'UNITS', [[103, 107]]], ['T1', 'VALUE', [[100, 102]]], ['T2', 'PK', [[52, 61]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-739',
    collData,
    {
        text: "The absorption of oral [14C]-bumetanide was rapid (absorption half-life 0.61 h) and complete with a urinary recovery of about 80% of the intravenous or oral dose during 48 h. 3.",
        entities: [['T0', 'PK', [[51, 71]]], ['T1', 'VALUE', [[72, 76]]], ['T2', 'UNITS', [[77, 78]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-740',
    collData,
    {
        text: "The AUC((0-infinity)) of 5-FU with consecutive administrations (3089.7 ng.h/ml) was far greater than with single administration (430.4 ng.h/ml).",
        entities: [['T0', 'UNITS', [[135, 142]]], ['T1', 'VALUE', [[129, 134]]], ['T2', 'UNITS', [[71, 78]]], ['T3', 'VALUE', [[64, 70]]], ['T4', 'PK', [[4, 21]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-741',
    collData,
    {
        text: "Variability in 5FU 300 Css was considerably less than previously reported; 94 ± 25 ng ml−1(CV = 27%).",
        entities: [['T0', 'UNITS', [[83, 90]]], ['T1', 'VALUE', [[75, 77]]], ['T2', 'PK', [[23, 26]]], ['T3', 'VALUE', [[80, 82]]], ['T4', 'VALUE', [[96, 98]]], ['T5', 'UNITS', [[98, 99]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-742',
    collData,
    {
        text: "We observed a higher proportion of courses with Cpss within the target range for individualized doses in the latter two consolidation courses: for consolidation 3 and 4: 9.6, 74.6, and 15.8 % of courses were below target, within target and above target, respectively; vs for consolidation 1 and 2: 15.5, 63.6, and 20.9 % of courses were below, within and above target, respectively (p < 0.001).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-743',
    collData,
    {
        text: "Therefore, for a purpose to identify the relevance between Fc modification and increased half-lives, elimination half-life parameter was calculated only towards the linear section (0 to 336 h, Fig 2), while other parameters were calculated towards both the linear and nonlinear section (0-720h, Fig 2).",
        entities: [['T0', 'UNITS', [[190, 191]]], ['T1', 'RANGE', [[181, 189]]], ['T2', 'UNITS', [[292, 293]]], ['T3', 'RANGE', [[287, 292]]], ['T4', 'PK', [[101, 122]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-744',
    collData,
    {
        text: "BMS‐962212 peak concentrations were observed within 1–2 h after administration.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-745',
    collData,
    {
        text: "After single-dose oral administration, GSK2647544 was readily absorbed with a tmax of 1 – 4 hours.",
        entities: [['T0', 'UNITS', [[92, 97]]], ['T1', 'RANGE', [[86, 91]]], ['T2', 'PK', [[78, 82]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-746',
    collData,
    {
        text: "The geometric mean area under the curve ratio of the PI study group to the controls was 1.50, with a 90% confidence interval of 1.21 to 1.86 (P = 0.004).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-747',
    collData,
    {
        text: "The in vitro observation that Merand Flt3 were the kinases most potently inhibited by 11 was confirmed for Mer kinase in B-ALL 697 cell lysates using theATP ActivX probe assay,28 where it demonstratedan IC50 of 0.05 nM for Mer (although the redundancy ofMer and Tyro3 peptides does not distinguish these kinases).",
        entities: [['T0', 'PK', [[203, 207]]], ['T1', 'VALUE', [[211, 215]]], ['T2', 'UNITS', [[216, 218]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-748',
    collData,
    {
        text: "However, considering both plasma concentrations and urinary excretion, we could estimate the half-life of free filterable species (60 min), the plasma clearance (125 ml/min) and the renal clearance (86 ml/min).",
        entities: [['T0', 'UNITS', [[134, 137]]], ['T1', 'VALUE', [[131, 133]]], ['T2', 'PK', [[93, 102]]], ['T3', 'PK', [[144, 160]]], ['T4', 'VALUE', [[162, 165]]], ['T5', 'UNITS', [[166, 172]]], ['T6', 'UNITS', [[202, 208]]], ['T7', 'VALUE', [[199, 201]]], ['T8', 'PK', [[182, 197]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R5', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-749',
    collData,
    {
        text: "The PK of aripiprazole following aripiprazole lauroxil was characterized by a steady rise in plasma concentrations (Tmax 44-50 days), a broad peak, and prolonged exposure attributable to the dissolution of aripiprazole lauroxil and formation rate-limited elimination of aripiprazole (t1/2=15.4-19.2 days).",
        entities: [['T0', 'PK', [[116, 120]]], ['T1', 'RANGE', [[121, 126]]], ['T2', 'UNITS', [[127, 131]]], ['T3', 'UNITS', [[299, 303]]], ['T4', 'RANGE', [[289, 298]]], ['T5', 'PK', [[284, 288]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-750',
    collData,
    {
        text: "A sorbitol bolus (5 mmol/kg) was given intravenously to 6 controls for determination of sorbitol elimination capacity (SEC) and distribution volume, V(sorb)d.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-751',
    collData,
    {
        text: "Cl was also four times higher in the HFB1iv compared to FB1iv group (6.7 and 1.8 L/kg/h respectively) which together with the differences in the volumes of distribution indicates that HFB1 is more rapidly cleared from the systemic circulation but also distributed more extensively into the extravasal space than FB1.",
        entities: [['T0', 'UNITS', [[81, 87]]], ['T1', 'VALUE', [[77, 80]]], ['T2', 'VALUE', [[69, 72]]], ['T3', 'PK', [[0, 2]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-752',
    collData,
    {
        text: "The peak plasma concentration (Cmax), time to Cmax (Tmax), area under the plasma concentration versus time curve from time 0 h to 36 h (AUC(0-36)), elimination half-life (t1/2), clearance rate (CL/F) and apparent volume of distribution (Vd) were (1.804 +- 1.706) ng/ml, (0.7 +- 0.3) h, (2.465 +- 1.693) ng x h/ml, (7.3 +- 7.0) h, (53.09 +- 34.65) x 10(3) L/h and (447.1 +- 440.8) x 10(3) L, respectively.",
        entities: [['T0', 'PK', [[4, 36]]], ['T1', 'VALUE', [[247, 252]]], ['T2', 'PK', [[38, 57]]], ['T3', 'VALUE', [[271, 274]]], ['T4', 'PK', [[59, 146]]], ['T5', 'VALUE', [[287, 292]]], ['T6', 'PK', [[148, 176]]], ['T7', 'VALUE', [[315, 318]]], ['T8', 'PK', [[178, 199]]], ['T9', 'VALUE', [[331, 336]]], ['T10', 'PK', [[204, 240]]], ['T11', 'VALUE', [[364, 369]]], ['T12', 'VALUE', [[256, 261]]], ['T13', 'UNITS', [[263, 268]]], ['T14', 'VALUE', [[278, 281]]], ['T15', 'UNITS', [[283, 284]]], ['T16', 'VALUE', [[296, 301]]], ['T17', 'UNITS', [[303, 312]]], ['T18', 'VALUE', [[340, 345]]], ['T19', 'UNITS', [[355, 358]]], ['T20', 'VALUE', [[322, 325]]], ['T21', 'UNITS', [[327, 328]]], ['T22', 'VALUE', [[373, 378]]], ['T23', 'UNITS', [[388, 389]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R3', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R4', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T9']]], ['R5', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T11']]], ['R6', 'D_VAL', [['Entity', 'T12'], ['D_VAL', 'T1']]], ['R7', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T12']]], ['R8', 'D_VAL', [['Entity', 'T14'], ['D_VAL', 'T3']]], ['R9', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T14']]], ['R10', 'D_VAL', [['Entity', 'T16'], ['D_VAL', 'T5']]], ['R11', 'RELATED', [['Entity', 'T17'], ['RELATED', 'T16']]], ['R12', 'D_VAL', [['Entity', 'T18'], ['D_VAL', 'T9']]], ['R13', 'RELATED', [['Entity', 'T19'], ['RELATED', 'T18']]], ['R14', 'D_VAL', [['Entity', 'T20'], ['D_VAL', 'T7']]], ['R15', 'RELATED', [['Entity', 'T21'], ['RELATED', 'T20']]], ['R16', 'D_VAL', [['Entity', 'T22'], ['D_VAL', 'T11']]], ['R17', 'RELATED', [['Entity', 'T23'], ['RELATED', 'T22']]], ['R18', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T1']]], ['R19', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T3']]], ['R20', 'RELATED', [['Entity', 'T17'], ['RELATED', 'T5']]], ['R21', 'RELATED', [['Entity', 'T21'], ['RELATED', 'T7']]], ['R22', 'RELATED', [['Entity', 'T19'], ['RELATED', 'T9']]], ['R23', 'RELATED', [['Entity', 'T23'], ['RELATED', 'T11']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-753',
    collData,
    {
        text: "Protease inhibitor (PI) or non-nucleoside reverse transcriptase inhibitor (NNRTI) Cmin was determined just before and 12 weeks after ezetimibe introduction.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-754',
    collData,
    {
        text: "Patients with advanced prostate cancer (castrate and noncastrate) were administered escalating doses of weekly 1-h infusion of i.v. EMP (500-1000-1500 mg/m(2)) in combination with weekly paclitaxel (100 mg/m(2) over 1 h) and i.v. carboplatin (area under the curve 6 mg/ml-min every 4 weeks).",
        entities: [['T0', 'UNITS', [[266, 275]]], ['T1', 'VALUE', [[264, 265]]], ['T2', 'PK', [[243, 263]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-755',
    collData,
    {
        text: "The apparent V ss was 69.9 ± 25.4 L/m2, plasma clearance 13.4 ± 2.5 L/h/m2 and plasma T1/2 3.7 ± 1.3 h.",
        entities: [['T0', 'UNITS', [[34, 38]]], ['T1', 'VALUE', [[22, 26]]], ['T2', 'VALUE', [[29, 33]]], ['T3', 'PK', [[4, 17]]], ['T4', 'PK', [[40, 56]]], ['T5', 'VALUE', [[57, 61]]], ['T6', 'UNITS', [[68, 74]]], ['T7', 'VALUE', [[64, 67]]], ['T8', 'PK', [[79, 90]]], ['T9', 'VALUE', [[91, 94]]], ['T10', 'UNITS', [[101, 102]]], ['T11', 'VALUE', [[97, 100]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T5']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R8', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T9']]], ['R9', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T9']]], ['R10', 'D_VAL', [['Entity', 'T11'], ['D_VAL', 'T9']]], ['R11', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T11']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-756',
    collData,
    {
        text: "Compound 1 on the other hand was less active than chloroquine with IC50 values of 0.505 and 0.463 µM for K1 and Dd2, respectively.",
        entities: [['T0', 'UNITS', [[98, 100]]], ['T1', 'VALUE', [[92, 97]]], ['T2', 'VALUE', [[82, 87]]], ['T3', 'PK', [[67, 71]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-757',
    collData,
    {
        text: "The mean volume of distribution of the central compartment was 0.09 liter/kg and the steady-state volume of distribution using noncompartmental analysis was 0.84 liter/kg.",
        entities: [['T0', 'UNITS', [[68, 76]]], ['T1', 'VALUE', [[63, 67]]], ['T2', 'PK', [[9, 58]]], ['T3', 'PK', [[85, 120]]], ['T4', 'VALUE', [[157, 161]]], ['T5', 'UNITS', [[162, 170]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-758',
    collData,
    {
        text: "Although the predose sampling occurred at least 12 h after the last known ingestion of I3C, 6 of 14 subjects exhibited Cmax for DIM in their predose plasma.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-759',
    collData,
    {
        text: "Eritoran demonstrated a slow plasma clearance (0.679 to 0.930 ml/h/kg of body weight), a small volume of distribution (45.6 to 49.8 ml/kg), and a relatively long half-life (50.4 to 62.7 h).",
        entities: [['T0', 'UNITS', [[62, 69]]], ['T1', 'RANGE', [[47, 61]]], ['T2', 'PK', [[29, 45]]], ['T3', 'PK', [[95, 117]]], ['T4', 'RANGE', [[119, 131]]], ['T5', 'UNITS', [[132, 137]]], ['T6', 'UNITS', [[186, 187]]], ['T7', 'RANGE', [[173, 185]]], ['T8', 'PK', [[162, 171]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R5', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-760',
    collData,
    {
        text: "A mean maximum concentration of 232 ng/ml was observed after 20 minutes.",
        entities: [['T0', 'UNITS', [[36, 41]]], ['T1', 'VALUE', [[32, 35]]], ['T2', 'PK', [[7, 28]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-761',
    collData,
    {
        text: "While BBR TD yielded higher berberine bioavailability (AUC0-8; 95.6 +- 23.7 ng·h/mL) as compared to oral (26.5 +- 2.9 ng·h/mL) this difference between routes of administration was not reflected in metabolite levels (Table 5).",
        entities: [['T0', 'UNITS', [[76, 83]]], ['T1', 'VALUE', [[63, 67]]], ['T2', 'VALUE', [[71, 75]]], ['T3', 'PK', [[55, 61]]], ['T4', 'VALUE', [[106, 110]]], ['T5', 'UNITS', [[118, 125]]], ['T6', 'VALUE', [[114, 117]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R6', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T4']]], ['R7', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-762',
    collData,
    {
        text: "In that study, the mean plasma exposure of tramiprosate at 78 weeks provided an AUC12 of 4429 ng/mL h.",
        entities: [['T0', 'UNITS', [[94, 101]]], ['T1', 'VALUE', [[89, 93]]], ['T2', 'PK', [[80, 85]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-763',
    collData,
    {
        text: "The median value of dose-normalized tacrolimus trough concentrations was 5.3 ng/mL/mg (IQR: 4.8–5.8 ng/mL/mg) in Weeks 1–2, and 4.7 ng/mL/mg (IQR: 4.3–5.3 ng/mL/mg) in Weeks 3–4.",
        entities: [['T0', 'UNITS', [[77, 85]]], ['T1', 'VALUE', [[73, 76]]], ['T2', 'PK', [[47, 68]]], ['T3', 'RANGE', [[92, 99]]], ['T4', 'UNITS', [[100, 108]]], ['T5', 'UNITS', [[132, 140]]], ['T6', 'VALUE', [[128, 131]]], ['T7', 'RANGE', [[147, 154]]], ['T8', 'UNITS', [[155, 163]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T6']]], ['R5', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T6']]], ['R6', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]], ['R7', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-764',
    collData,
    {
        text: "Target values of fAUC/MIC for stasis and 1 log10 kill were 1.22-13.5 and 3.72-28.0, respectively; 2 log10 kill was not achieved for any strain, even at the highest tolerated dose.",
        entities: [['T0', 'PK', [[17, 25]]], ['T1', 'RANGE', [[59, 68]]], ['T2', 'RANGE', [[73, 82]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-765',
    collData,
    {
        text: "The optimized Formulae achieved a controlled drug release over 24 h and the pharmacokinetic data revealed that the Cmax and AUC0-24 in the rats' brain after the intranasal application of the dispersion and in situ gel were significantly higher relative to the vinpocetine solution applied intravenously at the same dose.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-766',
    collData,
    {
        text: "An emerging approach relies on estimating in vitro clearance of DMEs or transporters using recombinant enzymes or cells.10, 11 These in vitro clearance data can be extrapolated to in vivo by incorporating tissue protein expression in the PBPK models, as discussed elsewhere.13, 14, 15 Therefore, protein expression data in human tissues are important for in vitro‐in vivo extrapolation and PBPK modeling from either primary cells or recombinant systems.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-767',
    collData,
    {
        text: "On day 2 of TC 1 the gMean AUC0−24 value for BIBF 1120 was 454 ng h ml−1.",
        entities: [['T0', 'PK', [[27, 34]]], ['T1', 'VALUE', [[59, 62]]], ['T2', 'UNITS', [[63, 72]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-768',
    collData,
    {
        text: "The mean plasma zinc area under the curve for zinc acetate at low pH (AL), zinc acetate at high pH (AH), zinc oxide at low pH (OL), and zinc oxide at high pH (OH) were 524, 378, 364, and 66 micrograms x h/dL, respectively.",
        entities: [['T0', 'PK', [[21, 41]]], ['T1', 'VALUE', [[168, 171]]], ['T2', 'VALUE', [[173, 176]]], ['T3', 'VALUE', [[178, 181]]], ['T4', 'VALUE', [[187, 189]]], ['T5', 'UNITS', [[190, 207]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-769',
    collData,
    {
        text: "The objective was to investigate the in vivo pharmacokinetics and tissue distribution of full-length recombinant human OPG (rhOPG) as well as its clearance mechanism using (125)I-labelled protein ((125)I-rhOPG) after intravenous administration to female Fischer rats.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-770',
    collData,
    {
        text: "The plasma elimination half-lives and the clearance values were not altered by the 29 days of Bendectin treatment for any of the species.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-771',
    collData,
    {
        text: "The maximum levels were observed in 2 hours.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-772',
    collData,
    {
        text: "Peak concentrations in serum noted in the absence of antacids ranged from 2.9 to 6.4 micrograms/ml, and peak concentrations in dialysate in the absence of antacids ranged from 1.8 to 4.5 micrograms/ml.",
        entities: [['T0', 'PK', [[0, 19]]], ['T1', 'RANGE', [[74, 84]]], ['T2', 'UNITS', [[85, 98]]], ['T3', 'PK', [[104, 123]]], ['T4', 'RANGE', [[176, 186]]], ['T5', 'UNITS', [[187, 200]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-773',
    collData,
    {
        text: "All limits of the 90% CIs of the estimated geometric mean ratios for Cmax and all AUC comparisons fell within the 80%–125% margins.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-774',
    collData,
    {
        text: "Since half of insulin that found in portal system is exposed to hepatic clearance to inhibit hepatic glucose production, portal insulin concentration is 2-4-folds higher than peripheral insulin concentration.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-775',
    collData,
    {
        text: "The population typical values of K12, CL/F, V/F, EC50, K(in), and E(max) were 0.259 h(-1), 179 L x h(-1), 632 L, 1.57 ng x mL(-1), 4.29 and 0.664, respectively.",
        entities: [['T0', 'PK', [[33, 36]]], ['T1', 'VALUE', [[78, 83]]], ['T2', 'PK', [[38, 42]]], ['T3', 'VALUE', [[91, 94]]], ['T4', 'PK', [[44, 47]]], ['T5', 'VALUE', [[106, 109]]], ['T6', 'PK', [[49, 53]]], ['T7', 'VALUE', [[113, 117]]], ['T8', 'PK', [[55, 60]]], ['T9', 'VALUE', [[131, 135]]], ['T10', 'PK', [[66, 72]]], ['T11', 'VALUE', [[140, 145]]], ['T12', 'UNITS', [[84, 89]]], ['T13', 'UNITS', [[95, 104]]], ['T14', 'UNITS', [[110, 111]]], ['T15', 'UNITS', [[118, 129]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R3', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R4', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T9']]], ['R5', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T11']]], ['R6', 'RELATED', [['Entity', 'T12'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T3']]], ['R8', 'RELATED', [['Entity', 'T14'], ['RELATED', 'T5']]], ['R9', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-776',
    collData,
    {
        text: "ASV CL/F for cirrhotic subjects is expected to be 0.65‐fold lower relative to subjects without cirrhosis.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-777',
    collData,
    {
        text: "The terminal elimination-phase half-life was 5.5 to 8.7 h in rodents, and it was ~9.3 h in dogs.",
        entities: [['T0', 'PK', [[4, 40]]], ['T1', 'RANGE', [[45, 55]]], ['T2', 'VALUE', [[82, 85]]], ['T3', 'UNITS', [[86, 87]]], ['T4', 'UNITS', [[56, 57]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-778',
    collData,
    {
        text: "During haemodialysis, the central volume V1 was estimated to be reduced by 0.198 L/h.",
        entities: [['T0', 'UNITS', [[81, 84]]], ['T1', 'VALUE', [[75, 80]]], ['T2', 'PK', [[26, 43]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-779',
    collData,
    {
        text: "DHA clearance increased 10.2% per unit (g/dl) of decrease of hemoglobin.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-780',
    collData,
    {
        text: "All three i.n. doses rapidly achieved plasma levels > 50% of peak concentrations (T50%) by 10 minutes, peaking at 15–30 minutes (Tmax).",
        entities: [['T0', 'PK', [[129, 133]]], ['T1', 'RANGE', [[114, 119]]], ['T2', 'UNITS', [[120, 127]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-781',
    collData,
    {
        text: "Peak concentrations of total GIP (intact+metabolite, mean+-SEM) and intact GIP (in brackets) were 920+-91 (442+-52) pmol/l in the type 2 diabetic patients and 775+-68 (424+-30) pmol/l in the healthy subjects (NS).",
        entities: [['T0', 'PK', [[0, 19]]], ['T1', 'VALUE', [[98, 101]]], ['T2', 'VALUE', [[107, 110]]], ['T3', 'VALUE', [[159, 162]]], ['T4', 'VALUE', [[168, 171]]], ['T5', 'VALUE', [[103, 105]]], ['T6', 'UNITS', [[116, 122]]], ['T7', 'VALUE', [[112, 114]]], ['T8', 'VALUE', [[164, 166]]], ['T9', 'UNITS', [[177, 183]]], ['T10', 'VALUE', [[173, 175]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T2']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R8', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T3']]], ['R9', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]], ['R10', 'D_VAL', [['Entity', 'T10'], ['D_VAL', 'T4']]], ['R11', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T10']]], ['R12', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T4']]], ['R13', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T3']]], ['R14', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T2']]], ['R15', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-782',
    collData,
    {
        text: "The aim of the present study was to compare the bioavailability of ranitidine (CAS 66357-35-5) from two different ranitidine hydrochloride (CAS 66357-59-3) film tablets (Ranitab 150 mg film tablets as test preparation and 150 mg film tablets of the originator product as reference preparation).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-783',
    collData,
    {
        text: "We show here that the t1/2 of AD-114-PA600 administered IV to cynomolgus monkeys ranged from 6.69 to 24.27 h.",
        entities: [['T0', 'UNITS', [[107, 108]]], ['T1', 'RANGE', [[93, 106]]], ['T2', 'PK', [[22, 26]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-784',
    collData,
    {
        text: "HBK was well eliminated by hollow fiber type artificial kidney (HFAK) with a half-life of 0.13 hr.",
        entities: [['T0', 'PK', [[77, 86]]], ['T1', 'VALUE', [[90, 94]]], ['T2', 'UNITS', [[95, 97]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-785',
    collData,
    {
        text: "After 30 min infusion of ABI-007, the concentration of paclitaxel began to decrease immediately upon cessation of the infusion with t1/2 of 17.3–27.3 h in the whole blood, which is nearly comparable with that of standard dose of solvent-based paclitaxel (6), and the decline of paclitaxel concentration from maximum was multiphasic.",
        entities: [['T0', 'UNITS', [[150, 151]]], ['T1', 'RANGE', [[140, 149]]], ['T2', 'PK', [[132, 136]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-786',
    collData,
    {
        text: "The time evolution profile of each local ROI could be well accounted for by a monoexponential decay function: I(t)=I0+Ime−tτ,(1)where τ is the decay time constant representing the clearance time constant, and I0 and Im stand for the luminescence intensity of the long-lasting background and the maximum, respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-787',
    collData,
    {
        text: "As the differences in peak concentration and AUC were less than 20%, even though they were statistically significant, the two formulations were considered bioequivalent according to FDA guidelines for bioequivalence.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-788',
    collData,
    {
        text: "The half-life of furaltadone was 13 min in the homogenates of caprine and bovine liver and 35 min in the in vivo study of the goat.",
        entities: [['T0', 'UNITS', [[36, 39]]], ['T1', 'VALUE', [[33, 35]]], ['T2', 'PK', [[4, 13]]], ['T3', 'VALUE', [[91, 93]]], ['T4', 'UNITS', [[94, 97]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-789',
    collData,
    {
        text: "The Cmax was 9.64 mg/g, 9.62 mg/g, 34.88 mg/l, 0.52 mg/l, and 2.13 mg/g for cornea, conjunctiva, aqueous humor, vitreous, and sclera, respectively.",
        entities: [['T0', 'UNITS', [[18, 22]]], ['T1', 'VALUE', [[13, 17]]], ['T2', 'UNITS', [[29, 33]]], ['T3', 'VALUE', [[24, 28]]], ['T4', 'UNITS', [[41, 45]]], ['T5', 'VALUE', [[35, 40]]], ['T6', 'UNITS', [[52, 56]]], ['T7', 'VALUE', [[47, 51]]], ['T8', 'UNITS', [[67, 71]]], ['T9', 'VALUE', [[62, 66]]], ['T10', 'PK', [[4, 8]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R3', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R4', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T9']]], ['R5', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T1']]], ['R6', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T3']]], ['R7', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T5']]], ['R8', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T7']]], ['R9', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T9']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-790',
    collData,
    {
        text: "After single intravenous dosing (2.5, 5, or 10 mg/kg) with the HPBCD-based formulation, the area under the plasma concentration-time curve of acitretin increased proportionally with the dose and its clearance remained unchanged within the tested dose range.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-791',
    collData,
    {
        text: "AUC values in four brain regions by the nasal route were 54- to 121-fold compared with the i.v. route, the drug targeting index (DTI) values of nasal route were 71-158 for different brain regions, and about 99% of RTX content within 360 min in the brain were transported via the olfactory pathway.",
        entities: [['T0', 'PK', [[107, 133]]], ['T1', 'RANGE', [[161, 167]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-792',
    collData,
    {
        text: "Mean maximum plasma concentrations of 3380 and 315 ng/mL for M461 and M557 respectively, occurred at 5 min post dose.",
        entities: [['T0', 'UNITS', [[51, 56]]], ['T1', 'VALUE', [[47, 50]]], ['T2', 'VALUE', [[38, 42]]], ['T3', 'PK', [[5, 34]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-793',
    collData,
    {
        text: "The half-time clearance rate from blood for these 131I-lymphocytes was calculated to be 171 min.",
        entities: [['T0', 'UNITS', [[92, 95]]], ['T1', 'VALUE', [[88, 91]]], ['T2', 'PK', [[4, 28]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-794',
    collData,
    {
        text: "The mean AUCs determined for the larger particle size of this compound were 387.44 ng·h/mL, whereas the mean values for the smaller particles were 718.63 ng·h/mL (P value = 0.0132).",
        entities: [['T0', 'UNITS', [[83, 90]]], ['T1', 'VALUE', [[76, 82]]], ['T2', 'UNITS', [[154, 161]]], ['T3', 'VALUE', [[147, 153]]], ['T4', 'PK', [[9, 13]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-795',
    collData,
    {
        text: "However, like Cmax, both of these confidence intervals are indicative, per the 80 to 125% criteria, of a drug interaction effect.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-796',
    collData,
    {
        text: "After single and four weekly SC injections, the median tmax ranged from 47 to 49 hours post-dose, indicating slow absorption with SC dosing (Tables 3, 4; Fig. 1b, c).",
        entities: [['T0', 'UNITS', [[81, 86]]], ['T1', 'RANGE', [[72, 80]]], ['T2', 'PK', [[55, 59]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-797',
    collData,
    {
        text: "The Vss is 2 to 3 times the plasma volume.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-798',
    collData,
    {
        text: "However, the AUC of 4-hydroxycyclophosphamide was overestimated (mean prediction error = 16.9%-23.6%).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-799',
    collData,
    {
        text: "Cortisol peaks were observed 1h after each HC intake and a dose response was demonstrated for cortisol peak and cortisol AUC.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-800',
    collData,
    {
        text: "The Cmax and AUC of 4-HBA in antibiotic-treated animals were significantly reduced from 4.2 µg/mL and 7.0 µg·h/mL to 2.5 µg/mL and 4.6 µg⋅h/mL, respectively.",
        entities: [['T0', 'PK', [[4, 8]]], ['T1', 'VALUE', [[88, 91]]], ['T2', 'VALUE', [[117, 120]]], ['T3', 'PK', [[13, 16]]], ['T4', 'VALUE', [[102, 105]]], ['T5', 'VALUE', [[131, 134]]], ['T6', 'UNITS', [[92, 97]]], ['T7', 'UNITS', [[106, 113]]], ['T8', 'UNITS', [[121, 126]]], ['T9', 'UNITS', [[135, 142]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T5']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T1']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T4']]], ['R6', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-801',
    collData,
    {
        text: "HB-002.1 has a molecular weight of ~80 kDa, isoelectric point of ~6.7, and an optimal target binding affinity of <1 nM. The pharmacokinetic profile was excellent with a half-life of 5 days, maximal concentration of 20.27 μg/ml, and area under the curve of 81.46 μg · days/ml.",
        entities: [['T0', 'PK', [[169, 178]]], ['T1', 'VALUE', [[182, 183]]], ['T2', 'PK', [[190, 211]]], ['T3', 'VALUE', [[215, 220]]], ['T4', 'PK', [[232, 252]]], ['T5', 'VALUE', [[256, 261]]], ['T6', 'UNITS', [[184, 188]]], ['T7', 'UNITS', [[221, 226]]], ['T8', 'UNITS', [[262, 274]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R3', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T1']]], ['R4', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T3']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-802',
    collData,
    {
        text: "The respective MICs of marbofloxacin against E. coli and P. multocida were 0.03 μg/mL and 0.4 μg/mL. The AUC0-24h/MIC ratios were 226.64 ± 7.21 h for E. coli and 16.99 ± 0.541 h for P. multocida.",
        entities: [['T0', 'PK', [[105, 124]]], ['T1', 'VALUE', [[130, 136]]], ['T2', 'VALUE', [[162, 167]]], ['T3', 'VALUE', [[139, 143]]], ['T4', 'UNITS', [[144, 145]]], ['T5', 'VALUE', [[170, 175]]], ['T6', 'UNITS', [[176, 177]]], ['T7', 'UNITS', [[80, 85]]], ['T8', 'VALUE', [[75, 79]]], ['T9', 'UNITS', [[94, 99]]], ['T10', 'VALUE', [[90, 93]]], ['T11', 'PK', [[15, 19]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T2']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T2']]], ['R8', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T8']]], ['R9', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T10']]], ['R10', 'C_VAL', [['Entity', 'T11'], ['C_VAL', 'T8']]], ['R11', 'C_VAL', [['Entity', 'T11'], ['C_VAL', 'T10']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-803',
    collData,
    {
        text: "The hydrolysis was seen with half-life (t(1/2)) of about 9.9, 65.0, 14.2, 3.4, 2.1 9.5, and 1.6 minutes for KI-306, 309, 312, 313, 315, 316, and 317, respectively.",
        entities: [['T0', 'PK', [[29, 47]]], ['T1', 'VALUE', [[57, 60]]], ['T2', 'VALUE', [[62, 66]]], ['T3', 'VALUE', [[68, 72]]], ['T4', 'VALUE', [[74, 77]]], ['T5', 'VALUE', [[79, 82]]], ['T6', 'VALUE', [[83, 86]]], ['T7', 'VALUE', [[92, 95]]], ['T8', 'UNITS', [[96, 103]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T5']]], ['R5', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T6']]], ['R6', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T7']]], ['R7', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]], ['R8', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T6']]], ['R9', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T5']]], ['R10', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T4']]], ['R11', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T3']]], ['R12', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T2']]], ['R13', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-804',
    collData,
    {
        text: "However, compounds with aralkyl groups (compounds 1l, 1m) have lower F values, particularly 1l.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-805',
    collData,
    {
        text: "The vitreous half-life of 1.25 mg/0.05 mL intravitreal bevacizumab was 6.61 days in this rabbit model.",
        entities: [['T0', 'UNITS', [[76, 80]]], ['T1', 'VALUE', [[71, 75]]], ['T2', 'PK', [[13, 22]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-806',
    collData,
    {
        text: "The half-lives were 69 hours in normal vitreous and 14.53 hours in infected vitreous.",
        entities: [['T0', 'PK', [[4, 14]]], ['T1', 'VALUE', [[20, 22]]], ['T2', 'VALUE', [[52, 57]]], ['T3', 'UNITS', [[58, 63]]], ['T4', 'UNITS', [[23, 28]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-807',
    collData,
    {
        text: "Pharmacokinetic studies with healthy subjects have shown that this drug is rapidly absorbed (time to Cmax about 0.65 h).",
        entities: [['T0', 'PK', [[93, 105]]], ['T1', 'VALUE', [[112, 116]]], ['T2', 'UNITS', [[117, 118]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-808',
    collData,
    {
        text: "A two-compartment model with mean t(1/2)alpha of 0.31 +- 0.27 hours and mean t(1/2)beta of 0.86 +- 0.78 hours best described the concentration-time curves for QC12.",
        entities: [['T0', 'PK', [[34, 45]]], ['T1', 'VALUE', [[49, 53]]], ['T2', 'VALUE', [[57, 61]]], ['T3', 'UNITS', [[62, 67]]], ['T4', 'PK', [[77, 87]]], ['T5', 'VALUE', [[91, 95]]], ['T6', 'VALUE', [[99, 103]]], ['T7', 'UNITS', [[104, 109]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T5']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-809',
    collData,
    {
        text: "The elimination of HTB was much slower with a t1/2 of 21.5 h and a Cl of 5.1 (mg/kg)/h.",
        entities: [['T0', 'PK', [[46, 50]]], ['T1', 'VALUE', [[54, 58]]], ['T2', 'PK', [[67, 69]]], ['T3', 'VALUE', [[73, 76]]], ['T4', 'UNITS', [[59, 60]]], ['T5', 'UNITS', [[77, 86]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-810',
    collData,
    {
        text: "The Ktrans values significantly decreased in five patients (18, 20, 21, 25 and 26), which is consistent with a reduction in tumour blood flow in response to study drug in these individuals (Galbraith et al, 2003).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-811',
    collData,
    {
        text: "Nonetheless, an important IIV was evidenced by these data, given that coefficient of variation (CV) was as high as 60% for Cmax, 56% for plasma concentration-time curve (AUC), and 64% for CL.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-812',
    collData,
    {
        text: "Apparent roflumilast clearance was estimated to be 2.34 L/h and 41.8 L/h for roflumilast and roflumilast‐N‐oxide dosing, respectively, whereas apparent roflumilast‐N‐oxide clearance was estimated to be 3.52 L/h and 1.09 L/h.",
        entities: [['T0', 'PK', [[0, 30]]], ['T1', 'VALUE', [[51, 55]]], ['T2', 'VALUE', [[64, 68]]], ['T3', 'UNITS', [[56, 59]]], ['T4', 'UNITS', [[69, 72]]], ['T5', 'PK', [[143, 181]]], ['T6', 'VALUE', [[202, 206]]], ['T7', 'UNITS', [[207, 210]]], ['T8', 'UNITS', [[220, 223]]], ['T9', 'VALUE', [[215, 219]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]], ['R4', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T6']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T9']]], ['R7', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T9']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-813',
    collData,
    {
        text: "Although supplementation with 200 mg/day androstenedione increases AUC for serum androstenedione in the day 0 condition, continued supplementation is characterised by a diminished treatment response, coupled with time 0 increases in testosterone precursors but not testosterone.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-814',
    collData,
    {
        text: "Elimination followed a biphasic course, with a rapid initial decline followed after 12-24 h by a late phase with a terminal half-life of about 10 h. About 100% of the administered dose could be recovered in urine within 72 h, mostly in conjugated form.",
        entities: [['T0', 'PK', [[115, 133]]], ['T1', 'VALUE', [[143, 145]]], ['T2', 'UNITS', [[146, 147]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-815',
    collData,
    {
        text: "Oral TAM bioavailability was 13,15% ± 4,18, with a steady state volume of distribution of 7831 ± 2922 (L/kg).",
        entities: [['T0', 'PK', [[9, 24]]], ['T1', 'VALUE', [[29, 34]]], ['T2', 'VALUE', [[38, 42]]], ['T3', 'UNITS', [[34, 35]]], ['T4', 'PK', [[51, 86]]], ['T5', 'VALUE', [[90, 94]]], ['T6', 'VALUE', [[97, 101]]], ['T7', 'UNITS', [[103, 107]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T5']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-816',
    collData,
    {
        text: "Linear calibration curves obtained with the peak-area ratio (y) of germacrone to internal standard (tanshinoneIIA) versus drug concentration (x) were found to be linear between 8.08 and 808 ng/ml.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-817',
    collData,
    {
        text: "Results revealed significant tumor regression effects in S-180 and EAC as T/Cmax values of 138 and 189 were obtained at its optimum dose of 60 mg/kg for QD1-7 .",
        entities: [['T0', 'PK', [[74, 80]]], ['T1', 'VALUE', [[91, 94]]], ['T2', 'VALUE', [[99, 102]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-818',
    collData,
    {
        text: "The loperamide from the syrup was absorbed more rapidly than from the capsule formulation, with the peak serum levels observed at a mean time of 2.4 +- 0.7 hours for the syrup and 5.2 +- 0.3 hours for the capsule formulation.",
        entities: [['T0', 'VALUE', [[187, 190]]], ['T1', 'VALUE', [[180, 183]]], ['T2', 'UNITS', [[191, 196]]], ['T3', 'VALUE', [[152, 155]]], ['T4', 'VALUE', [[145, 148]]], ['T5', 'UNITS', [[156, 161]]], ['T6', 'PK', [[132, 141]]]],
        relations: [['R0', 'D_VAL', [['Entity', 'T0'], ['D_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T0']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R4', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R6', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T4']]], ['R7', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-819',
    collData,
    {
        text: "Three-compartment modelling was performed for increasing fitting intervals (20-120 min) with both a 5-parameter (K1*-k4*, and vascular volume (Vo)) and a 4-parameter (K1*-k3*,Vo) model.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-820',
    collData,
    {
        text: "The k10 half-life ranged from 2.7 to 4.4 h. Cmax and AUC increased with dose in male rats, but these increases did not appear to be dose-proportional.",
        entities: [['T0', 'PK', [[8, 17]]], ['T1', 'RANGE', [[30, 40]]], ['T2', 'UNITS', [[41, 42]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-821',
    collData,
    {
        text: "In rats, rabbits and dogs, the Vss were 23.0, 51.7 and 7.3 L/kg, respectively, and the Vc were 2.33, 2.13 and 0.38 L/kg, respectively.",
        entities: [['T0', 'PK', [[31, 34]]], ['T1', 'VALUE', [[40, 44]]], ['T2', 'VALUE', [[46, 50]]], ['T3', 'VALUE', [[55, 58]]], ['T4', 'PK', [[87, 89]]], ['T5', 'VALUE', [[95, 99]]], ['T6', 'VALUE', [[101, 105]]], ['T7', 'VALUE', [[110, 114]]], ['T8', 'UNITS', [[59, 63]]], ['T9', 'UNITS', [[115, 119]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T6']]], ['R5', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T7']]], ['R6', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T2']]], ['R8', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T3']]], ['R9', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T5']]], ['R10', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T6']]], ['R11', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-822',
    collData,
    {
        text: "On day 7, small but statistically significant increases of 3.69 and 5.25 milliseconds in maximum 0–4‐hour QTcF were observed with FF/VI 50/25 and 100/25 μg, respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-823',
    collData,
    {
        text: "The mathematical relation between AUC0–24 h and particle size, AUC0–24 h = λ · sizen, is consistent across all sink-like ROIs with values of power coefficient n varying between 0.4 and 1.2, suggesting a moderate to strongly positive linear dependence (see Supplementary Fig. 19d, g, h).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-824',
    collData,
    {
        text: "The decline of morphine serum concentration after epidural administration of 0.1 mg/kg was described by a bi- or triexponential decay equation with a mean terminal half-life (t1/2) of 134.7 +- 107.9 min.",
        entities: [['T0', 'PK', [[155, 180]]], ['T1', 'VALUE', [[184, 189]]], ['T2', 'VALUE', [[193, 198]]], ['T3', 'UNITS', [[199, 202]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-825',
    collData,
    {
        text: "No correlation was found between AUC and BMI, LBM or adipose index (p = 0.34, 0.11 and 0.23, respectively).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-826',
    collData,
    {
        text: "An open-label placebo-controlled study of eight stable renal transplant patients found a 7% increase in AUC and 19% increase in Cmax of cyclosporine A, a CYP3A4 substrate, after co-administration of AZM, and concluded the drug-drug interaction not to be clinically significant [213].",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-827',
    collData,
    {
        text: "Mean Cmax increased from 0.52 to 9.75 μmol·L−1 after single i.v. doses of 0.3–4.8 mg·kg−1 lexaptepid respectively.",
        entities: [['T0', 'PK', [[5, 9]]], ['T1', 'VALUE', [[33, 37]]], ['T2', 'UNITS', [[38, 46]]], ['T3', 'VALUE', [[25, 29]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-828',
    collData,
    {
        text: "When AUCct was compared, a 126% increase was observed following vandetanib and rifampicin compared with vandetanib alone (gmean 44.26 vs 19.56 ng · h/mL).",
        entities: [['T0', 'UNITS', [[143, 152]]], ['T1', 'VALUE', [[137, 142]]], ['T2', 'VALUE', [[128, 133]]], ['T3', 'PK', [[5, 10]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-829',
    collData,
    {
        text: "SCYX-7158 did not exhibit any significant binding to this channel in a radioligand binding assay (−6% at 10 µM), and we confirmed this result by investigation of the ability of SCYX-7158 to block the hERG channel expressed in HEK-293 cells using a whole-cell patch clamp technique.[34], [35] At test concentrations of 30 and 100 µM, SCYX-7158 produced a mean fractional block of 0.108±0.037 and 0.198±0.018, respectively, indicative of a hERG IC50 >100 µM.",
        entities: [['T0', 'PK', [[443, 447]]], ['T1', 'VALUE', [[449, 452]]], ['T2', 'UNITS', [[453, 455]]], ['T3', 'COMPARE', [[448, 449]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-830',
    collData,
    {
        text: "LE was detected in all ocular tissues for both formulations within 5 min of dosing, and maximum concentrations were achieved within 1 h of instillation (Fig. 3).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-831',
    collData,
    {
        text: "The area under the drug concentration-time curves (AUC) and maximal blood concentration (C(max)) after oral administration of YH439 loaded on thermal reversible microemulsion were significantly increased than drug loaded on either Gelucire formulation or 5% Na-CMC suspension.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-832',
    collData,
    {
        text: "The phillygenin was slowly distributed to tissues, with a half-life of 150 min.",
        entities: [['T0', 'PK', [[58, 67]]], ['T1', 'VALUE', [[71, 74]]], ['T2', 'UNITS', [[75, 78]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-833',
    collData,
    {
        text: "Geometric mean (CV% geometric mean) of AR relative to cefiderocol dose was 56.1% (12.2%), and Fr was 62.3% (8.4%), suggesting that intermittent HD removed approximately 60% of the cefiderocol dose.",
        entities: [['T0', 'PK', [[39, 41]]], ['T1', 'VALUE', [[75, 79]]], ['T2', 'UNITS', [[79, 80]]], ['T3', 'PK', [[94, 96]]], ['T4', 'VALUE', [[101, 105]]], ['T5', 'UNITS', [[105, 106]]], ['T6', 'VALUE', [[82, 86]]], ['T7', 'UNITS', [[86, 87]]], ['T8', 'VALUE', [[108, 111]]], ['T9', 'UNITS', [[111, 112]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T4']]], ['R7', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-834',
    collData,
    {
        text: "Following i.v. administration of PCr 500 mg x kg(-1) and 1 000 mg x kg(-1) the C-T curve could be described by the two-compartment model with t1/2beta 22.5-23.3 min, V(d) 0.956 4-0.978 6 L x kg(-1), CL 0.029 L. kg(-1) x min(-1).",
        entities: [['T0', 'PK', [[142, 150]]], ['T1', 'RANGE', [[151, 160]]], ['T2', 'PK', [[166, 170]]], ['T3', 'RANGE', [[171, 186]]], ['T4', 'PK', [[199, 201]]], ['T5', 'VALUE', [[202, 207]]], ['T6', 'UNITS', [[161, 164]]], ['T7', 'UNITS', [[187, 197]]], ['T8', 'UNITS', [[208, 227]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R3', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T1']]], ['R4', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T3']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-835',
    collData,
    {
        text: "Mean Cmax increased in a dose‐proportional manner to 75 mg.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-836',
    collData,
    {
        text: "The concentration of embelin in plasma was low and the absorption was incomplete, which was indicated by the V/F of more than 6 L and the Cmax of 1.04 ± 0.21 μg/mL compared with the Cmax of 3.91 ± 1.34 μg/mL for intravenous administration [27].",
        entities: [['T0', 'PK', [[109, 112]]], ['T1', 'VALUE', [[126, 127]]], ['T2', 'UNITS', [[128, 129]]], ['T3', 'PK', [[138, 142]]], ['T4', 'VALUE', [[146, 150]]], ['T5', 'VALUE', [[153, 157]]], ['T6', 'UNITS', [[158, 163]]], ['T7', 'PK', [[182, 186]]], ['T8', 'VALUE', [[190, 194]]], ['T9', 'VALUE', [[197, 201]]], ['T10', 'UNITS', [[202, 207]]], ['T11', 'COMPARE', [[116, 120]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T4']]], ['R6', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T8']]], ['R7', 'D_VAL', [['Entity', 'T9'], ['D_VAL', 'T8']]], ['R8', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T9']]], ['R9', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-837',
    collData,
    {
        text: "The only pharmacodynamic parameter showing a statistically significant difference in change from baseline between the two formulations was DBP with mean (+- SD) change in AUC0-12 of -13.6(+- 20.8) and +8.4(+- 31.7) mm Hg h (p = 0.0135) and in AUC0-24 of -33.0(+- 43.7) and -0.3(+- 59.2) mm Hg h (p = 0.0463) for Cardizem SR and Bi-Tildiem, respectively.",
        entities: [['T0', 'PK', [[171, 178]]], ['T1', 'VALUE', [[182, 187]]], ['T2', 'VALUE', [[201, 205]]], ['T3', 'VALUE', [[191, 195]]], ['T4', 'UNITS', [[215, 222]]], ['T5', 'VALUE', [[209, 213]]], ['T6', 'PK', [[243, 250]]], ['T7', 'VALUE', [[254, 259]]], ['T8', 'VALUE', [[273, 277]]], ['T9', 'VALUE', [[263, 267]]], ['T10', 'UNITS', [[287, 294]]], ['T11', 'VALUE', [[281, 285]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T2']]], ['R5', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R8', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R9', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T8']]], ['R10', 'D_VAL', [['Entity', 'T9'], ['D_VAL', 'T7']]], ['R11', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T9']]], ['R12', 'D_VAL', [['Entity', 'T11'], ['D_VAL', 'T8']]], ['R13', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T11']]], ['R14', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T8']]], ['R15', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-838',
    collData,
    {
        text: "Peak and trough concentrations were significantly different between the continuous and intermittent groups both in the first (Cmax: 19.8 mg/L vs. 51.8 mg/L, P= 0.000; Cmin: 11.2 mg/L vs. 0.5 mg/L, P= 0.000) and third dosing periods (Cmax: 12.5 mg/L vs. 46.4 mg/L, P= 0.000; Cmin: 11.4 mg/L vs. 0.6 mg/L, P= 0.000).",
        entities: [['T0', 'PK', [[126, 130]]], ['T1', 'VALUE', [[132, 136]]], ['T2', 'VALUE', [[146, 150]]], ['T3', 'PK', [[167, 171]]], ['T4', 'VALUE', [[173, 177]]], ['T5', 'VALUE', [[187, 190]]], ['T6', 'PK', [[233, 237]]], ['T7', 'VALUE', [[239, 243]]], ['T8', 'VALUE', [[253, 257]]], ['T9', 'PK', [[274, 278]]], ['T10', 'VALUE', [[280, 284]]], ['T11', 'VALUE', [[294, 297]]], ['T12', 'UNITS', [[137, 141]]], ['T13', 'UNITS', [[151, 155]]], ['T14', 'UNITS', [[178, 182]]], ['T15', 'UNITS', [[191, 195]]], ['T16', 'UNITS', [[244, 248]]], ['T17', 'UNITS', [[258, 262]]], ['T18', 'UNITS', [[285, 289]]], ['T19', 'UNITS', [[298, 302]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T5']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R5', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T8']]], ['R6', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T10']]], ['R7', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T11']]], ['R8', 'RELATED', [['Entity', 'T12'], ['RELATED', 'T1']]], ['R9', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T2']]], ['R10', 'RELATED', [['Entity', 'T14'], ['RELATED', 'T4']]], ['R11', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T5']]], ['R12', 'RELATED', [['Entity', 'T16'], ['RELATED', 'T7']]], ['R13', 'RELATED', [['Entity', 'T17'], ['RELATED', 'T8']]], ['R14', 'RELATED', [['Entity', 'T18'], ['RELATED', 'T10']]], ['R15', 'RELATED', [['Entity', 'T19'], ['RELATED', 'T11']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-839',
    collData,
    {
        text: "Amsacrine was also found to be highly bound to plasma proteins (96.4%-97.7%), but changes in binding were not responsible for the reduced Cl and prolonged t1/2 beta observed between the first and third infusions.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-840',
    collData,
    {
        text: "Total clearance (CLT) was similar at the doses of 10 and 50 mg/kg, with values of 2.80 and 2.73 L/h/kg, respectively.",
        entities: [['T0', 'PK', [[0, 21]]], ['T1', 'VALUE', [[82, 86]]], ['T2', 'VALUE', [[91, 95]]], ['T3', 'UNITS', [[96, 102]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-841',
    collData,
    {
        text: "Remarkably, although the AUC remained unchanged, the Cmax of LVX [257] and the third-generation fluoroquinolone MXF [258] decreased by approximately 18% by means of concomitant treatment with calcium.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-842',
    collData,
    {
        text: "Elimination clearance was 0.0061 +- 0.0006 liters/min/kg for the 12-mg/kg group and 0.0086 +- 0.0013 liters/min/kg for the 60-mg/kg group (P greater than .05).",
        entities: [['T0', 'PK', [[0, 21]]], ['T1', 'VALUE', [[26, 32]]], ['T2', 'VALUE', [[84, 90]]], ['T3', 'VALUE', [[36, 42]]], ['T4', 'UNITS', [[43, 56]]], ['T5', 'VALUE', [[94, 100]]], ['T6', 'UNITS', [[101, 114]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T2']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-843',
    collData,
    {
        text: "The occurrence of elevated liver enzymes during the first 6 weeks in the EFV-containing arm was significantly (P = 0.036) correlated to the exposure of EFV (Cmin).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-844',
    collData,
    {
        text: "The calibration curve was prepared by determining the best fit of the peak-area ratios (peak area analyte/peak area IS) vs. concentration, and fitted to the y = mx + c using a weighing factor (1/x).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-845',
    collData,
    {
        text: "2. Totally, 14 constituents (two parent compounds and 12 metabolites) of Fructus Gardeniae were identified in human plasma and urine either by comparing the retention time and mass spectrometry data with that of reference compounds or by the accurate high-resolution MS/MS data of the chemicals.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-846',
    collData,
    {
        text: "The maximum levels were 54 to 106.4 ng/ml with the 30 mg dosage and 74.7 to 79.2 ng/ml with the 40 mg dosage, followed by a slow decline, with T1/2 ranging from 6.54 to 17.80 hr.",
        entities: [['T0', 'PK', [[4, 18]]], ['T1', 'RANGE', [[24, 35]]], ['T2', 'RANGE', [[68, 80]]], ['T3', 'PK', [[143, 147]]], ['T4', 'RANGE', [[161, 174]]], ['T5', 'UNITS', [[36, 41]]], ['T6', 'UNITS', [[81, 86]]], ['T7', 'UNITS', [[175, 177]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T2']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-847',
    collData,
    {
        text: "Moreover, the in situ gel achieved 2-3 fold higher peak plasma concentration (Cmax) and area under the curve (AUC) of THA in plasma and brain tissue, but lowered Cmax and AUC of the THA metabolites compared to that of oral solution.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-848',
    collData,
    {
        text: "In an exploratory analysis, relatively smaller differences in AUC(INF) were observed among the 3 groups after the exclusion of 3 patients (2 in the NRF group and 1 in the ESRD group) who had developed antidrug antibodies on day 1 of cycle 2.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-849',
    collData,
    {
        text: "Cinacalcet was rapidly absorbed, with a median tmax of 1 h (range 0.50 to 4.0 h) (Table 2, Fig. 2).",
        entities: [['T0', 'PK', [[47, 51]]], ['T1', 'VALUE', [[55, 56]]], ['T2', 'UNITS', [[57, 58]]], ['T3', 'RANGE', [[66, 77]]], ['T4', 'UNITS', [[78, 79]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-850',
    collData,
    {
        text: "The pharmacokinetic parameters such as elimination rate half-life (t1/2), area under curve (AUC), and plasma clearance (CL) were calculated to be 3.345±0.647 min, 5750±656.0 µg min/mL, and 5.891±0.458 mL/min/kg, respectively.",
        entities: [['T0', 'PK', [[39, 72]]], ['T1', 'VALUE', [[146, 151]]], ['T2', 'VALUE', [[152, 157]]], ['T3', 'UNITS', [[158, 161]]], ['T4', 'PK', [[74, 96]]], ['T5', 'VALUE', [[163, 167]]], ['T6', 'VALUE', [[168, 173]]], ['T7', 'UNITS', [[174, 183]]], ['T8', 'PK', [[102, 123]]], ['T9', 'VALUE', [[189, 194]]], ['T10', 'VALUE', [[195, 200]]], ['T11', 'UNITS', [[201, 210]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T5']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T5']]], ['R8', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T9']]], ['R9', 'D_VAL', [['Entity', 'T10'], ['D_VAL', 'T9']]], ['R10', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T10']]], ['R11', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T9']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-851',
    collData,
    {
        text: "In addition, no significant differences in mean cumulative urine volume were observed in empagliflozin versus placebo in the first 24 h (3.11–3.98 L and 3.17 L, respectively), or in the first 72 h (7.12–8.71 L and 7.30 L, respectively) [20].",
        entities: [['T0', 'PK', [[48, 71]]], ['T1', 'RANGE', [[137, 146]]], ['T2', 'VALUE', [[153, 157]]], ['T3', 'RANGE', [[198, 207]]], ['T4', 'VALUE', [[214, 218]]], ['T5', 'UNITS', [[147, 148]]], ['T6', 'UNITS', [[158, 159]]], ['T7', 'UNITS', [[208, 209]]], ['T8', 'UNITS', [[219, 220]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T2']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T3']]], ['R7', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-852',
    collData,
    {
        text: "In ISF, the observed versus population predicted r2, bias, and imprecision were 0.198, 20.1, and 1,394 (Fig. 2a), and the corresponding values for the observed versus individual MAP Bayesian plot were 0.887, −1.17, and 21.3, respectively (Fig. 2b).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-853',
    collData,
    {
        text: "The predicted bioavailability of the p.o. 25, 50, 100 and 400 mg doses of talinolol was 64, 76, 85, 94%, respectively.",
        entities: [['T0', 'PK', [[14, 29]]], ['T1', 'VALUE', [[88, 90]]], ['T2', 'VALUE', [[92, 94]]], ['T3', 'VALUE', [[96, 98]]], ['T4', 'VALUE', [[100, 102]]], ['T5', 'UNITS', [[102, 103]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T2']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R7', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-854',
    collData,
    {
        text: "The apparent volume of distribution (V/F) was significantly lower in patients receiving split doses of mefloquine monotherapy (mean, 8.14 L/kg; 95% CI, 7.49 to 8.86 L/kg) compared with a single dose (mean, 20.37 L/kg; 95% CI, 16.26 to 25.51 L/kg).",
        entities: [['T0', 'PK', [[4, 41]]], ['T1', 'VALUE', [[133, 137]]], ['T2', 'UNITS', [[138, 142]]], ['T3', 'VALUE', [[206, 211]]], ['T4', 'UNITS', [[212, 216]]], ['T5', 'RANGE', [[152, 164]]], ['T6', 'UNITS', [[165, 169]]], ['T7', 'RANGE', [[226, 240]]], ['T8', 'UNITS', [[241, 245]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T3']]], ['R7', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-855',
    collData,
    {
        text: "There was also a large inter-individual variability in QHS pharmacokinetic parameters, with a %CV of 43.5% (6.9-122.7%) for AUC0-t.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-856',
    collData,
    {
        text: "The metabolic ratio (1-hydroxytacrine AUC/tacrine AUC) was significantly (mean, 26%; P < .001) reduced in all 10 subjects.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-857',
    collData,
    {
        text: "Median time to maximum concentration (Tmax) was 1h and 1.5h for suspension and solution formulation, respectively.",
        entities: [['T0', 'PK', [[7, 43]]], ['T1', 'VALUE', [[48, 49]]], ['T2', 'VALUE', [[55, 58]]], ['T3', 'UNITS', [[49, 50]]], ['T4', 'UNITS', [[58, 59]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-858',
    collData,
    {
        text: "This approach is based on the CVWR: if the CVWR is inferior or equal to 30 % (≤30 %), the 90 % geometric confidence intervals of the ratio T/R of least-squares means of the ln-transformed Cmax should be within the acceptable range of 80.00–125.00 % to conclude bioequivalence.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-859',
    collData,
    {
        text: "The mean Tmax was 1.82, 2.3, 2.79 and 3.39 h, respectively.",
        entities: [['T0', 'PK', [[9, 13]]], ['T1', 'VALUE', [[18, 22]]], ['T2', 'VALUE', [[24, 27]]], ['T3', 'VALUE', [[29, 33]]], ['T4', 'VALUE', [[38, 42]]], ['T5', 'UNITS', [[43, 44]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-860',
    collData,
    {
        text: "Mean terminal half lives for total radioactivity ranged from 2.5 to 4.2 hours.",
        entities: [['T0', 'PK', [[5, 24]]], ['T1', 'RANGE', [[61, 71]]], ['T2', 'UNITS', [[72, 77]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-861',
    collData,
    {
        text: "The estimated AUC for the MD QD and BID groups was 26.2×106 and 18.4×106, respectively (Table S1).",
        entities: [['T0', 'PK', [[14, 17]]], ['T1', 'VALUE', [[51, 59]]], ['T2', 'VALUE', [[64, 72]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-862',
    collData,
    {
        text: "X‐82 blood pharmacokinetics appeared dose‐independent with a t1/2 of 5.13 hours and 6.48 hours for capsule and tablet formulations, respectively.",
        entities: [['T0', 'PK', [[61, 65]]], ['T1', 'VALUE', [[69, 73]]], ['T2', 'VALUE', [[84, 88]]], ['T3', 'UNITS', [[74, 79]]], ['T4', 'UNITS', [[89, 94]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-863',
    collData,
    {
        text: "We measured serum trough levels after week 1 in cohort 1 or after two consecutive weekly doses in cohorts 2 and 3.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-864',
    collData,
    {
        text: "Supplementary Figure S2 depicts this relationship and shows that the CL for paracetamol in zebrafish larvae obtained in this study does fall within the 95% confidence and prediction interval of this fit.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-865',
    collData,
    {
        text: "The mean half-life of the tracer in the lungs in Groups I-IV was 60, 58, 59 and 26 min, respectively.",
        entities: [['T0', 'PK', [[9, 18]]], ['T1', 'VALUE', [[65, 67]]], ['T2', 'VALUE', [[69, 71]]], ['T3', 'VALUE', [[73, 75]]], ['T4', 'VALUE', [[80, 82]]], ['T5', 'UNITS', [[83, 86]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-866',
    collData,
    {
        text: "Between‐subject variability in Cmax and area under the curve (AUC), as calculated using noncompartmental analysis (NCA) was generally low to moderate, with a coefficient of variation between 10–40% (Table S2).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-867',
    collData,
    {
        text: "The lead compound in the series, N-(2-phenethyl)-N'-(2-thiazolyl)thiourea (1), inhibits HIV-1 RT using rCdG as the template with an IC50 of 0.9 microM. In MT-4 cells, compound 1 inhibits HIV-1 with an ED50 of 1.3 microM.",
        entities: [['T0', 'PK', [[132, 136]]], ['T1', 'VALUE', [[140, 143]]], ['T2', 'UNITS', [[144, 150]]], ['T3', 'UNITS', [[213, 219]]], ['T4', 'VALUE', [[209, 212]]], ['T5', 'PK', [[201, 205]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-868',
    collData,
    {
        text: "For pharmacokinetic analysis, single steady‐state trough samples were obtained from all consenting patients immediately prior to dose administration during cycle 1 on days 7, 14, 21, and 28 along with cycle 2 on days 1 and 28.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-869',
    collData,
    {
        text: "The overall differences in PK parameters among formulations for African Americans were similar to the main analysis, suggesting that LCPT provided a higher AUC0–24 (RGM 138.2, p < 0.01, and 149.1, p = 0.02), Cmax was similar despite a higher AUC0–24 (RGM 107.4, p = 0.54, and 109.8, p = 0.22), Cmin was higher (RGM 125.3, p = 0.02, and 151.0, p < 0.01), Tmax was delayed (RGM 2.48, p = 0.22, and 2.55, p < 0.01) and intraday peak‐to‐trough fluctuation was lower (−39.64, p = 0.07, and −54.08, p = 0.02) for LCPT versus IR‐Tac and LCPT versus ER‐Tac, respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-870',
    collData,
    {
        text: "When the tmax values of the ingredients at a dose of 7.5 g were compared, it was found that atractylodin carboxylic acid, isoliquiritigenin, nobiletin, atractylodin, and heptamethoxyflavone were all rapid-acting, with values of 1 h or shorter, while liquiritigenin, naringenin, pachymic acid, and 18β-glycyrrhetinic acid showed values exceeding 3 h. When t1/2 values of the components at a dose of 7.5 g were compared, atractylodin carboxylic acid, atractylodin, heptamethoxyflavone, nobiletin, isoliquiritigenin, liquiritigenin, and naringenin had values < 10 h, while 18β-glycyrrhetinic acid, and pachymic acid had values exceeding 10 h. The plasma concentrations of atractylodin and pachymic acid just before the administration were BQL in all subjects, whereas peaks for other compounds (atractylodin carboxylic acid, heptamethoxyflavone, liquiritigenin, isoliquiritigenin, nobiletin, naringenin, and 18β-glycyrrhetinic acid) were detected in some subjects.",
        entities: [['T0', 'PK', [[9, 13]]], ['T1', 'VALUE', [[228, 229]]], ['T2', 'UNITS', [[230, 231]]], ['T3', 'UNITS', [[347, 348]]], ['T4', 'VALUE', [[345, 346]]], ['T5', 'UNITS', [[561, 562]]], ['T6', 'VALUE', [[558, 560]]], ['T7', 'UNITS', [[637, 638]]], ['T8', 'VALUE', [[634, 636]]], ['T9', 'COMPARE', [[556, 557]]], ['T10', 'PK', [[355, 359]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T6']]], ['R4', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T8']]], ['R5', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T6']]], ['R6', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R7', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T6']]], ['R8', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T8']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-871',
    collData,
    {
        text: "C0 was a poor predictor of the total MPA exposure [as measured by the area under the concentration-time curve AUC)], while a truncated AUC was a good surrogate of the 12-h profile (r = 0.91; p < 0.001) Graft function and cyclosporine therapy influenced MPA pharmacokinetics, as shown by the univariate and multivariate analyses.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-872',
    collData,
    {
        text: "The mean area under the concentration x time curve (AUC) was 498 ng.h/ml.",
        entities: [['T0', 'PK', [[9, 56]]], ['T1', 'VALUE', [[61, 64]]], ['T2', 'UNITS', [[65, 72]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-873',
    collData,
    {
        text: "The absorption of cyadox after oral administration was limited, reaching the maximum plasma concentration (Cmax = 0.031 μg/mL) at 2.41 h. After this point, the concentration of the drug quickly decreased to the quantification limit (0.02 μg/mL) by 12 h. The pharmacokinetic parameters derived from non-compartmental analysis are presented in Table 2, and the area under the concentration-time curve (AUC)0–24h of plasma was 0.22 μg/h/mL. Compared to the cyadox concentration in plasma, the concentration in the ileum fluid was markedly higher, with a Cmax of 23.66 μg/mL at 1.96 h, and the AUC0–24h (106.40 μg/h/mL) was also much higher.",
        entities: [['T0', 'PK', [[77, 111]]], ['T1', 'VALUE', [[114, 119]]], ['T2', 'PK', [[359, 409]]], ['T3', 'VALUE', [[424, 428]]], ['T4', 'PK', [[551, 555]]], ['T5', 'VALUE', [[559, 564]]], ['T6', 'PK', [[590, 598]]], ['T7', 'VALUE', [[600, 606]]], ['T8', 'UNITS', [[607, 614]]], ['T9', 'UNITS', [[565, 570]]], ['T10', 'UNITS', [[429, 436]]], ['T11', 'UNITS', [[120, 125]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R3', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R4', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]], ['R5', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T3']]], ['R7', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-874',
    collData,
    {
        text: "Measurements after cessation of treatment gave terminal half-lives in plasma of 11.5-23.0 h which is considerably longer than reported in the literature.",
        entities: [['T0', 'PK', [[47, 66]]], ['T1', 'RANGE', [[80, 89]]], ['T2', 'UNITS', [[90, 91]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-875',
    collData,
    {
        text: "After oral administration, the maximum plasma concentrations were obtained within 0.83-3.00 h and the half-life for each animal was almost the same as that after intravenous administration.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-876',
    collData,
    {
        text: "The 25% SLS formulation demonstrated bioequivalence to the reference 50% SLS formulation for Cmax , AUC0-last , and AUC0-∞ of alectinib, M4, and alectinib plus M4 under both fasted and fed conditions.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-877',
    collData,
    {
        text: "Over the dose range 2–120 mg, the slopes (β) for Cmax and AUC0−∞ vs dose plots (1.6 [95% confidence interval (CI) 1.5–1.7] and 2.8 [95% CI 2.6–2.9], respectively) were well above unity.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-878',
    collData,
    {
        text: "Thirteen of 14 subjects with AUC(24,36 h)> or =700 nmol l(-1) h responded to pharmacotherapy.",
        entities: [['T0', 'PK', [[29, 41]]], ['T1', 'VALUE', [[47, 50]]], ['T2', 'UNITS', [[51, 63]]], ['T3', 'COMPARE', [[41, 47]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-879',
    collData,
    {
        text: "Actual areas under the concentration-time curve (AUC) (mg/ml min) were 5.4, 5.7, 6.2, and 9.0 for the four patients with a target AUC (mg/ml min) of 5; 5.7, 6.2, and 7.1 for the three patients with a target AUC (mg/ml min) of 4; and 5.1 and 8.7 for the two hemodialysis patients with a target AUC (mg/ml min) of 5.",
        entities: [['T0', 'PK', [[7, 53]]], ['T1', 'VALUE', [[71, 74]]], ['T2', 'VALUE', [[76, 79]]], ['T3', 'VALUE', [[81, 84]]], ['T4', 'VALUE', [[90, 93]]], ['T5', 'PK', [[130, 133]]], ['T6', 'VALUE', [[149, 150]]], ['T7', 'VALUE', [[152, 155]]], ['T8', 'VALUE', [[157, 160]]], ['T9', 'VALUE', [[166, 169]]], ['T10', 'PK', [[207, 210]]], ['T11', 'VALUE', [[226, 227]]], ['T12', 'VALUE', [[233, 236]]], ['T13', 'VALUE', [[241, 244]]], ['T14', 'PK', [[293, 296]]], ['T15', 'VALUE', [[312, 313]]], ['T16', 'UNITS', [[298, 307]]], ['T17', 'UNITS', [[212, 221]]], ['T18', 'UNITS', [[135, 144]]], ['T19', 'UNITS', [[55, 64]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T6']]], ['R5', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T7']]], ['R6', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T8']]], ['R7', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T9']]], ['R8', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T11']]], ['R9', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T12']]], ['R10', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T13']]], ['R11', 'C_VAL', [['Entity', 'T14'], ['C_VAL', 'T15']]], ['R12', 'RELATED', [['Entity', 'T16'], ['RELATED', 'T15']]], ['R13', 'RELATED', [['Entity', 'T17'], ['RELATED', 'T11']]], ['R14', 'RELATED', [['Entity', 'T17'], ['RELATED', 'T12']]], ['R15', 'RELATED', [['Entity', 'T17'], ['RELATED', 'T13']]], ['R16', 'RELATED', [['Entity', 'T18'], ['RELATED', 'T6']]], ['R17', 'RELATED', [['Entity', 'T18'], ['RELATED', 'T7']]], ['R18', 'RELATED', [['Entity', 'T18'], ['RELATED', 'T8']]], ['R19', 'RELATED', [['Entity', 'T18'], ['RELATED', 'T9']]], ['R20', 'RELATED', [['Entity', 'T19'], ['RELATED', 'T1']]], ['R21', 'RELATED', [['Entity', 'T19'], ['RELATED', 'T2']]], ['R22', 'RELATED', [['Entity', 'T19'], ['RELATED', 'T3']]], ['R23', 'RELATED', [['Entity', 'T19'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-880',
    collData,
    {
        text: "During co-administration the CLR AUC increased by 57% and the Cmax by 26%.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-881',
    collData,
    {
        text: "The 90% CI for dronabinol Cmax fell outside the bioequivalence range of 80%–125%.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-882',
    collData,
    {
        text: "The female/male exposure ratios for the maximum (Cmax) and total (AUC0–t) exposure outcomes of all formulations are given in Tables 9 (Cmax data) and 10 (AUC data), respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-883',
    collData,
    {
        text: "The apparent clearance was calculated to be 0.8 +- 0.4 ml x min-1 x kg-1.",
        entities: [['T0', 'PK', [[4, 22]]], ['T1', 'VALUE', [[44, 47]]], ['T2', 'VALUE', [[51, 54]]], ['T3', 'UNITS', [[55, 72]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-884',
    collData,
    {
        text: "Peak concentration of morphine 79 +- 19 ng/ml was reached within 10 min after administration.",
        entities: [['T0', 'PK', [[0, 18]]], ['T1', 'VALUE', [[31, 33]]], ['T2', 'VALUE', [[37, 39]]], ['T3', 'UNITS', [[40, 45]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-885',
    collData,
    {
        text: "The distribution half-life (t1/2α) was 6.42±2.60 minutes.",
        entities: [['T0', 'UNITS', [[49, 56]]], ['T1', 'VALUE', [[39, 43]]], ['T2', 'VALUE', [[44, 48]]], ['T3', 'PK', [[4, 34]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-886',
    collData,
    {
        text: "The volume of distribution at steady-state was large (2.13 +- 0.17 l/kg), suggesting extensive tissue distribution, the clearance value was 0.60 +- 0.03 l/h.",
        entities: [['T0', 'UNITS', [[67, 71]]], ['T1', 'VALUE', [[54, 58]]], ['T2', 'UNITS', [[153, 156]]], ['T3', 'VALUE', [[140, 144]]], ['T4', 'VALUE', [[62, 66]]], ['T5', 'VALUE', [[148, 152]]], ['T6', 'PK', [[4, 42]]], ['T7', 'PK', [[120, 129]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T3']]], ['R5', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T5']]], ['R6', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T1']]], ['R7', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-887',
    collData,
    {
        text: "The retention time of tramadol, O-desmethyltramadol, and the internal standard were 7.2, 6.8, and 6.6 minutes, respectively.",
        entities: [['T0', 'UNITS', [[102, 109]]], ['T1', 'VALUE', [[98, 101]]], ['T2', 'VALUE', [[89, 92]]], ['T3', 'VALUE', [[84, 87]]], ['T4', 'PK', [[4, 18]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T2']]], ['R5', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-888',
    collData,
    {
        text: "Binding kinetics was determined by a mixture of two receptor subtypes, a low-affinity/high-capacity binding site (K(D,1) = 20.9 nmol, 89% of total receptors) and a high-affinity/low-capacity binding site (K(D,2) = 1.5 nmol, 11%).",
        entities: [['T0', 'UNITS', [[128, 132]]], ['T1', 'VALUE', [[123, 127]]], ['T2', 'UNITS', [[218, 222]]], ['T3', 'VALUE', [[214, 217]]], ['T4', 'PK', [[114, 120]]], ['T5', 'PK', [[205, 211]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-889',
    collData,
    {
        text: "Median time to progression was 2.8 months (95% confidence interval, 1.05–5.52) for group I and 3.2 months (95% confidence interval, 0.95–6.70) for group II.",
        entities: [['T0', 'UNITS', [[35, 41]]], ['T1', 'VALUE', [[31, 34]]], ['T2', 'PK', [[7, 26]]], ['T3', 'VALUE', [[95, 98]]], ['T4', 'UNITS', [[99, 105]]], ['T5', 'RANGE', [[68, 77]]], ['T6', 'RANGE', [[132, 141]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T5']]], ['R6', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T3']]], ['R7', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-890',
    collData,
    {
        text: "In the PK assessment of palbociclib 100 and 125 mg (part 1), higher than dose‐proportional exposure was observed at 125 mg (Table 4, Fig. 3), whereas median tmax (4–5 h) and t½ (23–26 h) values remained relatively constant (Table 4).",
        entities: [['T0', 'UNITS', [[167, 168]]], ['T1', 'RANGE', [[163, 166]]], ['T2', 'PK', [[157, 161]]], ['T3', 'UNITS', [[184, 185]]], ['T4', 'RANGE', [[178, 183]]], ['T5', 'PK', [[174, 176]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-891',
    collData,
    {
        text: "Because the mean intrinsic clearance (i.e., Vmax/Km) for the high-affinity site (i.e., 0.79 +- 0.69 ml/hr/mg protein) was about 30 times greater than that for the low-affinity site (i.e., 0.03 +- 0.01 ml/hr/mg protein), the high-affinity site was considered more important in the DP metabolism at its therapeutic concentrations (i.e., 2-5 micrograms/ml or 5-14 microM).",
        entities: [['T0', 'UNITS', [[100, 116]]], ['T1', 'VALUE', [[89, 91]]], ['T2', 'PK', [[17, 36]]], ['T3', 'VALUE', [[95, 99]]], ['T4', 'UNITS', [[201, 217]]], ['T5', 'VALUE', [[188, 192]]], ['T6', 'VALUE', [[196, 200]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T3']]], ['R4', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R5', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T5']]], ['R6', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T5']]], ['R7', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-892',
    collData,
    {
        text: "Comparability was declared if the 90% confidence interval for the geometric mean ratio of laropiprant+digoxin to digoxin alone of the area under the plasma concentration-time curve from time 0 to infinity (AUC(0-infinity)) for immunoreactive digoxin fell within 0.80 to 1.25.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-893',
    collData,
    {
        text: "Ten pharmacokinetic profiles obtained from 8 patients showed a maximum plasma diflunisal concentration of 62.0 +- 26.5 mg/L after 2.76 +- 1.87 hours, and an area under the plasma concentration-time curve (AUC) of 678.3 +- 362.3 mg/L.h.",
        entities: [['T0', 'PK', [[63, 102]]], ['T1', 'VALUE', [[106, 110]]], ['T2', 'UNITS', [[119, 123]]], ['T3', 'VALUE', [[222, 227]]], ['T4', 'VALUE', [[213, 218]]], ['T5', 'UNITS', [[228, 234]]], ['T6', 'PK', [[157, 209]]], ['T7', 'VALUE', [[114, 118]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R5', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T4']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T1']]], ['R7', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-894',
    collData,
    {
        text: "In contrast, 3 patients with trough levels < 4 ng/ml had ongoing rejection.",
        entities: [['T0', 'UNITS', [[47, 52]]], ['T1', 'VALUE', [[45, 46]]], ['T2', 'PK', [[29, 42]]], ['T3', 'COMPARE', [[43, 44]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-895',
    collData,
    {
        text: "The mean Cmax  (mean ± SD ng/mL) of test and reference formulation were 10.212 ± 2.23 and 11.422 ± 2.23, respectively, under fasting conditions.",
        entities: [['T0', 'VALUE', [[81, 85]]], ['T1', 'VALUE', [[72, 78]]], ['T2', 'UNITS', [[26, 31]]], ['T3', 'VALUE', [[99, 103]]], ['T4', 'VALUE', [[90, 96]]], ['T5', 'PK', [[9, 13]]]],
        relations: [['R0', 'D_VAL', [['Entity', 'T0'], ['D_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T0']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R4', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R5', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T4']]], ['R6', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T1']]], ['R7', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-896',
    collData,
    {
        text: "Relative to ROP, whose half-life was approximately 0.7 hours, the two conjugates prepared, following intravenous administration, showed markedly prolonged retention in systemic circulation with half-lives in blood of 78.4 and 88.3 hours, respectively.",
        entities: [['T0', 'UNITS', [[55, 60]]], ['T1', 'VALUE', [[51, 54]]], ['T2', 'UNITS', [[231, 236]]], ['T3', 'VALUE', [[226, 230]]], ['T4', 'VALUE', [[217, 221]]], ['T5', 'PK', [[23, 32]]], ['T6', 'PK', [[194, 213]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T4']]], ['R5', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-897',
    collData,
    {
        text: "The HDV half‐life in blood was 1.87 days, and the average steady‐state LNF efficacy in blocking HDV production was ɛ = 87.7% for group 1 and ɛ = 95.2% for group 2.",
        entities: [['T0', 'PK', [[8, 26]]], ['T1', 'VALUE', [[31, 35]]], ['T2', 'UNITS', [[36, 40]]], ['T3', 'UNITS', [[123, 124]]], ['T4', 'VALUE', [[119, 123]]], ['T5', 'UNITS', [[149, 150]]], ['T6', 'VALUE', [[145, 149]]], ['T7', 'PK', [[115, 116]]], ['T8', 'PK', [[141, 142]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T6']]], ['R4', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T4']]], ['R5', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-898',
    collData,
    {
        text: "In patients receiving maximum lipid-lowering therapy, mipomersen plasma t½ of approximately 30 days was reported across all dose groups, with no significant change seen with extension of dosing from 5 to 13 weeks [34].",
        entities: [['T0', 'UNITS', [[95, 99]]], ['T1', 'VALUE', [[92, 94]]], ['T2', 'PK', [[65, 74]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-899',
    collData,
    {
        text: "The % AUC of metabolite converted to parent upon its administration % A U C K - 09 K - 9 T was found to be 27.28 ± 2.67.",
        entities: [['T0', 'PK', [[4, 9]]], ['T1', 'VALUE', [[107, 112]]], ['T2', 'VALUE', [[115, 119]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-900',
    collData,
    {
        text: "The kinetics of (R)-Casodex were similar in subjects with and without liver disease (Cmax: 750 vs 848 ng ml(-1); tmax: 24 - 30 h; t(1/2): 7.40 vs 7.22 days; AUC: 182 vs 225 microg ml(-1) h).",
        entities: [['T0', 'UNITS', [[102, 111]]], ['T1', 'VALUE', [[98, 101]]], ['T2', 'UNITS', [[127, 128]]], ['T3', 'VALUE', [[124, 126]]], ['T4', 'UNITS', [[151, 155]]], ['T5', 'VALUE', [[146, 150]]], ['T6', 'PK', [[157, 160]]], ['T7', 'VALUE', [[169, 172]]], ['T8', 'VALUE', [[162, 165]]], ['T9', 'PK', [[130, 136]]], ['T10', 'VALUE', [[138, 142]]], ['T11', 'PK', [[113, 117]]], ['T12', 'VALUE', [[119, 121]]], ['T13', 'PK', [[85, 89]]], ['T14', 'VALUE', [[91, 94]]], ['T15', 'UNITS', [[173, 188]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R3', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T8']]], ['R5', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T10']]], ['R6', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T5']]], ['R7', 'C_VAL', [['Entity', 'T11'], ['C_VAL', 'T12']]], ['R8', 'C_VAL', [['Entity', 'T11'], ['C_VAL', 'T3']]], ['R9', 'C_VAL', [['Entity', 'T13'], ['C_VAL', 'T14']]], ['R10', 'C_VAL', [['Entity', 'T13'], ['C_VAL', 'T1']]], ['R11', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T14']]], ['R12', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T12']]], ['R13', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T10']]], ['R14', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T7']]], ['R15', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T8']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-901',
    collData,
    {
        text: "The volume of distribution of fenofibric acid (Vc/F) was 12.9 L, and the elimination rate constant of fenofibric acid (kel) was 0.27 h− 1.",
        entities: [['T0', 'PK', [[73, 123]]], ['T1', 'VALUE', [[128, 132]]], ['T2', 'UNITS', [[62, 63]]], ['T3', 'VALUE', [[57, 61]]], ['T4', 'UNITS', [[133, 137]]], ['T5', 'PK', [[4, 52]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-902',
    collData,
    {
        text: "The mean +- SD for the effective half-life after IV administration was 1.25 +- 0.30 hours.",
        entities: [['T0', 'PK', [[23, 42]]], ['T1', 'VALUE', [[71, 75]]], ['T2', 'VALUE', [[79, 83]]], ['T3', 'UNITS', [[84, 89]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-903',
    collData,
    {
        text: "Moreover, the oral bioavailability of Fpx could be dramatically increased up to 9% by including the nanoparticles into gastroresistant capsules.",
        entities: [['T0', 'UNITS', [[81, 82]]], ['T1', 'VALUE', [[80, 81]]], ['T2', 'COMPARE', [[74, 79]]], ['T3', 'PK', [[14, 34]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-904',
    collData,
    {
        text: "The population area under the curve from 0 to 24 h (AUC0-24) was calculated as 158.5 mg · h/liter (±79.5 mg · h/liter; n = 13).",
        entities: [['T0', 'UNITS', [[85, 97]]], ['T1', 'VALUE', [[79, 84]]], ['T2', 'VALUE', [[100, 104]]], ['T3', 'UNITS', [[105, 117]]], ['T4', 'PK', [[15, 60]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-905',
    collData,
    {
        text: "The estimated parameters [median (range)] were clearance half-life of 23.67 (14.79-59.93) min, synthesis onset time of 2206 (1940-0029), synthesis offset time of 0621 (0246-0817), and maximum N-acetyltransferase activity of 7.17(2.34-17.93) pmol x l(-1) x min(-1).",
        entities: [['T0', 'PK', [[47, 66]]], ['T1', 'VALUE', [[70, 75]]], ['T2', 'UNITS', [[90, 93]]], ['T3', 'RANGE', [[77, 88]]], ['T4', 'PK', [[184, 220]]], ['T5', 'VALUE', [[224, 228]]], ['T6', 'RANGE', [[229, 239]]], ['T7', 'UNITS', [[241, 263]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T5']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-906',
    collData,
    {
        text: "Non-compartmental pharmacokinetic analysis showed that the values for t(12)beta of 75.5 +- 16.9 h, the area under the curve (AUC(0-infinity)) of 1.33 +- 0.156 microg h ml(-1) and the MRT(0-infinity) of 32.8 +- 4.45 h obtained in cattle infected with the drug-resistant trypanosome population were significantly lower than the values of 424 +- 146 h for t(12)beta, 1.67 +- 0.233 microg h ml(-1) for AUC(0-infinity) and 297 +- 159 h for MRT(0-infinity) obtained in cattle infected with the drug-sensitive population.",
        entities: [['T0', 'PK', [[70, 79]]], ['T1', 'VALUE', [[83, 87]]], ['T2', 'PK', [[103, 141]]], ['T3', 'VALUE', [[145, 149]]], ['T4', 'PK', [[183, 198]]], ['T5', 'VALUE', [[202, 206]]], ['T6', 'PK', [[353, 362]]], ['T7', 'VALUE', [[336, 339]]], ['T8', 'PK', [[398, 413]]], ['T9', 'VALUE', [[364, 368]]], ['T10', 'PK', [[435, 450]]], ['T11', 'VALUE', [[418, 421]]], ['T12', 'VALUE', [[91, 95]]], ['T13', 'UNITS', [[96, 97]]], ['T14', 'VALUE', [[153, 158]]], ['T15', 'UNITS', [[159, 174]]], ['T16', 'VALUE', [[210, 214]]], ['T17', 'UNITS', [[215, 216]]], ['T18', 'VALUE', [[343, 346]]], ['T19', 'UNITS', [[347, 348]]], ['T20', 'VALUE', [[372, 377]]], ['T21', 'UNITS', [[378, 393]]], ['T22', 'VALUE', [[425, 428]]], ['T23', 'UNITS', [[429, 430]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R3', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R4', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T9']]], ['R5', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T11']]], ['R6', 'D_VAL', [['Entity', 'T12'], ['D_VAL', 'T1']]], ['R7', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T12']]], ['R8', 'D_VAL', [['Entity', 'T14'], ['D_VAL', 'T3']]], ['R9', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T14']]], ['R10', 'D_VAL', [['Entity', 'T16'], ['D_VAL', 'T5']]], ['R11', 'RELATED', [['Entity', 'T17'], ['RELATED', 'T16']]], ['R12', 'D_VAL', [['Entity', 'T18'], ['D_VAL', 'T7']]], ['R13', 'RELATED', [['Entity', 'T19'], ['RELATED', 'T18']]], ['R14', 'D_VAL', [['Entity', 'T20'], ['D_VAL', 'T9']]], ['R15', 'RELATED', [['Entity', 'T21'], ['RELATED', 'T20']]], ['R16', 'D_VAL', [['Entity', 'T22'], ['D_VAL', 'T11']]], ['R17', 'RELATED', [['Entity', 'T23'], ['RELATED', 'T22']]], ['R18', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T1']]], ['R19', 'RELATED', [['Entity', 'T17'], ['RELATED', 'T5']]], ['R20', 'RELATED', [['Entity', 'T19'], ['RELATED', 'T7']]], ['R21', 'RELATED', [['Entity', 'T21'], ['RELATED', 'T9']]], ['R22', 'RELATED', [['Entity', 'T23'], ['RELATED', 'T11']]], ['R23', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-907',
    collData,
    {
        text: "In Study 1 Part I, Ae% was dose-dependent with mean values ranging from 7.20 % after 50 mg to 14.6 % after 300 mg.",
        entities: [['T0', 'UNITS', [[99, 100]]], ['T1', 'VALUE', [[94, 98]]], ['T2', 'PK', [[19, 22]]], ['T3', 'VALUE', [[72, 76]]], ['T4', 'UNITS', [[77, 78]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-908',
    collData,
    {
        text: "After IA bolus, IFN is distributed from the blood with a t1/2 below, 2 hours, with dose-dependent serum peak concentrations (c = 47 IU for 3 MU and 145 IU for 5 MU).",
        entities: [['T0', 'UNITS', [[71, 76]]], ['T1', 'VALUE', [[69, 70]]], ['T2', 'PK', [[57, 61]]], ['T3', 'COMPARE', [[62, 67]]], ['T4', 'PK', [[98, 126]]], ['T5', 'VALUE', [[129, 131]]], ['T6', 'VALUE', [[148, 151]]], ['T7', 'UNITS', [[152, 154]]], ['T8', 'UNITS', [[132, 134]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T6']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-909',
    collData,
    {
        text: "TFV exposures (area under the concentration-time curve from 0 to 24 h [AUC0-24]) were higher in SP than in BP (median AUC0-24, 7.01 versus 2.97 mg · liter-1 · h, respectively).",
        entities: [['T0', 'PK', [[118, 125]]], ['T1', 'VALUE', [[127, 131]]], ['T2', 'VALUE', [[139, 143]]], ['T3', 'UNITS', [[144, 160]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-910',
    collData,
    {
        text: "The median 3TC area under the curve from 0 to 12 h after the last drug intake were 5.6 mg · h/liter (IQR, 4.1 to 7.8 mg · h/liter), 5.9 mg · h/liter (IQR, 5.1 to 7.5 mg · h/liter), and 7.3 mg · h/liter (IQR, 4.9 to 8.5 mg · h/liter) at weeks 6, 26, and 38, respectively.",
        entities: [['T0', 'PK', [[15, 50]]], ['T1', 'VALUE', [[83, 86]]], ['T2', 'VALUE', [[132, 135]]], ['T3', 'VALUE', [[185, 188]]], ['T4', 'RANGE', [[106, 116]]], ['T5', 'UNITS', [[117, 129]]], ['T6', 'RANGE', [[155, 165]]], ['T7', 'UNITS', [[166, 178]]], ['T8', 'RANGE', [[208, 218]]], ['T9', 'UNITS', [[219, 231]]], ['T10', 'UNITS', [[189, 201]]], ['T11', 'UNITS', [[136, 148]]], ['T12', 'UNITS', [[87, 99]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T2']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R7', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T3']]], ['R8', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]], ['R9', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T3']]], ['R10', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T2']]], ['R11', 'RELATED', [['Entity', 'T12'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-911',
    collData,
    {
        text: "In vitro plasma protein binding was described by a Langmuir model with a maximal binding capacity (Bmax = 767 microM) and an equilibrium dissociation constant (KD = 1.02 microM).",
        entities: [['T0', 'PK', [[73, 103]]], ['T1', 'VALUE', [[106, 109]]], ['T2', 'UNITS', [[110, 116]]], ['T3', 'UNITS', [[170, 176]]], ['T4', 'VALUE', [[165, 169]]], ['T5', 'PK', [[125, 162]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-912',
    collData,
    {
        text: "Given the peak and trough levels of colistin relative to the minimum inhibitory concentration for the organism (0.5 μg/ml), it would seem that the dosage of 2.5 mg/kg administered every 24 hours for this patient on dialysis was appropriate.",
        entities: [['T0', 'UNITS', [[116, 121]]], ['T1', 'VALUE', [[112, 115]]], ['T2', 'PK', [[61, 93]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-913',
    collData,
    {
        text: "Moreover, unchanged Pd-Ia recovered from the gastrointestinal tract at 24 hrs (GI24 h) was below detection limit for both groups; the total amount of unchanged Pd-Ia in 8 hrs bile (expressed in terms of percentage of i.v. dose) were 0.092% and 0.126% for control and LC rats, suggesting that the contribution of gastrointestinal and biliary excretion to CLNR of Pd-Ia was also negligible Hence, the CLNR could represent hepatic intrinsic clearance (CLint) of Pd-Ia which was metabolized almost completely after i.v. administration.",
        entities: [['T0', 'UNITS', [[249, 250]]], ['T1', 'VALUE', [[244, 249]]], ['T2', 'UNITS', [[238, 239]]], ['T3', 'VALUE', [[233, 238]]], ['T4', 'PK', [[134, 165]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-914',
    collData,
    {
        text: "Maximum serum concentration of robenacoxib (Cmax) was 2.2µg/ml [range: 1.2–4.6] (median [range: minimum-maximum]) and time of Cmax (Tmax) was 90 min [range: 60–120] in the conscious dogs.",
        entities: [['T0', 'PK', [[0, 49]]], ['T1', 'VALUE', [[54, 57]]], ['T2', 'PK', [[118, 137]]], ['T3', 'VALUE', [[142, 144]]], ['T4', 'RANGE', [[157, 163]]], ['T5', 'UNITS', [[145, 148]]], ['T6', 'RANGE', [[71, 78]]], ['T7', 'UNITS', [[57, 62]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-915',
    collData,
    {
        text: "The mean initial trough level was as low as 8.80 mcg/ml with a difference of 5.95 mcg/ml compared with the lower limit of the vancomycin target range.",
        entities: [['T0', 'PK', [[9, 29]]], ['T1', 'VALUE', [[44, 48]]], ['T2', 'UNITS', [[49, 55]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-916',
    collData,
    {
        text: "Clearly, FLT-loaded CAS nanoparticles exhibited a longer circulation time and a markedly delayed blood clearance with a drug level of 440.35 ng/mL at 48 hours after administration.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-917',
    collData,
    {
        text: "Most notably, the small molecule integrin imaging agent cleared rapidly from the blood and achieved ~30% of the injected dose in the tissue at 1 h. In the absence of high plasma levels to drive tissue accumulation, this agent started clearing from the tissue immediately thereafter with a tissue half-life of approximately 20 h. The vascular and nanoparticle agents, despite sharing very similar plasma pharmacokinetics, differed in their tissue distribution kinetics, with the vascular agent showing peak tissue signal (~60%ID) at 5 h and a tissue half-life of ~40 h and the nanoparticles showing substantially lower peak tissue accumulation (~35%ID) but with a very long residence time (tissue t1/2>100 h).",
        entities: [['T0', 'PK', [[289, 305]]], ['T1', 'VALUE', [[323, 325]]], ['T2', 'UNITS', [[326, 327]]], ['T3', 'UNITS', [[566, 567]]], ['T4', 'VALUE', [[563, 565]]], ['T5', 'PK', [[542, 558]]], ['T6', 'PK', [[689, 700]]], ['T7', 'VALUE', [[701, 704]]], ['T8', 'UNITS', [[705, 706]]], ['T9', 'COMPARE', [[700, 701]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]], ['R6', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-918',
    collData,
    {
        text: "The mutant selection window (MSW) of enrofloxacin on isolate AH10 was determined to be 0.5 - 3 μg/mL based on the mutant prevention concentration (MPC) and minimum inhibitory concentration (MIC) value.",
        entities: [['T0', 'UNITS', [[95, 100]]], ['T1', 'RANGE', [[87, 94]]], ['T2', 'PK', [[4, 33]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-919',
    collData,
    {
        text: "Geometric least-squares means for maximum plasma nicotine concentration (Cmax), generated by the mixed-effect model for exposure comparison, were 9.7, 11.2, and 9.8 ng/mL for the 50, 80, and 150 µg/puff P3L variants, respectively, compared to 6.1 ng/mL after Nicorette inhalator use.",
        entities: [['T0', 'UNITS', [[165, 170]]], ['T1', 'VALUE', [[161, 164]]], ['T2', 'VALUE', [[151, 155]]], ['T3', 'VALUE', [[146, 149]]], ['T4', 'PK', [[34, 78]]], ['T5', 'UNITS', [[247, 252]]], ['T6', 'VALUE', [[243, 246]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T2']]], ['R5', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R6', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T6']]], ['R7', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-920',
    collData,
    {
        text: "The mean peak concentration was 30.2 +- 5.0 ng X ml-1, the mean half-life (t1/2) of the elimination phase was 3.4 +- 1.1 h, and the total body clearance was 628 +- 13 ml X min-1.",
        entities: [['T0', 'PK', [[9, 27]]], ['T1', 'VALUE', [[32, 36]]], ['T2', 'PK', [[64, 105]]], ['T3', 'VALUE', [[110, 113]]], ['T4', 'PK', [[132, 152]]], ['T5', 'VALUE', [[157, 160]]], ['T6', 'VALUE', [[164, 166]]], ['T7', 'UNITS', [[167, 177]]], ['T8', 'VALUE', [[117, 120]]], ['T9', 'UNITS', [[121, 122]]], ['T10', 'VALUE', [[40, 43]]], ['T11', 'UNITS', [[44, 53]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R3', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T5']]], ['R4', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R5', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T3']]], ['R6', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]], ['R7', 'D_VAL', [['Entity', 'T10'], ['D_VAL', 'T1']]], ['R8', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T10']]], ['R9', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T1']]], ['R10', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T3']]], ['R11', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-921',
    collData,
    {
        text: "The absorption rate constant (Ka) of the ZgI and the ZgI-SMEDDS were 1.04 ± 0.02 × 10−4 cm/s and 5.71 ± 0.24 × 10−4 cm/s, respectively (P < 0.05).",
        entities: [['T0', 'PK', [[4, 33]]], ['T1', 'VALUE', [[69, 73]]], ['T2', 'VALUE', [[97, 101]]], ['T3', 'VALUE', [[76, 87]]], ['T4', 'UNITS', [[88, 92]]], ['T5', 'VALUE', [[104, 115]]], ['T6', 'UNITS', [[116, 120]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T5'], ['D_VAL', 'T2']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-922',
    collData,
    {
        text: "Floating lag time (FLT) and total floating time (TFT) of the formulations were observed visually and were in the range of 60–220 sec and 8 to >12 h (Table 3).",
        entities: [['T0', 'UNITS', [[129, 132]]], ['T1', 'RANGE', [[122, 128]]], ['T2', 'UNITS', [[146, 147]]], ['T3', 'RANGE', [[137, 145]]], ['T4', 'PK', [[0, 23]]], ['T5', 'PK', [[28, 53]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-923',
    collData,
    {
        text: "However, ADHC-L treatment showed a drastic increase in the half-life of the elimination phase t1/2β (195.44 hours) compared with free ADHC administered at the same dose (28.71 hours), while the clearance rate of 3 mg/kg free ADHC treatment (0.07 L/h/kg) and 9 mg/kg free ADHC treatment (0.13 L/h/kg) was 3.5-fold and 6.0-fold that of ADHC-L treatment (0.02 L/h/kg), respectively.",
        entities: [['T0', 'UNITS', [[108, 113]]], ['T1', 'VALUE', [[101, 107]]], ['T2', 'PK', [[59, 99]]], ['T3', 'VALUE', [[170, 175]]], ['T4', 'UNITS', [[176, 181]]], ['T5', 'PK', [[194, 208]]], ['T6', 'VALUE', [[241, 245]]], ['T7', 'UNITS', [[246, 252]]], ['T8', 'UNITS', [[292, 298]]], ['T9', 'VALUE', [[287, 291]]], ['T10', 'UNITS', [[357, 363]]], ['T11', 'VALUE', [[352, 356]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T6']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R6', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T9']]], ['R7', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T9']]], ['R8', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T11']]], ['R9', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T11']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-924',
    collData,
    {
        text: "After discontinuation of the glycoside the serum half life was 54 h. During the digitalization period the cardiac glycoside effects could be measured by ECG changes, especially a shortening of the QT interval as well as a shortening of the left ventricular ejection time and the pre ejection period, corrected for the heart rate.",
        entities: [['T0', 'PK', [[43, 58]]], ['T1', 'VALUE', [[63, 65]]], ['T2', 'UNITS', [[66, 67]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-925',
    collData,
    {
        text: "Both studies reported longer half-lives (19 and 21 h, respectively) and a greater AUC0→∞ (89 and 81 h *",
        entities: [['T0', 'PK', [[29, 39]]], ['T1', 'VALUE', [[41, 43]]], ['T2', 'VALUE', [[48, 50]]], ['T3', 'UNITS', [[51, 52]]], ['T4', 'PK', [[82, 88]]], ['T5', 'VALUE', [[90, 92]]], ['T6', 'VALUE', [[97, 99]]], ['T7', 'UNITS', [[100, 101]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R5', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T6']]], ['R6', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T6']]], ['R7', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-926',
    collData,
    {
        text: "For rat and rabbit albumin, affinities ranged from 0.04 to 2.5 microM. Reduced affinity for albumin correlated with a reduced half-life and higher clearance rates in both species; the beta half-life ranged 6-fold while clearance ranged over 50-fold in rats and 20-fold in rabbits.",
        entities: [['T0', 'UNITS', [[63, 69]]], ['T1', 'RANGE', [[51, 62]]], ['T2', 'PK', [[28, 38]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-927',
    collData,
    {
        text: "JNJ-54861911 plasma PK profiles were characterized by rapid absorption (median Tmax of 0.75–2 hours following single dose, and 2–4 hours after multiple dosing) and essentially biphasic decline at all dose levels (Supplementary Figs. S1).",
        entities: [['T0', 'PK', [[79, 83]]], ['T1', 'RANGE', [[87, 93]]], ['T2', 'UNITS', [[94, 99]]], ['T3', 'RANGE', [[127, 130]]], ['T4', 'UNITS', [[131, 136]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-928',
    collData,
    {
        text: "Whereas hMAb-10058 produced in serum-free, defined medium had a clearance rate of 14.4 ml/min/kg and an effective half-life of 0.12 h, the same hMAb-10058 raised in mouse ascites had a decreased clearance rate of 0.092 ml/min/kg and an increased effective half-life of 12 h. This 100-fold enhancement of the hMAb's half-life was not affected by the purification process.",
        entities: [['T0', 'PK', [[64, 78]]], ['T1', 'VALUE', [[82, 86]]], ['T2', 'UNITS', [[87, 96]]], ['T3', 'PK', [[104, 123]]], ['T4', 'VALUE', [[127, 131]]], ['T5', 'UNITS', [[132, 133]]], ['T6', 'PK', [[195, 209]]], ['T7', 'VALUE', [[213, 218]]], ['T8', 'UNITS', [[219, 228]]], ['T9', 'PK', [[246, 265]]], ['T10', 'VALUE', [[269, 271]]], ['T11', 'UNITS', [[272, 273]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]], ['R6', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T10']]], ['R7', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T10']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-929',
    collData,
    {
        text: "SN-38 and SN-38G had low plasma availabilities (3% and 10% relative to CPT-11), with mean t1/2 values of 11.6 and 10.5 hours, respectively.",
        entities: [['T0', 'UNITS', [[119, 124]]], ['T1', 'VALUE', [[114, 118]]], ['T2', 'VALUE', [[105, 109]]], ['T3', 'PK', [[90, 94]]], ['T4', 'UNITS', [[57, 58]]], ['T5', 'VALUE', [[55, 57]]], ['T6', 'UNITS', [[49, 50]]], ['T7', 'VALUE', [[48, 49]]], ['T8', 'PK', [[25, 46]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]], ['R4', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R6', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T7']]], ['R7', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-930',
    collData,
    {
        text: "The final elimination half-life was 13.3 h and 12.6 h at baseline and 6 months after administration, respectively.",
        entities: [['T0', 'PK', [[4, 31]]], ['T1', 'VALUE', [[36, 40]]], ['T2', 'UNITS', [[41, 42]]], ['T3', 'UNITS', [[52, 53]]], ['T4', 'VALUE', [[47, 51]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-931',
    collData,
    {
        text: "Biological half-life (t1/2) was 2.08±0.99, 3.13±1.19 and 1.07±0.38h for AP, DP and NP, respectively.",
        entities: [['T0', 'PK', [[0, 27]]], ['T1', 'VALUE', [[32, 36]]], ['T2', 'VALUE', [[37, 41]]], ['T3', 'UNITS', [[66, 67]]], ['T4', 'VALUE', [[43, 47]]], ['T5', 'VALUE', [[57, 61]]], ['T6', 'VALUE', [[48, 52]]], ['T7', 'VALUE', [[62, 66]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T5']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T4']]], ['R6', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T6']]], ['R7', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T5']]], ['R8', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T7']]], ['R9', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T5']]], ['R10', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R11', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-932',
    collData,
    {
        text: "The maximum fall in blood pressure (approximately 30%) was attained after 90 min in the dialysis patients and after 120 min in the non-dialysis group.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-933',
    collData,
    {
        text: "The terminal half-life and mean residence time were 9.7 (9.6) h and 10.5 (10.1) h, respectively.",
        entities: [['T0', 'PK', [[4, 22]]], ['T1', 'VALUE', [[52, 55]]], ['T2', 'PK', [[27, 46]]], ['T3', 'VALUE', [[68, 72]]], ['T4', 'UNITS', [[62, 63]]], ['T5', 'UNITS', [[80, 81]]], ['T6', 'VALUE', [[74, 78]]], ['T7', 'VALUE', [[57, 60]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T3']]], ['R5', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-934',
    collData,
    {
        text: "The plasma concentration of GRB1 reached the maximum concentration (2 ng/ml after a 5-g administration of TJ-100) at approximately 4 h after administration and the half-life of GRB1 was approximately 40 h. The plasma concentration of GRG1 was extremely low (<0.023 ng/ml).",
        entities: [['T0', 'PK', [[45, 66]]], ['T1', 'VALUE', [[68, 69]]], ['T2', 'PK', [[164, 173]]], ['T3', 'VALUE', [[200, 202]]], ['T4', 'UNITS', [[70, 75]]], ['T5', 'UNITS', [[203, 204]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-935',
    collData,
    {
        text: "The ΔF/F0 values reach a maximum of 3–4, and the [nicotine] giving half-ΔFmax/F0 is on the order of 20 µM.",
        entities: [['T0', 'PK', [[4, 9]]], ['T1', 'RANGE', [[36, 39]]], ['T2', 'PK', [[67, 80]]], ['T3', 'VALUE', [[100, 102]]], ['T4', 'UNITS', [[103, 105]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-936',
    collData,
    {
        text: "In addition, the area under the serum concentration-time curve (AUC) at 8 h is increased proportionally from 4298.3 to 16944.8 h*nM.",
        entities: [['T0', 'UNITS', [[127, 131]]], ['T1', 'VALUE', [[119, 126]]], ['T2', 'VALUE', [[109, 115]]], ['T3', 'PK', [[17, 75]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-937',
    collData,
    {
        text: "The Cmax varied between 11.46 and 26.44 microg mL(-1) with three of the subjects having Cmax greater than the 20 microg mL(-1) limit for therapeutic level.",
        entities: [['T0', 'PK', [[4, 8]]], ['T1', 'RANGE', [[24, 39]]], ['T2', 'UNITS', [[40, 53]]], ['T3', 'UNITS', [[113, 126]]], ['T4', 'VALUE', [[110, 112]]], ['T5', 'PK', [[88, 92]]], ['T6', 'COMPARE', [[93, 100]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-938',
    collData,
    {
        text: "Based on the first pass equations for single dosage and multiple dosing, the maximal metabolic rate (Vm = 0.043 mg l-1 h-1) corresponding to 310 mg per day and the Michaelis constant (Km = 0.10 mg/l) were calculated for propranolol.",
        entities: [['T0', 'UNITS', [[112, 122]]], ['T1', 'VALUE', [[106, 111]]], ['T2', 'PK', [[77, 103]]], ['T3', 'PK', [[164, 186]]], ['T4', 'VALUE', [[189, 193]]], ['T5', 'UNITS', [[194, 198]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-939',
    collData,
    {
        text: "The flux (Jss) value was 3,842 ± 115 µg/cm2/h, while the permeability coefficient (Kp) was 9.8 × 10−8 cm/s.",
        entities: [['T0', 'PK', [[4, 14]]], ['T1', 'VALUE', [[25, 30]]], ['T2', 'UNITS', [[37, 45]]], ['T3', 'PK', [[57, 86]]], ['T4', 'VALUE', [[91, 101]]], ['T5', 'UNITS', [[102, 106]]], ['T6', 'VALUE', [[33, 36]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-940',
    collData,
    {
        text: "This study showed that the median tmax of selumetinib peaked at 1.0 to 1.6 h for all ethnic groups while the arithmetic mean terminal t½ value was slightly higher in All Asian subjects (10.4 h) compared with Western subjects (9.1 h) (Table 1).",
        entities: [['T0', 'UNITS', [[75, 76]]], ['T1', 'RANGE', [[64, 74]]], ['T2', 'PK', [[34, 38]]], ['T3', 'UNITS', [[191, 192]]], ['T4', 'VALUE', [[186, 190]]], ['T5', 'PK', [[125, 136]]], ['T6', 'UNITS', [[230, 231]]], ['T7', 'VALUE', [[226, 229]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T7']]], ['R5', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-941',
    collData,
    {
        text: "After oral administration to conscious ambulatory rats in an aqueous-based methylcellulose/Tween 80 suspension, the bioavailability of both compounds was low (< 2% of administered dose).",
        entities: [['T0', 'COMPARE', [[159, 160]]], ['T1', 'VALUE', [[161, 162]]], ['T2', 'UNITS', [[162, 163]]], ['T3', 'PK', [[116, 131]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-942',
    collData,
    {
        text: "Oral dose of MCBL was characterized by a median (range) terminal half-life, mean transit time, mean absorption time, and apparent oral clearance of 2.89 (2.21-4.88) h, 2.67 (1.80-2.87) h, 0.410 (0.350-0.770) h, and 16.5 (13.0-20) mL/min/kg.",
        entities: [['T0', 'PK', [[56, 74]]], ['T1', 'VALUE', [[148, 152]]], ['T2', 'PK', [[76, 93]]], ['T3', 'VALUE', [[168, 172]]], ['T4', 'PK', [[95, 115]]], ['T5', 'VALUE', [[188, 193]]], ['T6', 'PK', [[121, 144]]], ['T7', 'VALUE', [[215, 219]]], ['T8', 'UNITS', [[185, 186]]], ['T9', 'UNITS', [[208, 209]]], ['T10', 'UNITS', [[165, 166]]], ['T11', 'UNITS', [[230, 239]]], ['T12', 'RANGE', [[221, 228]]], ['T13', 'RANGE', [[195, 206]]], ['T14', 'RANGE', [[174, 183]]], ['T15', 'RANGE', [[154, 163]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R3', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R4', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T3']]], ['R5', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T1']]], ['R7', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T7']]], ['R8', 'D_VAL', [['Entity', 'T12'], ['D_VAL', 'T7']]], ['R9', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T12']]], ['R10', 'D_VAL', [['Entity', 'T13'], ['D_VAL', 'T5']]], ['R11', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T13']]], ['R12', 'D_VAL', [['Entity', 'T14'], ['D_VAL', 'T3']]], ['R13', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T14']]], ['R14', 'D_VAL', [['Entity', 'T15'], ['D_VAL', 'T1']]], ['R15', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T15']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-943',
    collData,
    {
        text: "Monte Carlo simulation using this MIC distribution revealed that the probability that AZM-SR monotherapy would produce an AUC/MIC exceeding the AUC/MIC target of 59.5 was 47%.",
        entities: [['T0', 'PK', [[144, 158]]], ['T1', 'VALUE', [[162, 166]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-944',
    collData,
    {
        text: "The net iron bioavailability (mean +- SE) of Stuartnatal Plus and Materna, accounting for diurnal variation, and the iron ingested with the standardized meal was 5.4 +- 0.4 and 4.6 +- 0.2 mg, respectively, while fasting and 2.9 +- 0.4 and 2.7 +- 0.4 mg, respectively, postprandially.",
        entities: [['T0', 'UNITS', [[188, 190]]], ['T1', 'VALUE', [[177, 180]]], ['T2', 'VALUE', [[162, 165]]], ['T3', 'UNITS', [[250, 252]]], ['T4', 'VALUE', [[239, 242]]], ['T5', 'VALUE', [[224, 227]]], ['T6', 'VALUE', [[246, 249]]], ['T7', 'VALUE', [[231, 234]]], ['T8', 'VALUE', [[169, 172]]], ['T9', 'VALUE', [[184, 187]]], ['T10', 'PK', [[4, 28]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T5']]], ['R4', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T4']]], ['R5', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T6']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T5']]], ['R7', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T7']]], ['R8', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T2']]], ['R9', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T8']]], ['R10', 'D_VAL', [['Entity', 'T9'], ['D_VAL', 'T1']]], ['R11', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T9']]], ['R12', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T2']]], ['R13', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T1']]], ['R14', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T5']]], ['R15', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-945',
    collData,
    {
        text: "The geometric mean maximum concentration of a drug in serum (Cmax) and the area under the concentration-time curve from 0 to infinity (AUC0–∞) were 563.1 ng/ml and 4,701.8 ng · h/ml in cirrhotic patients versus 364.8 ng/ml and 1,917.1 ng · h/ml in healthy volunteers, respectively.",
        entities: [['T0', 'PK', [[19, 66]]], ['T1', 'VALUE', [[148, 153]]], ['T2', 'VALUE', [[211, 216]]], ['T3', 'PK', [[75, 142]]], ['T4', 'VALUE', [[164, 171]]], ['T5', 'VALUE', [[227, 234]]], ['T6', 'UNITS', [[154, 159]]], ['T7', 'UNITS', [[172, 181]]], ['T8', 'UNITS', [[235, 244]]], ['T9', 'UNITS', [[217, 222]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T5']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T1']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T4']]], ['R6', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T5']]], ['R7', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-946',
    collData,
    {
        text: "The PK of norbuprenorphine was best described using a two compartment model for which four parameters common to the three administration routes could be estimated: norbuprenorphine clearance (CLMet = 0.42 L kg-1 hour-1, IIV 4.3%), volume of distribution of the central compartment (V1Met = 0.323 L kg-1, 0.1%), intercompartmental clearance (CL2 Met = 7.662 L kg-1 hour-1) and volume of distribution of the peripheral compartment (and V2 Met = 4.69 L kg-1).",
        entities: [['T0', 'UNITS', [[357, 370]]], ['T1', 'VALUE', [[351, 356]]], ['T2', 'PK', [[311, 348]]], ['T3', 'UNITS', [[296, 302]]], ['T4', 'VALUE', [[290, 295]]], ['T5', 'PK', [[231, 287]]], ['T6', 'PK', [[181, 197]]], ['T7', 'VALUE', [[200, 204]]], ['T8', 'UNITS', [[205, 218]]], ['T9', 'UNITS', [[448, 454]]], ['T10', 'VALUE', [[443, 447]]], ['T11', 'PK', [[434, 440]]], ['T12', 'VALUE', [[304, 307]]], ['T13', 'UNITS', [[307, 308]]], ['T14', 'VALUE', [[224, 227]]], ['T15', 'UNITS', [[227, 228]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]], ['R6', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T10']]], ['R7', 'C_VAL', [['Entity', 'T11'], ['C_VAL', 'T10']]], ['R8', 'D_VAL', [['Entity', 'T12'], ['D_VAL', 'T4']]], ['R9', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T12']]], ['R10', 'D_VAL', [['Entity', 'T14'], ['D_VAL', 'T7']]], ['R11', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T14']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-947',
    collData,
    {
        text: "When the MoIFN gamma-R protein was traced by the capacity of the animal sera to displace the binding of radiolabeled MoIFN gamma-R from affinity purified rabbit anti-MoIFN gamma-R antibodies, a blood half-life of 1 h was determined.",
        entities: [['T0', 'PK', [[194, 209]]], ['T1', 'VALUE', [[213, 214]]], ['T2', 'UNITS', [[215, 216]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-948',
    collData,
    {
        text: "Each compound (3H-labeled) was injected at a dose of 2.5 mumole/kg, producing plasma concentrations of 1 to 5 microM. Despite extensive plasma binding (greater than 95%), the uncorrected renal clearance of BaP-7,8-dihydrodiol exceeded the glomerular filtration rate (GFR) by more than 20-fold.",
        entities: [['T0', 'UNITS', [[167, 168]]], ['T1', 'VALUE', [[165, 167]]], ['T2', 'PK', [[136, 150]]], ['T3', 'COMPARE', [[152, 159]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-949',
    collData,
    {
        text: "In contrary, the combination of IFN with FA leads to a non-significant change of the 5FU pharmacokinetics, although the bioavailability is increased to 18%.",
        entities: [['T0', 'PK', [[120, 135]]], ['T1', 'VALUE', [[152, 154]]], ['T2', 'UNITS', [[154, 155]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-950',
    collData,
    {
        text: "A peak concentration of 0.16+-0.01 IU/mL and an average aPTT of 24 seconds (2-fold increase) were obtained 7 hours after oral dosing of Eudragit RL/PCL NPs containing heparin, exhibiting an absolute bioavailability of 23%.",
        entities: [['T0', 'PK', [[2, 20]]], ['T1', 'VALUE', [[24, 28]]], ['T2', 'PK', [[190, 214]]], ['T3', 'VALUE', [[218, 220]]], ['T4', 'VALUE', [[30, 34]]], ['T5', 'UNITS', [[35, 40]]], ['T6', 'UNITS', [[220, 221]]], ['T7', 'PK', [[56, 60]]], ['T8', 'VALUE', [[64, 66]]], ['T9', 'UNITS', [[67, 74]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T3']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]], ['R6', 'C_VAL', [['Entity', 'T7'], ['C_VAL', 'T8']]], ['R7', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-951',
    collData,
    {
        text: "Peak concentrations (Cmax) of 2.0 ± 0.5 nmol FB1−m or 3.3 ± 1.7 nmol FB1+m per L serum were reached (tmax) after 9.5 ± 5.4 h and 13.6 ± 2.5 h, respectively.",
        entities: [['T0', 'VALUE', [[36, 39]]], ['T1', 'VALUE', [[30, 33]]], ['T2', 'UNITS', [[40, 50]]], ['T3', 'UNITS', [[69, 86]]], ['T4', 'VALUE', [[60, 63]]], ['T5', 'VALUE', [[54, 57]]], ['T6', 'VALUE', [[119, 122]]], ['T7', 'VALUE', [[113, 116]]], ['T8', 'UNITS', [[123, 124]]], ['T9', 'PK', [[0, 26]]], ['T10', 'PK', [[101, 105]]], ['T11', 'VALUE', [[129, 133]]], ['T12', 'VALUE', [[136, 139]]], ['T13', 'UNITS', [[140, 141]]]],
        relations: [['R0', 'D_VAL', [['Entity', 'T0'], ['D_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T0']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T0']]], ['R3', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T5']]], ['R4', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R5', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T7']]], ['R6', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T6']]], ['R7', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T1']]], ['R8', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T5']]], ['R9', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T7']]], ['R10', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T11']]], ['R11', 'D_VAL', [['Entity', 'T12'], ['D_VAL', 'T11']]], ['R12', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T12']]], ['R13', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R14', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R15', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T5']]], ['R16', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]], ['R17', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T11']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-952',
    collData,
    {
        text: "The obtained pharmacokinetic values at a dose of 3.36 +- 1.91 mg/kg bodyweight were as follows: time to peak serum MZR concentration, 2.94 +- 0.82 h; peak serum MZR concentration, 1.59 +- 1.16 microg/mL; half-life, 1.96 +- 0.92 h; area under the serum MZR concentration-time curve from time zero to infinity, 9.36 +- 6.58 microg h/mL; volume of the distribution of MZR at a steady state, 2.03 +- 0.80 L/kg; and rate of urinary excretion of MZR, 49.1 +- 18.7%.",
        entities: [['T0', 'PK', [[96, 132]]], ['T1', 'VALUE', [[134, 138]]], ['T2', 'PK', [[150, 178]]], ['T3', 'VALUE', [[180, 184]]], ['T4', 'PK', [[204, 213]]], ['T5', 'VALUE', [[215, 219]]], ['T6', 'PK', [[231, 307]]], ['T7', 'VALUE', [[309, 313]]], ['T8', 'PK', [[335, 386]]], ['T9', 'VALUE', [[388, 392]]], ['T10', 'VALUE', [[142, 146]]], ['T11', 'UNITS', [[147, 148]]], ['T12', 'VALUE', [[188, 192]]], ['T13', 'UNITS', [[193, 202]]], ['T14', 'VALUE', [[223, 227]]], ['T15', 'UNITS', [[228, 229]]], ['T16', 'VALUE', [[317, 321]]], ['T17', 'UNITS', [[322, 333]]], ['T18', 'VALUE', [[396, 400]]], ['T19', 'UNITS', [[401, 405]]], ['T20', 'UNITS', [[457, 458]]], ['T21', 'VALUE', [[445, 449]]], ['T22', 'VALUE', [[453, 457]]], ['T23', 'PK', [[411, 436]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R3', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R4', 'C_VAL', [['Entity', 'T8'], ['C_VAL', 'T9']]], ['R5', 'D_VAL', [['Entity', 'T10'], ['D_VAL', 'T1']]], ['R6', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T10']]], ['R7', 'D_VAL', [['Entity', 'T12'], ['D_VAL', 'T3']]], ['R8', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T12']]], ['R9', 'D_VAL', [['Entity', 'T14'], ['D_VAL', 'T5']]], ['R10', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T14']]], ['R11', 'D_VAL', [['Entity', 'T16'], ['D_VAL', 'T7']]], ['R12', 'RELATED', [['Entity', 'T17'], ['RELATED', 'T16']]], ['R13', 'D_VAL', [['Entity', 'T18'], ['D_VAL', 'T9']]], ['R14', 'RELATED', [['Entity', 'T19'], ['RELATED', 'T18']]], ['R15', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T1']]], ['R16', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T3']]], ['R17', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T5']]], ['R18', 'RELATED', [['Entity', 'T17'], ['RELATED', 'T7']]], ['R19', 'RELATED', [['Entity', 'T19'], ['RELATED', 'T9']]], ['R20', 'RELATED', [['Entity', 'T20'], ['RELATED', 'T21']]], ['R21', 'D_VAL', [['Entity', 'T22'], ['D_VAL', 'T21']]], ['R22', 'RELATED', [['Entity', 'T20'], ['RELATED', 'T22']]], ['R23', 'C_VAL', [['Entity', 'T23'], ['C_VAL', 'T21']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-953',
    collData,
    {
        text: "After oral administration of 1-g/kg doses, mean area under the curve (AUC) and C(max) values were significantly reduced in BHR-treated rats (16.1 +- 10.0 and 0.3 +- 0.1 mg/ml, respectively) as compared with saline-treated (37.9 +- 14.4 and 0.7 +- 0.7 mg/ml, respectively) and placebo solution-treated (63.0 +- 46.4 and 0.7 +- 0.4 mg/ml, respectively) rats.",
        entities: [['T0', 'VALUE', [[149, 153]]], ['T1', 'VALUE', [[141, 145]]], ['T2', 'UNITS', [[169, 174]]], ['T3', 'VALUE', [[165, 168]]], ['T4', 'VALUE', [[158, 161]]], ['T5', 'UNITS', [[251, 256]]], ['T6', 'VALUE', [[240, 243]]], ['T7', 'VALUE', [[223, 227]]], ['T8', 'VALUE', [[231, 235]]], ['T9', 'VALUE', [[247, 250]]], ['T10', 'UNITS', [[330, 335]]], ['T11', 'VALUE', [[319, 322]]], ['T12', 'VALUE', [[302, 306]]], ['T13', 'VALUE', [[310, 314]]], ['T14', 'VALUE', [[326, 329]]], ['T15', 'PK', [[48, 74]]], ['T16', 'PK', [[79, 85]]]],
        relations: [['R0', 'D_VAL', [['Entity', 'T0'], ['D_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T0']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T6']]], ['R5', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T7']]], ['R6', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T7']]], ['R7', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T8']]], ['R8', 'D_VAL', [['Entity', 'T9'], ['D_VAL', 'T6']]], ['R9', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T9']]], ['R10', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T4']]], ['R11', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R12', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T11']]], ['R13', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T12']]], ['R14', 'D_VAL', [['Entity', 'T13'], ['D_VAL', 'T12']]], ['R15', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T13']]], ['R16', 'D_VAL', [['Entity', 'T14'], ['D_VAL', 'T11']]], ['R17', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T14']]], ['R18', 'C_VAL', [['Entity', 'T15'], ['C_VAL', 'T1']]], ['R19', 'C_VAL', [['Entity', 'T16'], ['C_VAL', 'T4']]], ['R20', 'C_VAL', [['Entity', 'T15'], ['C_VAL', 'T7']]], ['R21', 'C_VAL', [['Entity', 'T16'], ['C_VAL', 'T6']]], ['R22', 'C_VAL', [['Entity', 'T15'], ['C_VAL', 'T12']]], ['R23', 'C_VAL', [['Entity', 'T16'], ['C_VAL', 'T11']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-954',
    collData,
    {
        text: "4. Bacteria identified from various diseases were 29 strains of 9 species, and the eradication rate was 82.8%.",
        entities: [['T0', 'PK', [[83, 99]]], ['T1', 'VALUE', [[104, 108]]], ['T2', 'UNITS', [[108, 109]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-955',
    collData,
    {
        text: "The predicted AUCRs ranged between 0.35 and 0.71 and the Cmax ratios ranged between 0.41 and 0.79 for the CYP2C9 genotypes (Table3).",
        entities: [['T0', 'PK', [[57, 68]]], ['T1', 'RANGE', [[84, 97]]], ['T2', 'PK', [[14, 19]]], ['T3', 'RANGE', [[35, 48]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-956',
    collData,
    {
        text: "Based on this approach, effect compartment concentrations of sertindole needed to attain 50% occupancy and half-maximal effect in the CAR paradigm were 133 and 338 ng/ml, respectively.",
        entities: [['T0', 'UNITS', [[164, 169]]], ['T1', 'VALUE', [[160, 163]]], ['T2', 'VALUE', [[152, 155]]], ['T3', 'PK', [[107, 126]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T2']]], ['R3', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-957',
    collData,
    {
        text: "The maximum plasma concentration of paracetamol glucuronide tended to be higher in the paracetamol group 213.27 mg/L (90 % CI 1.06, 1.25).",
        entities: [['T0', 'UNITS', [[112, 116]]], ['T1', 'VALUE', [[105, 111]]], ['T2', 'PK', [[4, 32]]], ['T3', 'RANGE', [[126, 136]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-958',
    collData,
    {
        text: "Cmin increased to 13.7 ng/mL (CV% 53.9) (p = 0.018).",
        entities: [['T0', 'UNITS', [[23, 28]]], ['T1', 'VALUE', [[18, 22]]], ['T2', 'PK', [[0, 4]]], ['T3', 'VALUE', [[34, 38]]], ['T4', 'UNITS', [[32, 33]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'D_VAL', [['Entity', 'T3'], ['D_VAL', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-959',
    collData,
    {
        text: "The mean oral bioavailability of 35- and 70-mg ALN tablets was less than 0.6%, comparable to adult studies.",
        entities: [['T0', 'PK', [[9, 29]]], ['T1', 'VALUE', [[73, 76]]], ['T2', 'UNITS', [[76, 77]]], ['T3', 'COMPARE', [[63, 67]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-960',
    collData,
    {
        text: "The overall response rate was 81% in the 5-day arm and 87% in the 8-day arm, with median survival durations of 7.1 and 9.4 months, respectively (no significant differences).",
        entities: [['T0', 'PK', [[4, 25]]], ['T1', 'VALUE', [[30, 32]]], ['T2', 'VALUE', [[55, 57]]], ['T3', 'UNITS', [[32, 33]]], ['T4', 'UNITS', [[57, 58]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-961',
    collData,
    {
        text: "Liver clearance was observed with a time constant of 0.014/hour and blood clearance was observed with a biological half-life of 46 hours.",
        entities: [['T0', 'UNITS', [[131, 136]]], ['T1', 'VALUE', [[128, 130]]], ['T2', 'PK', [[104, 124]]], ['T3', 'UNITS', [[58, 63]]], ['T4', 'VALUE', [[53, 58]]], ['T5', 'PK', [[36, 49]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-962',
    collData,
    {
        text: "For an efficacy target of 90% survival, AUC was predicted as 67 microg.",
        entities: [['T0', 'PK', [[40, 43]]], ['T1', 'VALUE', [[61, 63]]], ['T2', 'UNITS', [[64, 70]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-963',
    collData,
    {
        text: "The combination of florfenicol and gefitinib exhibited a significantly higher AUC0~12h (8.01 vs. 4.91 (µg/mL)·h, p < 0.05), as well as a lower Cl (2.57 vs. 4.43 mg/kg/h/(μg/mL), p < 0.05), accordingly, increasing the bioavailability to 78.4%, compared to florfenicol alone.",
        entities: [['T0', 'PK', [[78, 86]]], ['T1', 'VALUE', [[88, 92]]], ['T2', 'VALUE', [[97, 101]]], ['T3', 'UNITS', [[161, 176]]], ['T4', 'VALUE', [[147, 151]]], ['T5', 'PK', [[143, 145]]], ['T6', 'PK', [[217, 232]]], ['T7', 'VALUE', [[236, 240]]], ['T8', 'UNITS', [[240, 241]]], ['T9', 'UNITS', [[102, 111]]], ['T10', 'VALUE', [[156, 160]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T4']]], ['R3', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]], ['R6', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T2']]], ['R7', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T1']]], ['R8', 'C_VAL', [['Entity', 'T5'], ['C_VAL', 'T10']]], ['R9', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T10']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-964',
    collData,
    {
        text: "Following inhalation from either device, tiotropium was rapidly absorbed with similar tmax,ss values for all treatments ranging between 5 and 7 minutes postdosing.",
        entities: [['T0', 'UNITS', [[144, 151]]], ['T1', 'RANGE', [[136, 143]]], ['T2', 'PK', [[86, 93]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-965',
    collData,
    {
        text: "Metabolism was hampered, but DCTX area under the curve (AUC)/CTX AUC ratios varying between 0.7-0.9 were reached peroperatively.",
        entities: [['T0', 'PK', [[34, 75]]], ['T1', 'RANGE', [[92, 99]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-966',
    collData,
    {
        text: "Using the linear mixed-effects modeling to evaluate the relationship between ddQTcF and peginesatide plasma concentrations showed that at the mean peginesatide Cmax for 0.1 mg/kg, the ddQTcF was −0.9 milliseconds, 90% CI: (−2.0, 0.3 milliseconds).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-967',
    collData,
    {
        text: "Only one of the three chronoid preparations had appropriately delayed bioavailability 89% in comparison to normal acting formulation.",
        entities: [['T0', 'PK', [[70, 85]]], ['T1', 'VALUE', [[86, 88]]], ['T2', 'UNITS', [[88, 89]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-968',
    collData,
    {
        text: "The ED50 (n = 4/group) for three doses was 2.01 ± 0.19, 2.04 ± 0.26 and 2.61 ± 0.44 mg/kg for the sensitive versus 1.99 ± 0.27, 2.66 ± 0.36 and 2.88 ± 0.48 mg/kg for the resistant strain, giving a resistance index (resistant/sensitive ED50) of 0.99−1.11 [64].",
        entities: [['T0', 'PK', [[4, 8]]], ['T1', 'VALUE', [[43, 47]]], ['T2', 'VALUE', [[56, 60]]], ['T3', 'VALUE', [[72, 76]]], ['T4', 'VALUE', [[115, 119]]], ['T5', 'VALUE', [[128, 132]]], ['T6', 'VALUE', [[144, 148]]], ['T7', 'VALUE', [[50, 54]]], ['T8', 'UNITS', [[84, 89]]], ['T9', 'VALUE', [[63, 67]]], ['T10', 'VALUE', [[79, 83]]], ['T11', 'VALUE', [[122, 126]]], ['T12', 'UNITS', [[156, 161]]], ['T13', 'VALUE', [[135, 139]]], ['T14', 'VALUE', [[151, 155]]], ['T15', 'PK', [[197, 240]]], ['T16', 'RANGE', [[244, 253]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T4']]], ['R4', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T5']]], ['R5', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T6']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T1']]], ['R7', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]], ['R8', 'D_VAL', [['Entity', 'T9'], ['D_VAL', 'T2']]], ['R9', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T9']]], ['R10', 'D_VAL', [['Entity', 'T10'], ['D_VAL', 'T3']]], ['R11', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T10']]], ['R12', 'D_VAL', [['Entity', 'T11'], ['D_VAL', 'T4']]], ['R13', 'RELATED', [['Entity', 'T12'], ['RELATED', 'T11']]], ['R14', 'D_VAL', [['Entity', 'T13'], ['D_VAL', 'T5']]], ['R15', 'RELATED', [['Entity', 'T12'], ['RELATED', 'T13']]], ['R16', 'D_VAL', [['Entity', 'T14'], ['D_VAL', 'T6']]], ['R17', 'RELATED', [['Entity', 'T12'], ['RELATED', 'T14']]], ['R18', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T3']]], ['R19', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T2']]], ['R20', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T1']]], ['R21', 'RELATED', [['Entity', 'T12'], ['RELATED', 'T6']]], ['R22', 'RELATED', [['Entity', 'T12'], ['RELATED', 'T5']]], ['R23', 'RELATED', [['Entity', 'T12'], ['RELATED', 'T4']]], ['R24', 'C_VAL', [['Entity', 'T15'], ['C_VAL', 'T16']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-969',
    collData,
    {
        text: "Following a 90-min washout period, the intravenous bolus injection (108, 430, 860 and 1,720 micrograms/kg) and the constant-rate infusion (108, 433, 866 and 1,730 micrograms/kg/hr) of DTZ into the right femoral vein were made and the achievement of the steady-state plasma levels (Css of 50, 200, 400 and 800 ng/ml) of DTZ were conformed at 60, 70 and 80 min.",
        entities: [['T0', 'UNITS', [[309, 314]]], ['T1', 'VALUE', [[292, 295]]], ['T2', 'VALUE', [[297, 300]]], ['T3', 'VALUE', [[305, 308]]], ['T4', 'PK', [[253, 284]]], ['T5', 'VALUE', [[288, 290]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T2']]], ['R2', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T3']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R5', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T2']]], ['R6', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R7', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-970',
    collData,
    {
        text: "Mean time to first increase in dose was 6.5 ± 3.6 days.",
        entities: [['T0', 'PK', [[5, 35]]], ['T1', 'VALUE', [[40, 43]]], ['T2', 'VALUE', [[46, 49]]], ['T3', 'UNITS', [[50, 54]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-971',
    collData,
    {
        text: "The primary outcome was difference in plasma IL-6 measured as area under the curve between Days 3 and 8, corrected for baseline value.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-972',
    collData,
    {
        text: "The linear elimination half-life was 12 days, with a volume of distribution close to the intravascular plasma space.",
        entities: [['T0', 'PK', [[4, 32]]], ['T1', 'VALUE', [[37, 39]]], ['T2', 'UNITS', [[40, 44]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-973',
    collData,
    {
        text: "The peak concentration (Cmax,ss) of the SC regimen at steady state was reached around 4 days post-dose.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-974',
    collData,
    {
        text: "ATI animals also exhibited RORR faster than YOH animals (p = 0.0022 and AUC = 1; very strong effect).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-975',
    collData,
    {
        text: "When the ceftriaxone/DCEA formulation was administered into a nonclosed segment of duodenum of rats, C(max) (the maximum drug concentration in plasma) and AUC (area under the curve) were significantly increased and its bioavailability was increased up to 70%.",
        entities: [['T0', 'PK', [[219, 234]]], ['T1', 'VALUE', [[255, 257]]], ['T2', 'UNITS', [[257, 258]]], ['T3', 'COMPARE', [[249, 254]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-976',
    collData,
    {
        text: "With mean (±SD) total daily dose of vancomycin 31.9 (±10.5) mg/kg/day that was administered, more than 90% of measured vancomycin trough concentrations were outside the range of 15-20 mg/L and 54.3% of patients had trough concentrations below 10 mg/L. Of 46 patients, 21 patients (45.7%) developed acute kidney injury (AKI) during vancomycin therapy; among them 19 patients were receiving nephrotoxic drug(s) concomitantly.",
        entities: [['T0', 'UNITS', [[184, 188]]], ['T1', 'RANGE', [[178, 183]]], ['T2', 'PK', [[130, 151]]], ['T3', 'PK', [[215, 236]]], ['T4', 'VALUE', [[243, 245]]], ['T5', 'UNITS', [[246, 250]]], ['T6', 'COMPARE', [[237, 242]]], ['T7', 'COMPARE', [[157, 164]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T3'], ['C_VAL', 'T4']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T4']]], ['R4', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T4']]], ['R5', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-977',
    collData,
    {
        text: "The AIC/BIC ratio was 1, 044/1, 066.",
        entities: [['T0', 'PK', [[4, 17]]], ['T1', 'VALUE', [[22, 35]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-978',
    collData,
    {
        text: "Pharmacokinetic evaluation demonstrated a more than proportional increase in plasma exposure relative to BI 655064 dose, with a terminal half-life between 4 h and 4 days IV and approximately 5 days SC; doses ≥ 20 mg IV and 120 mg SC showed > 90% CD40 receptor occupancy and inhibition of CD54 upregulation, which lasted 7 days in the 120 mg IV and SC groups.",
        entities: [['T0', 'UNITS', [[157, 158]]], ['T1', 'VALUE', [[155, 156]]], ['T2', 'UNITS', [[165, 169]]], ['T3', 'VALUE', [[163, 164]]], ['T4', 'PK', [[128, 146]]], ['T5', 'VALUE', [[191, 192]]], ['T6', 'UNITS', [[193, 197]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R4', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R5', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-979',
    collData,
    {
        text: "Non-compartmental pharmacokinetic analysis of S-26 in rat plasma showed that clearance (CL), volume of distribution (Vd(ss)), and half-life (T(1/2)) of S-26 were 0.30 + or - 0.07 l/h/kg, 1.44 + or - 0.33 l/kg, and 4 h, respectively, after intravenous (i.v.) administration.",
        entities: [['T0', 'PK', [[77, 91]]], ['T1', 'VALUE', [[162, 166]]], ['T2', 'PK', [[93, 124]]], ['T3', 'VALUE', [[187, 191]]], ['T4', 'PK', [[130, 148]]], ['T5', 'VALUE', [[214, 215]]], ['T6', 'UNITS', [[216, 217]]], ['T7', 'UNITS', [[204, 208]]], ['T8', 'UNITS', [[179, 185]]], ['T9', 'VALUE', [[174, 178]]], ['T10', 'VALUE', [[199, 203]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R3', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R4', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T3']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T1']]], ['R6', 'D_VAL', [['Entity', 'T9'], ['D_VAL', 'T1']]], ['R7', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T9']]], ['R8', 'D_VAL', [['Entity', 'T10'], ['D_VAL', 'T3']]], ['R9', 'RELATED', [['Entity', 'T7'], ['RELATED', 'T10']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-980',
    collData,
    {
        text: "Peak 2 eluted with the same retention time as authentic resveratrol-3-sulphate and yielded m/z=307, consistent with resveratrol sulphate.",
        entities: [['T0', 'PK', [[91, 94]]], ['T1', 'VALUE', [[95, 98]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-981',
    collData,
    {
        text: "For EFV (n = 44), the geometric mean ratios (90% confidence interval [CI]) for maximum concentration (C(max)), area under the plasma concentration-time curve from time 0 to the last quantifiable concentration (AUC(0-last)), and area under the plasma concentration-time curve from time 0 extrapolated to infinity (AUC(inf)) were 99.9 (93.4 to 107), 95.7 (90.5 to 101), and 95.2 (88.9 to 102), respectively.",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-982',
    collData,
    {
        text: "Parameter adjustment finally gave clearance (L/h) = 1.33 × MR0.18 (R2 = 0.66).",
        entities: [],
        relations: []
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-983',
    collData,
    {
        text: "Mean plasma citrulline levels were maintained at approximately 125 mumol/L, with a calculated clearance of 0.52 L/(h.kg).",
        entities: [['T0', 'UNITS', [[112, 120]]], ['T1', 'VALUE', [[107, 111]]], ['T2', 'PK', [[94, 103]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-984',
    collData,
    {
        text: "Correlations of plasma CL and V with maximum blood/plasma ratios (ranging from 13 to 114) were strong (r = 0.65 and r = 0.73).",
        entities: [['T0', 'PK', [[37, 64]]], ['T1', 'RANGE', [[79, 88]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-985',
    collData,
    {
        text: "Mean (standard deviation, SD) population parameters included volume of distribution of central compartment: 0.45 (0.084) L/kg; total body clearance: 0.0476 (0.0147) L/h/kg; distribution rate constants, central to peripheral compartment (k(12)): 0.24 (0.12)/h, and peripheral to central (k(21)): 0.70 (0.22)/h.",
        entities: [['T0', 'PK', [[61, 106]]], ['T1', 'VALUE', [[108, 112]]], ['T2', 'PK', [[127, 147]]], ['T3', 'VALUE', [[149, 155]]], ['T4', 'PK', [[173, 243]]], ['T5', 'VALUE', [[245, 249]]], ['T6', 'PK', [[264, 293]]], ['T7', 'VALUE', [[295, 299]]], ['T8', 'VALUE', [[114, 119]]], ['T9', 'UNITS', [[121, 125]]], ['T10', 'VALUE', [[157, 163]]], ['T11', 'UNITS', [[165, 171]]], ['T12', 'VALUE', [[251, 255]]], ['T13', 'UNITS', [[256, 258]]], ['T14', 'VALUE', [[301, 305]]], ['T15', 'UNITS', [[306, 308]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T5']]], ['R3', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T7']]], ['R4', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T8']]], ['R6', 'D_VAL', [['Entity', 'T10'], ['D_VAL', 'T3']]], ['R7', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T10']]], ['R8', 'D_VAL', [['Entity', 'T12'], ['D_VAL', 'T5']]], ['R9', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T12']]], ['R10', 'D_VAL', [['Entity', 'T14'], ['D_VAL', 'T7']]], ['R11', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T14']]], ['R12', 'RELATED', [['Entity', 'T9'], ['RELATED', 'T1']]], ['R13', 'RELATED', [['Entity', 'T11'], ['RELATED', 'T3']]], ['R14', 'RELATED', [['Entity', 'T13'], ['RELATED', 'T5']]], ['R15', 'RELATED', [['Entity', 'T15'], ['RELATED', 'T7']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-986',
    collData,
    {
        text: "The absorption ratio (Fa) and the mean absorption time (ta) from the intestinal tract were 52.2% and 4.29 hr, respectively.",
        entities: [['T0', 'PK', [[4, 25]]], ['T1', 'VALUE', [[91, 95]]], ['T2', 'PK', [[34, 59]]], ['T3', 'VALUE', [[101, 105]]], ['T4', 'UNITS', [[106, 108]]], ['T5', 'UNITS', [[95, 96]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T3']]], ['R3', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T1']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-987',
    collData,
    {
        text: "On day 9, maximum anti-Xa activity, corresponding to the peak apixaban concentration at 3 hours, was 5.57 (SD, 1.54) IU/mL; minimum anti-Xa activity, coinciding with the trough apixaban concentration at 12 hours, was 1.94 (SD, 0.54) IU/mL, based on mean measurement data.",
        entities: [['T0', 'PK', [[10, 34]]], ['T1', 'VALUE', [[101, 105]]], ['T2', 'VALUE', [[111, 115]]], ['T3', 'UNITS', [[117, 122]]], ['T4', 'UNITS', [[233, 238]]], ['T5', 'VALUE', [[217, 221]]], ['T6', 'PK', [[124, 148]]], ['T7', 'VALUE', [[227, 231]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'D_VAL', [['Entity', 'T2'], ['D_VAL', 'T1']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T2']]], ['R3', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R4', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R5', 'C_VAL', [['Entity', 'T6'], ['C_VAL', 'T5']]], ['R6', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-988',
    collData,
    {
        text: "The overall elimination half-life (MTX T1/2) was well defined from one to about six hours after i.v. administration; in 25 patients it ranged from 102 min to 750 min and was inversely related to endogenous creatinine clearance, which ranged from 6 to 140 ml/min.",
        entities: [['T0', 'UNITS', [[151, 154]]], ['T1', 'VALUE', [[147, 150]]], ['T2', 'UNITS', [[162, 165]]], ['T3', 'VALUE', [[158, 161]]], ['T4', 'PK', [[4, 44]]], ['T5', 'UNITS', [[84, 89]]], ['T6', 'RANGE', [[67, 83]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T1']]], ['R3', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T3']]], ['R4', 'RELATED', [['Entity', 'T5'], ['RELATED', 'T6']]], ['R5', 'C_VAL', [['Entity', 'T4'], ['C_VAL', 'T6']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-989',
    collData,
    {
        text: "The mean metabolite area under the concentration-time curve increased by 34% and the time to maximum concentration of the metabolite was delayed from 2.3 to 4 hours by concurrent fluconazole.",
        entities: [['T0', 'UNITS', [[159, 164]]], ['T1', 'VALUE', [[157, 158]]], ['T2', 'PK', [[85, 114]]], ['T3', 'VALUE', [[150, 153]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T1']]], ['R2', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R3', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-990',
    collData,
    {
        text: "Following intramuscular administration, an elimination rate constant (β), the area under the curve from zero to infinity (AUC(0-∞)) and the mean absorption time (MAT) were 0.015±0.001h(-1), 23.49±1.722μg·h/mL and 7.50±0.58h, respectively.",
        entities: [['T0', 'UNITS', [[183, 188]]], ['T1', 'VALUE', [[172, 177]]], ['T2', 'UNITS', [[201, 208]]], ['T3', 'VALUE', [[190, 195]]], ['T4', 'UNITS', [[222, 223]]], ['T5', 'VALUE', [[213, 217]]], ['T6', 'VALUE', [[178, 183]]], ['T7', 'VALUE', [[196, 201]]], ['T8', 'VALUE', [[218, 222]]], ['T9', 'PK', [[43, 72]]], ['T10', 'PK', [[140, 166]]], ['T11', 'PK', [[78, 131]]]],
        relations: [['R0', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T1']]], ['R1', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T3']]], ['R2', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R3', 'D_VAL', [['Entity', 'T6'], ['D_VAL', 'T1']]], ['R4', 'RELATED', [['Entity', 'T0'], ['RELATED', 'T6']]], ['R5', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T3']]], ['R6', 'RELATED', [['Entity', 'T2'], ['RELATED', 'T7']]], ['R7', 'D_VAL', [['Entity', 'T8'], ['D_VAL', 'T5']]], ['R8', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T8']]], ['R9', 'C_VAL', [['Entity', 'T9'], ['C_VAL', 'T1']]], ['R10', 'C_VAL', [['Entity', 'T10'], ['C_VAL', 'T5']]], ['R11', 'C_VAL', [['Entity', 'T11'], ['C_VAL', 'T3']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-991',
    collData,
    {
        text: "Initially, the plasma concentration-versus-time decay in three patients was linear, with a mean half-life (t1/2) of 1.3 +- 0.5 h, while five patients had detectable concentrations in plasma after 4 h with an apparent delayed terminal-phase t1/2 of 4.8 +- 2.8 h. At week 6 the prolonged elimination pattern was noted in all patients (terminal t1/2 = 4.1 +- 2.0 h).",
        entities: [['T0', 'PK', [[208, 244]]], ['T1', 'VALUE', [[248, 251]]], ['T2', 'PK', [[333, 346]]], ['T3', 'VALUE', [[349, 352]]], ['T4', 'VALUE', [[123, 126]]], ['T5', 'VALUE', [[116, 119]]], ['T6', 'UNITS', [[127, 128]]], ['T7', 'VALUE', [[255, 258]]], ['T8', 'UNITS', [[259, 260]]], ['T9', 'VALUE', [[356, 359]]], ['T10', 'UNITS', [[360, 361]]], ['T11', 'PK', [[96, 112]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T2'], ['C_VAL', 'T3']]], ['R2', 'D_VAL', [['Entity', 'T4'], ['D_VAL', 'T5']]], ['R3', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T4']]], ['R4', 'D_VAL', [['Entity', 'T7'], ['D_VAL', 'T1']]], ['R5', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T7']]], ['R6', 'D_VAL', [['Entity', 'T9'], ['D_VAL', 'T3']]], ['R7', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T9']]], ['R8', 'RELATED', [['Entity', 'T6'], ['RELATED', 'T5']]], ['R9', 'RELATED', [['Entity', 'T8'], ['RELATED', 'T1']]], ['R10', 'RELATED', [['Entity', 'T10'], ['RELATED', 'T3']]], ['R11', 'C_VAL', [['Entity', 'T11'], ['C_VAL', 'T5']]]]
        },
    webFontURLs, 
    );
     
    Util.embed(
    'embedding-992',
    collData,
    {
        text: "Based on urinary recovery data, F was 49 or 43% for the 12.5 mg/kg oral dose and 34 or 30% for the 50 mg/kg oral dose, depending on the reference intravenous dose used.",
        entities: [['T0', 'PK', [[32, 33]]], ['T1', 'VALUE', [[38, 40]]], ['T2', 'VALUE', [[81, 83]]], ['T3', 'UNITS', [[46, 47]]], ['T4', 'UNITS', [[89, 90]]], ['T5', 'VALUE', [[87, 89]]], ['T6', 'VALUE', [[44, 46]]]],
        relations: [['R0', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T1']]], ['R1', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T2']]], ['R2', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T1']]], ['R3', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T2']]], ['R4', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T5']]], ['R5', 'RELATED', [['Entity', 'T4'], ['RELATED', 'T5']]], ['R6', 'RELATED', [['Entity', 'T3'], ['RELATED', 'T6']]], ['R7', 'C_VAL', [['Entity', 'T0'], ['C_VAL', 'T6']]]]
        },
    webFontURLs, 
    );
    }); 
var collData = 
{
    entity_types: [
    {type: 'PK',labels : ['PK', 'PK'], bgColor: '#ffa9b8',borderColor: 'darken'},
    {type: 'VALUE', labels : ['VALUE', 'V'], bgColor: '#d1caff', borderColor: 'darken'},
    {type: 'UNITS', labels : ['UNITS', 'U'],bgColor: '#00ffff',borderColor: 'darken'},
    {type: 'TYPE_MEAS',labels : ['TYPE_MEAS', 'T'],bgColor: '#ffa973',borderColor: 'darken'},
    {type: 'COMPARE', labels : ['COMPARE', 'COM'], bgColor: '#9effd6',borderColor: 'darken'},
    {type: 'RANGE', labels : ['RANGE', 'R'], bgColor: '#66f542',borderColor: 'darken'}       
    ],
    relation_types: [
    { type: 'C_VAL', labels: ['C_VAL', 'C'], color : 'blue'},
    { type: 'D_VAL', labels   : ['D_VAL', 'D'], color: '#ff8c00'},
    { type: 'RELATED', labels: ['RELATED', 'R'], color: '#32cd32',}
    ]
};
</script>
</body>
</html>
